Genworth Financial (GNW) 10-K28 Feb 232022 FY Annual reportFinancial data

Company Profile

Cover Page

Cover Page - USD ($) $ in Billions	12 Months Ended
Cover Page - USD ($) $ in Billions	Dec. 31, 2022	Feb. 16, 2023	Jun. 30, 2022
Cover [Abstract]
Document Type	10-K
Amendment Flag	false
Document Fiscal Year Focus	2022
Document Fiscal Period Focus	FY
Entity Central Index Key	0001276520
Current Fiscal Year End Date	--12-31
Document Annual Report	true
Document Transition Report	false
Document Period End Date	Dec. 31, 2022
Entity Registrant Name	GENWORTH FINANCIAL, INC.
Entity File Number	001-32195
Entity Tax Identification Number	80-0873306
Entity Incorporation, State or Country Code	DE
Entity Current Reporting Status	Yes
Entity Well-known Seasoned Issuer	Yes
Entity Voluntary Filers	No
Entity Filer Category	Large Accelerated Filer
Entity Shell Company	false
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Address, Address Line One	6620 West Broad Street
Entity Address, State or Province	VA
Entity Address, City or Town	Richmond
Entity Address, Postal Zip Code	23230
Entity Interactive Data Current	Yes
City Area Code	804
Local Phone Number	281-6000
Trading Symbol	GNW
Security Exchange Name	NYSE
Title of 12(b) Security	Class A Common Stock, par value $.001 per share
Entity Common Stock, Shares Outstanding		493,346,260
Entity Public Float			$ 1.8
ICFR Auditor Attestation Flag	true
Auditor Name	KPMG LLP
Auditor Firm ID	185
Auditor Location	Richmond, VA

CONSOLIDATED BALANCE SHEETS

CONSOLIDATED BALANCE SHEETS - USD ($) $ in Millions	Dec. 31, 2022	Dec. 31, 2021
Assets
Fixed maturity securities available-for-sale, at fair value (amortized cost of $50,834 and $52,611, respectively, and allowance for credit losses of $— as of December 31, 2022 and 2021)	$ 46,583	$ 60,480
Equity securities, at fair value	319	198
Commercial mortgage loans (net of unamortized balance of loan origination fees and costs of $4 as of December 31, 2022 and 2021)	7,032	6,856
Less: Allowance for credit losses	(22)	(26)
Commercial mortgage loans, net	7,010	6,830
Policy loans	2,139	2,050
Limited partnerships	2,331	1,900
Other invested assets	566	820
Total investments	58,948	72,278
Cash, cash equivalents and restricted cash	1,799	1,571
Accrued investment income	643	647
Deferred acquisition costs	2,200	1,146
Intangible assets	241	143
Reinsurance recoverable	16,495	16,868
Less: Allowance for credit losses	(60)	(55)
Reinsurance recoverable, net	16,435	16,813
Other assets	415	388
Deferred tax asset	1,344	119
Separate account assets	4,417	6,066
Total assets	86,442	99,171
Liabilities and equity
Future policy benefits	38,064	41,528
Policyholder account balances	17,113	19,354
Liability for policy and contract claims	12,234	11,841
Unearned premiums	584	672
Other liabilities	1,672	1,511
Long-term borrowings	1,611	1,899
Separate account liabilities	4,417	6,066
Liabilities related to discontinued operations	8	34
Total liabilities	75,703	82,905
Commitments and contingencies
Equity:
Class A common stock, $0.001 par value; 1.5 billion shares authorized; 600 million and 596 million shares issued as of December 31, 2022 and 2021, respectively; 495 million and 508 million shares outstanding as of December 31, 2022 and 2021, respectively	1	1
Additional paid-in capital	11,869	11,858
Accumulated other comprehensive income (loss)	(2,220)	3,861
Retained earnings	3,098	2,490
Treasury stock, at cost (105 million and 88 million shares as of December 31, 2022 and 2021, respectively)	(2,764)	(2,700)
Total Genworth Financial, Inc.'s stockholders' equity	9,984	15,510
Noncontrolling interests	755	756
Total equity	10,739	16,266
Total liabilities and equity	$ 86,442	$ 99,171

CONSOLIDATED BALANCE SHEETS (Pa

CONSOLIDATED BALANCE SHEETS (Parenthetical) - USD ($) shares in Millions, $ in Millions	Dec. 31, 2022	Dec. 31, 2021
Debt securities amortized costs	$ 50,834	$ 52,611
Debt securities allowance for credit losses	0	0
Unamortized balance of loan origination fees	$ 4	$ 4
Class A common stock, par value	$ 0.001	$ 0.001
Class A common stock, shares authorized	1,500	1,500
Class A common stock, shares issued	600	596
Class A common stock, shares outstanding	495	508
Treasury stock, shares	105	88

CONSOLIDATED STATEMENTS OF INCO

CONSOLIDATED STATEMENTS OF INCOME - USD ($) shares in Millions, $ in Millions		12 Months Ended
		Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Revenues:
Premiums		$ 3,719	$ 3,435	$ 3,836
Net investment income		3,146	3,370	3,227
Net investment gains (losses)		(17)	323	492
Policy fees and other income		659	704	729
Total revenues		7,507	7,832	8,284
Benefits and expenses:
Benefits and other changes in policy reserves		4,242	4,383	5,214
Interest credited		503	508	549
Acquisition and operating expenses, net of deferrals		1,371	1,223	935
Amortization of deferred acquisition costs and intangibles		307	377	463
Interest expense		106	160	195
Total benefits and expenses		6,529	6,651	7,356
Income from continuing operations before income taxes		978	1,181	928
Provision for income taxes		239	263	230
Income from continuing operations		739	918	698
Income (loss) from discontinued operations, net of taxes		0	27	(486)
Net income		739	945	212
Less: net income from continuing operations attributable to noncontrolling interests		130	33	0
Less: net income from discontinued operations attributable to noncontrolling interests		0	8	34
Net income available to Genworth Financial, Inc.'s common stockholders		609	904	178
Net income (loss) available to Genworth Financial, Inc.'s common stockholders:
Income from continuing operations available to Genworth Financial, Inc.'s common stockholders		609	885	698
Income (loss) from discontinued operations available to Genworth Financial, Inc.'s common stockholders		0	19	(520)
Net income available to Genworth Financial, Inc.'s common stockholders		$ 609	$ 904	$ 178
Income from continuing operations available to Genworth Financial, Inc.'s common stockholders per share:
Basic		$ 1.21	$ 1.75	$ 1.38
Diluted		1.19	1.72	1.36
Net income available to Genworth Financial, Inc.'s common stockholders per share:
Basic	[1]	1.21	1.78	0.35
Diluted	[1]	$ 1.19	$ 1.76	$ 0.35
Weighted-average common shares outstanding:
Basic		504.5	506.9	505.2
Diluted		511	514.7	511.6

[1]May not total due to whole number calculation.

CONSOLIDATED STATEMENTS OF COMP

CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Net income	$ 739	$ 945	$ 212
Other comprehensive income (loss), net of taxes:
Net unrealized gains (losses) on securities without an allowance for credit losses	(5,372)	(370)	764
Net unrealized gains (losses) on securities with an allowance for credit losses	0	6	(6)
Derivatives qualifying as hedges	(825)	(186)	209
Foreign currency translation and other adjustments	30	148	55
Total other comprehensive income (loss)	(6,167)	(402)	1,022
Total comprehensive income (loss)	(5,428)	543	1,234
Less: comprehensive income attributable to noncontrolling interests	44	177	64
Total comprehensive income (loss) available to Genworth Financial, Inc.'s common stockholders	$ (5,472)	$ 366	$ 1,170

CONSOLIDATED STATEMENTS OF CHAN

CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY - USD ($) $ in Millions	Total	Cumulative effect of change in accounting, net of taxes	Common stock	Common stock Cumulative effect of change in accounting, net of taxes	Additional paid-in capital	Additional paid-in capital Cumulative effect of change in accounting, net of taxes	Accumulated other comprehensive income (loss)	Accumulated other comprehensive income (loss) Cumulative effect of change in accounting, net of taxes	Retained earnings	Retained earnings Cumulative effect of change in accounting, net of taxes	Treasury stock, at cost	Treasury stock, at cost Cumulative effect of change in accounting, net of taxes	Total Genworth Financial, Inc.‘s stockholders' equity	Total Genworth Financial, Inc.‘s stockholders' equity Cumulative effect of change in accounting, net of taxes	Noncontrolling interests	Noncontrolling interests Cumulative effect of change in accounting, net of taxes
Balances, beginning at Dec. 31, 2019	$ 14,632	$ (55)	$ 1	$ 0	$ 11,990	$ 0	$ 3,433	$ 0	$ 1,461	$ (55)	$ (2,700)	$ 0	$ 14,185	$ (55)	$ 447	$ 0
Comprehensive income (loss):
Net income	212		0		0		0		178		0		178		34
Other comprehensive income (loss), net of taxes	1,022		0		0		992		0		0		992		30
Total comprehensive income (loss)	1,234												1,170		64
Dividends to noncontrolling interests	(9)		0		0		0		0		0		0		(9)
Stock-based compensation expense and exercises and other	18		0		18		0		0		0		18		0
Balances, ending at Dec. 31, 2020	15,820		1		12,008		4,425		1,584		(2,700)		15,318		502
Initial sale of subsidiary shares to noncontrolling interests	580		0		(167)		(26)		0		0		(193)		773
Sale of business that included noncontrolling interests	(657)		0		0		0		0		0		0		(657)
Comprehensive income (loss):
Net income	945		0		0		0		904		0		904		41
Other comprehensive income (loss), net of taxes	(402)		0		0		(538)		0		0		(538)		136
Total comprehensive income (loss)	543												366		177
Dividends to noncontrolling interests	(37)		0		0		0		0		0		0		(37)
Stock-based compensation expense and exercises and other	17		0		17		0		2		0		19		(2)
Balances, ending at Dec. 31, 2021	16,266		1		11,858		3,861		2,490		(2,700)		15,510		756
Comprehensive income (loss):
Net income	739		0		0		0		609		0		609		130
Other comprehensive income (loss), net of taxes	(6,167)		0		0		(6,081)		0		0		(6,081)		(86)
Total comprehensive income (loss)	(5,428)												(5,472)		44
Treasury stock acquired in connection with share repurchases	(64)		0		0		0		0		(64)		(64)		0
Dividends to noncontrolling interests	(46)		0		0		0		0		0		0		(46)
Stock-based compensation expense and exercises and other	11		0		11		0		(1)		0		10		1
Balances, ending at Dec. 31, 2022	$ 10,739		$ 1		$ 11,869		$ (2,220)		$ 3,098		$ (2,764)		$ 9,984		$ 755

CONSOLIDATED STATEMENTS OF CASH

CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Cash flows from (used by) operating activities:
Net income	$ 739	$ 945	$ 212
Less (income) loss from discontinued operations, net of taxes	0	(27)	486
Adjustments to reconcile net income to net cash from operating activities:
Amortization of fixed maturity securities discounts and premiums	(154)	(176)	(157)
Net investment (gains) losses	17	(323)	(492)
Charges assessed to policyholders	(596)	(620)	(646)
Acquisition costs deferred	0	(8)	(3)
Amortization of deferred acquisition costs and intangibles	307	377	463
Deferred income taxes	235	290	228
Derivative instruments, limited partnerships and other	(335)	(359)	(112)
Stock-based compensation expense	37	40	39
Change in certain assets and liabilities:
Accrued investment income and other assets	(161)	(129)	(92)
Insurance reserves	863	642	1,217
Current tax liabilities	(1)	(34)	6
Other liabilities, policy and contract claims and other policy-related balances	129	310	830
Cash used by operating activities—discontinued operations	(31)	(491)	(19)
Net cash from operating activities	1,049	437	1,960
Cash flows from (used by) investing activities:
Fixed maturity securities	2,705	4,162	3,637
Commercial mortgage loans	759	874	744
Limited partnerships and other invested assets	185	255	182
Proceeds from sales of investments:
Fixed maturity and equity securities	2,658	2,273	3,040
Purchases and originations of investments:
Fixed maturity and equity securities	(4,035)	(5,216)	(7,763)
Commercial mortgage loans	(958)	(963)	(547)
Limited partnerships and other invested assets	(645)	(767)	(449)
Short-term investments, net	23	18	35
Policy loans, net	41	57	190
Proceeds from sale of business, net of cash transferred	0	270	0
Cash from (used by) investing activities—discontinued operations	0	(67)	(222)
Net cash from (used by) investing activities	733	896	(1,153)
Cash flows from (used by) financing activities:
Deposits to universal life and investment contracts	606	669	862
Withdrawals from universal life and investment contracts	(1,668)	(2,071)	(2,282)
Redemption of non-recourse funding obligations	0	0	(315)
Proceeds from issuance of long-term debt	0	0	738
Repayment and repurchase of long-term debt	(297)	(1,541)	(490)
Proceeds from sale of subsidiary shares to noncontrolling interests	0	529	0
Treasury stock acquired in connection with share repurchases	(64)	0	0
Dividends paid to noncontrolling interests	(46)	(37)	0
Other, net	(85)	32	(2)
Cash used by financing activities—discontinued operations	0	0	(18)
Net cash used by financing activities	(1,554)	(2,419)	(1,507)
Effect of exchange rate changes on cash, cash equivalents and restricted cash (includes $—, $(1) and $18 related to discontinued operations for the years ended December 31, 2022, 2021 and 2020, respectively)	0	1	15
Net change in cash, cash equivalents and restricted cash	228	(1,085)	(685)
Cash, cash equivalents and restricted cash at beginning of period	1,571	2,656	3,341
Cash, cash equivalents and restricted cash at end of period	1,799	1,571	2,656
Less cash, cash equivalents and restricted cash of discontinued operations at end of period	0	0	95
Cash, cash equivalents and restricted cash of continuing operations at end of period	$ 1,799	$ 1,571	$ 2,561

CONSOLIDATED STATEMENTS OF CA_2

CONSOLIDATED STATEMENTS OF CASH FLOWS (Parenthetical) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Statement of Cash Flows [Abstract]
Discontinued operations exchange rate effect	$ 0	$ (1)	$ 18

Nature of Business and Formatio

Nature of Business and Formation of Genworth	12 Months Ended
Nature of Business and Formation of Genworth	Dec. 31, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Nature of Business and Formation of Genworth	(1) Nature of Business and Formation of Genworth Genworth Holdings, Inc. (“Genworth Holdings”) (formerly known as Genworth Financial, Inc.) was incorporated in Delaware in 2003 in preparation for an initial public offering (“IPO”) of its common stock, which was completed on May 28, 2004. On April 1, 2013, Genworth Holdings completed a holding company reorganization pursuant to which Genworth Holdings became a direct, 100% owned subsidiary of a new public holding company that it had formed. The new public holding company was incorporated in Delaware on December 5, 2012, in connection with the reorganization, and was renamed Genworth Financial, Inc. (“Genworth Financial”) upon the completion of the reorganization. The accompanying financial statements include on a consolidated basis the accounts of Genworth Financial and its affiliate companies in which it holds a majority voting interest or power to direct activities of certain variable interest entities (“VIEs”), which on a consolidated basis is referred to as “Genworth,” the “Company,” “we,” “us” or “our” unless the context otherwise requires. All intercompany accounts and transactions have been eliminated in consolidation. References to “Genworth Financial” refer solely to Genworth Financial, Inc., and not to any of its consolidated subsidiaries. We operate our business through the following three operating segments: • Enact. • U.S. Life Insurance. • Runoff. In addition to our three operating business segments, we also have Corporate and Other activities which include debt financing expenses that are incurred at the Genworth Holdings level, unallocated corporate income and expenses, eliminations of inter-segment transactions and the results of other businesses that are reported outside of our operating segments, including certain international mortgage insurance businesses and discontinued operations. See note 23 for additional information related to discontinued operations. On May 2, 2022, Genworth Financial’s Board of Directors authorized a share repurchase program under which Genworth Financial may repurchase up to $350 million of its outstanding Class A common stock. Pursuant to the program, during 2022, Genworth Financial repurchased 16,173,196 shares of its common stock at an average price of $3.94 per share for a total cost of $64 million, including costs paid in connection with acquiring the shares. The repurchased shares were recorded at cost and presented as treasury stock in a separate caption in equity in our consolidated balance sheet. Genworth Financial also repurchased 5,912,297 shares from February 9 4 2023 of its common stock at an ave r age price of $ per share for a total cost of $ million, leaving approximately $ million that may yet be purchased under the share repurchase program. Under the program, share repurchases may be made at Genworth’s discretion from time to time in open market transactions, privately negotiated transactions or by other means, including through 10b5-1 trading plans. The timing and number of future shares repurchased under the program will depend on a variety of factors, including Genworth Financial’s stock price and trading volume, and general business and market conditions, among other factors. The authorization has no expiration date and may be modified, suspended or terminated at any time.

Summary of Significant Accounti

Summary of Significant Accounting Policies	12 Months Ended
Summary of Significant Accounting Policies	Dec. 31, 2022
Disclosue of Accounting Changes [Abstract]
Summary of Significant Accounting Policies	(2) Summary of Significant Accounting Policies Our consolidated financial statements have been prepared on the basis of U.S. generally accepted accounting principles (“U.S. GAAP”). Preparing financial statements in conformity with U.S. GAAP requires us to make estimates and assumptions that affect reported amounts and related disclosures. Actual results could differ from those estimates. Certain prior year amounts have been reclassified to conform to the current year presentation. a) Premiums For traditional long-duration insurance contracts, we report premiums as earned when due. For short-duration insurance contracts, we report premiums as revenue over the terms of the related insurance policies on a pro-rata For single premium mortgage insurance contracts, we report premiums over the estimated policy life in accordance with the expected pattern of risk emergence as further described in our accounting policy for unearned premiums. In addition, we refund post-delinquent premiums received to the insured party if the delinquent loan goes to claim. We record a liability for premiums received on the delinquent loans consistent with our expectations of the rates at which delinquencies go to claim (“claim rates”). Premiums received under annuity contracts without significant mortality risk and premiums received on investment and universal life insurance products are not reported as revenues but rather as deposits and are included in liabili ti b) Net Investment Income and Net Investment Gains and Losses Investment income is recognized when earned. Income or loss upon call or prepayment of available-for-sale Investment income on mortgage-backed and asset-backed securities is initially based upon yield, cash flow and prepayment assumptions at the date of purchase. Subsequent revisions in those assumptions are recorded using the retrospective or prospective method. Under the retrospective method used for mortgage-backed and asset-backed securities of high credit quality (ratings equal to or greater than “AA” or that are backed by a U.S. agency) which cannot be contractually prepaid in such a manner that we would not recover a substantial portion of the initial investment, amortized cost of the security is adjusted to the amount that would have existed had the revised assumptions been in place at the date of purchase. The adjustments to amortized cost are recorded as a charge or credit to net investment income. Under the prospective method, which is used for all other mortgage-backed c) Policy Fees and Other Income Policy fees and other income consists primarily of insurance charges assessed on universal and term universal life insurance contracts and fees assessed against customer account values. For universal and term universal life insurance contracts, charges to policyholder accounts for cost of insurance are recognized as revenue when due. Variable product fees are charged to variable annuity contractholders and variable life insurance policyholders based upon the daily net assets of the contractholder’s and policyholder’s account values and are recognized as revenue when charged. Policy surrender fees are recognized as income when the policy is surrendered. d) Investment Securities At the time of purchase, we designate our fixed maturity securities as either available-for-sale available-for-sale Allowance for Credit Losses and Write-Downs of Available-For-Sale We regularly review securities in an unrealized loss position to determine whether the decline in fair value is related to credit losses or other factors. If we have either (i) the intent to sell the security, or (ii) it is more likely than not that we will be required to sell the security prior to recovering the amortized cost, we record a reduction to the security’s amortized cost and recognize the loss in net investment gains (losses) for the difference between the security’s amortized cost and fair value. If neither of the two preceding conditions exist, we determine whether the decline in fair value is related to credit losses or other factors. In making this assessment, we consider the extent to which fair value is less than amortized cost, any changes to the rating of the security by a rating agency/agencies and adverse conditions specifically related to the security, among other factors. If a credit loss exists, the present value of cash flows expected to be collected from the security is compared to the amortized cost basis of the security and a credit loss allowance is recognized in net investment gains (losses), limited to the amount that the fair value is less than the amortized cost basis. Losses are written off against the allowance when deemed uncollectible or when we intend to sell or expect we will be required to sell a security prior to recovering its amortized cost. When there is an allowance for credit losses, we reassess the credit losses each balance sheet date and subsequent increases or decreases are recorded as an adjustment to the allowance for credit losses, with a corresponding gain or loss recorded in net investment gains (losses). Estimating the cash flows expected to be collected is a quantitative and qualitative process that incorporates information received from third-party sources along with internal assumptions and judgments. When developing the estimate of cash flows expected to be collected at the individual security level, we utilize an analytical model that provides for various loss scenarios and consider the industry sector, current levels of subordination, geographic location and other relevant characteristics of the security or underlying assets, as well as reasonable and supportable forecasts. We regularly monitor our investment portfolio to ensure that securities with a credit loss are identified in a timely manner and any losses are recognized in the proper period. Accrued interest is included in accrued investment income in our consolidated balance sheet and had a carrying value of $511 million and $523 million as of December 31, 2022 and 2021, respectively. We exclude available-for-sale available-for-sale e) Fair Value Measurements Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. We have fixed maturity securities, equity securities, short-term investments, limited partnerships, derivatives, embedded derivatives, separate account assets and certain other financial instruments, which are carried at fair value. Fair value measurements are based upon observable and unobservable inputs. Observable inputs reflect market data obtained from independent sources, while unobservable inputs reflect our view of market assumptions in the absence of observable market information. We utilize valuation techniques that maximize the use of observable inputs and minimize the use of unobservable inputs. All assets and liabilities carried at fair value are classified and disclosed in one of the following three categories: • Level 1—Quoted prices for identical instruments in active markets. • Level 2—Quoted prices for similar instruments in active markets; quoted prices for ide n • Level 3—Instruments for which significant value drivers are unobservable. Level 1 primarily consists of financial instruments whose value is based on quoted market prices such as actively traded equity securities and actively traded mutual fund investments. Level 2 includes those financial instruments that are valued using industry-standard pricing methodologies, models or other valuation methodologies. These models are primarily industry-standard models that consider various inputs, such as interest rate, credit spread and foreign exchange rates for the underlying financial instruments. All significant inputs are observable, or derived from observable information in the marketplace or are supported by observable levels at which transactions are executed in the marketplace. Financial instruments in this category primarily include: certain public and private corporate fixed maturity and equity securities; government or agency securities; certain mortgage-backed and asset-backed securities; certain non-exchange-traded Level 3 comprises financial instruments whose fair value is estimated based on industry-standard pricing methodologies and internally developed models utilizing significant inputs not based on, nor corroborated by, readily available market information. In certain instances, this category may also utilize non-binding quotes. This category primarily consists of certain less liquid fixed maturity and equity securities and certain derivative instruments or embedded derivatives where we cannot corroborate the significant valuation inputs with market observable data . As of each reporting period, all assets and liabilities recorded at fair value are classified in their entirety based on the lowest level of input that is significant to the fair value measurement. Our assessment of the significance of a particular input to the fair value measurement in its entirety requires judgment, and considers factors specific to the asset or liability, such as the relative impact on the fair value as a result of including a particular input. We review the fair value hierarchy classifications each reporting period. Changes in the observability of the valuation attributes may result in a reclassification of certain financial assets or liabilities. Such reclassifications are reported as transfers in and out of Level 3 at the beginning fair value for the reporting period in which the changes occur. See note 16 for additional information related to fair value measurements. f) Commercial Mortgage Loans The carrying value of commercial mortgage loans is stated at principal amounts outstanding, net of unamortized premium or discount, deferred expenses and allowance for credit losses. Interest on loans is recognized on an accrual basis at the applicable interest rate on the principal amount outstanding. Loan origination fees and direct costs, as well as premiums and discounts, are amortized as level yield adjustments over the respective loan terms. Unamortized net fees or costs are recognized upon early repayment of the loans. Loan commitment fees are deferred and amortized on an effective yield basis over the term of the loan. Commercial mortgage loans are considered past due when contractual payments have not been received from the borrower by the required payment date. Loans that are considered uncollectible are carried on non-accrual non-accrual loan-to-value. non-accrual We determine the adequacy of the allowance for credit losses utilizing an analytical model that provides various loss scenarios based on historical experience adjusted for current events, trends, economic conditions and reasonable and supportable forecasts that result in a loss in the loan portfolio over the estimated life of the loans. We revert to historical credit loss experience for periods beyond forecasts that are reasonable and supportable. The allowance for credit losses is measured on a collective basis with consideration for debt service coverage ratio, debt-to-value, Accrued interest related to commercial mortgage loans is included in accrued investment income in our consolidated balance sheet and had a carrying value of $22 million and $23 million as of December 31, 2022 and 2021. We do not measure an allowance for credit losses related to accrued interest as uncollectible accrue d interest related to our commercial mortgage loans is written off after 90 days and once collectability is determined to be uncertain and not probable. Amounts written off related to accrued interest are recorded as a credit loss expense included in net investment gains (losses). g) Limited Partnerships Limited partnerships are accounted for at fair value when our partnership interest is considered minor (generally less than 3% ownership in the limited partnerships) and we exercise no influence over operating and financial policies. For limited partnerships that do not have a readily determinable fair value, we utilize the net asset value (“NAV”) from the underlying fund statements as a practical expedient for fair value. Changes in the estimated fair value of these investments are included in net investment gains (losses) and income and expenses are reported in net investment income. Investment distributions are evaluated to determine whether the distribution is a return on investment, such as dividend income, or a return of capital. If our ownership percentage exceeds the minor threshold, limited partnerships are accounted for using the equity method of accounting. Our proportionate share of the earnings or losses for limited partnerships accounted for using the equity method of accounting is included in net investment income. In applying either method, we use financial information provided by the investee generally on a one- h) Cash, Cash Equivalents and Restricted Cash Certificates of deposit, money market funds and other highly liquid investments with original maturities of three months or less are considered cash equivalents in the consolidated balance sheets and consolidated statements of cash flows. Items with maturities greater than three months but less than one year at the time of acquisition are generally considered short-term investments. i) Deferred Acquisition Costs Acquisition costs include costs that are directly related to the successful acquisition of new or renewal insurance contracts. Acquisition costs are deferred and amortized to the extent they are recoverable from future profits. Long-Duration Contracts in-force Amortization for deferred annuity and universal life insurance contracts is based on expected gross profits. Expected gross profits are adjusted quarterly to reflect actual experience to date or for changes in underlying assumptions relating to future gross profits. Estimates of gross profits for DAC amortization are based on assumptions including interest rates, policyholder persistency or lapses, insured l if We are required to analyze the impacts from net unrealized investment gains and losses on our available-for-sale available-for-sale Therefore, DAC amortized based on expected gross profits is adjusted to reflect the effects that would have been recognized had the unrealized investment (gains) losses been actually realized with a corresponding amount recorded in other comprehensive income (loss) (“OCI”). DAC associated with traditional long-duration insurance contracts is not adjusted for unrealized investment (gains) or losses unless a premium deficiency would have resulted upon the (gain) or loss being realized. Short-Duration Contracts. We regularly review our assumptions and test DAC for recoverability at least annually. For deferred annuity and universal life insurance contracts, if the present value of expected future gross profits is less than the unamortized DAC for a line of business, a charge to net income (loss) is recorded for additional DAC amortization. For traditional long-duration and short-duration contracts, if the benefit reserve plus anticipated future premiums and interest income for a line of business are less than the current estimate of future benefits and expenses (including any unamortized DAC), a charge to net income (loss) is recorded for additional DAC amortization or for increased benefit reserves. See note 6 for additional information related to DAC including loss recognition and recoverability. j) Intangible Assets Present Value of Future Profits. We regularly review our PVFP assumptions and periodically test PVFP for recoverability similar to our treatment of DAC. See note 7 for additional information related to PVFP including recoverability. Deferred Sales Inducements to Contractholders. Other Intangible Assets cash flows, which requires the use of estimates and judgment, and, if impaired, written down to fair value based on either discounted cash flows or appraised values. Intangible assets with indefinite lives are tested at least annually for impairment using a qualitative or quantitative assessment and are written down to fair value as required. k) Reinsurance Premium revenue, benefits and acquisition and operating expenses, net of deferrals, are reported net of the amounts relating to reinsurance ceded to other companies. Amounts due from reinsurers for incurred and estimated future claims are reflected in the reinsurance recoverable asset. Amounts received from reinsurers that represent recovery of acquisition costs are netted against DAC so that the net amount is capitalized. The cost of reinsurance is accounted for over the terms of the related treaties using assumptions consistent with those used to account for the underlying reinsured policies. Gains from cost of reinsurance are deferred and amortized to current period net income (loss) over the reinsurance contract period or life of the underlying reinsured contract. Premium revenue, benefits and acquisition and operating expenses, net of deferrals, for reinsurance contracts that do not qualify for reinsurance accounting are accounted for under the deposit method of accounting. Allowance for Credit Losses on Reinsurance Recoverables The allowance for credit losses related to reinsurance recoverables is evaluated based on historical loss experience adjusted for current events and reasonable and supportable forecasts from both internal and external sources. The allowance is measured by reinsurer, taking into consideration the reinsured product type and collateral type, and is calculated based on an externally reported probability of default corresponding to the reinsurer’s credit rating and the expected duration of the reinsurer’s contractual obligation to reimburse us for ceded claims on the underlying policies. Our estimate of the allowance reflects consideration for collateral securing the reinsurance agreements and expected recoveries of amounts previously charged off and expected to be charged off. We also consider other credit risk factors, including, among other factors, the historical frequency and severity of the associated insurance claims, aging of recoverables and regulatory, legal and economic factors, to determine if an additional incremental allowance for credit losses is required. No reversion adjustments are necessary as the starting point for our allowance for credit losses reflects historical loss experience covering the expected duration of the reinsurer’s contractual obligation to reimburse us. If available facts and circumstances indicate the reinsurance recoverable does not reflect expectations consistent with the collective analysis, the reinsurance recoverable is assessed on a separate basis. Write-offs are deducted from the allowance in the period the reinsurance recoverable is determined to be uncollectible. l) Derivatives Derivative instruments are used to manage risk through one of four principal risk management strategies including: (i) liabilities; (ii) invested assets; (iii) portfolios of assets or liabilities; and (iv) forecasted transactions. On the date we enter into a derivative contract, management designates the derivative as a hedge of the identified exposure (cash flow or foreign currency). If a derivative does not qualify for hedge accounting, the changes in its fair value and all scheduled periodic settlement receipts and payments are reported in net income (loss). We formally document all relationships between hedging instruments and hedged items, as specifically identify the asset, liability or forecasted transaction that has been designated as a hedged item, state how the hedging instrument is expected to hedge the risks related to the hedged item and set forth the method that will be used to retrospectively and prospectively assess the hedging instrument’s effectiveness. We generally determine hedge effectiveness based on total changes in fair value of the hedged item attributable to the hedged risk and the total changes in fair value of the derivative instrument. We discontinue hedge accounting prospectively when: (i) it is determined that the derivative is no longer effective in offsetting changes in the cash flows of a hedged item; (ii) the derivative expires or is sold, terminated or exercised; (iii) the derivative is de-designated For all qualifying and highly effective cash flow hedges, changes in fair value of the derivative instrument are reported as a separate component of accumulated other comprehensive income (loss). When hedge accounting is discontinued because it is probable that a forecasted transaction will not occur, the derivative continues to be carried in the consolidated balance sheets at its fair value, and gains and losses that were accumulated in OCI are recognized immediately in net income (loss). When the hedged forecasted transaction is no longer probable, but is reasonably possible, the accumulated gain or loss remains in OCI and is recognized when the transaction affects net income (loss); however, prospective hedge accounting for the transaction is terminated. In all other situations in which hedge accounting is discontinued on a cash flow hedge, amounts previously deferred in OCI are reclassified into net income (loss) when net income (loss) is impacted by the variability of the cash flow of the hedged item. We may enter into contracts that are not themselves derivative instruments but contain embedded derivatives. For each contract, we assess whether the economic characteristics of the embedded derivative are clearly and closely related to those of the host contract and determine whether a separate instrument with the same terms as the embedded instrument would meet the definition of a derivative instrument. If it is determined that the embedded derivative possesses economic characteristics that are not clearly and closely related to the economic characteristics of the host contract, and that a separate instrument with the same terms would qualify as a derivative instrument, the embedded derivative is separated from the host contract and accounted for as a stand-alone derivative. Such embedded derivatives are recorded in the consolidated balance sheets at fair value and are classified consistent with their host contract. Changes in their fair value are recognized in current period net income (loss). If we are unable to properly identify and measure an embedded derivative for separation from its host contract, the entire contract is carried in the consolidated balance sheets at fair value, with changes in fair value recognized in current period net income (loss). Changes in the fair value of non-qualifying The majority of our derivative arrangements require the posting of collateral upon meeting certain net exposure thresholds. The amounts recognized for derivative counterparty collateral received by us are recorded in cash, cash equivalents and restricted cash with a corresponding amount recorded in other liabilities to represent our obligation to return the collateral retained by us. As of December 31, 2022 and 2021, the amount of cash collateral received from counterparties was $16 million and $255 million, respectively. We also receive non-cash re-pledge non-cash re-pledged. We pledged $ million and $ million of fixed maturity securities as of December 31, 2022 and 2021, respectively. Fixed maturity securities that we pledge as collateral remain in our consolidated balance sheet within fixed maturity securities available-for-sale. Any cash collateral pledged to a derivative counterparty is derecognized with a receivable recorded in other assets for the right to receive our cash collateral back from the counterparty. Daily changes in the fair value of the derivative contract, commonly referred to as variation margin, for derivatives cleared through a Central Clearing Party, such as the Chicago Mercantile Exchange are treated as daily settlements of the derivative contract. m) Separate Accounts and Related Insurance Obligations Separate account assets represent funds for which the investment income and investment gains and losses accrue directly to the contractholders and are reflected in our consolidated balance sheets at fair value, reported as summary total separate account assets with an equivalent summary total reported for liabilities. Amounts assessed against the contractholders for mortality, administrative and other services are included in revenues. Changes in liabilities for minimum guarantees are included in benefits and other changes in policy reserves. Net investment income, net investment gains (losses) and the related liability changes associated with the separate account are offset within the same line item in the consolidated statements of income. There are no gains or losses on transfers of assets from the general account to the separate account. We offer certain minimum guarantees associated with our variable annuity contracts. Our variable annuity contracts usually contain a basic guaranteed minimum death benefit (“GMDB”) which provides a minimum benefit to be paid upon the annuitant’s death equal to the larger of account value or the return of net deposits. Some variable annuity contracts permit contractholders to purchase through riders, at an additional charge, enhanced death benefits such as the highest contract anniversary value (“ratchets”), accumulated net deposits at a stated rate (“rollups”), or combinations thereof. Additionally, some of our variable annuity contracts provide the contractholder with living benefits such as a guaranteed minimum withdrawal benefit (“GMWB”) or certain types of guaranteed annuitization benefits. The GMWB allows contractholders to withdraw a pre-defined Most of our reserves for additional insurance and annuitization benefits are calculated by applying a benefit ratio to accumulated contractholder assessments, and then deducting accumulated paid claims. The benefit ratio is equal to the ratio of benefits to assessments, accumulated with interest and considering both past and anticipated future experience. The projections utilize stochastic scenarios of separate account returns incorporating reversion to the mean, as well as assumptions for mortality and lapses. Some of our minimum guarantees, mainly GMWBs, are accounted for as embedded derivatives; see notes 5 and 16 for additional information on these embedded derivatives and related fair value measurement disclosures. n) Insurance Reserves Future Policy Benefits The liability for future policy benefits is equal to the present value of ex pe and investment returns, health care experience (including type of care and cost of care), policyholder persistency or lapses (i.e., the probability that a policy or contract will remain in-force locked-in The liability for future policy benefits is evaluated at least annually to determine if a premium deficiency exists. Loss recognition testing is generally performed at the line of business level, with acquired blocks and certain reinsured blocks tested separately. If the liability for future policy benefits plus the current present value of expected future gross premiums are less than the current present value of expected future benefits and expenses (including any unamortized DAC), a charge to net income (loss) is recorded for accelerated DAC amortization and, if necessary, a premium deficiency reserve is established. If a charge is recorded, DAC amortization and the liability for future policy benefits are measured using updated assumptions, which become the new locked-in in-force We are also required to accrue additional future policy benefit reserves when the overall reserve is adequate, but profits are projected in early periods followed by losses projected in later periods. When this pattern of projected profits followed by projected losses exists, we ratably accrue this additional profits followed by losses liability over time, increasing reserves in the profitable periods to offset estimated losses expected during the periods that follow. We calculate and adjust the additional reserves using our current best estimate of the amount necessary to offset the losses in future periods, based on the pattern of expected income and current best estimate assumptions consistent with our loss recognition testing. We adjust the accrual rate prospectively, over the remaining profit periods, without any catch-up For long-term care insurance products, benefit reductions are treated as partial lapse of coverage with the balance of our future policy benefits and DAC both reduced in proportion to the reduced coverage. For level premium term life insurance products, we floor the liability for future policy benefits on each policy at zero. Estimates and actuarial assumptions used for establishing the liability for future policy benefits and in loss recognition testing involve the exercise of significant judgment, and changes in assumptions or deviations of actual experience from assumptions can have material impacts on our liability for future policy benefits and net income (loss). Because these assumptions relate to factors that are not known in advance, change over time, are difficult to accurately predict and are inherently uncertain, we cannot determine with precision the ultimate amounts we will pay for actual claims or the timing of those payments. Small changes in assumptions or small deviations of actual experience from assumptions can have, and in the past have had, material impacts on our reserves, results of operations and financial condition. The risk that our claims experience may differ significantly from our pricing and valuation assumptions is particularly significant for our long-term care insurance products. Long-term care insurance policies provide for long-duration coverage and, therefore, our actual claims experience will emerge over many years after pricing and locked-in Policyholder Account Balances The liability for policyholder account balances represents the contract value that has accrued to the benefit of the policyholder as of the balance sheet date for investment-type and universal and term universal life insurance contracts. We are also required to establish additional benefit reserves for guarantees or product features in addition to the contract value where the additional benefit reserves are calculated by applying a benefit ratio to accumulated contractholder assessments, and then deducting accumulated paid claims. The benefit ratio is equal to the ratio of benefits to assessments, accumulated with interest and considering both past and anticipated future claims experience, which includes assumptions for insured mortality (i.e. life expectancy or longevity), interest rates and policyholder persistency or lapses (i.e., the probability that a policy or contract will remain in-force Investment-type contracts are broadly defined to include contracts without significant mortality or morbidity risk. Payments received from sales of investment contracts are recognized by providing a liability equal to the current account value of the policyholders’ contracts. Interest rates credited to investment contracts are guaranteed for the initial policy term with renewal rates determined as necessary by management. o) Liability for Policy and Contract Claims The liability for policy and contract claims, or claim reserves, represents the amount needed to provide for the estimated ultimate cost of settling claims relating to insured events that have occurred on or before the end of the respective reporting period. The estimated liability includes requirements for future payments of: (i) claims that have been reported to the insurer; (ii) claims related to insured events that have occurred but that have not been reported to the insurer as of the date the liability is estimated; and (iii) claim adjustment expenses. Claim adjustment expenses include costs incurred in the claim settlement process such as legal fees and costs to record, process and adjust claims. Our liability for policy and contract claims is reviewed regularly, with changes in our estimates of future claims recorded through net income (loss). Estimates and actuarial assumptions used for establishing the liability for policy and contract claims involve the exercise of significant judgment, and changes in assumptions or deviations of actual experience from assumptions can have material impacts on our liability for policy and contract claims and net income (loss). Because these assumptions relate to factors that are not known in advance, change over time, are difficult to accuratel

Earnings (Loss) Per Share

Earnings (Loss) Per Share	12 Months Ended
Earnings (Loss) Per Share	Dec. 31, 2022
Earnings (Loss) Per Share	(3) Earnings (Loss) Per Share Basic and diluted earnings (loss) per share are calculated by dividing each income (loss) category presented below by the weighted-average basic and diluted common shares outstanding for the years ended December 31: (Amounts in millions, except per share amounts) 2022 2021 2020 Weighted-average common shares used in basic earnings (loss) per share calculations 504.5 506.9 505.2 Potentially dilutive securities: Stock options, restricted stock units and other equity-based awards 6.5 7.8 6.4 Weighted-average common shares used in diluted earnings (loss) per share calculations 511.0 514.7 511.6 Income from continuing operations: Income from continuing operations $ 739 $ 918 $ 698 Less: net income from continuing operations attributable to noncontrolling interests 130 33 — Income from continuing operations available to Genworth Financial, Inc.’s common stockholders $ 609 $ 885 $ 698 Basic per share $ 1.21 $ 1.75 $ 1.38 Diluted per share $ 1.19 $ 1.72 $ 1.36 Income (loss) from discontinued operations: Income (loss) from discontinued operations, net of taxes $ — $ 27 $ (486 ) Less: net income from discontinued operations attributable to noncontrolling interests — 8 34 Income (loss) from discontinued operations available to Genworth Financial, Inc.’s common stockholders $ — $ 19 $ (520 ) Basic per share $ — $ 0.04 $ (1.03 ) Diluted per share $ — $ 0.04 $ (1.02 ) Net income (loss): Income from continuing operations $ 739 $ 918 $ 698 Income (loss) from discontinued operations, net of taxes — 27 (486 ) Net income 739 945 212 Less: net income attributable to noncontrolling interests 130 41 34 Net income available to Genworth Financial, Inc.’s common stockholders $ 609 $ 904 $ 178 Basic per share (1 ) $ 1.21 $ 1.78 $ 0.35 Diluted per share (1) $ 1.19 $ 1.76 $ 0.35 (1) May

Investments

Investments	12 Months Ended
Investments	Dec. 31, 2022
Investments	(4) Investments (a) Net Investment Income Sources of net investment income were as follows for the years ended December 31: (Amounts in millions) 2022 2021 2020 Fixed maturity securities—taxable $ 2,296 $ 2,411 $ 2,448 Fixed maturity securities—non-taxable 5 7 6 Equity securities 10 9 12 Commercial mortgage loans 321 376 345 Policy loans 211 189 199 Limited partnerships 99 223 72 Other invested assets 267 241 223 Cash, cash equivalents, restricted cash and short-term investments 20 1 15 Gross investment income before expenses and fees 3,229 3,457 3,320 Expenses and fees (83 (87 ) (93 Net investment income $ 3,146 $ 3,370 $ 3,227 (b) Net Investment Gains (Losses) The following table sets forth net investment gains (losses) for the years ended December 31: (Amounts in millions) 2022 2021 2020 Realized investment gains (losses): Available-for-sale Realized gains $ 28 $ 67 $ 471 Realized losses (102 ) (10 ) (29 ) Net realized gains (losses) on available-for-sale (74 ) 57 442 Net realized gains (losses) on equity securities sold — (7 ) (1 ) Net realized gains (losses) on limited partnerships — 3 — Total net realized investment gains (losses) (74 ) 53 441 Net change in allowance for credit losses on available-for-sale — (6 ) (5 ) Write-down of available-for-sale (1 ) (2 ) (1 ) (4 ) Net unrealized gains (losses) on equity securities still held (35 ) 1 4 Net unrealized gains (losses) on limited partnerships 71 264 112 Commercial mortgage loans 4 (3 ) (2 ) Derivative instruments (2) 17 14 (49 ) Other 2 1 (5 ) Net investment gains (losses) $ (17 ) $ 323 $ 492 (1) Represents write-down of securities deemed uncollectible or that we intend to sell or will be required to sell prior to recovery of the amortized cost basis. (2) See note 5 for additional information on the impact of derivative instruments included in net investment gains (losses). See note 2 for a discussion of our policy for evaluating and measuring the allowance for credit losses related to our available-for-sale fixed maturity securities. There was no allowance for credit losses related to our available-for-sale fixed maturity securities as of and for the year ended December 31, 2022. The following tables represent the allowance for credit losses aggregated by security type for available-for-sale fixed maturity securities as of and for the years ended December 31: 2021 Increase from Increase securities (decrease) Decrease without from securities due to change allowance in with allowance in intent or Beginning previous in previous Securities requirement Ending (Amounts in millions) balance periods periods sold to sell Write-offs Recoveries balance Fixed maturity securities: Non-U.S. $ 1 $ — $ 6 $ (7 ) $ — $ — $ — $ — Commercial mortgage-backed 3 — — — — (3 ) — — Total available-for-sale $ 4 $ — $ 6 $ (7 ) $ — $ (3 ) $ — $ — 2020 Increase from Increase securities (decrease) Decrease without from securities due to change allowance in with allowance in intent or Beginning previous in previous Securities requirement Ending (Amounts in millions) balance periods periods sold to sell Write-offs Recoveries balance Fixed maturity securities: Non-U.S. $ — $ 4 $ (2 ) $ (1 ) $ — $ — $ — $ 1 Commercial mortgage-backed — 3 — — — — — 3 Total available-for-sale $ — $ 7 $ (2 ) $ (1 ) $ — $ — $ — $ 4 (c) Unrealized Investment Gains and Losses Net unrealized gains and losses on available-for-sale (Amounts in millions) 2022 2021 2020 Net unrealized gains (losses) on fixed maturity securities without an allowance for credit losses (1) $ (4,251 ) $ 7,869 $ 10,159 Net unrealized gains (losses) on fixed maturity securities with an allowance for credit losses (1) — — (7 ) Adjustments to DAC, PVFP, sales inducements, benefit reserves and policyholder contract balances 44 (5,487 ) (7,302 ) Income taxes, net 710 (507 ) (611 ) Net unrealized investment gains (losses) (3,497 ) 1,875 2,239 Less: net unrealized investment gains (losses) attributable to noncontrolling interests (71 ) 15 25 Net unrealized investment gains (losses) attributable to Genworth Financial, Inc. $ (3,426 ) $ 1,860 $ 2,214 (1) Excludes foreign exchange. The change in net unrealized gains (losses) on available-for-sale (Amounts in millions) 2022 2021 2020 Beginning balance $ 1,860 $ 2,214 $ 1,456 Unrealized gains (losses) arising during the period: Unrealized gains (losses) on fixed maturity securities (12,194 ) (2,218 ) 3,950 Adjustment to DAC (1) 1,332 30 122 Adjustment to PVFP 81 — (1 ) Adjustment to sales inducements 28 12 (5 ) Adjustment to benefit reserves and policyholder contract balances (2) 4,090 1,773 (2,629 ) Provision for income taxes 1,233 90 (305 ) Change in unrealized gains (losses) on investment securities (5,430 ) (313 ) 1,132 Reclassification adjustments to net investment (gains) losses, net of taxes of $(16), $14 and $100 58 (51 ) (374 ) Change in net unrealized investment gains (losses) (5,372 ) (364 ) 758 Less: change in net unrealized investment gains (losses) attributable to noncontrolling interests (86 ) (10 ) — Ending balance $ (3,426 ) $ 1,860 $ 2,214 (1) See note 6 for additional information. (2) See note 9 for additional information. The net unrealized losses on fixed maturity securities recognized during the year ended December 31, 2022 were largely due to increasing interest rates and widening credit spreads. Amounts reclassified out of accumulated other comprehensive income (loss) to net investment gains (losses) include realized gains (losses) on sales of securities, which are determined on a specific identification basis. (d) Fixed Maturity Securities As of December 31, 2022, the amortized cost or cost, gross unrealized gains (losses), allowance for credit losses and fair value of our fixed maturity securities classified as available-for-sale Amortized Gross Gross Allowance cost or unrealized unrealized for credit Fair (Amounts in millions) cost gains losses losses value Fixed maturity securities: U.S. government, agencies and government-sponsored enterprises $ 3,446 $ 86 $ (191 ) $ — $ 3,341 State and political subdivisions 2,726 19 (346 ) — 2,399 Non-U.S. 731 15 (101 ) — 645 U.S. corporate: Utilities 4,295 50 (447 ) — 3,898 Energy 2,450 33 (221 ) — 2,262 Finance and insurance 8,005 59 (871 ) — 7,193 Consumer—non-cyclical 4,776 84 (403 ) — 4,457 Technology and communications 3,265 43 (361 ) — 2,947 Industrial 1,312 15 (130 ) — 1,197 Capital goods 2,290 41 (193 ) — 2,138 Consumer—cyclical 1,758 14 (155 ) — 1,617 Transportation 1,165 32 (97 ) — 1,100 Other 325 3 (18 ) — 310 Total U.S. corporate 29,641 374 (2,896 ) — 27,119 Non-U.S. Utilities 817 — (77 ) — 740 Energy 1,009 19 (68 ) — 960 Finance and insurance 2,124 30 (208 ) — 1,946 Consumer—non-cyclical 655 1 (90 ) — 566 Technology and communications 997 4 (107 ) — 894 Industrial 880 8 (70 ) — 818 Capital goods 606 3 (63 ) — 546 Consumer—cyclical 308 — (32 ) — 276 Transportation 392 12 (29 ) — 375 Other 932 15 (58 ) — 889 Total non-U.S. 8,720 92 (802 ) — 8,010 Residential mortgage-backed 1,059 7 (71 ) — 995 Commercial mortgage-backed 2,183 2 (277 ) — 1,908 Other asset-backed 2,328 1 (163 ) — 2,166 Total available-for-sale $ 50,834 $ 596 $ (4,847 ) $ — $ 46,583 As of December 31, 2021, the amortized cost or cost, gross unrealized gains (losses), allowance for credit losses and fair value of our fixed maturity securities classified as available-for-sale Amortized Gross Gross Allowance cost or unrealized unrealized for credit Fair (Amounts in millions) cost gains losses losses value Fixed maturity securities: U.S. government, agencies and government-sponsored enterprises $ 3,368 $ 1,184 $ — $ — $ 4,552 State and political subdivisions 2,982 474 (6 ) — 3,450 Non-U.S. 762 86 (13 ) — 835 U.S. corporate: Utilities 4,330 783 (9 ) — 5,104 Energy 2,581 363 (10 ) — 2,934 Finance and insurance 8,003 1,012 (24 ) — 8,991 Consumer—non-cyclical 5,138 1,029 (8 ) — 6,159 Technology and communications 3,345 476 (13 ) — 3,808 Industrial 1,322 175 (3 ) — 1,494 Capital goods 2,334 415 (4 ) — 2,745 Consumer—cyclical 1,703 203 (7 ) — 1,899 Transportation 1,122 249 — — 1,371 Other 379 41 (1 ) — 419 Total U.S. corporate 30,257 4,746 (79 ) — 34,924 Non-U.S. Utilities 867 63 (2 ) — 928 Energy 1,194 190 (1 ) — 1,383 Finance and insurance 2,171 270 (9 ) — 2,432 Consumer—non-cyclical 664 81 (2 ) — 743 Technology and communications 1,085 166 (1 ) — 1,250 Industrial 933 117 (3 ) — 1,047 Capital goods 640 66 (1 ) — 705 Consumer—cyclical 316 27 (2 ) — 341 Transportation 422 68 (1 ) — 489 Other 1,052 169 (4 ) — 1,217 Total non-U.S. 9,344 1,217 (26 ) — 10,535 Residential mortgage-backed 1,325 116 (1 ) — 1,440 Commercial mortgage-backed 2,435 152 (3 ) — 2,584 Other asset-backed 2,138 29 (7 ) — 2,160 Total available-for-sale $ 52,611 $ 8,004 $ (135 ) $ — $ 60,480 The following table presents the gross unrealized losses and fair values of our fixed maturity securities for which an allowance for credit losses has not been recorded, aggregated by investment type and length of time that individual fixed maturity securities have been in a continuous unrealized loss position, as of December 31, 2022: Less than 12 months 12 months or more Total Gross Gross Gross Fair unrealized Number of Fair unrealized Number of Fair unrealized Number of (Dollar amounts in millions) value losses securities value losses securities value losses securities Description of Securities Fixed maturity securities: U.S. government, agencies and government-sponsored enterprises $ 1,585 $ (189 ) 55 $ 17 $ (2 ) 6 $ 1,602 $ (191 ) 61 State and political subdivisions 1,559 (269 ) 258 261 (77 ) 66 1,820 (346 ) 324 Non-U.S. 351 (54 ) 59 152 (47 ) 23 503 (101 ) 82 U.S. corporate 18,480 (2,344 ) 2,452 2,001 (552 ) 236 20,481 (2,896 ) 2,688 Non-U.S. 5,593 (599 ) 732 748 (203 ) 111 6,341 (802 ) 843 Residential mortgage-backed 569 (51 ) 192 65 (20 ) 22 634 (71 ) 214 Commercial mortgage-backed 1,765 (255 ) 265 88 (22 ) 16 1,853 (277 ) 281 Other asset-backed 1,455 (83 ) 347 598 (80 ) 101 2,053 (163 ) 448 Total for fixed maturity securities in an unrealized loss position $ 31,357 $ (3,844 ) 4,360 $ 3,930 $ (1,003 ) 581 $ 35,287 $ (4,847 ) 4,941 % Below cost: <20% Below cost $ 27,596 $ (2,587 ) 3,835 $ 1,819 $ (291 ) 310 $ 29,415 $ (2,878 ) 4,145 20%-50% 3,757 (1,251 ) 523 2,111 (712 ) 271 5,868 (1,963 ) 794 >50% Below cost 4 (6 ) 2 — — — 4 (6 ) 2 Total for fixed maturity securities in an unrealized loss position $ 31,357 $ (3,844 ) 4,360 $ 3,930 $ (1,003 ) 581 $ 35,287 $ (4,847 ) 4,941 Investment grade $ 29,959 $ (3,687 ) 4,158 $ 3,590 $ (915 ) 537 $ 33,549 $ (4,602 ) 4,695 Below investment grade 1,398 (157 ) 202 340 (88 ) 44 1,738 (245 ) 246 Total for fixed maturity securities in an unrealized loss position $ 31,357 $ (3,844 ) 4,360 $ 3,930 $ (1,003 ) 581 $ 35,287 $ (4,847 ) 4,941 The following table presents the gross unrealized losses and fair values of our corporate securities for which an allowance for credit losses has not been recorded, aggregated by investment type and length of time that individual investment securities have been in a continuous unrealized loss position, based on industry, as of December 31, 2022: Less than 12 months 12 months or more Total Gross Gross Gross Fair unrealized Number of Fair unrealized Number of Fair unrealized Number of (Dollar amounts in millions) value losses securities value losses securities value losses securities Description of Securities U.S. corporate: Utilities $ 2,447 $ (398 ) 345 $ 187 $ (49 ) 37 $ 2,634 $ (447 ) 382 Energy 1,538 (187 ) 226 144 (34 ) 14 1,682 (221 ) 240 Finance and insurance 5,250 (668 ) 696 706 (203 ) 74 5,956 (871 ) 770 Consumer—non-cyclical 2,805 (342 ) 317 201 (61 ) 22 3,006 (403 ) 339 Technology and communications 2,259 (273 ) 304 271 (88 ) 32 2,530 (361 ) 336 Industrial 829 (105 ) 104 110 (25 ) 13 939 (130 ) 117 Capital goods 1,332 (153 ) 169 148 (40 ) 16 1,480 (193 ) 185 Consumer—cyclical 1,138 (108 ) 173 194 (47 ) 22 1,332 (155 ) 195 Transportation 746 (93 ) 95 21 (4 ) 5 767 (97 ) 100 Other 136 (17 ) 23 19 (1 ) 1 155 (18 ) 24 Subtotal, U.S. corporate securities 18,480 (2,344 ) 2,452 2,001 (552 ) 236 20,481 (2,896 ) 2,688 Non-U.S. Utilities 640 (63 ) 66 57 (14 ) 9 697 (77 ) 75 Energy 604 (61 ) 69 40 (7 ) 5 644 (68 ) 74 Finance and insurance 1,310 (122 ) 204 296 (86 ) 42 1,606 (208 ) 246 Consumer—non-cyclical 491 (74 ) 56 54 (16 ) 11 545 (90 ) 67 Technology and communications 740 (96 ) 93 39 (11 ) 8 779 (107 ) 101 Industrial 480 (45 ) 71 105 (25 ) 13 585 (70 ) 84 Capital goods 394 (46 ) 52 62 (17 ) 6 456 (63 ) 58 Consumer—cyclical 241 (28 ) 31 23 (4 ) 6 264 (32 ) 37 Transportation 180 (21 ) 26 29 (8 ) 5 209 (29 ) 31 Other 513 (43 ) 64 43 (15 ) 6 556 (58 ) 70 Subtotal, non-U.S. 5,593 (599 ) 732 748 (203 ) 111 6,341 (802 ) 843 Total for corporate securities in an unrealized loss position $ 24,073 $ (2,943 ) 3,184 $ 2,749 $ (755 ) 347 $ 26,822 $ (3,698 ) 3,531 We did not recognize an allowance for credit losses on securities in an unrealized loss position included in the tables above. Based on a qualitative and quantitative review of the issuers of the securities, we believe the decline in fair value was largely due to increasing interest rates and widening credit spreads and was not indicative of credit losses. The issuers continue to make timely principal and interest payments. For all securities in an unrealized loss position without an allowance for credit losses, we expect to recover the amortized cost based on our estimate of the amount and timing of cash flows to be collected. We do not intend to sell nor do we expect that we will be required to sell these securities prior to recovering our amortized cost. The following table presents the gross unrealized losses and fair values of our fixed maturity securities for which an allowance for credit losses has not been recorded, aggregated by investment type and length of time that individual fixed maturity securities have been in a continuous unrealized loss position, as of December 31, 2021: Less than 12 months 12 months or more Total Gross Gross Gross Fair unrealized Number of Fair unrealized Number of Fair unrealized Number of (Dollar amounts in millions) value losses securities value losses securities value losses securities Description of Securities Fixed maturity securities: State and political subdivisions $ 339 $ (6 ) 67 $ — $ — — $ 339 $ (6 ) 67 Non-U.S. 173 (9 ) 28 19 (4 ) 1 192 (13 ) 29 U.S. corporate 2,593 (64 ) 266 196 (15 ) 22 2,789 (79 ) 288 Non-U.S. 912 (21 ) 124 62 (5 ) 8 974 (26 ) 132 Residential mortgage-backed 97 (1 ) 22 — — — 97 (1 ) 22 Commercial mortgage-backed 113 (2 ) 17 31 (1 ) 4 144 (3 ) 21 Other asset-backed 764 (7 ) 111 — — — 764 (7 ) 111 Total for fixed maturity securities in an unrealized loss position $ 4,991 $ (110 ) 635 $ 308 $ (25 ) 35 $ 5,299 $ (135 ) 670 % Below cost: <20% Below cost $ 4,991 $ (110 ) 635 $ 297 $ (20 ) 33 $ 5,288 $ (130 ) 668 20%-50% — — — 11 (5 ) 2 11 (5 ) 2 Total for fixed maturity securities in an unrealized loss position $ 4,991 $ (110 ) 635 $ 308 $ (25 ) 35 $ 5,299 $ (135 ) 670 Investment grade $ 4,644 $ (101 ) 587 $ 241 $ (12 ) 25 $ 4,885 $ (113 ) 612 Below investment grade 347 (9 ) 48 67 (13 ) 10 414 (22 ) 58 Total for fixed maturity securities in an unrealized loss position $ 4,991 $ (110 ) 635 $ 308 $ (25 ) 35 $ 5,299 $ (135 ) 670 The following table presents the gross unrealized losses and fair values of our corporate securities for which an allowance for credit losses has not been recorded, aggregated by investment type and length of time that individual investment securities have been in a continuous unrealized loss position, based on industry, as of December 31, 2021: Less than 12 months 12 months or more Total Gross Gross Gross Fair unrealized Number of Fair unrealized Number of Fair unrealized Number of (Dollar amounts in millions) value losses securities value losses securities value losses securities Description of Securities U.S. corporate: Utilities $ 211 $ (7 ) 32 $ 29 $ (2 ) 7 $ 240 $ (9 ) 39 Energy 166 (3 ) 18 25 (7 ) 4 191 (10 ) 22 Finance and insurance 960 (22 ) 89 62 (2 ) 3 1,022 (24 ) 92 Consumer—non-cyclical 296 (7 ) 30 14 (1 ) 2 310 (8 ) 32 Technology and communications 378 (12 ) 37 29 (1 ) 2 407 (13 ) 39 Industrial 143 (3 ) 18 — — — 143 (3 ) 18 Capital goods 171 (3 ) 16 18 (1 ) 2 189 (4 ) 18 Consumer—cyclical 268 (7 ) 26 — — — 268 (7 ) 26 Other — — — 19 (1 ) 2 19 (1 ) 2 Subtotal, U.S. corporate securities 2,593 (64 ) 266 196 (15 ) 22 2,789 (79 ) 288 Non-U.S. Utilities 69 (2 ) 9 — — — 69 (2 ) 9 Energy 64 (1 ) 10 — — — 64 (1 ) 10 Finance and insurance 366 (8 ) 43 18 (1 ) 2 384 (9 ) 45 Consumer—non-cyclical 67 (1 ) 12 6 (1 ) 1 73 (2 ) 13 Technology and communications 48 (1 ) 8 — — — 48 (1 ) 8 Industrial 122 (3 ) 14 — — — 122 (3 ) 14 Capital goods 78 (1 ) 8 — — — 78 (1 ) 8 Consumer—cyclical 22 (1 ) 8 15 (1 ) 3 37 (2 ) 11 Transportation 37 (1 ) 7 — — — 37 (1 ) 7 Other 39 (2 ) 5 23 (2 ) 2 62 (4 ) 7 Subtotal, non-U.S. 912 (21 ) 124 62 (5 ) 8 974 (26 ) 132 Total for corporate securities in an unrealized loss position $ 3,505 $ (85 ) 390 $ 258 $ (20 ) 30 $ 3,763 $ (105 ) 420 The scheduled maturity distribution of fixed maturity securities as of December 31, 2022 is set forth below. Actual maturities may differ from contractual maturities because issuers of securities may have the right to call or prepay obligations with or without call or prepayment penalties. Amortized cost or Fair (Amounts in millions) cost value Due one year or less $ 1,239 $ 1,234 Due after one year through five years 8,264 7,931 Due after five years through ten years 13,120 11,915 Due after ten years 22,641 20,434 Subtotal 45,264 41,514 Residential mortgage-backed 1,059 995 Commercial mortgage-backed 2,183 1,908 Other asset-backed 2,328 2,166 Total $ 50,834 $ 46,583 As of December 31, 2022, securities issued by finance and insurance, consumer—non-cyclical, As of December 31, 2022, we did not hold any fixed maturity securities in any single issuer, other than securities issued or guaranteed by the U.S. government, which exceeded 10% of stockholders’ equity. As of December 31, 2022 and 2021, securities of $42 (e) Commercial Mortgage Loans Our mortgage loans are collateralized by commercial properties, including multi-family residential buildings. The carrying value of commercial mortgage loans is stated at original cost net of principal payments, amortization and allowance for credit losses. We diversify our commercial mortgage loans by both property type and geographic region. The following tables set forth the distribution across property type and geographic region for commercial mortgage loans as of December 2022 2021 Carrying % of Carrying % of (Amounts in millions) value total value total Property type: Retail $ 2,916 42 % $ 2,774 40 % Office 1,579 22 1,526 22 Industrial 1,456 21 1,420 21 Apartments 561 8 585 9 Mixed use 371 5 330 5 Other 149 2 221 3 Subtotal 7,032 100 % 6,856 100 % Allowance for credit losses (22 ) (26 ) Total $ 7,010 $ 6,830 2022 2021 Carrying % of Carrying % of (Amounts in millions) value total value total Geographic region: South Atlantic $ 1,809 26 % $ 1,770 26 % Pacific 1,340 19 1,360 20 Mountain 1,023 15 892 13 Mid dle 988 14 964 14 West South Central 578 8 483 7 East North Central 454 6 465 7 West North Central 438 6 461 7 East South Central 218 3 224 3 New England 184 3 237 3 Subtotal 7,032 100 % 6,856 100 % Allowance for credit losses (22 ) (26 ) Total $ 7,010 $ 6,830 As of December 31, 2022, we had no commercial mortgage loans past due or on non-accrual non-accrual non-accrual During the year ended December 31, 2022, we did not have any loan modifications or extensions associated with borrowers experiencing financial difficulty that resulted in the consideration of whether to establish a new loan or to continue accounting for the modification or extension under the existing loan. During the year ended December 31, 2021, prior to the adoption of new accounting guidance related to troubled debt restructurings, we did not have any modifications or extensions that were considered troubled debt restructurings. The following table sets forth the allowance for credit losses related to commercial mortgage loans as of and for the years ended December 31: (Amounts in millions) 2022 2021 2020 Allowance for credit losses: Beginning balance $ 26 $ 31 $ 13 Cumulative effect of change in accounting — — 16 Provision (5 ) 3 2 Write-offs — (8 ) — Recoveries 1 — — Ending balance $ 22 $ 26 $ 31 In evaluating the credit quality of commercial mortgage loans, we assess the performance of the underlying loans using both quantitative and qualitative criteria. Certain risks associated with commercial mortgage loans can be evaluated by reviewing both the debt-to-value debt-to-value debt-to-value one-time non-recurring The following tables set forth commercial mortgage loans by year of origination and credit quality indicator as of December 31, 2022: 2017 and (Amounts in millions) 2022 2021 2020 2019 2018 prior Total Debt-to-value: 0% - 50% $ 42 $ 41 $ 98 $ 110 $ 204 $ 1,890 $ 2,385 51% - 60% 58 98 62 131 229 764 1,342 61% - 75% 848 788 334 460 380 445 3,255 76% - 100% — — — 8 28 14 50 Greater than 100% — — — — — — — Total amortized cost $ 948 $ 927 $ 494 $ 709 $ 841 $ 3,113 $ 7,032 Debt service coverage ratio: Less than 1.00 $ 7 $ 9 $ 6 $ 47 $ 58 $ 143 $ 270 1.00 - 1.25 17 1 16 19 94 125 272 1.26 - 1.50 290 70 65 163 140 390 1,118 1.51 - 2.00 580 614 207 270 348 1,066 3,085 Greater than 2.00 54 233 200 210 201 1,389 2,287 Total amortized cost $ 948 $ 927 $ 494 $ 709 $ 841 $ 3,113 $ 7,032 The following tables set forth the debt-to-value of commercial mortgage loans by property type as of December 31: 2022 Greater (Amounts in millions) 0% - 50% 51% - 60% 61% - 75% 76% - 100% than 100% Total Property type: Retail $ 907 $ 649 $ 1,332 $ 28 $ — $ 2,916 Office 445 272 848 14 — 1,579 Industrial 668 243 545 — — 1,456 Apartments 184 90 279 8 — 561 Mixed use 93 79 199 — — 371 Other 88 9 52 — — 149 Total amortized cost $ 2,385 $ 1,342 $ 3,255 $ 50 $ — $ 7,032 % of total 34 % 19 % 46 % 1 % — % 100 % Weighted-average debt service coverage ratio 2.35 1.95 1.63 1.34 — 1.93 2021 (Amounts in millions) 0% - 50% 51% - 60% 61% - 75% 76% - 100% Greater 100% Total Property type: Retail $ 853 $ 611 $ 1,310 $ — $ — $ 2,774 Office 505 395 604 — 22 1,526 Industrial 745 240 435 — — 1,420 Apartments 200 102 283 — — 585 Mixed use 120 70 140 — — 330 Other 57 121 43 — — 221 Total amortized cost $ 2,480 $ 1,539 $ 2,815 $ — $ 22 $ 6,856 % of total 36 % 23 % 41 % — % — % 100 % Weighted-average debt service coverage ratio 2.36 1.83 1.61 — 0.68 1.93 The following tables set forth the debt service coverage ratio for fixed rate commercial mortgage loans by property type as of December 31: 2022 Greater (Amounts in millions) Less than 1.00 1.00 - 1.25 1.26 - 1.50 1.51 - 2.00 than 2.00 Total Property type: Retail $ 88 $ 68 $ 560 $ 1,380 $ 820 $ 2,916 Office 81 131 155 666 546 1,579 Industrial 20 44 194 574 624 1,456 Apartments 14 11 150 242 144 561 Mixed use 25 16 50 190 90 371 Other 42 2 9 33 63 149 Total amortized cost $ 270 $ 272 $ 1,118 $ 3,085 $ 2,287 $ 7,032 % of total 4 % 4 % 16 % 44 % 32 % 100 % Weighted-average debt-to-value 61 % 62 % 63 % 60 % 44 % 56 % 2021 Greater (Amounts in millions) Less than 1.00 1.00 - 1.25 1.26 - 1.50 1.51 - 2.00 than 2.00 Total Property type: Retail $ 102 $ 166 $ 405 $ 1,375 $ 726 $ 2,774 Office 67 109 167 593 590 1,526 Industrial 9 64 82 599 666 1,420 Apartments 17 62 84 225 197 585 Mixed use 24 32 40 118 116 330 Other 4 126 13 48 30 221 Total amortized cost $ 223 $ 559 $ 791 $ 2,958 $ 2,325 $ 6,856 % of total 3 % 8 % 12 % 43 % 34 % 100 % Weighted-average debt-to-value 68 % 61 % 61 % 60 % 43 % 55 % (f) Limited Partnerships or Similar Entities Investments in limited partnerships or similar entities are generally considered VIEs when the equity group lacks sufficient financial control. Generally, these investments are limited partner or non-managing

Derivative Instruments

Derivative Instruments	12 Months Ended
Derivative Instruments	Dec. 31, 2022
Derivative Instruments	(5) Derivative Instruments Our business activities routinely deal with fluctuations in interest rates, equity prices, currency exchange rates and other asset and liability prices. We use derivative instruments to mitigate or reduce some of these risks. We have established policies for managing each of these risks, including prohibitions on derivatives market-making and other speculative derivatives activities. These policies require the use of derivative instruments in concert with other techniques to reduce or mitigate these risks. While we use derivatives to mitigate or reduce risks, certain derivatives do not meet the accounting requirements to be designated as hedging instruments and are denoted as “derivatives not designated as hedges” in the following disclosures. For derivatives that meet the accounting requirements to be designated as hedges, the following disclosures for these derivatives are denoted as “derivatives designated as hedges,” which include cash flow hedges. The following table sets forth our positions in derivative instruments as of December 31: Derivative assets Derivative liabilities Fair value Fair value Balance Balance (Amounts in millions) sheet classification 2022 2021 sheet classification 2022 2021 Derivatives designated as hedges Cash flow hedges: Interest rate swaps Other invested assets $ 24 $ 364 Other liabilities $ 522 $ 26 Foreign currency swaps Other invested assets 20 6 Other liabilities — — Total cash flow hedges 44 370 522 26 Total derivatives designated as hedges 44 370 522 26 Derivatives not designated as hedges Equity index options Other invested assets 6 42 Other liabilities — — Financial futures Other invested assets — — Other liabilities — — Other foreign currency contracts Other invested assets — 2 Other liabilities — — GMWB embedded derivatives Reinsurance (1) 16 19 Policyholder (2) 223 271 Fixed index annuity embedded derivatives Other assets — — Policyholder (3) 202 294 Indexed universal life embedded derivatives Reinsurance — — Policyholder (4) 15 25 Total derivatives not designated as hedges 22 63 440 590 Total derivatives $ 66 $ 433 $ 962 $ 616 (1) Represents embedded derivatives associated with the reinsured portion of our GMWB liabilities. (2) Represents the embedded derivatives associated with our GMWB liabilities, excluding the impact of reinsurance. (3) Represents the embedded derivatives associated with our fixed index annuity liabilities. (4) Represents the embedded derivatives associated with our indexed universal life liabilities. The fair value of derivative positions presented above was not offset by the respective collateral amounts received or provided under these agreements. The activity associated with derivative instruments can generally be measured by the change in notional value over the periods presented. However, for GMWB embedded derivatives, fixed index annuity embedded derivatives and indexed universal life embedded derivatives, the change between periods is best illustrated by the number of policies. The following tables represent activity associated with derivative instruments as of the dates indicated: December 31, Maturities/ December 31, (Notional in millions) Measurement 2021 Additions terminations 2022 Derivatives designated as hedges Cash flow hedges: Interest rate swaps Notional $ 7,653 $ 1,109 $ (220 ) $ 8,542 Foreign currency swaps Notional 127 17 — 144 Total cash flow hedges 7,780 1,126 (220 ) 8,686 Total derivatives designated as hedges 7,780 1,126 (220 ) 8,686 Derivatives not designated as hedges Equity index options Notional 1,446 946 (1,456 ) 936 Financial futures Notional 946 4,405 (3,948 ) 1,403 Other foreign currency contracts Notional 83 — (83 ) — Total derivatives not designated as hedges 2,475 5,351 (5,487 ) 2,339 Total derivatives $ 10,255 $ 6,477 $ (5,707 ) $ 11,025 December 31, Maturities/ December 31, (Number of policies) Measurement 2021 Additions terminations 2022 Derivatives not designated as hedges GMWB embedded derivatives Policies 21,804 — (1,876 ) 19,928 Fixed index annuity embedded derivatives Policies 9,344 — (2,029 ) 7,315 Indexed universal life embedded derivatives Policies 806 — (35 ) 771 Cash Flow Hedges Certain derivative instruments are designated as cash flow hedges. The changes in fair value of these instruments are recorded as a component of OCI. We designate and account for the following as cash flow hedges when they have met the effectiveness requirements: (i) various types of interest rate swaps to convert floating rate investments to fixed rate investments; (ii) various types of interest rate swaps to convert floating rate liabilities into fixed rate liabilities; (iii) receive U.S. dollar fixed on foreign currency swaps to hedge the foreign currency cash flow exposure of foreign currency denominated investments; (iv) forward starting interest rate swaps to hedge against changes in interest rates associated with future fixed rate bond purchases and/or interest income; and (v) other instruments to hedge the cash flows of various forecasted transactions. The following table provides information about the pre-tax income effects of cash flow hedges for the year ended December 31, 2022: Gain (loss) Gain (loss) reclassified into Classification of gain (loss) Gain (loss) Classification of gain recognized net income reclassified into recognized in (loss) recognized in (Amounts in millions) in OCI from OCI net income net income net income Interest rate swaps hedging assets $ (854 ) $ 225 Net investment income $ — Net investment Interest rate swaps hedging assets — 9 Net investment gains (losses) — Net investment Interest rate swaps hedging — (3 ) Interest expense — Net investment Foreign currency swaps 15 — Net investment income — Net investment Total $ (839 ) $ 231 $ — The following table provides information about the pre-tax income effects of cash flow hedges for the year ended December 31, 2021: Gain (loss) Gain (loss) reclassified into Classification of gain (loss) Gain (loss) Classification of gain recognized net income reclassified into recognized in (loss) recognized in (Amounts in millions) in OCI from OCI net income net income net income Interest rate swaps hedging assets $ (100 ) $ 217 Net investment $ — Net investment Interest rate swaps hedging assets — 1 Net investment — Net investment Interest rate swaps hedging 36 (1 ) Interest — Net investment Foreign currency 7 — Net investment — Net investment Total $ (57 ) $ 217 $ — The following table provides information about the pre-tax income effects of cash flow hedges for the year ended December 31, 2020: Gain (loss) Gain (loss) reclassified into Classification of gain (loss) Gain (loss) Classification of gain recognized net income reclassified into recognized in (loss) recognized in (Amounts in millions) in OCI from OCI net income net income net income Interest rate swaps hedging $ 482 $ 196 Net $ — Net investment Interest rate swaps hedging — 12 Net — Net investment Interest rate swaps hedging (38 ) — Interest — Net investment gains (losses) Foreign currency swaps (5 ) — Net — Net investment Total $ 439 $ 208 $ — The following table provides a reconciliation of current period changes, net of applicable income taxes, for these designated derivatives presented in the separate component of stockholders’ equity labeled “derivatives qualifying as hedges,” for the years ended December 31: (Amounts in millions) 2022 2021 2020 Derivatives qualifying as effective accounting hedges as of January 1 $ 2,025 $ 2,211 $ 2,002 Current period increases (decreases) in fair value, net of deferred taxes of $165, $12 and $(95) (674 ) (45 ) 344 Reclassification to net (income), net of deferred taxes of $80, $76 and $73 (151 ) (141 ) (135 ) Derivatives qualifying as effective accounting hedges as of December 31 $ 1,200 $ 2,025 $ 2,211 The total of derivatives designated as cash flow hedges of $1,200 million, net of taxes, recorded in stockholders’ equity as of December 31, 2022 is expected to be reclassified to net income (loss) in the future, concurrently with and primarily offsetting changes in interest expense and interest income on floating rate instruments and interest income on future fixed rate bond purchases. Of this amount, $143 million, net of taxes, is expected to be reclassified to net income (loss) in the next 12 months. Actual amounts may vary from this amount as a result of market conditions. All forecasted transactions associated with qualifying cash flow hedges are expected to occur by 2057. During the years ended December 31, 2022, 2021 and 2020, we reclassified $11 million, $10 million and $15 million, respectively, to net income in connection with forecasted transactions that were no longer considered probable of occurring. Derivatives Not Designated As Hedges We also enter into certain non-qualifying derivative instruments such as equity index options and financial futures to mitigate the risks associated with liabilities that have guaranteed minimum benefits, fixed index annuities and indexed universal life. We previously entered into interest rate swaps and financial futures to mitigate interest rate risk as part of managing regulatory capital positions and foreign currency options and forward contracts to mitigate currency risk associated with dividends, cash payments to AXA S.A. (“AXA”) reported as discontinued operations and/or other cash flows from certain foreign subsidiaries to our holding company. Additionally, we provide GMWBs on certain variable annuities that are required to be bifurcated as embedded derivatives. We also offer fixed index annuity and indexed universal life insurance products and have reinsurance agreements with certain features that are required to be bifurcated as embedded derivatives. The following table provides the pre-tax gain (loss) recognized in net income for the effects of derivatives not designated as hedges for the years ended December 31: Classification of gain (loss) recognized (Amounts in millions) 2022 2021 2020 in net income Interest rate swaps $ — $ 2 $ (11 ) Net investment gains (losses) Equity index options (20 ) 18 4 Net investment gains (losses) Financial futures (81 ) (123 ) 2 Net investment gains (losses) Other foreign currency contracts — — 6 Net investment gains (losses) GMWB embedded derivatives 66 124 (28 ) Net investment gains (losses) Fixed index annuity embedded derivatives 16 (32 ) (51 ) Net investment gains (losses) Indexed universal life embedded derivatives 27 24 17 Net investment gains (losses) Total derivatives not designated as hedges $ 8 $ 13 $ (61 ) Derivative Counterparty Credit Risk Most of our derivative arrangements with counterparties require the posting of collateral upon meeting certain net exposure thresholds. The following table presents additional information about derivative assets and liabilities subject to an enforceable master netting arrangement as of December 31: 2022 2021 Derivative Derivative Net Derivative Derivative Net (Amounts in millions) assets (1) liabilities (1) derivatives assets (1) liabilities (1) derivatives Amounts presented in the balance sheet: Gross amounts recognized $ 50 $ 522 $ (472 ) $ 414 $ 26 $ 388 Gross amounts offset in the balance sheet — — — — — — Net amounts presented in the balance sheet 50 522 (472 ) 414 26 388 Gross amounts not offset in the balance sheet: Financial instruments (2) (25 ) (25 ) — (20 ) (20 ) — Collateral received (21 ) — (21 ) (308 ) — (308 ) Collateral pledged — (1,095 ) 1,095 — (536 ) 536 Over collateralization — 598 (598 ) 2 530 (528 ) Net amount $ 4 $ — $ 4 $ 88 $ — $ 88 (1) Does not include amounts related to embedded derivatives as of December 31, 2022 and 2021. (2) Amounts represent derivative assets and/or liabilities that are presented gross within the balance sheet but are held with the same counterparty where we have a master netting arrangement. This adjustment results in presenting the net asset and net liability position for each counterparty.

Deferred Acquisition Costs

Deferred Acquisition Costs	12 Months Ended
Deferred Acquisition Costs	Dec. 31, 2022
Deferred Acquisition Costs	(6) Deferred Acquisition Costs The following table presents the activity impacting DAC as of and for the years ended December 31: (Amounts in millions) 2022 2021 2020 Unamortized balance as of January 1 $ 2,438 $ 2,809 $ 3,243 Costs deferred — 8 3 Amortization, net of interest accretion (278 ) (379 ) (437 ) Unamortized balance as of December 31 2,160 2,438 2,809 Accumulated effect of net unrealized investment (gains) losses 40 (1,292 ) (1,322 ) Balance as of December 31 $ 2,200 $ 1,146 $ 1,487 We regularly review DAC to determine if it is recoverable from future income. In 2022, 2021 and 2020, we recorded DAC impairments of $52 million, $117 million and $63 million, respectively, in our universal and term universal life insurance products due principally to lower future estimated gross profits. As of December 31, 2022, 2021 and 2020, all of our other products had sufficient future income and therefore the related DAC was recoverable. See note 9 for additional information related to loss recognition testing. In the fourth quarter of 2020, as part of our annual review of assumptions, we increased DAC amortization by $48 million in our universal and term universal life insurance products predominantly due to changes in expected gross profits driven mostly by lower projected cost of insurance assessments on our universal life insurance products and a model refinement in our term universal life insurance product related to persistency and grace period timing. As of December 31, 2022, 2021 and 2020, shadow accounting adjustments increased (decreased) the DAC balance by $40 million, $(1,292) million and $(1,322) million, respectively, with an offsetting amount recorded in accumulated other comprehensive income (loss). The majority of the shadow accounting adjustments as of December 31, 2021 and 2020 were recorded in our long-term care insurance business, which reduced its DAC balance to zero in each year. As of December 31, 2022, due to the higher interest rate environment, there were no shadow accounting adjustments in our long-term care insurance business. There was no impact to net income related to our shadow accounting adjustments. See note 2 for further information related to shadow accounting adjustments.

Intangible Assets

Intangible Assets	12 Months Ended
Intangible Assets	Dec. 31, 2022
Intangible Assets	(7) Intangible Assets The following table presents our intangible assets as of December 31: 2022 2021 Gross Gross carrying Accumulated carrying Accumulated (Amounts in millions) amount amortization amount amortization PVFP $ 2,146 $ (1,989 ) $ 2,065 $ (1,994 ) Capitalized software 482 (427 ) 465 (403 ) Deferred sales inducements to contractholders 325 (298 ) 295 (288 ) Other 158 (156 ) 159 (156 ) Total $ 3,111 $ (2,870 ) $ 2,984 $ (2,841 ) Amortization expense related to PVFP, capitalized software and other intangible assets for th e Present Value of Future Profits The following table presents the activity in PVFP as of and for the years ended December 31: (Amounts in millions) 2022 2021 2020 Unamortized balance as of January 1 $ 152 $ 154 $ 154 Interest accreted at 5.18%, 5.23% and 5.19% 8 8 8 Amortization (3 ) (10 ) (8 ) Unamortized balance as of December 31 157 152 154 Accumulated effect of net unrealized investment (gains) losses — (81 ) (81 ) Balance as of December 31 $ 157 $ 71 $ 73 We regularly review our assumptions and periodically test PVFP for recoverability in a manner similar to our treatment of DAC. As of December 31, 2022, 2021 and 2020 we believe all of our businesses have sufficient future income and therefore the related PVFP is recoverable. The percentage of the PVFP balance net of interest accretion, before the effect of unrealized investment gains or losses, estimated to be amortized over each of the next five years is as follows: 2023 10.3 % 2024 10.3 % 2025 10.2 % 2026 10.1 % 2027 10.1 % The amortization percentages in t

Reinsurance

Reinsurance	12 Months Ended
Reinsurance	Dec. 31, 2022
Reinsurance	(8) Reinsurance We reinsure a portion of our policy risks to other insurance companies in order to reduce our ultimate losses, diversify our exposures and provide capital flexibility. We also assume certain policy risks written by other insurance companies. Reinsurance accounting is followed for assumed and ceded transactions when there is adequate insurance risk transfer. Otherwise, the deposit method of accounting is followed. Reinsurance does not relieve us from our obligations to policyholders. In the event that the reinsurers are unable to meet their obligations, we remain liable for the reinsured claims. We monitor both the financial condition of individual reinsurers and risk concentrations arising from similar geographic regions, activities and economic characteristics of reinsurers to lessen the risk of default by such reinsurers. Other than the relationship discussed below with Union Fidelity Life Insurance Company (“UFLIC”), we do not have significant concentrations of reinsurance with any one reinsurer that could have a material impact on our financial position. U.S. Life Insurance As of December 31, 2022, the maximum amount of individual ordinary life insurance normally retained by us on any one individual life policy was $5 million. We have several significant reinsurance transactions (“Reinsurance Transactions”) with UFLIC, an affiliate of our former parent, General Electric Company (“GE”). In the Reinsurance Transactions, we ceded to UFLIC in-force in-force As of December 31, 2022 and 2021, we had a reinsurance recoverable of $12,686 Under the terms of certain reinsurance agreements that our life insurance subsidiaries have with external parties, we pledged assets in either separate portfolios or in trust for the benefit of external reinsurers. These assets support the reserves ceded to those external reinsurers. We have pledged fixed maturity securities and commercial mortgage loans of $10,218 million and $576 million, respectively, as of December 31, 2022 and $13,123 million and $810 million, respectively, as of December 31, 2021 in connection with these reinsurance agreements. However, we maintain the ability to substitute these pledged assets for other qualified collateral, and may use, commingle, encumber or dispose of any portion of the collateral as long as there is no event of default and the remaining qualified collateral is sufficient to satisfy the collateral maintenance level. The following table sets forth net domestic life insurance in-force as of December 31: (Amounts in millions) 2022 2021 2020 Direct life insurance in-force $ 430,151 $ 471,147 $ 509,670 Amounts assumed from other companies 527 573 624 Amounts ceded to other companies (1) (383,350 ) (427,464 ) (458,999 ) Net life insurance in-force $ 47,328 $ 44,256 $ 51,295 Percentage of amount assumed to net 1 % 1 % 1 % (1) Includes amounts accounted for under the deposit method. Enact Enact Holdings , through Enact Mortgage Insurance Corporation (“EMICO”), its principal U.S. mortgage insurance subsidiary, reinsures a portion of its mortgage insurance risk in order to obtain credit towards the financial requirements of the government-sponsored enterprises’ (“GSEs”) private mortgage insurer eligibility requirements (“PMIERs”). The transactions are structured as excess of loss coverage where both the attachment and detachment points of the ceded risk tier are within the PMIERs capital requirements at inception. Each reinsurance treaty has a term of 10 years or more and grants Enact Holdings a unilateral right to commute the treaty prior to the full term, subject to certain performance triggers. In 2022, Enact Holdings executed three excess of loss reinsurance transactions with a panel of reinsurers that provide up to approximately $422 During 2021, Enact Holdings obtained approximately $1,170 non-recourse Holdings retains pre-established Premiums Written and Earned The following table sets forth the effects of reinsurance on premiums written and earned for the years ended December 31: Written Earned (Amounts in millions) 2022 2021 2020 2022 2021 2020 Direct: Life insurance $ 738 $ 774 $ 795 $ 738 $ 775 $ 795 Accident and health insurance (1) 2,746 2,797 2,836 2,786 2,834 2,860 Mortgage insurance 979 990 947 1,023 1,050 1,023 Total direct 4,463 4,561 4,578 4,547 4,659 4,678 Assumed: Life insurance 1 2 1 1 2 2 Accident and health insurance (1) 292 300 313 295 304 322 Mortgage insurance 3 3 3 3 3 4 Total assumed 296 305 317 299 309 328 Ceded: Life insurance (2) (505 ) (913 ) (558 ) (505 ) (913 ) (559 ) Accident and health insurance (1) (531 ) (541 ) (550 ) (542 ) (548 ) (562 ) Mortgage insurance (80 ) (72 ) (49 ) (80 ) (72 ) (49 ) Total ceded (1,116 ) (1,526 ) (1,157 ) (1,127 ) (1,533 ) (1,170 ) Net premiums $ 3,643 $ 3,340 $ 3,738 $ 3,719 $ 3,435 $ 3,836 Percentage of amount assumed to net 8 % 9 % 9 % (1) Accident and health insurance is comprised almost entirely of our long-term care insurance products. (2) Effective December 1, 2021 and included in the year ended December 31, 2021, we entered into a reinsurance agreement with SCOR Global Life USA Reinsurance Company, under which we ceded premiums of $360 Reinsurance recoveries recognized as a reduction of benefits and other changes in policy reserves amounted to $2,537 million, $2,850 million and $2,649 million during 2022, 2021 and 2020, respectively. Allowance for Credit Losses on Reinsurance Recoverables The following table sets forth the changes in the allowance for credit losses related to reinsurance recoverables as of and for the years ended December 31: (Amounts in millions) 2022 2021 2020 Allowance for credit losses: Beginning balance $ 55 $ 45 $ — Cumulative effect of change in accounting — — 40 Provision 5 10 5 Write-offs — — — Recoveries — — — Ending balance $ 60 $ 55 $ 45 Our policy for evaluating and measuring the allowance for credit losses related to reinsurance recoverables utilizes the reinsurer’s credit rating, updated quarterly, to assess the credit quality of reinsurance recoverables. The following tables set forth A.M. Best Company, Inc.’s (“A.M. Best”) credit ratings related to our reinsurance recoverables, gross of the allowance for credit losses, as of December 31: 2022 (Amounts in millions) Collateralized Non-collateralized Total Credit rating: A++ $ — $ 570 $ 570 A+ 1,286 1,819 3,105 A 19 25 44 Not rated 12,687 89 12,776 Total reinsurance recoverable $ 13,992 $ 2,503 $ 16,495 2021 (Amounts in millions) Collateralized Non-collateralized Total Credit rating: A++ $ — $ 543 $ 543 A+ 1,581 1,510 3,091 A 18 41 59 Not rated 13,099 76 13,175 Total reinsurance recoverable $ 14,698 $ 2,170 $ 16,868 In March 2019, upon UFLIC’s request, A.M. Best withdrew UFLIC’s credit rating. There was no impact to us from this action as UFLIC has trust accounts and a guarantee from its parent, as discussed above, and is sufficiently collateralized. Accordingly, the reinsurance recoverable with UFLIC is fully collectible and no allowance for credit losses was recorded as of December 31, 2022 and 2021. Reinsurance recoverables are considered past due when contractual payments have not been received from the reinsurer by the required payment date. Claims submitted for payment are generally due in less than one year. As of December 31, 2022 and 2021, we did not have any reinsurance recoverables past due, except for Scottish Re US Inc. (“Scottish Re”), a reinsurance company domiciled in Delaware. On March 6, 2019, Scotti sh

Insurance Reserves

Insurance Reserves	12 Months Ended
Insurance Reserves	Dec. 31, 2022
Insurance Reserves	(9) Insurance Reserves Future Policy Benefits The following table sets forth our recorded liabilities and the major assumptions underlying our future policy benefits as of December 31: Mortality/ morbidity Interest rate (Amounts in millions) assumption assumption 2022 2021 Long-term care insurance contracts (a) 3.75% - 7.50 % $ 26,209 $ 28,232 Structured settlements with life contingencies (b) 1.00% - 8.00 % 7,900 8,075 Annuity contracts with life contingencies (b) 1.00% - 8.00 % 1,754 2,934 Traditional life insurance contracts ( c 3.00% - 7.50 % 1,872 1,956 Supplementary contracts with life contingencies (b) 1.00% - 8.00 % 329 331 Total future policy benefits $ 38,064 $ 41,528 (a) The 1983 Individual Annuitant Mortality Table or the 2000 U.S. Annuity Table, or the 1983 Group Annuitant Mortality Table or the 1994 Group Annuitant Mortality Table and company experience. (b) Assumptions for limited-payment contracts come from either the U.S. Population Table, the 1983 Group Annuitant Mortality Table, the 1983 Individual Annuitant Mortality Table, the Annuity 2000 Mortality Table or the 2012 Individual Annuity Reserving Table. (c) Principally modifications based on company experience of the Society of Actuaries 1965-70 1975-80 We regularly review our assumptions and perform loss recognition testing at least annually. The 2022, 2021 and 2020 tests did not result in a premium deficiency for any of our products and therefore our liability for future policy benefits was sufficient. The liability for future policy benefits for our products represents our current best estimate; however, there may be future adjustments to this estimate and related assumptions. Such adjustments, reflecting any variety of new and adverse trends, could possibly be significant and result in increases in the related future policy benefit reserves by an amount that could be material to our results of operations and financial condition and liquidity. As of December 31, 2022 and 2021, we accrued future policy benefit reserves of $1.7 care insurance business. The present value of expected future losses was approximately $2.3 billion and $2.5 billion as of December 31, 2022 and 2021, respectively. As of December 31, 2022 and 2021, we estimate a factor of approximately 79% and 76%, respectively, of those profits on our long-term care insurance block, excluding the acquired block, will be accrued in the future to offset estimated future losses during later periods. The factor increased compared to December 31, 2021 due mostly to lower actual profits in 2022 resulting in a need to accelerate the accrual for incremental future policy benefits for profits followed by losses. Policyholder Account Balances The following table sets forth our recorded liabilities for policyholder account balances as of December 31: (Amounts in millions) 2022 2021 Annuity contracts $ 5,652 $ 6,816 Funding agreements 200 250 Structured settlements without life contingencies 930 1,027 Supplementary contracts without life contingencies 499 550 Other 13 14 Total investment contracts 7,294 8,657 Universal and term universal life insurance contracts 9,819 10,697 Total policyholder account balances $ 17,113 $ 19,354 In the fourth quarter of 2022, as part of our annual review of assumptions, we decreased our liability for policyholder account balances by $ million in our universal and term universal life insurance products primarily related to higher interest rates. In the fourth quarter of 2021, as part of our annual review of assumptions, we increased our liability for policyholder account balances by million in our term universal and universal life insurance products primarily related to higher pre-coronavirus pandemic (“COVID-19”) mortality experience. Certain of our U.S. life insurance companies are members of the Federal Home Loan Bank (the “FHLB”) system in their respective Shadow Accounting Adjustments As of December 31, 2021, we accrued future policy benefit reserves of $3.2 billion with an offsetting amount recorded in accumulated other comprehensive income (loss) related to shadow accounting adjustments, the majority of which were recorded in our long-term care insurance business. In addition, as of December 31, 2021, we accrued policyholder account balances of $0.9 billion in our universal life insurance products with an offsetting amount recorded in accumulated other comprehensive income (loss) related to shadow accounting adjustments. As of December 31, 2022, there were no shadow accounting adjustments recorded to our insurance reserves for our long-term care and universal life insurance products primarily due to an increase in interest rates. There was no impact to net income related to our shadow accounting adjustments. See note 2 for further information related to shadow accounting adjustments. Certain Non-Traditional Long-Duration Contracts The following table sets forth information about our variable annuity products with death and living benefit guarantees as of December 31: (Dollar amounts in millions) 2022 2021 Account values with death benefit guarantees (net of reinsurance): Standard death benefits (return of net deposits) account value $ 1,878 $ 2,547 Net amount at risk $ 2 $ 1 Average attained age of contractholders 77 76 Enhanced death benefits (ratchet, rollup) account value $ 1,004 $ 1,326 Net amount at risk $ 187 $ 94 Average attained age of contractholders 76 76 Account values with living benefit guarantees: GMWBs $ 1,352 $ 1,893 Guaranteed annuitization benefits $ 767 $ 1,002 Variable annuity contracts may contain more than one death or living benefit; therefore, the amounts listed above are not mutually exclusive. Substantially all of our variable annuity contracts have some form of GMDB. As of December 31, 2022 and 2021, our total liability associated with variable annuity contracts with minimum guarantees was approximately $3,397 million and $4,492 million, respectively. Account value decreased compared to 2021 principally driven by the continued runoff of these products. The liability, net of reinsurance, for our variable annuity contracts with GMDB and guaranteed annuitization benefits was $137 million and $135 million as of December 31, 2022 and 2021, respectively. The contracts underlying the lifetime benefits such as GMWB and guaranteed annuitization benefits are considered “in the money” if the contractholder’s benefit base, or the protected value, is greater than the account value. As of December 31, 2022 and 2021, our exposure related to GMWB and guaranteed annuitization benefit contracts that were considered “in the money” was $860 million and $602 million, respectively. For GMWBs and guaranteed annuitization benefits, the only way the contractholder can monetize the excess of the benefit base over the account value of the contract is through lifetime withdrawals or lifetime income payments after annuitization. Account balances of variable annuity contracts with death or living benefit guarantees were invested in separate account investment options as follows as of December 31: (Amounts in millions) 2022 2021 Balanced funds $ 1,686 $ 2,397 Equity funds 721 913 Bond funds 214 297 Money market funds 186 189 Total $ 2,807 $ 3,796

Liability for Policy and Contra

Liability for Policy and Contract Claims	12 Months Ended
Liability for Policy and Contract Claims	Dec. 31, 2022
Liability for Policy and Contract Claims	(10) Liability for Policy and Contract Claims The following table sets forth our liability for policy and contract claims as of December 31: (Amounts in millions) 2022 2021 Liability for policy and contract claims for insurance lines other than short-duration contracts: U.S. Life Insurance segment: Long-term care insurance $ 11,380 $ 10,861 Life insurance 299 308 Fixed annuities 16 14 Runoff segment 14 8 Total 11,709 11,191 Liability for policy and contract claims related to short-duration contracts: Enact segment 519 641 Other mortgage insurance businesses 6 9 Total 525 650 Total liability for policy and contract claims $ 12,234 $ 11,841 The liability for policy and contract claims represents our current best estimate; however, there may be future adjustments to this estimate and related assumptions. Such adjustments, reflecting any variety of new and adverse trends, could be significant, and result in increases in reserves by an amount that could be material to our results of operations and financial condition and liquidity. In addition, loss reserves recorded on new delinquencies in our Enact segment have a high degree of estimation, particularly due to the level of uncertainty regarding whether borrowers in forbearance will ultimately cure or result in claim payments, as well as the timing and severity of those payments. Given the extended period of time that may exist between the reporting of a delinquency and the claim payment, and changes in economic conditions and the real estate market, significant uncertainty and variability exist on amounts actually paid. The liability for policy and contract claims increased $519 million in our long-term care insurance business as discussed further below. The decrease in the liability for policy and contract claims of $122 million in our Enact segment was principally attributable to net favorable reserve adjustments primarily related to COVID-19 Long-term care insurance The following table sets forth changes in the liability for policy and contract claims for our long-term care insurance business for the dates indicated: (Amounts in millions) 2022 2021 2020 Beginning balance as of January 1 $ 10,861 $ 10,518 $ 10,239 Less reinsurance recoverables (2,260 ) (2,260 ) (2,283 ) Net balance as of January 8,601 8,258 7,956 Incurred related to insured events of: Current year 2,954 2,761 2,595 Prior years (458 ) (610 ) (398 ) Total incurred 2,496 2,151 2,197 Paid related to insured events of: Current year (211 ) (203 ) (189 ) Prior years (2,173 ) (2,011 ) (2,118 ) Total paid (2,384 ) (2,214 ) (2,307 ) Interest on liability for policy and contract claims 422 406 412 Net balance as of December 31 9,135 8,601 8,258 Add reinsurance recoverables 2,245 2,260 2,260 Ending balance as of December 31 $ 11,380 $ 10,861 $ 10,518 In 2022, the liability for policy and contract claims increased $519 million in our long-term care insurance business largely attributable to new claims and claim severity as a result of the aging of the in-force to our claim reserves . For the year ended December 31, 2022, the favorable development of $458 million related to insured events of prior years was primarily driven by favorable claim terminations mostly attributable to higher mortality, favorable development on prior year incurred but not reported (“IBNR”) claims and favorable experience on pending claims that did not become an active claim. As of December 31, 2022, the balance of incremental claim reserves recorded in connection with changes to claims incidence and mortality experience resulting from COVID-19, COVID-19 In 2021, the liability for policy and contract claims increased $343 million in our long-term care insurance business primarily attributable to new claims and claim severity as a result of the aging of the in-force COVID-19 pre-pandemic COVID-19. COVID-19 $199 million, respectively. We completed our annual review of assumptions and methodologies in the fourth quarter of 2021 and did not make any significant changes, other than routine updates. The COVID-19 For the year ended December 31, 2021, the favorable development of $610 million related to insured events of prior years was primarily attributable to favorable development on prior year IBNR claims, favorable claim terminations mostly attributable to higher mortality and favorable experience on pending claims that did not become an active claim. In 2020, the liability for policy and contract claims increased $279 million in our long-term care insurance business. The increase was primarily attributable to new claims and claim severity as a result of the aging of the in-force COVID-19 COVID-19 pre-pandemic For the year ended December 31, 2020, the favorable development of $398 million related to insured events of prior years was primarily attributable to favorable claim terminations mostly attributable to higher mortality, favorable development on prior year IBNR claims and favorable experience on pending claims that did not become an active claim. These decreases were partially offset by unfavorable impacts from changes in assumptions and methodologies associated with our annual claim reserve review completed in the fourth quarter of 2020 and from higher reserves associated with changes to incidence and mortality experience driven by COVID-19. Enact segment The following table sets forth information about incurred claims, net of reinsurance, as well as cumulative number of reported delinquencies and the total of IBNR liabilities plus expected development on reported claims included within the net incurred claims amounts for our Enact segment as of December 31, 2022. The information about the incurred claims development for the years ended December , to and the historical reported delinquencies as of December , and prior are presented as supplementary information. Incurred claims and allocated claim adjustment expenses, net of reinsurance Total of Number of (2) (Dollar For the years ended December 31, Accident (1) 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 Unaudited 2013 $ 475 $ 407 $ 392 $ 387 $ 384 $ 382 $ 381 $ 381 $ 381 $ 381 $ — 22,502 2014 — 328 288 269 261 259 258 259 259 258 — 17,809 2015 — — 235 208 187 181 180 180 179 179 — 15,400 2016 — — — 198 160 138 136 137 136 135 — 13,970 2017 — — — — 171 121 102 105 104 102 — 15,097 2018 — — — — — 117 84 84 78 73 — 11,269 2019 — — — — — — 106 111 98 71 — 11,883 2020 — — — — — — — 365 362 107 — 38,863 2021 — — — — — — — — 141 119 1 12,585 2022 — — — — — — — — — 220 24 14,329 Total incurred $ 1,645 (1) Represents the year in which first monthly mortgage payments have been missed by the borrower. (2) Represents reported and outstanding delinquencies less actual cures as of December 31 for each respective accident year. The following table sets forth paid claims development, net of reinsurance, for our Enact segment for the year ended December 31, 2022. The information about paid claims development for the years ended December 31, 2013 to 2021 is presented as supplementary information. (Amounts in millions) Cumulative paid claims and allocated claim adjustment expenses, net of reinsurance Accident year (1) 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 Unaudited 2013 $ 44 $ 202 $ 297 $ 340 $ 362 $ 372 $ 375 $ 376 $ 377 $ 378 2014 — 22 127 195 233 247 253 254 255 255 2015 — — 12 85 145 167 173 175 176 177 2016 — — — 10 64 110 124 127 128 129 2017 — — — — 6 46 77 87 90 92 2018 — — — — — 3 32 48 55 59 2019 — — — — — — 2 18 31 38 2020 — — — — — — — 1 8 13 2021 — — — — — — — — — 2 2022 — — — — — — — — — — Total paid $ 1,143 Total incurred $ 1,645 Total paid 1,143 All outstanding liabilities before 2013 17 Liability for policy and contract claims $ 519 (1) Represents the year in which first monthly mortgage payments have been missed by the borrower. The following table sets forth our average payout of incurred claims by age for our Enact segment as of December 31, 2022: Average annual percentage payout of incurred claims by age Years 1 2 3 4 5 6 7 8 9 10 Unaudited Percentage of payout 4.8 % 30.1 % 24.5 % 11.2 % 4.1 % 1.8 % 0.7 % 0.3 % 0.2 % 0.1 %

Employee Benefit Plans

Employee Benefit Plans	12 Months Ended
Employee Benefit Plans	Dec. 31, 2022
Employee Benefit Plans	(11) Employee Benefit Plans (a) Pension and Retiree Health and Life Insurance Benefit Plans Essentially all of our employees are enrolled in a qualified defined contribution pension plan. The plan is 100% funded by Genworth. We make annual contributions to each employee’s pension plan account based on the employee’s age, service and eligible pay. Employees are vested in the plan after three years of service. As of December 31, 2022 and 2021, we recorded a liability related to these benefits of $8 million and $11 million, respectively. In addition, certain employees also participate in non-qualified non-qualified individually or in the aggregate. As of December 31, 2022 and 2021, we recorded a liability related to these plans of $47 million and $65 million, respectively, which we accrued in other liabilities in the consolidated balance sheets. In 2022 and 2021, we recognized an increase of $26 million and $6 million, respectively, in OCI. Prior to the third quarter of 2022, the First Colony Life Insurance Company Pension Plan (“FCL Plan”) was one of our defined benefit pension plans available to certain of our employees. The First Colony Life Insurance Pension Plan Committee (“FCL Committee”), as the appointed delegate by Genworth Financial’s Board of Directors, adopted resolutions to terminate the FCL Plan in a standard termination effective December 31, 2021. The Internal Revenue Service (“IRS”) was notified of the intent to terminate the FCL Plan and subsequently issued a favorable determination letter to the FCL Committee on June 22, 2022. As permitted by the IRS determination letter, the FCL Plan settled the projected benefit obligation during 2022 by distributing FCL Plan assets to FCL Plan participants in the form of a lump sum distribution, an individual retirement account rollover to another qualified plan or by purchasing a non-participating pre-tax We provide retiree health benefits to domestic employees hired prior to January 1, 2005 who meet certain service requirements. Under this plan, retirees over 65 years of age receive a subsidy towards the purchase of a Medigap policy, and retirees under 65 years of age receive medical benefits similar to our employees’ medical benefits. In December 2009, we announced that eligibility for retiree medical benefits would be limited to associates who were within 10 years of retirement eligibility as of January 1, 2010. We also provide retiree life and long-term care insurance benefits. The plans are funded as claims are incurred. As of December 31, 2022 and 2021, the accumulated postretirement benefit obligation associated with these benefits was $50 million and $71 million, respectively, which we accrued in other liabilities in the consolidated balance sheets. In 2022 and 2021, we recognized an increase of $18 million and $11 million, respectively, in OCI. The decrease in our pension and postretirement benefit obligations and corresponding increase in OCI for the year ended December 31, 2022 was principally due to higher interest rates used to measure our pension and postretirement liabilities. Our cost associated with our pension, retiree health and life insurance benefit plans was $22 million, $18 million and $18 million for the years ended December 31, 2022, 2021 and 2020, respectively. (b) Savings Plans Our domestic employees participate in qualified and non-qualified pre-tax after two complete years ® Prior to January 2021, employees also had the option of purchasing a fund which invests primarily in Genworth Financial stock as part of the defined contribution savings plan. We had contracted with Newport Trust Company (“Newport”) to act as an independent fiduciary and investment manager with respect to Genworth Financial stock in the defined contribution savings plan. On January 8, 2021, Newport froze the fund and accordingly, future investments or transfers into the fund were suspended indefinitely. Our cost associated with these plans was $13 million for each of the years ended December 31, 2022, 2021 and 2020. (c) Health and Welfare Benefits for Active Employees We provide health and welfare benefits to our employees, including health, life, disability, dental and long-term care insurance, among others. Our long-term care insurance is provided through our group long-term care insurance products. The premiums recorded by this business related to these benefits were insignificant during 2022, 2021 and 2020.

Borrowings and Other Financings

Borrowings and Other Financings	12 Months Ended
Borrowings and Other Financings	Dec. 31, 2022
Borrowings and Other Financings	(12) Borrowings and Other Financings (a) Long-Term Borrowings The following table sets forth total long-term borrowings as of December 31: (Amounts in millions) 2022 2021 Genworth Holdings 4.80% Senior Notes, due 2024 $ — $ 282 6.50% Senior Notes, due 2034 285 298 Floating Rate Junior Subordinated Notes, due 2066 599 598 Subtotal 884 1,178 Bond consent fees (10 ) (12 ) Deferred borrowing charges (6 ) (7 ) Total Genworth Holdings 868 1,159 Enact Holdings 6.50% Senior Notes, due 2025 750 750 Deferred borrowing charges (7 ) (10 ) Total Enact Holdings 743 740 Total $ 1,611 $ 1,899 Genworth Holdings Long-Term Senior N o During the first half of 2022, Genworth Holdings repurchased $ 130 million principal amount of its % senior notes due in for a pre-tax loss of $ million and paid accrued interest thereon. On September 21, 2022, Genworth Holdings early redeemed the remainder of its % senior notes originally scheduled to mature in and wrote off $ million of bond consent fees and deferred borrowing costs. The senior notes were fully redeemed with a cash payment of $ million, comprised of the outstanding principal balan ce of $ 152 million, accrued interest of $ million and a make-whole premium of $ million. As of December 31, 2022, Genworth Holdings had outstanding fixed rate senior notes with a principal balance of $287 million and a discount of $2 million, with an interest rate of 6.50% due in June 2034. The senior notes are Genworth Holdings’ direct, unsecured obligations and rank equally in right of payment with all of its existing and future unsecured and unsubordinated obligations. Genworth Financial provides a full and unconditional guarantee to the trustee of Genworth Holdings’ outstanding senior notes and the holders of the senior notes, on an unsecured unsubordinated basis, of the full and punctual payment of the principal of, premium, if any and interest on, and all other amounts payable under, the senior notes, and the full and punctual payment of all other amounts payable by Genworth Holdings under the senior notes indenture in respect of such senior notes. Genworth Holdings has the option to redeem all or a portion of the senior notes at any time with notice to the noteholders at a price equal to the greater of 100% of principal or the sum of the present value of the remaining scheduled payments of principal and interest discounted at the then-current treasury rate plus an applicable spread. In the fourth quarter of 2022, Genworth Holdings repurchased $13 million principal amount of its senior notes due in 2034 for a pre-tax Long-Term Junior Subordinated Notes As of December 31, 2022, Genworth Holdings had outstanding floating rate junior notes having an aggregate principal amount of $600 million and a discount of $1 million, with an annual interest rate equal to three-month LIBOR plus 2.0025% payable quarterly, until the notes mature in November 2066 (“2066 Notes”). The United Kingdom Financial Conduct Authority announced its intention to eliminate the use of three-month LIBOR effective June 30, 2023. The Alternate Reference Rate Committee, convened by the Board of Governors of the Federal Reserve System and the New York Federal Reserve Bank, has endorsed the Secured Overnight Financing Rate (“SOFR”) as its preferred replacement benchmark for U.S. dollar LIBOR. SOFR is calculated and published by the New York Federal Reserve Bank and reflects the combination of three overnight U.S. Treasury Repo Rates. The rate is different from LIBOR, in that it is a risk-free rate, is backward-looking instead of forward-looking, is a secured rate and currently is available primarily as an overnight rate rather than a one-, three- or six-month rate available for LIBOR. We currently have no intention of refinancing the 2066 Notes and until the elimination of the published three-month LIBOR and transition to SOFR becomes effective and binding under the indenture governing the 2066 notes, we will continue to calculate and record interest payable and expense using three-month LIBOR plus 2.0025%. Subject to certain conditions, Genworth Holdings has the right, on one or more occasions, to defer the payment of interest on the 2066 Notes during any period of up In connection with the issuance of the 2066 Notes, we entered into a Replacement Capital Covenant, whereby we agreed, for the benefit of holders of Genworth Holdings’ 6.50% Senior Notes due 2034, that Genworth Holdings will not repay, redeem or repurchase all or any part of the 2066 Notes on or before November 15, 2046, unless such repayment, redemption or repurchase is made from the proceeds of the issuance of certain replacement capital securities and pursuant to the other terms and conditions set forth in the Replacement Capital Covenant. During the 180-day period prior to November 15, 2036 , the “scheduled redemption date,” Genworth Holdings must use its commercially reasonable efforts, subject to certain conditions, to raise sufficient net proceeds from the sale of certain qualifying capital securities to redeem the 2066 Notes on the scheduled redemption date. If Genworth Holdings has not raised sufficient net proceeds to repay the 2066 Notes in full on the scheduled redemption date, it shall repay the Notes in part on such date and on each quarterly interest payment date thereafter to the extent that it has received net proceeds from the sale of such qualifying capital securities, until the 2066 Notes have been redeemed in full. Genworth Holdings may otherwise redeem the 2066 Notes at any time in whole or in part at their principal amount plus accrued and unpaid interest to the date of redemption, subject to compliance with the Replacement Capital Covenant. The 2066 Notes will be subordinated to all existing and future senior, subordinated and junior subordinated debt of Genworth Holdings, except for any future debt that by its terms is not superior in right of payment, and will be effectively subordinated to all liabilities of our subsidiaries. Genworth Financial provides a full and unconditional guarantee to the trustee of the 2066 Notes and the holders of the 2066 Notes, on an unsecured subordinated basis, of the full and punctual payment of the principal of, premium, if any and interest on, and all other amounts payable under, the outstanding 2066 Notes, and the full and punctual payment of all other amounts payable by Genworth Holdings under the 2066 Notes indenture in respect of the 2066 Notes. Enact Holdings As of December 31, 2022, Enact Holdings had $750 million principal amount of 6.50% senior notes due in 2025. Interest on the notes is payable semi-annually in arrears on February 15 and August 15 of each year. The notes mature on August 15, 2025. Enact Holdings may redeem the notes, in whole or in part, at any time prior to February 15, 2025 at its option, by paying a make-whole premium, plus accrued and unpaid interest, if any. At any time on or after February 15, 2025, Enact Holdings may redeem the notes, in whole or in part, at its option, at 100% of the principal amount, plus accrued and unpaid interest. The notes contain customary events of default, which subject to certain notice and cure conditions, can result in the acceleration of the principal and accrued interest on the outstanding notes if Enact Holdings breaches the terms of the indenture. (b) Revolving Credit Facility Enact Holdings On June 30, 2022, Enact Holdings entered into a credit agreement with a syndicate of lenders that provides for a five-year unsecured revolving credit facility in the initial aggregate principal amount of $200 million, including the ability for Enact Holdings to increase the commitments under the credit facility on an uncommitted basis, by an additional aggregate principal amount of up to $100 million. Any borrowings under Enact Holdings’ credit facility will bear interest at a per annum rate equal to a floating rate tied to a standard short-term borrowing index selected at Enact Holdings’ option, plus an applicable margin, pursuant to the terms of the credit agreement. The applicable margin is based on Enact Holdings’ ratings established by certain debt rating agencies for its outstanding debt. Enact Holdings’ credit facility includes customary representations, warranties, covenants, terms and conditions. As of December 31, 2022, Enact Holdings was in compliance with all covenants and the credit facility remained undrawn. (c) Liquidity Principal amounts under our long-term borrowings by maturity were as follows as of December 31, 2022: (Amounts in millions) 2023 $ — 2024 — 2025 750 2026 — 2027 and thereafter 887 Total $ 1,637

Income Taxes

Income Taxes	12 Months Ended
Income Taxes	Dec. 31, 2022
Income Taxes	(13) Income Taxes Income from continuing operations before income taxes included the following components for the years ended December 31: (Amounts in millions) 2022 2021 2020 Domestic $ 978 $ 1,184 $ 931 Foreign — (3 ) (3 ) Income from continuing operations before income taxes $ 978 $ 1,181 $ 928 The total provision for income taxes was as follows for the years ended December 31: (Amounts in millions) 2022 2021 2020 Current federal income taxes $ — $ (32 ) $ — Deferred federal income taxes 239 288 226 Total federal income taxes 239 256 226 Current state income taxes 4 5 3 Deferred state income taxes (5 ) 2 2 Total state income taxes (1 ) 7 5 Current foreign income taxes — — — Deferred foreign income taxes 1 — (1 ) Total foreign income taxes 1 — (1 ) Total provision for income taxes $ 239 $ 263 $ 230 Our current income tax receivable (payable) was $3 million and $(2) million as of December 31, 2022 and 2021, respectively. The reconciliation of the federal statutory tax rate to the effective income tax rate was as follows for the years ended December 31: 2022 2021 2020 Statutory U.S. federal income tax rate 21.0 % 21.0 % 21.0 % Increase (reduction) in rate resulting from: Tax on income from terminated swaps 3.2 2.5 3.0 Reduction in uncertain tax positions — (1.8 ) — Other, net 0.2 0.6 0.8 Effective rate 24.4 % 22.3 % 24.8 % The effective tax rate for the years ended December 31, 2022, 2021 and 2020 was above the statutory U.S. federal income tax rate of 21% largely due to tax expense on certain forward starting swap gains that are tax effected at the previously enacted federal income tax rate of 35% as they are amortized into net investment income. The effective tax rate for the year ended December 31, 2022 increased compared to the year ended December 31, 2021 primarily attributable to higher tax expense on certain forward starting swap gains in relation to pre-tax The effective tax rate for the year ended December 31, 2021 decreased compared to the year ended December 31, 2020 primarily attributable to changes in uncertain tax positions due to the expiration of certain statute of limitations in 2021. The components of our deferred income taxes were as follows as of December 31: (Amounts in millions) 2022 2021 Assets: Foreign tax credit carryforwards $ 156 $ 174 Net operating loss carryforwards 4 202 Capital loss carryforwards 146 142 State income taxes 396 388 Insurance reserves 161 178 Accrued commission and general expenses 113 118 Liabilities associated with discontinued operations 122 122 Net unrealized losses on investment securities 897 — Net unrealized losses on derivatives 102 — Other 9 18 Gross deferred income tax assets 2,106 1,342 Valuation allowance (583 ) (382 ) Total deferred income tax assets 1,523 960 Liabilities: Net unrealized gains on investment securities — 506 Net unrealized gains on derivatives — 73 DAC 29 98 PVFP and other intangibles 37 38 Insurance reserves transition adjustment 74 99 Investments 20 10 Other 19 17 Total deferred income tax liabilities 179 841 Net deferred income tax asset $ 1,344 $ 119 The U.S. federal net operating loss (“NOL”) carryforward was fully utilized during 2022. The remaining NOL carryforwards relate to foreign jurisdictions and are fully offset by a valuation allowance. Foreign tax credit carryforwards amounted to $ 156 Gross capital Our valuation allowance as of December 31, 2022 and 2021 was $583 million and $382 million, respectively. Given the change in our unrealized gains (losses) on our fixed maturity securities and forward starting swaps in 2022 due to rising interest rates and the corresponding reduction in the amount of unrealized capital gains expected to be available in the future to offset our capital loss carryforwards and other capital deferred tax assets, we recorded an additional valuation allowance of $200 million during 2022 through accumulated other comprehensive income (loss) related to deferred tax assets that would produce capital losses. The remainder of the valuation allowance as of December 31, 2022 and 2021 is related to state deferred tax assets and foreign net operating losses. The state deferred tax assets related primarily to the future deductions associated with the Section 338 elections and non-insurance NOL carryforwards. Our ability to realize our net deferred tax asset of $1,344 million, which includes deferred tax assets related to capital loss, foreign tax credit and NOL carryforwards, is primarily dependent upon generating sufficient taxable income and capital gains in future years. We have net deferred tax assets of $1,267 million that have or will produce capital losses. As part of the assessment of the amount of the valuation allowance, management has asserted that it has the ability and intent to execute tax planning strategies including holding certain investment assets with unrealized losses to recovery or maturity if necessary to ensure recognition of the deferred tax asset. We have net deferred tax assets of $77 million that will produce ordinary income (loss) in future years. Management has concluded that there is sufficient positive evidence to support the expected realization of these deferred tax assets for U.S. federal income tax purposes. This positive evidence includes the fact that: (i) we are currently in a cumulative three-year income position; (ii) our U.S. operating forecasts are profitable, which include in-force premium rate increases and associated benefit reductions already obtained in our long-term care insurance business; and (iii) overall domestic losses that we have incurred are allowed to be reclassified as foreign source income which, along with future projections of foreign source income, is sufficient to cover the foreign tax credits being carried forward. After consideration of all available evidence, we have concluded that it is more likely than not that our deferred tax assets, with the exception of capital loss carryforwards, other capital deferred tax assets, state deferred tax assets and certain foreign net operating losses for which a valuation allowance has been established, will be realized. If our actual results do not validate the current projections of pre-tax As a consequence of our separation from GE and our joint election with GE to treat that separation as an asset sale under Section 338 of the Internal Revenue Code, we became entitled to additional tax deductions in post IPO periods. We were obligated, pursuant to our Tax Matters Agreement with GE, to make fixed payments to GE on an after-tax A reconciliation of the beginning and ending amount of unrecognized tax benefits was as follows: (Amounts in millions) 2022 2021 2020 Balance as of January 1 $ 40 $ 62 $ 64 Tax positions related to the current period: Gross additions — — — Gross reductions (3 ) (3 ) (3 ) Tax positions related to the prior years: Gross additions — — 1 Gross reductions (4 ) (19 ) — Balance as of December 31 $ 33 $ 40 $ 62 The total amount of unrecognized tax benefits was million as of December 31, 2022, which if recognized would affect the effective tax rate on continuing operations by million. We believe it is reasonably possible that if the uncertain tax positions were resolved in 2023, approximately $ 22 million of the unrecognized tax benefits would be recognized. We recognize accrued interest and penalties related to unrecognized tax benefits as components of income tax expense. We recorded $ — and $ 2 million of benefit in 2022 and 2021, respectively, and less than million of expense in 2020 related to interest and penalties. Our companies have elected to file a single U.S. consolidated income tax return (the “life/non-life consolidated return”). All companies domesticated in the United States are included in the life/non-life consolidated return as allowed by the tax law and regulations. We have a tax sharing agreement in place and all intercompany balances related to this agreement are settled at least annually. We are not currently subject to any significant examinations by federal or state income tax authorities. Generally, we are no longer subject to federal or state income tax examinations for years prior to 2019.

Supplemental Cash Flow Informat

Supplemental Cash Flow Information	12 Months Ended
Supplemental Cash Flow Information	Dec. 31, 2022
Supplemental Cash Flow Information	(14) Supplemental Cash Flow Information Net cash (paid) received for taxes was $(5) million, $(7) million and $3 million and cash paid for interest was $101 million, $186 million and $176 million for the years ended December 31, 2022, 2021 and 2020, respectively.

Stock-Based Compensation

Stock-Based Compensation	12 Months Ended
Stock-Based Compensation	Dec. 31, 2022
Stock-Based Compensation	(15) Stock-Based Compensation Prior to May 2012, we granted share-based awards to employees and directors, including stock options, stock appreciation rights (“SARs”), restricted stock units (“RSUs”), deferred stock units (“DSUs”) and performance stock units (“PSUs”) under the 2004 Genworth Financial, Inc. Omnibus Incentive Plan (the “2004 Omnibus Incentive Plan”). In May 2012, the 2012 Genworth Financial, Inc. Omnibus Incentive Plan (the “2012 Omnibus Incentive Plan”) was approved by stockholders. Under the 2012 Omnibus Incentive Plan, we were authorized to grant 16 million equity awards, plus a number of additional shares not to exceed 25 million underlying awards outstanding under the 2004 Omnibus Incentive Plan. In December 2018, the 2018 Genworth Financial, Inc. Omnibus Incentive Plan (the “2018 Omnibus Incentive Plan”) was approved by stockholders. Under the 2018 Omnibus Incentive Plan, we were authorized to grant 25 million equity awards, plus a number of additional shares not to exceed 20 million underlying awards outstanding under the prior Plans. In May 2021, the 2021 Genworth Financial, Inc. Omnibus Incentive Plan (the “2021 Omnibus Incentive Plan”) was approved by stockholders. Under the 2021 Omnibus Incentive Plan, we are authorized to grant 25 million equity awards, plus a number of additional shares not to exceed 20 million underlying awards outstanding under the prior Plans. The 2004 Omnibus Incentive Plan together with the 2012, 2018 and 2021 Omnibus Incentive Plans are referred to collectively as the “Omnibus Incentive Plans.” We recorded stock-based compensation expense under the Omnibus Incentive Plans of $27 million, $38 million and $39 million, respectively, for the years ended December 31, 2022, 2021 and 2020. For awards issued prior to January 1, 2006, stock-based compensation expense was recognized on a graded vesting attribution method over the awards’ respective vesting schedule. For awards issued after January 1, 2006, stock-based compensation expense was recognized evenly on a straight-line attribution method over the awards’ respective vesting period. For purposes of determining the fair value of stock-based payment awards on the date of grant, we have historically used the Black-Scholes Model. However, no SARs or stock options were granted during 2022, 2021 and 2020 and therefore, the Black-Scholes Model was not used in those respective years. The Black-Scholes Model requires the input of certain assumptions that involve judgment. Circumstances may change and additional data may become available over time, which could result in changes to these assumptions and methodologies. During 2022, 2021 and 2020, we issued RSUs with average restriction periods of three years, with a fair value per share of $4.25, $3.31 and $3.53, respectively, which were measured at the market price of a share of our Class A Common Stock on the grant date. During 2022, 2021 and 2020, we granted PSUs with a fair value per share of $4.47, $3.45 and $3.03, respectively. The PSUs were granted at market price as of the approval date by Genworth Financial’s Board of Directors. PSUs may be earned over a three-year period based upon the achievement of certain performance goals. The PSUs granted in 2022 have a three-year measurement period starting on January 1, 2022 going through December 31, 2024. The performance metric is based on our Enact segment’s adjusted operating income (loss), consolidated statutory net income of our U.S. life insurance business and Genworth’s total shareholder return over the three-year measurement period compared to certain of its peer companies established as of the grant date. See note 18 for our definition of adjusted operating income. The grant-date fair value for the adjusted operating income (loss) and consolidated statutory net income performance measures was $4.27. The grant-date fair value for the total relative shareholder return performance metric was $5.30, which was calculated using the Monte Carlo simulation. The PSUs granted in 2021 have a three-year measurement period starting on January 1, 2021 going through December 31, 2023. The performance metric is based on Genworth’s consolidated adjusted operating income and its total shareholder return relative to certain of its peer companies as of the grant date. The grant-date fair value for the adjusted operating income performance measure was $3.31. The grant-date fair value for the total relative shareholder return performance metric was $4.18, which was calculated using the Monte Carlo simulation. The valuation assumptions used in the Monte Carlo simulation to calculate the total relative shareholder return performance metric for the PSUs granted in 2022 and 2021 were as follows: 2022 2021 Valuation-date stock $ 4.27 $ 3.31 Volatility 64.6 % 65.0 % Dividend yield — % — % Risk-free rate 1.8 % 0.3 % Valuation maximum 800% of grant-date stock price 800% of grant-date stock price The PSUs granted in 2020 have a three-year measurement period starting on January 1, 2020 going through December 31, 2022. The performance metrics are based on adjusted operating income of our Enact segment and gross incremental annual premiums in our long-term care insurance business, defined as approved weighted-average premium rate increases multiplied by the annualized in-force For all PSU awards granted, the compensation committee of our Board of Directors determines and approves no later than March 15, following the end of the three-year performance period for each applicable performance period, the number of units earned and vested for each distinct performance period. For the years ended December 31, 2022, 2021 and 2020, we recorded $3 million, $16 million and $18 million, respectively, of expense associated with our PSUs. In 2022, 2021 and 2020, we granted time-based cash awards with a fair value of $1.00 per award and tha t The following table summarizes cash award activity as of December 31, 2022 and 2021: Performance- Time-based based Cash settled RSUs cash awards cash awards Number of Weighted-average Number of Number of (Awards in thousands) awards fair value awards awards Balance as of January 1, 2021 — $ — 30,429 6,938 Granted — $ — 15,473 — Performance adjustment — $ — — 5,838 Vested — $ — (14,774 ) (12,776 ) Forfeited — $ — (3,432 ) — Balance as of January 1, 2022 — $ — 27,696 — Granted 2,957 $ 4.27 208 — Performance adjustment — $ — — — Vested (23 ) $ 4.17 (13,992 ) — Forfeited (180 ) $ 4.31 (1,020 ) — Balance as of December 31, 2022 2,754 $ 4.27 12,892 — The following tables summarize the status of our other equity-based awards as of December 31, 2022 and 2021: RSUs PSUs DSUs SARs Weighted- Weighted- average Weighted- Weighted- average Number grant Number average Number average Number grant of date fair of fair of fair of date fair (Awards in thousands) awards value awards value awards value awards value Balance as of January 1, 2021 2,534 $ 3.48 5,734 $ 3.79 1,537 $ 3.95 7,030 $ 3.32 Granted 1,391 $ 3.31 2,510 $ 3.45 315 $ 2.52 — $ — Performance adjustment (1) — $ — 626 $ 3.58 — $ — — $ — Exercised (1,474 ) $ 3.47 (1,365 ) $ 3.58 (15 ) $ 7.46 — $ — Terminated (134 ) $ 3.53 — $ — — $ — (835 ) $ 3.04 Balance as of January 1, 2022 2,317 $ 3.38 7,505 $ 3.70 1,837 $ 3.42 6,195 $ 3.36 Granted 1,105 $ 4.25 2,182 $ 4.47 281 $ 2.51 — $ — Performance adjustment (1) — $ — 2,308 $ 4.61 — $ — — $ — Exercised (1,004 ) $ 3.39 (4,616 ) $ 4.61 (954 ) $ 4.02 — $ — Terminated (299 ) $ 3.52 (718 ) $ 3.55 — $ — (2,295 ) $ 2.52 Balance as of December 31, 2022 2,119 $ 3.81 6,661 $ 3.65 1,164 $ 2.44 3,900 $ 3.85 (1) The performance adjustment relates to additional awards expected to be earned through the achievement of certain performance metrics . As of December 31, 2022 and 2021, total unrecognized stock-based compensation expense related to non-vested non-cash awards not yet recognized was $ 16 million and $ 17 million, respectively. This expense is expected to be recognized over a weighted-average period of approximately two years . The actual tax benefit realized for the tax deductions from the exercise of share-based awards was $5 million and $4 million for the years ended December 31, 2022 and 2021, respectively. In connection with the minority IPO of Enact Holdings, our indirect subsidiary, Enact Holdings granted equity-based awards to its employees, including RSUs and DSUs. Additionally, in 2021, the Enact Holdings, Inc. 2021 Omnibus Incentive Plan was adopted and approved by Enact Holdings’ shareholders. Under the Enact Holdings, Inc. 2021 Omnibus Incentive Plan, Enact Holdings is authorized to issue up to four million equity awards. During 2022, Enact Holdings granted PSUs with a fair value of $22.15. The PSUs granted in 2022 have a three-year measurement period starting on January 1, 2022, going through December 31, 2024. The performance metrics are based on the standalone results of Enact Holdings, and are measured by the growth in consolidated book value per share over the three-year measurement period, calculated as the increase in book value divided by the average number of shares outstanding from January 1, 2022 to December 31, 2024. The PSUs were granted at market price as of the approval date by Enact Holdings’ Board of Directors. For the year ended December 31, 2022, and in accordance with our majority ownership, we recorded $1 million of expense associated with Enact Holdings’ PSUs. The following table summarizes the status of Enact Holdings’ equity-based awards as of December 31, 2022 and 2021: RSUs DSUs PSUs Weighted- Weighted- Weighted- Number average Number average Number average of fair of fair of fair (Awards in thousands) awards value awards value awards value Balance as of January 1, 2021 — $ — — $ — — $ — Granted 628 $ 19.02 17 $ 20.87 — $ — Dividend equivalents 36 $ 21.25 — $ — — $ — Vested — $ — — $ — — $ — Terminated (10 ) $ 19.00 — $ — — $ — Balance as of January 1, 2022 654 $ 19.02 17 $ 20.87 — $ — Granted 322 $ 22.18 78 $ 22.02 156 $ 22.15 Dividend equivalents 62 $ 24.00 5 $ 24.00 10 $ 24.00 Vested (3 ) $ 19.00 — $ — — $ — Terminated (26 ) $ 19.73 — $ — — $ — Balance as of December 31, 2022 1,009 $ 20.07 100 $ 21.81 166 $ 22.15 For the years ended December 31, 2022 and 2021, and in accordance with our majority ownership, we recorded $10 million and $2 million, respectively, of stock-based compensation expense and estimate total unrecognized expense of $13 million and $11 million, respectively, related to these awards. This expense is expected to be recognized over a weighted-average period of approximately two years.

Fair Value of Financial Instrum

Fair Value of Financial Instruments	12 Months Ended
Fair Value of Financial Instruments	Dec. 31, 2022
Fair Value of Financial Instruments	(16) Fair Value of Financial Instruments Recurring Fair Value Measurements We have fixed maturity securities, equity securities, limited partnerships, derivatives, short-term investments, embedded derivatives, separate account assets and certain other financial instruments, which are carried at fair value. Below is a description of the valuation techniques and inputs used to determine fair value by class of instrument. Fixed maturity securities, equity securities and short-term investments The fair value of fixed maturity securities, equity securities and short-term investments is estimated primarily based on information derived from third-party pricing services (“pricing services”), internal models and/or broker quotes, which use a market approach, income approach or a combination of the market and income approach depending on the type of instrument and availability of information. In general, a market approach is utilized if there is readily available and relevant market activity for an individual security. In certain cases where market information is not available for a specific security but is available for similar securities, that security is valued using market information for similar securities, which is also a market approach. When market information is not available for a specific security (or similar securities) or is available but such information is less relevant or reliable, an income approach or a combination of a market and income approach is utilized. For securities with optionality, such as call or prepayment features (including mortgage-backed or asset-backed securities), an income approach may be used. In addition, a combination of the results from market and income approaches may be used to estimate fair value. These valuation techniques may change from period to period, based on the relevance and availability of market data. Further, while we consider the valuations provided by pricing services and broker quotes to be of high quality, management determines the fair value of our investment securities after considering all relevant and available information. In general, we first obtain valuations from pricing services. If prices are unavailable for public securities, we obtain broker quotes. For all securities, excluding certain private fixed maturity securities, if neither a pricing service nor broker quotes valuation is available, we determine fair value using internal models. For certain private fixed maturity securities where we do not obtain valuations from pricing services, we utilize an internal model to determine fair value since transactions for similar securities are not readily observable and these securities are not typically valued by pricing services. Given our understanding of the pricing methodologies and procedures of pricing services, the securities valued by pricing services are typically classified as Level 2 unless we determine the valuation process for a security or group of securities utilizes significant unobservable inputs, which would result in the valuation being classified as Level 3. Broker quotes are typically based on an income approach given the lack of available market data. As the valuation typically includes significant unobservable inputs, we classify the securities where fair value is based on our consideration of broker quotes as Level 3 measurements. For private fixed maturity securities, we utilize an income approach where we obtain public bond spreads and utilize those in an internal model to determine fair value. Other inputs to the model include rating and weighted-average life, as well as sector which is used to assign the spread. We then add an additional premium, which represents an unobservable input, to the public bond spread to adjust for the liquidity and other features of our private placements. We utilize the estimated market yield to discount the expected cash flows of the security to determine fair value. We utilize price caps for securities where the estimated market yield results in a valuation that may exceed the amount that would be received in a market transaction. When a security does not have an external rating, we assign the security an internal rating to determine the appropriate public bond spread that should be utilized in the valuation. While we generally consider the public bond spreads by sector and maturity to be observable inputs, we evaluate the similarities of our private placement with the public bonds, any price caps utilized, liquidity premiums applied, and whether external ratings are available for our private placements to determine whether the spreads utilized would be considered observable inputs. We classify private securities without an external rating or public bond spread as Level 3. In general, a significant increase (decrease) in credit spreads would have resulted in a significant decrease (increase) in the fair value for our fixed maturity securities as of December 31, 2022. For remaining securities priced using internal models, we determine fair value using an income approach. We maximize the use of observable inputs but typically utilize significant unobservable inputs to determine fair value. Accordingly, the valuations are typically classified as Level 3. Our assessment of whether or not there were significant unobservable inputs related to fixed maturity securities was based on our observations obtained through the course of managing our investment portfolio, including interaction with other market participants, observations related to the availability and consistency of pricing and/or rating, and understanding of general market activity such as new issuance and the level of secondary market trading for a class of securities. Additionally, we considered data obtained from pricing services to determine whether our estimated values incorporate significant unobservable inputs that would result in the valuation being classified as Level 3. A summary of the inputs used for our fixed maturity securities, equity securities and short-term investments based on the level in which instruments are classified is included below. We have combined certain classes of instruments together as the nature of the inputs is similar. Level 1 measurements Equity securities. Separate account assets. Level 2 measurements Fixed maturity securities • Third-party pricing services: and type of inputs used may change frequently as certain inputs may be more direct drivers of valuation at the time of pricing. Examples of significant inputs incorporated by pricing services may include sector and issuer spreads, seasoning, capital structure, security optionality, collateral data, prepayment assumptions, default assumptions, delinquencies, debt covenants, benchmark yields, trade data, dealer quotes, credit ratings, maturity and weighted-average life. We conduct regular meetings with our pricing services for the purpose of understanding the methodologies, techniques and inputs used by the third-party pricing providers. The following table presents a summary of the significant inputs used by our pricing services for certain fair value measurements of fixed maturity securities that are classified as Level 2 as of December 31, 2022: (Amounts in millions) Fair value Primary methodologies Significant inputs U.S. government, agencies and $ 3,341 Price quotes from trading desk, broker feeds Bid side prices, trade prices, Option Adjusted Spread State and political subdivisions $ 2,344 Multi-dimensional attribute-based modeling systems, third-party pricing vendors Trade prices, material event notices, Municipal Market Data Non-U.S. $ 645 Matrix pricing, spread priced to Benchmark yields, trade prices, broker quotes, comparative bid-offer U.S. corporate $ 23,537 Multi-dimensional attribute-based Bid side prices to Treasury Curve, Issuer Curve, which includes sector, quality, duration, OAS percentage and change for spread matrix, trade prices, comparative transactions, Trade Reporting and Compliance Engine (“TRACE”) reports Non-U.S. $ 6,305 Multi-dimensional attribute-based OAS-based Benchmark yields, trade prices, broker quotes, comparative transactions, issuer spreads, bid-offer Residential mortgage-backed $ 973 OAS-based Prepayment and default assumptions, aggregation of bonds with similar characteristics, including collateral type, vintage, tranche type, weighted-average life, weighted-average loan age, issuer program and delinquency ratio, pay up and pay down factors, TRACE reports Commercial mortgage-backed $ 1,896 Multi-dimensional attribute-based Credit risk, interest rate risk, prepayment speeds, new issue Other asset-backed $ 2,072 Multi-dimensional attribute-based Spreads to daily updated swap curves, spreads derived from • Internal models: non-U.S. Equity securities. Short-term investments. Level 3 measurements Fixed maturity securities • Broker quotes: non-U.S. • Internal models: non-U.S. Equity securities. rating. Limited partnerships. Net asset value Limited partnerships. Derivatives We set-off non-performance non-performance non-performance Interest rate swaps. Foreign currency swaps. Level 2. Equity index options. We have equity index options associated with various equity indices. The valuation of equity index options is determined using an income approach. The primary inputs into the valuation represent forward interest rates, equity index volatility, equity index and time value component associated with the optionality in the derivative. The equity index volatility surface is determined based on market information that is not readily observable and is developed based upon inputs received from several third-party sources. Accordingly, these options are classified as Level 3. As of December 31, 2022, a significant increase (decrease) in the equity index volatility discussed above would have resulted in a significantly higher (lower) fair value measurement. Financial futures. Other foreign currency contracts. Level 2. GMWB embedded derivatives We are required to bifurcate an embedded derivative for certain features associated with annuity products and related reinsurance agreements where we provide a GMWB to the policyholder and are required to record the GMWB embedded derivative at fair value. The valuation of our GMWB embedded derivative is based on an income approach that incorporates inputs such as forward interest rates, equity index volatility, equity index and fund correlation, and policyholder assumptions such as utilization, lapse and mortality. We determine fair value using an internal model based on the various inputs noted above. Non-performance non-performance non-performance We classify the GMWB valuation as Level 3 based on having significant unobservable inputs, with equity index volatility and non-performance non-performance measurement. Fixed index annuity and indexed universal life embedded derivatives We have fixed index annuity and indexed universal life insurance products where interest is credited to the policyholder’s account balance based on equity index changes. This feature is required to be bifurcated as an embedded derivative and recorded at fair value. Fair value is determined using an income approach where the present value of the excess cash flows above the guaranteed cash flows is used to determine the value attributed to the equity index feature. The inputs used in determining the fair value include policyholder behavior (lapses and withdrawals), near-term equity index volatility, expected future interest credited, forward interest rates and an adjustment to the discount rate to incorporate non-performance risk and risk margins. As a result of our assumptions for expected future interest credited being considered significant unobservable inputs, we classify these instruments as Level 3. As expected future interest credited decreases, the value of our embedded derivative liability will decrease. As of December 31, 2022, a significant change in the unobservable inputs discussed above would have resulted in a significantly lower or higher fair value measurement. The following tables set forth our assets by class of instrument that are measured at fair value on a recurring basis as of December 31: 2022 (Amounts in millions) Total Level 1 Level 2 Level 3 NAV (1) Assets Investments: Fixed maturity securities: U.S. government, agencies and government-sponsored enterprises $ 3,341 $ — $ 3,341 $ — $ — State and political subdivisions 2,399 — 2,344 55 — Non-U.S. 645 — 645 — — U.S. corporate: Utilities 3,898 — 3,056 842 — Energy 2,262 — 2,146 116 — Finance and insurance 7,193 — 6,506 687 — Consumer—non-cyclical 4,457 — 4,375 82 — Technology and communications 2,947 — 2,923 24 — Industrial 1,197 — 1,175 22 — Capital goods 2,138 — 2,104 34 — Consumer—cyclical 1,617 — 1,504 113 — Transportation 1,100 — 1,057 43 — Other 310 — 151 159 — Total U.S. corporate 27,119 — 24,997 2,122 — Non-U.S. corporate: Utilities 740 — 445 295 — Energy 960 — 842 118 — Finance and insurance 1,946 — 1,821 125 — Consumer—non-cyclical 566 — 493 73 — Technology and communications 894 — 868 26 — Industrial 818 — 770 48 — Capital goods 546 — 451 95 — Consumer—cyclical 276 — 212 64 — Transportation 375 — 355 20 — Other 889 — 868 21 — Total non-U.S. corporate 8,010 — 7,125 885 — Residential mortgage-backed 995 — 973 22 — Commercial mortgage-backed 1,908 — 1,896 12 — Other asset-backed 2,166 — 2,072 94 — Total fixed maturity securities 46,583 — 43,393 3,190 — Equity securities 319 239 46 34 — Limited partnerships 1,816 — — 24 1,792 Other invested assets: Derivative assets: Interest rate swaps 24 — 24 — — Foreign currency swaps 20 — 20 — — Equity index options 6 — — 6 — Total derivative assets 50 — 44 6 — Short-term investments 3 — 3 — — Total other invested assets 53 — 47 6 — Reinsurance recoverable (2) 16 — — 16 — Separate account assets 4,417 4,417 — — — Total assets $ 53,204 $ 4,656 $ 43,486 $ 3,270 $ 1,792 (1) Limited partnerships that are measured at fair value using the NAV per share (or its equivalent) practical expedient have not been categorized in the fair value hierarchy. (2) Represents embedded derivatives associated with the reinsured portion of our GMWB liabilities. 2021 (Amounts in millions) Total Level 1 Level 2 Level 3 NAV (1) Assets Investments: Fixed maturity securities: U.S. government, agencies and government-sponsored enterprises $ 4,552 $ — $ 4,552 $ — $ — State and political subdivisions 3,450 — 3,368 82 — Non-U.S. 835 — 833 2 — U.S. corporate: Utilities 5,104 — 4,154 950 — Energy 2,934 — 2,858 76 — Finance and insurance 8,991 — 8,306 685 — Consumer—non-cyclical 6,159 — 6,055 104 — Technology and communications 3,808 — 3,779 29 — Industrial 1,494 — 1,457 37 — Capital goods 2,745 — 2,700 45 — Consumer—cyclical 1,899 — 1,762 137 — Transportation 1,371 — 1,307 64 — Other 419 — 165 254 — Total U.S. corporate 34,924 — 32,543 2,381 — Non-U.S. corporate: Utilities 928 — 583 345 — Energy 1,383 — 1,238 145 — Finance and insurance 2,432 — 2,272 160 — Consumer—non-cyclical 743 — 680 63 — Technology and communications 1,250 — 1,222 28 — Industrial 1,047 — 954 93 — Capital goods 705 — 532 173 — Consumer—cyclical 341 — 265 76 — Transportation 489 — 436 53 — Other 1,217 — 1,191 26 — Total non-U.S. corporate 10,535 — 9,373 1,162 — Residential mortgage-backed 1,440 — 1,413 27 — Commercial mortgage-backed 2,584 — 2,568 16 — Other asset-backed 2,160 — 2,022 138 — Total fixed maturity securities 60,480 — 56,672 3,808 — Equity securities 198 101 60 37 — Limited partnerships 1,462 — — 26 1,436 Other invested assets: Derivative assets: Interest rate swaps 364 — 364 — — Foreign currency swaps 6 — 6 — — Equity index options 42 — — 42 — Other foreign currency contracts 2 — 2 — — Total derivative assets 414 — 372 42 — Short-term investments 26 — 26 — — Total other invested assets 440 — 398 42 — Reinsurance recoverable (2) 19 — — 19 — Separate account assets 6,066 6,066 — — — Total assets $ 68,665 $ 6,167 $ 57,130 $ 3,932 $ 1,436 (1) Limited partnerships that are measured at fair value using the NAV per share (or its equivalent) practical expedient have not been categorized in the fair value hierarchy. (2) Represents embedded derivatives associated with the reinsured portion of our GMWB liabilities. The following tables present additional information about assets measured at fair value on a recurring basis and for which we have utilized significant unobservable (Level 3) inputs to determine fair value as of and for the dates indicated: Beginning balance as of January 1, Total realized and Ending balance as of December 31, 2022 Total gains (losses) (Amounts in millions) Included in net income Included Purchases Sales Issuances Settlements Transfer into Level 3 (1) Transfer out of Level 3 (1) Included Included Fixed maturity securities: State political subdivisions $ 82 $ 3 $ (30 ) $ — $ — $ — $ — $ — $ — $ 55 $ 3 $ (31 ) Non-U.S. government 2 — — 2 (3 ) — (1 ) — — — — — U.S. corporate: Utilities 950 — (211 ) 130 — — (19 ) 3 (11 ) 842 — (210 ) Energy 76 — (19 ) — — — (9 ) 68 — 116 — (20 ) Finance and insurance 685 — (147 ) 216 — — (19 ) 8 (56 ) 687 — (141 ) Consumer—non-cyclical 104 — (13 ) — — — (9 ) — — 82 — (13 ) Technology and communications 29 — (5 ) — — — — — — 24 — (5 ) Industrial 37 — (4 ) — — — (11 ) — — 22 — (4 ) Capital goods 45 — (7 ) — — — (4 ) — — 34 — (7 ) Consumer—cyclical 137 — (18 ) — — — (6 ) — — 113 — (18 ) Transportation 64 — (8 ) 5 — — (5 ) — (13 ) 43 — (7 ) Other 254 — (27 ) — (41 ) — (10 ) — (17 ) 159 — (28 ) Total U.S. corporate 2,381 — (459 ) 351 (41 ) — (92 ) 79 (97 ) 2,122 — (453 ) Non-U.S. corporate: Utilities 345 — (56 ) 24 — — (18 ) — — 295 — (55 ) Energy 145 — (15 ) 13 (21 ) — (24 ) 20 — 118 — (15 ) Finance and insurance 160 5 (40 ) — — — — — — 125 5 (41 ) Consumer—non-cyclical 63 — (8 ) 9 — — — 18 (9 ) 73 — (8 ) Technology and communications 28 — (2 ) — — — — — — 26 — (2 ) Industrial 93 — (33 ) 22 — — (20 ) — (14 ) 48 — (31 ) Capital goods 173 — (16 ) — (10 ) — (52 ) — — 95 — (16 ) Consumer—cyclical 76 — (15 ) — — — — 17 (14 ) 64 — (16 ) Transportation 53 — (3 ) — — — (30 ) — — 20 — (3 ) Other 26 — (5 ) — — — — — — 21 — (4 ) Total non-U.S. corporate 1,162 5 (193 ) 68 (31 ) — (144 ) 55 (37 ) 885 5 (191 ) Residential mortgage-backed 27 — (8 ) 14 — — (2 ) 4 (13 ) 22 — (6 ) Commercial mortgage-backed 16 — (5 ) — — — — 1 — 12 — (6 ) Other asset-backed 138 — (15 ) 77 (6 ) — (7 ) — (93 ) 94 — (13 ) Total fixed maturity securities 3,808 8 (710 ) 512 (81 ) — (246 ) 139 (240 ) 3,190 8 (700 ) Equity securities 37 — — 1 (3 ) — — — (1 ) 34 — — Limited partnerships 26 (2 ) — — — — — — — 24 (2 ) — Other invested assets: Derivative assets: Equity index options 42 (20 ) — 13 — — (29 ) — — 6 (7 ) — Total derivative assets 42 (20 ) — 13 — — (29 ) — — 6 (7 ) — Total other invested assets 42 (20 ) — 13 — — (29 ) — — 6 (7 ) — Reinsurance recoverable (2) 19 (4 ) — — — 1 — — — 16 (4 ) — Total Level 3 assets $ 3,932 $ (18 ) $ (710 ) $ 526 $ (84 ) $ 1 $ (275 ) $ 139 $ (241 ) $ 3,270 $ (5 ) $ (700 ) (1) The transfers into and out of Level 3 for fixed maturity securities were related to changes in the primary pricing source and changes in the observability of external information used in determining the fair value, such as external ratings or credit spreads, as well as changes in the industry sectors assigned to specific securities. (2) Represents embedded derivatives associated with the reinsured portion of our GMWB liabilities. Beginning balance as of January 1, Total realized and Ending balance as of December 31, 2021 Total gains (losses) (Amounts in millions) Included in net income Included Purchases Sales Issuances Settlements Transfer into Level 3 (1) Transfer out of Level 3 (1) Included Included Fixed maturity securities: State political subdivisions $ 66 $ 3 $ 13 $ — $ — $ — $ — $ — $ — $ 82 $ 3 $ 13 Non-U.S. government — — — 2 — — — — — 2 — — U.S. corporate: Utilities 842 — 3 118 — — (18 ) 18 (13 ) 950 — 4 Energy 128 — 4 50 — — (10 ) 8 (104 ) 76 — 1 Finance and insurance 607 — (18 ) 233 — — (46 ) 17 (108 ) 685 — (16 ) Consumer—non-cyclical 109 — (2 ) — — — (3 ) 3 (3 ) 104 — (2 ) Technology and communications 47 — (1 ) 12 — — — 4 (33 ) 29 — (1 ) Industrial 40 — — 17 — — (20 ) — — 37 — (1 ) Capital goods 60 — (1 ) — — — (14 ) — — 45 — (2 ) Consumer—cyclical 150 — — — — — (5 ) — (8 ) 137 — — Transportation 70 — (1 ) — — — (5 ) — — 64 — (1 ) Other 219 — (1 ) — — — (32 ) 88 (20 ) 254 — 1 Total U.S. corporate 2,272 — (17 ) 430 — — (153 ) 138 (289 ) 2,381 — (17 ) Non-U.S. corporate: Utilities 352 — (5 ) 30 — — (8 ) — (24 ) 345 — (6 ) Energy 245 — 7 — — — (28 ) — (79 ) 145 — 3 Finance and insurance 305 3 (1 ) 1 (2 ) — (62 ) — (84 ) 160 5 (14 ) Consumer—non-cyclical 67 1 (2 ) 8 — — (14 ) 3 — 63 — (2 ) Technology and communications 28 — — — — — — — — 28 — (1 ) Industrial 95 2 (4 ) 14 — — (14 ) — — 93 — (2 ) Capital goods 178 — 1 25 — — — — (31 ) 173 — — Consumer—cyclical 146 — — 17 — — — — (87 ) 76 — — Transportation 109 3 (3 ) — — — (49 ) — (7 ) 53 — — Other 83 6 (3 ) — — — (45 ) — (15 ) 26 — (1 ) Total non-U.S. 1,608 15 (10 ) 95 (2 ) — (220 ) 3 (327 ) 1,162 5 (23 ) Residential mortgage-backed 14 — — 5 — — (2 ) 10 — 27 — — Commercial mortgage-backed 20 — (2 ) 1 — — (3 ) — — 16 1 (2 ) Other asset-backed 109 — — 69 — — (25 ) 35 (50 ) 138 — — Total fixed maturity securities 4,089 18 (16 ) 602 (2 ) — (403 ) 186 (666 ) 3,808 9 (29 ) Equity securities 51 — — — (9 ) — (5 ) — — 37 — — Limited partnerships 17 1 — 8 — — — — — 26 1 — Other invested assets: Derivative assets: Equity index options 63 18 — 31 — — (70 ) — — 42 10 — Total derivative assets 63 18 — 31 — — (70 ) — — 42 10 — Total other invested assets 63 18 — 31 — — (70 ) — — 42 10 — Reinsurance recoverable (2) 26 (9 ) — — — 2 — — — 19 (9 ) — Total Level 3 assets $ 4,246 $ 28 $ (16 ) $ 641 $ (11 ) $ 2 $ (478 ) $ 186 $ (666 ) $ 3,932 $ 11 $ (29 ) (1) The transfers into and out of Level 3 for fixed maturity securities were related to changes in the primary pricing source and changes in the observability of external information used in determining the fair value, such as external ratings or credit spreads, as well as changes in the industry sectors assigned to specific securities. (2) Represents embedded derivatives associated with the reinsured portion of our GMWB liabilities. Beginning balance as of January 1, Total realized and Ending balance as of December 31, 2020 Total gains (losses) (Amounts in millions) Included net income Included Purchases Sales Issuances Settlements Transfer into Level 3 (1) Transfer out of Level 3 (1) Included Included Fixed maturity securities: State political subdivisions $ 102 $ 3 $ (11 ) $ — $ — $ — $ (1 ) $ — $ (27 ) $ 66 $ 3 $ (11 ) Non-U.S. government — — — — — — (1 ) 1 — — — — U.S. corporate: Utilities 865 9 8 76 (13 ) — (56 ) 42 (89 ) 842 — 14 Energy 129 1 1 30 (21 ) — (21 ) 22 (13 ) 128 — (3 ) Finance and insurance 572 2 16 167 — — (41 ) — (109 ) 607 — 19 Consumer—non-cyclical 94 — 4 8 — — (22 ) 25 — 109 — 4 Technology and communications 50 — 3 82 — — (1 ) 13 (100 ) 47 — 5 Industrial 40 — — — — — — — — 40 — — Capital goods 102 — — — — — (8 ) 11 (45 ) 60 — 1 Consumer—cyclical 173 3 4 15 — — (36 ) 47 (56 ) 150 — 6 Transportation 78 — (1 ) — — — (4 ) 27 (30 ) 70 — 2 Other 136 — 2 25 — — (7 ) 87 (24 ) 219 — 2 Total U.S. corporate 2,239 15 37 403 (34 ) — (196 ) 274 (466 ) 2,272 — 50 Non-U.S. corporate: Utilities 374 — 10 13 — — — 28 (73 ) 352 — 9 Energy 247 — (5 ) 7 — — (28 ) 24 — 245 — (5 ) Finance and insurance 234 4 17 15 — — (10 ) 77 (32 ) 305 4 17 Consumer—non-cyclical 59 — 3 20 — — — 1 (16 ) 67 — 2 Technology and communications 28 — — — — — — — — 28 — 1 Industrial 104 — 4 — — — (5 ) — (8 ) 95 — 3 Capital goods 161 1 1 20 — — (39 ) 34 — 178 — 1 Consumer—cyclical 147 — 3 21 — — (26 ) 32 (31 ) 146 — 2 Transportation 191 — 1 7 — — (10 ) 22 (102 ) 109 — 4 Other 140 9 (1 ) 6 — — (72 ) 1 — 83 — 2 Total non-U.S. 1,685 14 33 109 — — (190 ) 219 (262 ) 1,608 4 36 Residential mortgage-backed 27 — (1 ) — — — (1 ) 4 (15 ) 14 — — Commercial mortgage-backed 6 — 1 — — — — 20 (7 ) 20 — 1 Other asset-backed 93 — 1 124 — — (16 ) 10 (103 ) 109 — — Total fixed maturity securities 4,152 32 60 636 (34 ) — (405 ) 528 (880 ) 4,089 7 76 Equity securities 51 — — 6 (7 ) — — 1 — 51 — — Limited partnerships 16 (2 ) — 3 — — — — — 17 (2 ) — Other invested assets: Derivative assets: Equity index options 81 4 — 59 — — (81 ) — — 63 5 — Total derivative assets 81 4 — 59 — — (81 ) — — 63 5 — Total other invested assets 81 4 — 59 — — (81 ) — — 63 5 — Reinsurance recoverable (2) 20 4 — — — 2 — — — 26 4 — Total Level 3 assets $ 4,320 $ 38 $ 60 $ 704 $ (41 ) $ 2 $ (486 ) $ 529 $ (880 ) $ 4,246 $ 14 $ 76 (1) The transfers into and out of Level 3 for fixed maturity securities were related to changes in the primary pricing source and changes in the observability of external information used in determining the fair value, such as external ratings or credit spreads, as well as changes in the industry sectors assigned to specific securities. (2) Represents embedded derivatives associated with the reinsured portion of our GMWB liabilities. The following table presents the gains and losses included in net income from assets measured at fair value on a recurring basis and for which we have utilized significant unobservable (Level 3) inputs to determine fair value and the related income statement line item in which these gains and losses were presented for the years ended December 31: (Amounts in millions) 2022 2021 2020 Total realized and unrealized gains (losses) included in net income: Net investment income $ 8 $ 19 $ 32 Net investment gains (26 ) 9 6 To t l $ (18 ) $ 28 $ 38 Total gains (losses) included in net income attributable to assets still held: Net investment income $ 8 $ 9 $ 7 Net investment gains (13 ) 2 7 T ot l $ (5 ) $ 11 $ 14 The amount presented for realized and unrealized gains (losses) included in net income for fixed maturity securities primarily represents amortization and accretion of premiums and discounts on certain fixed maturity securities. The following table presents a summary of the significant unobservable inputs used for certain asset fair value measurements that are based on internal models and classified as Level 3 as of December 31, 2022 : (Amounts in millions) Valuation technique Fair value Unobservable input Range Weighted-average (1) Fixed maturity securities: U.S. corporate: Utilities Internal models $ 813 Credit spreads 55 bps - 279 bps 168 bps Energy Internal models 45 Credit spreads 132 bps - 272 bps 197 bps Finance and insurance Internal models 674 Credit spreads 67 bps - 292 bps 208 bps Consumer—non-cyclical Internal models 82 Credit spreads 71 bps - 272 bps 152 bps Technology and communications Internal models 24 Credit spreads 113 bps - 181 bps 153 bps Industrial Internal models 22 Credit spreads 132 bps - 239 bps 161 bps Capital goods Internal models 34 Credit spreads 85 bps - 211 bps 159 bps Consumer—cyclical Internal models 113 Credit spreads 105 bps - 222 bps 154 bps Transportation Internal models 43 Credit spreads 49 bps - 188 bps 126 bps Other Internal models 111 Credit spreads 90 bps - 153 bps 102 bps Total U.S. corporate Internal models $ 1,961 Credit spreads 49 bps - 292 bps 176 bps Non-U.S. corporate: Utilities Internal models $ 295 Credit spreads 82 bps - 224 bps 145 bps Energy Internal models 110 Credit spreads 102 bps - 239 bps 171 bps Finance and insurance Internal models 124 Credit spreads 136 bps - 203 bps 161 bps Consumer—non-cyclical Internal models 70 Credit spreads 71 bps - 163 bps 110 bps Technology and communications Internal models 25 Credit spreads 102 bps - 138 bps 126 bps Industrial Internal models 48 Credit spreads 85 bps - 197 bps 149 bps Capital goods Internal models 95 Credit spreads 71 bps - 272 bps 167 bps Consumer—cyclical Internal models 50 Credit spreads 102 bps - 197 bps 159 bps Transportation Internal models 20 Credit spreads 138 bps - 197 bps 150 bps Other Internal models 21 Credit spreads 84 bps - 158 bps 132 bps Total non-U.S. corporate Internal models $ 858 Credit spreads 71 bps - 272 bps 150 bps Derivative assets: Equity index options Discounted cash flows $ 6 Equity index 6 % - 25 % 20% (1) Unobservable inputs weighted by the relative fair value of the associated instrument for fixed maturity securities and by notional for derivative assets. Certain classes of instruments classified as Level 3 are excluded above as a result of not being material or due to limitations in being able to obtain the underlying inputs used by certain third-party sources, such as broker quotes, used as an input in determining fair value. The following tables set forth our liabilities by class of instrument that are measured at fair value on a recurring basis as of December 31: 2022 (Amounts in millions) Total Level 1 Level 2 Level 3 Liabilities Policyholder account balances: GMWB embedded derivatives (1) $ 223 $ — $ — $ 223 Fixed index annuity embedded derivatives 202 — — 202 Indexed universal life embedded derivatives 15 — — 15 Total policyholder account balances 440 — — 440 Derivative liabilities: Interest rate swaps 522 — 522 — Total derivative liabilities 522 — 522 — Total liabilities $ 962 $ — $ 522 $ 440 (1) Represents embedded derivatives associated with our GMWB liabilities, excluding the impact of reinsurance. 2021 (Amounts in millions) Total Level 1 Level 2 Level 3 Liabilities Policyholder account balances: GMWB embedded derivatives (1) $ 271 $ — $ — $ 271 Fixed index annuity embedded derivatives 294 — — 294 Indexed universal life embedded derivatives 25 — — 25 Total policyholder account balances 590 — — 590 Derivative liabilities: Interest rate swaps 26 — 26 — Total derivative liabilities 26 — 26 — Total liabilities $ 616 $ — $ 26 $ 590 (1) Represents embedded derivatives associated with our GMWB liabilities, excluding the impact of reinsurance. The following tables present additional information about liabilities measured at fair value on a recurring basis and for which we have utilized significant unobservable (Level 3) inputs to determine fair value as of and for the dates indicated: Beginning as of Total realized and Ending as of Total (gains) losses (Amounts in millions) Included in net Included Purchases Sales Issuances Settlements Transfer Transfer Included Included Policyholder account balances: GMWB derivatives (1) $ 271 $ (70 ) $ — $ — $ — $ 22 $ — $ — $ — $ 223 $ (66 ) $ — Fixed index annuity embedded derivatives 294 (16 ) — — — — (73 ) — (3 ) 202 (16 ) — Indexed universal life embedded derivatives 25 (27 ) — — — 17 — — — 15 (27 ) — Total policyholder account balances 590 (113 ) — — — 39 (73 ) — (3 ) 440 (109 ) — Total Level 3 liabilities $ 590 $ (113 ) $ — $ — $ — $ 39 $ (73 ) $ — $ (3 ) $ 440 $ (109 ) $ — (1) Represents embedded derivatives associated with our GMWB liabilities, excluding the impact of reinsurance. Beginning as of Total realized and Ending as of Total (gains) losses (Amounts in millions) Included in Included Purchases Sales Issuances Settlements Transfer Transfer Included Included Policyholder account balances: GMWB derivatives (1) $ 379 $ (133 ) $ — $ — $ — $ 25 $ — $ — $ — $ 271 $ (127 ) $ — Fixed index annuity embedded derivatives 399 32 — — — — (136 ) — (1 ) 294 32 — Indexed universal life embedded derivatives 26 (24 ) — — — 23 — — — 25 (24 ) — Total policyholder account balances 804 (125 ) — — — 48 (136 ) — (1 ) 590 (119 ) — Total Level 3 liabilities $ 804 $ (125 ) $ — $ — $ — $ 48 $ (136 ) $ — $ (1 ) $ 590 $ (119 ) $ — (1) Represents embedded derivatives associated with our GMWB liabilities, excluding the impact of reinsurance. Beginning as of Total realized and Ending as of Total (gains) losses (Amounts in millions) Included in Included Purchases Sales Issuances Settlements Transfer Transfer Included Included Policyholder account balances: GMWB derivatives (1) $ 323 $ 32 $ — $ — $ — $ 24 $ — $ — $ — $ 379 $ 38 $ — Fixed index annuity embedded derivatives 452 51 — — — — (104 ) — — 399 51 — Indexed universal life embedded derivatives 19 (17 ) — — — 24 — — — 26 (17 ) — Total policyholder account balances 794 66 — — — 48 (104 ) — — 804 72 — Total Level 3 liabilities $ 794 $ 66 $ — $ — $ — $ 48 $ (104 ) $ — $ — $ 804 $ 72 $ — (1) Represents embedded derivatives associated with our GMWB liabilities, excluding the impact of reinsurance. The following table presents the gains and losses included in net (income) from liabilities measured at fair value on a recurring basis and for which we have utilized significant unobservable (Level 3) inputs to determine fair value and the related income statement line item in which these gains and losses were presented for the years ended December 31: (Amounts in millions) 2022 2021 2020 Tot

Insurance Subsidiary Financial

Insurance Subsidiary Financial Information and Regulatory Matters	12 Months Ended
	Dec. 31, 2022
Insurance Subsidiary Financial Information and Regulatory Matters	(17) Insurance Subsidiary Financial Information and Regulatory Matters Dividends Our insurance subsidiaries are subject to oversight by applicable insurance laws and regulations as to the amount of dividends they may pay to their parent in any year, the purpose of which is to protect affected insurance policyholders or contractholders, not stockholders. In general, dividends and distributions are required to be submitted to an insurer’s domiciliary department of insurance for review, and the payment of any dividend or distribution from a source other than unassigned surplus requires prior written regulatory approval. Enact Holdings’ ability to pay dividends is limited in part by such regulatory restrictions on its insurance subsidiaries. Based on estimated statutory results as of December 31, 2022, in accordance with applicable dividend restrictions, Enact Holdings’ mortgage insurance subsidiaries could pay dividends of approximately $ 292 million in 2023 from unassigned surplus without affirmative regulatory approval, although notice of the intent to pay must be provided to the state insurance commissioner 30 days in advance thereof, during which time the commissioner may review the dividend pursuant to statutory standards. Even though the approximately $292 million is considered unrestricted, Enact Holdings may not pay dividends at this level in 2023 for a variety of reasons, including the need to preserve capital for regulatory purposes, future growth and capital requirements. Although the financial results of our principal U.S. life insurance subsidiaries have improved, they had negative unassigned surplus of $849 m 2023 or the foreseeable future if they need to meet capital requirements and desired thresholds. As of December 31, 2022, Genworth Financial’s and Genworth Holdings’ consolidated subsidiaries had restricted net assets of respectively. Enact Holdings paid dividends during 2022, 2021 and 2020 of $251 million, $200 million and $437 million, respectively. Dividends paid by Enact Holdings in 2022 and 2021 included cash dividends to Genworth Holdings of $205 conditions. Our principal U.S. life insurance subsidiaries did not pay any dividends in 2022, 2021 or 2020. In the first quarter of 2021, our international subsidiaries paid a dividend of $370 million to Genworth Holdings from the net proceeds of the Genworth Mortgage Insurance Limited (“Genworth Australia”) U.S. domiciled insurance subsidiaries—statutory financial information Our U.S. domiciled insurance subsidiaries file financial statements with state insurance regulatory authorities and the NAIC that are prepared on an accounting basis either prescribed or permitted by such authorities. Statutory accounting practices differ from U.S. GAAP in several respects, causing differences in reported net income (loss) and stockholders’ equity. Permitted statutory accounting practices encompass all accounting practices not so prescribed but that have been specifically allowed by individual state insurance authorities. Our U.S. domiciled insurance subsidiaries have no material permitted accounting practices, except for River Lake Insurance Company VI (“River Lake VI”), River Lake Insurance Company VII (“River Lake VII”), River Lake Insurance Company VIII (“River Lake VIII”) and River Lake Insurance Company X (“River Lake X”), collectively, the “SPFCs.” The permitted practices of the SPFCs were an essential element of their design and were expressly included in their plans of operation and in the licensing orders issued by their domiciliary state regulators and without those permitted accounting practices, these entities could be subject to regulatory action. Accordingly, we believe that the permitted accounting practices will remain in effect for so long as we maintain the SPFCs. The material permitted accounting practices for the SPFCs were as follows: • In 2022 and 2021, River Lake VI had a permitted accounting practice from the State of Delaware to carry its excess of loss reinsurance agreement with The Canada Life Assurance Company for its universal life insurance business assumed from Genworth Life and Annuity Insurance Company (“GLAIC”) as an admitted asset. Effective December 1, 2021, River Lake VI was granted a permitted accounting practice from the State of Delaware to carry its excess of loss reinsurance agreement with The Canada Life Assurance Company for its term life insurance business assumed from GLAIC as an admitted asset. • Effective December 1, 2021, River Lake X was granted a permitted accounting practice from the State of Vermont to carry its excess of loss reinsurance agreement with Hannover Life Reassurance Company of America for its term life insurance business assumed from GLAIC as an admitted asset. In 2020, River Lake VII, River Lake VIII and River Lake X each had a permitted accounting practice from the State of Vermont to carry their reserves on a basis similar to U.S. GAAP, which was withdrawn by River Lake X in 2021. As of December 31, 2021, there were no remaining statutory reserves in River Lake VII and River Lake VIII as discussed below. The impact of these permitted accounting practices of the SPFCs on our combined U.S. domiciled life insurance subsidiaries’ statutory capital and surplus was zero as of December 31, 2022 and 2021. If these permitted accounting practices had not been used, no regulatory event would have been triggered. For regulatory purposes, our U.S. mortgage insurers are required to establish a special statutory contingency reserve. Annual additions to the statutory contingency reserve must be at least 50% of net earned premiums, as defined by state insurance laws and regulations. These contingency reserves generally are held until the earlier of (i) the time that loss ratios exceed 35% or (ii) 10 years. However, approval by the North Carolina Department of Insurance (“NCDOI”) is required for contingency reserve releases when loss ratios exceed 35%. The statutory contingency reserve for our U.S. mortgage insurers was approximately $3.6 billion and $3.0 billion, respectively, as of December 31, 2022 and 2021 and is included in the table below containing combined statutory capital and surplus balances. The tables below include the combined statutory net income and statutory capital and surplus for our U.S. domiciled insurance subsidiaries for the periods indicated: Years ended December 31, (Amounts in millions) 2022 2021 2020 Combined statutory net income (loss): Life insurance subsidiaries, excluding captive life reinsurance subsidiaries $ 276 $ 654 $ 197 Mortgage insurance subsidiaries 747 593 404 Combined statutory net income, excluding captive reinsurance subsidiaries 1,023 1,247 601 Captive life insurance subsidiaries 253 (1,351 ) 9 Combined statutory net income (loss) $ 1,276 $ (104 ) $ 610 As of December 31, (Amounts in millions) 2022 2021 Combined statutory capital and surplus: Life insurance subsidiaries, excluding captive life reinsurance subsidiaries $ 3,082 $ 2,945 Mortgage insurance subsidiaries 4,687 4,439 Combined statutory capital and surplus $ 7,769 $ 7,384 The statutory net income (loss) from our captive life reinsurance subsidiaries relates to the reinsurance of term and universal life insurance statutory reserves assumed from our U.S. domiciled life insurance companies. These reserves are, in turn, secured by excess of loss reinsurance treaties with third parties. Additionally, the life insurance subsidiaries’ combined statutory net income (loss) and distributable income are not affected by the statutory net income (loss) of the captives, except to the extent dividends are received from the captives. The combined statutory capital and surplus of our life insurance subsidiaries does not include the capital and surplus of our captive life reinsurance subsidiaries of $ million as of December , and , respectively. In December 2021, GLAIC recaptured its term life insurance business previously ceded to River Lake VII and River Lake VIII. GLAIC then immediately ceded that recaptured business to SCOR Global Life USA Reinsurance Company. Prior to the GLAIC recapture, River Lake VII and River Lake VIII also recaptured all external reinsurance with third parties and terminated those agreements. As a result, there was no remaining reinsurance (assumed or ceded) in River Lake VII or River Lake VIII. River Lake VII and River Lake VIII also returned capital of $29 Effective July 1, 2021, GLAIC recaptured all of the term and universal life insurance business previously ceded to Jamestown Assignment Company, Inc. (“Jamestown”), its wholly-owned subsidiary. Additionally, Jamestown novated all of its remaining ceded reinsurance agreements to GLAIC. During 2021, Jamestown returned $104 Capital Requirements of U.S. Life Insurers The NAIC has adopted RBC requirements to evaluate the adequacy of statutory capital and surplus in relation to risks associated with: (i) asset risk; (ii) insurance risk; (iii) interest rate and equity market risk; and (iv) business risk. The RBC formula is designated as an early warning tool for the states to identify possible undercapitalized companies for the purpose of initiating regulatory action. In the course of operations, we periodically monitor the RBC level of each of our life insurance subsidiaries. As of December 31, 2022 and 2021, each of our life insurance subsidiaries exceeded the minimum required RBC levels in their respective domiciliary state. The consolidated RBC ratio of our U.S. domiciled life insurance subsidiaries was approximately 291% and 289% as of December 31, 2022 and 2021, respectively. In released guarantees as part of Actuarial Guideline 38 8D (“AG 38 8D”) in our Virginia and Delaware licensed life insurance subsidiaries. additional AG 38 8D statutory reserves. As a part of our cash flow testing process for our U.S. life insurance subsidiaries, we consider incremental benefits from expected future in-force rate actions in our long-term care insurance products that would help mitigate the impact of deteriorating experience. The New York State Department of Financial Services (“NYDFS”), which regulates Genworth Life Insurance Company of New York (“GLICNY”), generally does not permit in-force rate increases for long-term care insurance to be used in asset adequacy analysis until such increases have been approved. However, the NYDFS has allowed GLICNY to incorporate recently filed in-force rate actions in its asset adequacy analysis prior to approval in the past. Moreover, the NYDFS has consistently granted approval for GLICNY to spread asset adequacy analysis reserve deficiencies related to its long-term care insurance business over future years. The NYDFS also requires specific adequacy testing scenarios that are generally more severe than those deemed acceptable in other states. Moreover, the required testing scenarios by the NYDFS have a disproportionate impact on our long-term care insurance products. In addition, we historically used nationwide experience for setting assumptions in our long-term care insurance products in cash flow testing for all of our legal entities, including GLICNY. We have been monitoring emerging experience with our GLICNY policyholders, as their experience has been began 2020 the $98 million and $ million of additional statutory reserves in 2022 and 2021, respectively. As a result of the 2022 and 2021 activity, the aggregate amount of statutory reserves established by GLICNY for asset adequacy deficits increased to million related to long-term care insurance and million related to variable annuities) and Capital Requirements of U.S. Mortgage Insurers Mortgage insurers are not subject to the NAIC’s RBC requirements but certain states and other regulators impose another form of capital requirement on mortgage insurers requiring maintenance of a risk-to-capital ratio not to exceed :1. Fifteen other states maintain similar risk-to-capital requirements. As of December 31, 2022 and 2021, the risk-to-capital ratio of Enact Holdings’ combined insurance subsidiaries was approximately :1 and :1, respectively, under the current regulatory framework as established under North Carolina law and enforced by the NCDOI, Enact Holdings’ insurance subsidiaries’ domestic insurance regulator. Each of Enact Holdings’ insurance subsidiaries met its respective capital requirements as of December 31, 2022 and 2021. Private mortgage insurers must meet the operational and financial requirements under PMIERs as set forth by the GSEs in order to remain eligible to insure loans that are purchased by the GSEs. Each approved mortgage insurer is required to provide the GSEs with an annual certification and a quarterly report evidencing its compliance with PMIERs. Since 2020, the GSEs have issued several amendments to PMIERs, which implemented both permanent and temporary revisions to PMIERs. Many of the provisions are no longer applicable, but for loans that became non-performing COVID-19, risk-based (ii) above include those that are either in a repayment plan or loan modification trial period following the forbearance plan unless reported to the approved insurer that the loan is no longer in such forbearance plan, repayment plan, or loan modification trial period. The PMIERs amendment dated June 30, 2021 further allows loans that enter a forbearance plan due to COVID-19 hardship on or after April 1, 2021 to remain eligible for extended application of the reduced PMIERs capital factor for as long as the loan remains in forbearance. In addition, the PMIERs amendments made permanent revisions to the risk-based required asset amount factor for non-performing loans for properties located in future Federal Emergency Management Agency Declared Major Disaster Areas eligible for individual assistance. In September 2020, subsequent to the issuance of Enact Holdings’ senior notes due in 2025, the GSEs imposed certain restrictions (the “GSE Restrictions”) with respect to capital on Enact. In May 2021, in connection with their conditional approval of the then potential partial sale of Enact Holdings, the GSEs confirmed the GSE Restrictions will remain in effect until the following collective conditions (“GSE Conditions”) are met for two consecutive quarters: (a) EMICO obtains “BBB+”/“Baa1” (or higher) rating from Standard & Poor’s Financial Services, LLC, Moody’s Investors Service, Inc. or Fitch Ratings, Inc. and (b) Genworth achieves certain financial metrics. EMICO maintained the requisite ratings for two consecutive quarters prior to the end of 2022. Given Genworth’s strengthened financial position, Genworth’s financial metrics were met in the third and fourth quarters of 2022, marking two consecutive quarters of achieving the financial metrics. Therefore, we believe the GSE Conditions have been fully satisfied and expect the GSE Restrictions to be lifted in early 2023, subject to GSE review and confirmation. Prior to the satisfaction of the GSE Conditions, the GSE Restrictions require: • EMICO to maintain 120% of PMIERs minimum required assets through 2022 (which it maintained) and 125% thereafter; • Enact Holdings to retain $300 million of its holding company cash that can be drawn down exclusively for its debt service or to contribute to EMICO to meet its regulatory capital needs including PMIERs; and • written approval must be received from the GSEs prior to any additional debt issuance by either EMICO or Enact Holdings. Until the GSE Conditions imposed in connection with the GSE Restrictions are met, Enact Holdings’ liquidity must not fall below 13.5 % of its outstanding debt. As of December 31, 2022, after taking into account debt service to date, Enact Holdings must maintain holding company liquidity of approximately $ 203 million. Enact Holdings had $453 million of cash, cash equivalents and invested assets as of December 31, 2022. Enact has met all PMIERs reporting requirements as required by the GSEs. As of December 31, 2022 and 2021, Enact had estimated available assets of $ December 31, 2022 and 2021 was 165 % for both periods, or $ 2,050 million and $ 2,003 million, respectively, above the published PMIERs requirements. PMIERs sufficiency is based on the published requirements applicable to private mortgage insurers and does not give effect to the GSE Restrictions imposed on Enact. Enact’s PMIERs required assets as of December 31, 2022 and 2021 benefited from the application of a 0.30 0.30 multiplier to all eligible delinquencies provided $ 132 million and $ 390 million of benefit to Enact’s December 31, 2022 and 2021 PMIERs required assets, respectively. Securities on deposit Certain of our insurance subsidiaries have securities on deposit with various state or foreign government insurance departments in order to comply with relevant insurance regulations. See note 4(d) for additional in Guarantees of obligations In addition to the commitments discussed in note 20, Genworth Financial and certain of its holding companies provide guarantees to third parties for the performance of certain obligations of their subsidiaries. We estimate that our potential obligations under such guarantees were $69 million and $10 million as of December 31, 2022 and 2021, respectively. The potential obligations as of December 31, 2022 include amounts associated with leasing agreements related to our new headquarters office. Genworth Holdings has provided a limited guarantee of up to $175 million, subject to adjustments, to one of its insurance subsidiaries to support its mortgage insurance business in Mexico. In January 2022, Genworth Holdings terminated this limited guarantee in regard to new business. We believe this insurance subsidiary has adequate reserves to cover its underlying obligations. Genworth Holdings also provided an unlimited guarantee for the benefit of policyholders for the payment of valid claims by our European mortgage insurance subsidiary prior to its sale in May 2016. Following the sale of this United Kingdom subsidiary to AmTrust Financial Services, Inc., the guarantee was limited to the payment of valid claims on policies in-force mi On March 1, 2021, Genworth Holdings entered into a guarantee agreement with Genworth Financial International Holdings, LLC (“GFIH”) whereby Genworth Holdings agreed to contribute additional capital to GFIH related to certain of its liabilities, or otherwise satisfy or discharge those liabilities. The liabilities include but are not limited to, claims and financial obligations or other liabilities of GFIH that existed immediately prior to the distribution of the net proceeds from the Genworth Australia sale. Pursuant to the agreement, Genworth Holdings paid AXA approximately €15 million ($18 million) in the second quarter of 2021 to settle amounts owed related to underwriting losses on a product sold by a distributor in our former lifestyle protection insurance business.

Segment Information

Segment Information	12 Months Ended
Segment Information	Dec. 31, 2022
Segment Information	(18) Segment Information (a) Operating Segment Information We have the following three operating business segments: Enact; U.S. Life Insurance (which includes our long-term care insurance, life insurance and fixed annuities businesses); and Runoff (which includes the results of non-strategic products which have not been actively sold since 2011). In addition to our three operating business segments, we also have Corporate and Other activities which include debt financing expenses that are incurred at the Genworth Holdings level, unallocated corporate income and expenses, eliminations of inter-segment transactions and the results of other businesses that are reported outside of our operating segments, including certain international mortgage insurance businesses and discontinued operations. We tax our businesses at the U.S. corporate federal income tax rate of %. Each segment is then adjusted to reflect the unique tax attributes of that segment, such as permanent differences between U.S. GAAP and tax law. The difference between the consolidated provision for income taxes and the sum of the provision for income taxes in each segment is reflected in Corporate and Other activities. We use the same accounting policies and procedures to measure segment income (loss) and assets as our consolidated net income and assets. Our chief operating decision maker evaluates segment performance and allocates resources on the basis of “adjusted operating income (loss) available to Genworth Financial, Inc.’s common stockholders.” We define adjusted operating income (loss) available to Genworth Financial, Inc.’s common stockholders as income (loss) from continuing operations excluding the after-tax non-operating non-recourse non-operating non-operating While some of these items may be significant components of net income (loss) available to Genworth Financial, Inc.’s common stockholders in accordance with U.S. GAAP, we believe that adjusted operating income (loss) available to Genworth Financial, Inc.’s common stockholders, and measures that are derived from or incorporate adjusted operating income (loss) available to Genworth Financial, Inc.’s common stockholders, are appropriate measures that are useful to investors because they identify the income (loss) attributable to the ongoing operations of the business. Management also uses adjusted operating income (loss) available to Genworth Financial, Inc.’s common stockholders as a basis for determining awards and compensation for senior management and to evaluate performance on a basis comparable to that used by analysts. However, the items excluded from adjusted operating income (loss) available to Genworth Financial, Inc.’s common stockholders have occurred in the past and could, and in some cases will, recur in the future. Adjusted operating income (loss) available to Genworth Financial, Inc.’s common stockholders is not a substitute for net income (loss) available to Genworth Financial, Inc.’s common stockholders determined in accordance with U.S. GAAP. In addition, our definition of adjusted operating income (loss) available to Genworth Financial, Inc.’s common stockholders may differ from the definitions used by other companies. Adjustments to reconcile net income (loss) available to Genworth Financial, Inc.’s common stockholders to adjusted operating income (loss) assume a 21% tax rate and are net of the portion attributable to noncontrolling interests. Net investment gains (losses) are also adjusted for DAC and other intangible amortization and certain benefit reserves. During 2022, we paid a pre-tax pre-tax pre-tax pre-tax pre-tax pre-tax pre-tax pre-tax Life Insurance Company non-recourse pre-tax write-off In 2021, we recorded a pre-tax In 2022, 2021 and 2020, we recorded a pre-tax During 2022, we incurred $8 million of pre-tax The following is a summary of our segments and Corporate and Other activities as of and for the years ended December 31: U.S. Life Corporate 2022 Enact Insurance Runoff and Other Total (Amounts in millions) Premiums $ 940 $ 2,773 $ — $ 6 $ 3,719 Net investment income 155 2,769 214 8 3,146 Net investment gains (losses) (2 ) 16 (16 ) (15 ) (17 ) Policy fees and other income 2 543 114 — 659 Total revenues 1,095 6,101 312 (1 ) 7,507 Benefits and other changes in policy reserves (94 ) 4,301 35 — 4,242 Interest credited — 322 181 — 503 Acquisition and operating expenses, net of deferrals 227 1,078 42 24 1,371 Amortization of deferred acquisition costs and intangibles 12 272 23 — 307 Interest expense 52 — — 54 106 Total benefits and expenses 197 5,973 281 78 6,529 Income (loss) from continuing operations before income taxes 898 128 31 (79 ) 978 Provision (benefit) for income taxes 194 55 5 (15 ) 239 Income (loss) from continuing operations 704 73 26 (64 ) 739 Income from discontinued operations, net of taxes — — — — — Net income (loss) 704 73 26 (64 ) 739 Less: net income from continuing operations attributable to noncontrolling interests 130 — — — 130 Less: net income from discontinued operations attributable to noncontrolling interests — — — — — Net income (loss) available to Genworth Financial, Inc.’s common stockholders $ 574 $ 73 $ 26 $ (64 ) $ 609 Net income (loss) available to Genworth Financial, Inc.’s common stockholders: Income (loss) from continuing operations available to Genworth Financial, Inc.’s common stockholders $ 574 $ 73 $ 26 $ (64 ) $ 609 Income from discontinued operations available to Genworth Financial, Inc.’s common stockholders — — — — — Net income (loss) available to Genworth Financial, Inc.’s common stockholders $ 574 $ 73 $ 26 $ (64 ) $ 609 Total assets $ 5,712 $ 70,977 $ 7,888 $ 1,865 $ 86,442 U.S. Life Corporate 2021 Enact Insurance Runoff and Other Total (Amounts in millions) Premiums $ 975 $ 2,454 $ — $ 6 $ 3,435 Net investment income 141 3,029 194 6 3,370 Net investment gains (losses) (2 ) 329 3 (7 ) 323 Policy fees and other income 4 565 134 1 704 Total revenues 1,118 6,377 331 6 7,832 Benefits and other changes in policy reserves 125 4,230 27 1 4,383 Interest credited — 346 162 — 508 Acquisition and operating expenses, net of deferrals 230 865 53 75 1,223 Amortization of deferred acquisition costs and intangibles 15 340 20 2 377 Interest expense 51 — — 109 160 Total benefits and expenses 421 5,781 262 187 6,651 Income (loss) from continuing operations before income taxes 697 596 69 (181 ) 1,181 Provision (benefit) for income taxes 148 155 13 (53 ) 263 Income (loss) from continuing operations 549 441 56 (128 ) 918 Income from discontinued operations, net of taxes — — — 27 27 Net income (loss) 549 441 56 (101 ) 945 Less: net income from continuing operations attributable to noncontrolling interests 33 — — — 33 Less: net income from discontinued operations attributable to noncontrolling interests — — — 8 8 Net income (loss) available to Genworth Financial, Inc.’s common stockholders $ 516 $ 441 $ 56 $ (109 ) $ 904 Net income (loss) available to Genworth Financial, Inc.’s common stockholders: Income (loss) from continuing operations available to Genworth Financial, Inc.’s common stockholders $ 516 $ 441 $ 56 $ (128 ) $ 885 Income from discontinued operations available to Genworth Financial, Inc.’s common stockholders — — — 19 19 Net income (loss) available to Genworth Financial, Inc.’s common stockholders $ 516 $ 441 $ 56 $ (109 ) $ 904 Total assets $ 5,850 $ 81,210 $ 9,460 $ 2,651 $ 99,171 U.S. Life Corporate 2020 Enact Insurance Runoff and Other Total (Amounts in millions) Premiums $ 971 $ 2,858 $ — $ 7 $ 3,836 Net investment income 133 2,878 210 6 3,227 Net investment gains (losses) (4 ) 517 (26 ) 5 492 Policy fees and other income 6 595 130 (2 ) 729 Total revenues 1,106 6,848 314 16 8,284 Benefits and other changes in policy reserves 381 4,781 48 4 5,214 Interest credited — 383 166 — 549 Acquisition and operating expenses, net of deferrals 206 620 48 61 935 Amortization of deferred acquisition costs and intangibles 21 418 23 1 463 Interest expense 18 5 — 172 195 Total benefits and expenses 626 6,207 285 238 7,356 Income (loss) from continuing operations before income taxes 480 641 29 (222 ) 928 Provision (benefit) for income taxes 102 163 4 (39 ) 230 Income (loss) from continuing operations 378 478 25 (183 ) 698 Loss from discontinued operations, net of taxes — — — (486 ) (486 ) Net income (loss) 378 478 25 (669 ) 212 Less: net income from continuing operations attributable to noncontrolling interests — — — — — Less: net income from discontinued operations attributable to noncontrolling interests — — — 34 34 Net income (loss) available to Genworth Financial, Inc.’s common stockholders $ 378 $ 478 $ 25 $ (703 ) $ 178 Net income (loss) available to Genworth Financial, Inc.’s common stockholders: Income (loss) from continuing operations available to Genworth Financial, Inc.’s common stockholders $ 378 $ 478 $ 25 $ (183 ) $ 698 Loss from discontinued operations available to Genworth Financial, Inc.’s common stockholders — — — (520 ) (520 ) Net income (loss) available to Genworth Financial, Inc.’s common stockholders $ 378 $ 478 $ 25 $ (703 ) $ 178 (b) Revenues of Major Product Groups The following is a summary of revenues of major product groups for our segments and Corporate and Other activities for the years ended December 31: (Amounts in millions) 2022 2021 2020 Revenues: Enact segment $ 1,095 $ 1,118 $ 1,106 U.S. Life Insurance segment: Long-term care insurance 4,459 4,875 4,960 Life insurance 1,253 996 1,357 Fixed annuities 389 506 531 U.S. Life Insurance segment 6,101 6,377 6,848 Runoff segment 312 331 314 Corporate and Other activities (1 ) 6 16 Total revenues $ 7,507 $ 7,832 $ 8,284 (c) Reconciliations The following tables present the reconciliation of net income available to Genworth Financial, Inc.’s common stockholders to adjusted operating income available to Genworth Financial, Inc.’s common stockholders and a summary of adjusted operating income (loss) available to Genworth Financial, Inc.’s common stockholders for our segments and Corporate and Other activities for the years ended December 31: (Amounts in millions) 2022 2021 2020 Net income available to Genworth Financial, Inc.’s common stockholders $ 609 $ 904 $ 178 Add: net income from continuing operations attributable to noncontrolling interests 130 33 — Add: net income from discontinued operations attributable to noncontrolling interests — 8 34 Net income 739 945 212 Less: income (loss) from discontinued operations, net of taxes — 27 (486 ) Income from continuing operations 739 918 698 Less: net income from continuing operations attributable to noncontrolling interests 130 33 — Income from continuing operations available to Genworth Financial, Inc.’s common stockholders 609 885 698 Adjustments to income from continuing operations available to Genworth Financial, Inc.’s common stockholders: Net investment (gains) losses, net (1) 14 (324 ) (503 ) Losses on early extinguishment of debt 6 45 9 Initial loss from life block transaction — 92 — Expenses related to restructuring 2 34 3 Pension plan termination costs 8 — — Taxes on adjustments (6 ) 33 103 Adjusted operating income available to Genworth Financial, Inc.’s common stockholders $ 633 $ 765 $ 310 (1) For the years ended December 31, 2022, 2021 and 2020, net investment (gains) losses were adjusted f (3) million, $(1) million and $ (11) million, respectively. (Amounts in millions) 2022 2021 2020 Adjusted operating income (loss) available to Genworth Financial, Inc.’s common stockholders: Enact segment $ 578 $ 520 $ 381 U.S. Life Insurance segment: Long-term care insurance 142 445 237 Life insurance (148 ) (269 ) (247 ) Fixed annuities 72 91 78 U.S. Life Insurance segment 66 267 68 Runoff segment 37 54 43 Corporate and Other activities (48 ) (76 ) (182 ) Adjusted operating income available to Genworth Financial, Inc.’s common stockholders $ 633 $ 765 $ 310 (d) Geographic Segment Information The following is a summary of geographic region activity as of and for the years ended December 31: 2022 (Amounts in millions) United States International (1) Total Total revenues $ 7,499 $ 8 $ 7,507 Income (loss) from continuing operations $ 739 $ — $ 739 Net income (loss) $ 739 $ — $ 739 Total assets $ 86,400 $ 42 $ 86,442 2021 (Amounts in millions) United States International (1) Total Total revenues $ 7,825 $ 7 $ 7,832 Income (loss) from continuing operations $ 921 $ (3 ) $ 918 Net income (loss) $ 948 $ (3 ) $ 945 Total assets $ 99,117 $ 54 $ 99,171 2020 (Amounts in millions) United States International (1) Total Total revenues $ 8,275 $ 9 $ 8,284 Income (loss) from continuing operations $ 700 $ (2 ) $ 698 Net income $ 214 $ (2 ) $ 212 (1) Predominantly comprised of operations in Mexico.

Quarterly Results of Operations

Quarterly Results of Operations (unaudited)	12 Months Ended
Quarterly Results of Operations (unaudited)	Dec. 31, 2022
Quarterly Results of Operations (unaudited)	(19) Quarterly Results of Operations (unaudited) Our unaudited quarterly results of operations for the year ended December 31, 2022 are summarized in the table below. Three months ended March 31, June 30, September 30, December 31, (Amounts in millions, except per share amounts) 2022 2022 2022 2022 Total revenues $ 1,892 $ 1,881 $ 1,839 $ 1,895 Total benefits and expenses (1), (2) $ 1,653 $ 1,588 $ 1,653 $ 1,635 Income from continuing operations (1), (2) $ 181 $ 220 $ 134 $ 204 Income (loss) from discontinued operations, net of taxes $ (2 ) $ (1 ) $ 5 $ (2 ) Net income (1), (2) $ 179 $ 219 $ 139 $ 202 Net income from continuing operations attributable to noncontrolling interests $ 30 $ 38 $ 35 $ 27 Net income from discontinued operations attributable to noncontrolling interests $ — $ — $ — $ — Net income available to Genworth Financial, Inc.’s common stockholders (1), (2) $ 149 $ 181 $ 104 $ 175 Net income available to Genworth Financial, Inc.’s common stockholders: Income from continuing operations available to Genworth Financial, Inc.’s common stockholders $ 151 $ 182 $ 99 $ 177 Income (loss) from discontinued operations available to Genworth Financial, Inc.’s (2 ) (1 ) 5 (2 ) Net income available to Genworth Financial, Inc.’s common stockholders $ 149 $ 181 $ 104 $ 175 Income from continuing operations available to Genworth Financial, Inc.’s common stockholders per share: Basic $ 0.30 $ 0.36 0.20 $ 0.36 Diluted $ 0.29 $ 0.36 $ 0.19 $ 0.35 Net income available to Genworth Financial, Inc.’s common stockholders per share: Basic $ 0.29 $ 0.36 $ 0.21 $ 0.35 Diluted $ 0.29 $ 0.35 $ 0.20 $ 0.35 Weighted-average common shares outstanding: Basic 508.3 509.0 504.0 496.7 Diluted 517.4 514.2 509.4 503.2 (1) In the fourth quarter of 2022, our Enact segment recorded a pre-tax net favorable reserve adjustment of 42 million primarily related to COVID-19 delinquencies in 2020 and 2021 curing at levels above original reserve expectations. (2) In the fourth quarter of 2022, our life insurance business completed its annual review of assumptions for its universal and term universal life insurance products and recorded a pre-tax favorable unlocking of 43 million mostly attributable to higher interest rates. Our unaudited quarterly results of operations for the year ended December 31, 2021 are summarized in the table below. Three months ended March 31, June 30, September 30, December 31, (Amounts in millions, except per share amounts) 2021 2021 2021 2021 Total revenues (1) $ 1,985 $ 2,041 $ 2,070 $ 1,736 Total benefits and expenses (2) $ 1,752 $ 1,721 $ 1,697 $ 1,481 Income from continuing operations (1), (2), (3) $ 174 $ 245 $ 306 $ 193 Income (loss) from discontinued operations, net of taxes $ 21 $ (5 ) $ 12 $ (1 ) Net income (1), (2), (3) $ 195 $ 240 $ 318 $ 192 Net income from continuing operations attributable to noncontrolling interests (4) $ — $ — $ 4 $ 29 Net income from discontinued operations attributable to noncontrolling interests $ 8 $ — $ — $ — Net income available to Genworth Financial, Inc.’s (4) $ 187 $ 240 $ 314 $ 163 Net income available to Genworth Financial, Inc.’s common stockholders: Income from continuing operations available to Genworth Financial, Inc.’s common stockholders $ 174 $ 245 $ 302 $ 164 Income (loss) from discontinued operations available to Genworth Financial, Inc.’s common stockholders 13 (5 ) 12 (1 ) Net income available to Genworth Financial, Inc.’s common stockholders $ 187 $ 240 $ 314 $ 163 Income from continuing operations available to Genworth Financial, Inc.’s common stockholders per share: Basic $ 0.35 $ 0.48 $ 0.59 $ 0.32 Diluted $ 0.34 $ 0.47 $ 0.59 $ 0.32 Net income available to Genworth Financial, Inc.’s common stockholders per share: Basic $ 0.37 $ 0.47 $ 0.62 $ 0.32 Diluted $ 0.37 $ 0.47 $ 0.61 $ 0.32 Weighted-average common shares outstanding: Basic 506.0 507.0 507.4 507.4 Diluted 513.8 515.0 514.2 515.6 (1) In the fourth quarter of 2021, our life insurance business initially ceded $360 million of premiums associated with certain term life insurance policies under a new reinsurance treaty as part of a life block transaction. (2) In the fourth quarter of 2021, our life insurance business initially ceded $268 million of certain term life insurance reserves under a new reinsurance treaty as part of a life block transaction. Our life insurance business also completed its annual review of assumptions in the fourth quarter of 2021. This review resulted in higher total benefits and expenses of $87 million from an unfavorable unlocking in our term universal and universal life insurance products largely attributable to higher pre-COVID-19 (3) In the fourth quarter of 2021, our life insurance business recorded a net loss of $131 million predominantly driven by an initial loss of $73 million as a result of ceding certain term life insurance policies as part of a life block transaction, an unfavorable unlocking of $70 million associated with its annual review of assumptions and a DAC impairment of $32 million as a result of recoverability testing. (4) On September 20, 2021, we completed the minority IPO of Enact Holdings, which reduced our ownership percentage to 81.6%, and lowered our available net income by $29 million in the fourth quarter of 2021.

Commitments and Contingencies

Commitments and Contingencies	12 Months Ended
Commitments and Contingencies	Dec. 31, 2022
Commitments and Contingencies	(20) Commitments and Contingencies (a) Litigation and Regulatory Matters We face the risk of litigation and regulatory investigations and actions in the ordinary course of operating our businesses, including the risk of class action lawsuits. Our pending legal and regulatory actions include proceedings specific to us and others generally applicable to business practices in the industries in which we operate. In our insurance operations, we are, have been, or may become subject to class actions and individual suits alleging, among other things, issues relating to sales or underwriting practices, increases to in-force In October 2016, Genworth Financial, certain members of its executive management team, including its former and present chief executive officer, and current and former members of its board of directors were named as defendants in a shareholder derivative suit filed by Esther Chopp in the Court of Chancery of the State of Delaware. The case is captioned Chopp v. McInerney, et al In September 2018, GLAIC, our indirect wholly-owned subsidiary, was named as a defendant in a putative class action lawsuit pending in the United States District Court for the Eastern District of Virginia captioned TVPX ARX INC., as Securities Intermediary for Consolidated Wealth Management, LTD. on behalf of itself and all others similarly situated v. Genworth Life and Annuity Insurance Company non-mortality for the Eleventh Circuit. On June 22, 2022, we filed our opening brief in support of the appeal. Plaintiff filed its respondent’s brief on September 20, 2022, and we filed our reply brief on November 10, 2022. We intend to continue to vigorously defend this action. In September 2018, Genworth Financial, Genworth Holdings, Genworth North America Corporation, GFIH and Genworth Life Insurance Company (“GLIC”) were named as defendants in a putative class action lawsuit pending in the Court of Chancery of the State of Delaware captioned Richard F. Burkhart, William E. Kelly, Richard S. Lavery, Thomas R. Pratt, Gerald Green, individually and on behalf of all other persons similarly situated v. pay-off On April 6, 2020, GLAIC was named as a defendant in a putative class action lawsuit filed in the United States District Court for the Eastern District of Virginia, captioned Brighton Trustees, LLC, on behalf of and as trustee for Diamond LS Trust; and Bank of Utah, solely as securities intermediary for Diamond LS Trust; on behalf of themselves and all others similarly situated v. Genworth Life and Annuity Insurance Company Ronald L. Daubenmier, individually and on behalf of himself and all others similarly situated v. Genworth Life and Annuity Insurance Company cases. On July 17, 2020, the Brighton Trustees and Daubenmier plaintiffs filed a consolidated complaint, alleging that GLAIC subjected policyholders to unlawful and excessive increases to cost of insurance charges. The consolidated complaint asserts claims for breach of contract and injunctive relief, and seeks damages in excess of $5 million. The parties participated in a mediation on November 18, 2021. On March 25, 2022, the parties reached an agreement in principle to settle the action for $25 million, subject to Court approval. The Court gave final approval to the settlement on October 17, 2022. We accrued $25 million for this litigation as of March 31, 2022. In the second quarter of 2022, we paid the accrued balance in full, and accordingly, have no remaining amounts outstanding related to the settlement. In January 2021, GLIC and Genworth Life Insurance Company of New York (“GLICNY”) were named as defendants in a putative class action lawsuit pending in the United States District Court for the Eastern District of Virginia captioned Judy Halcom, Hugh Penson, Harold Cherry, and Richard Landino, individually, and on behalf of all others similarly situated v. Genworth Life Insurance Company and Genworth Life Insurance Company of New York The trial was scheduled to commence on June 1, 2022. On June 18, 2021, following two days of mediation, the parties reached an agreement in principle to settle this matter on a nationwide basis and signed the settlement agreement on August 23, 2021. On August 31, 2021, the Court preliminarily approved the settlement. The final approval hearing occurred on 2022, the Court issued its final approval of the settlement, which became final on July 29, 2022, when the appeals period expired and no appeal was filed. We began implementation of this settlement on August 1, 2022, which did not have a material impact on our results of operations during 2022. Because the election mailings occur based on the policyholder’s policy anniversary date, the majority of the impacts are expected to be realized in 2023. We expect an overall net favorable impact to our long-term care insurance business from the settlement of this case. In January 2021, GLAIC was named as a defendant in a putative class action lawsuit pending in the United States District Court for the District of Oregon captioned Patsy H. McMillan, Individually and On Behalf Of All Others Similarly Situated, v. Genworth Life and Annuity Insurance Company On February 10, 2023, the parties reached an agreement in principle to settle the action for an immaterial amount. If the settlement is not finalized, we intend to continue to vigorously defend this action. On August 11, 2021, GLIC and GLICNY received a request for pre-suit million. Genworth participated in pre-suit mediation in November 2021 and January 2022. On January 15, 2022, the parties reached an agreement in principle to settle the dispute on a nationwide basis, subject to the negotiation and execution of a final settlement agreement, and Court approval thereof. On January 28, 2022, the complaint was filed in the United States District Court for the Eastern District of Virginia captioned Fred Haney, Marsha Merrill, Sylvia Swanson, and Alan Wooten, individually, and on behalf of all others similarly situated v. Genworth Life Insurance Company and Genworth Life Insurance Company of New York preliminarily approved the settlement. The final approval hearing commenced on November 17, 2022 and the Court entered judgment finally approving the settlement on February 15, 2023. The judgment will become final 30 days after its entry, or upon the final resolution of any timely appeal. We expect an overall net favorable impact to our long-term care insurance business from the settlement of this case. On August 1, 2022, a putative class action was filed in the United States District Court for the Eastern District of Virginia by two former Genworth employees against Genworth Financial, its Board of Directors and the Fiduciary and Investments Committee of Genworth Financial’s Retirement and Savings Plan (“Savings Plan”). Plaintiffs purport to act on behalf of the Savings Plan and all similarly simulated participants and beneficiaries of the Savings Plan. The complaint asserts that the defendants breached their fiduciary duties under the Employee Retirement Income Security Act of 1974 by imprudently offering and inadequately monitoring a suite of BlackRock Target Date Funds as a retirement investment option for Genworth employees. Plaintiffs seek declaratory and injunctive relief, monetary damages, and attorney’s fees. By stipulation entered September 6, 2022, the complaint was dismissed, without prejudice, against the Board of Directors and the Fiduciary and Investments Committee of Genworth Financial’s Savings Plan. On October 17, 2022, we moved to dismiss the complaint against the sole remaining defendant, Genworth Financial. Plaintiffs filed opposition papers on November 10, 2022, and we filed our reply papers on November 16, 2022. By order dated January 20, 2023, the Court granted plaintiffs’ motion to serve an amended complaint, and as a result, our initial motion to dismiss is now moot. On January 20, 2023, plaintiffs filed an amended complaint and on February 2, 2023, we filed a motion to dismiss the amended complaint. We intend to continue to vigorously defend this action. On December 16, 2022, Blue Cross Blue Shield of Nebraska (“BCBSNE”) served an arbitration demand on GLIC in relation to BCBSNE’s stated intent to recapture a block of long-term care insurance policies for which the risk was partly ceded to GLIC. In its arbitration demand, BCBSNE alleges that GLIC breached the governing reinsurance agreement by refusing to agree to transfer assets equal to the fair value of the liabilities being recaptured. BCBSNE asserts it has satisfied all of its obligations under the reinsurance agreement and is seeking to recapture the ceded block of reinsurance. BCBSNE seeks damages equal to the fair value of the recaptured liabilities, plus interest and other damages, including attorneys’ fees and costs. The parties are currently appointing the arbitration panel. We intend to vigorously defend this arbitration proceeding. At this time, we cannot determine or predict the ultimate outcome of any of the pending legal and regulatory matters specifically identified above or the likelihood of potential future legal and regulatory matters against us. Except as disclosed above, we are not able to provide an estimate or range of reasonably possible losses related to these matters. Therefore, we cannot ensure that the current investigations and proceedings will not have a material adverse effect on our business, financial condition or results of operations. In addition, it is possible that related investigations and proceedings may be commenced in the future, and we could become subject to additional unrelated investigations and lawsuits. Increased regulatory scrutiny and any resulting investigations or proceedings could result in new legal precedents and industry-wide regulations or practices that could adversely affect our business, financial condition and results of operations. (b) Commitments As of December 31, 2022, we were committed to fund $1,365 million in limited partnership investments, $70 million of bank loan investments which had not yet been drawn, $19 million in private placement investments and $5 million in commercial mortgage loan investments.

Changes in Accumulated Other Co

Changes in Accumulated Other Comprehensive Income (Loss)	12 Months Ended
Changes in Accumulated Other Comprehensive Income (Loss)	Dec. 31, 2022
Changes In Accumulated Other Comprehensive Income (Loss)	(21) Changes in Accumulated Other Comprehensive Income (Loss) The following tables show the changes in accumulated other comprehensive income (loss), net of taxes, by component as of and for the periods indicated: Net Foreign unrealized currency investment Derivatives translation gains qualifying as and other (Amounts in millions) (losses) (1) hedges (2) adjustments Total Balances as of January 1, 2022 $ 1,860 $ 2,025 $ (24 ) $ 3,861 OCI before reclassifications (5,430 ) (674 ) 37 (6,067 ) Amounts reclassified from (to) OCI 58 (151 ) (7 ) (100 ) Current period OCI (5,372 ) (825 ) 30 (6,167 ) Balances as of December 31, 2022 before noncontrolling interests (3,512 ) 1,200 6 (2,306 ) Less: change in OCI attributable to noncontrolling interests (86 ) — — (86 ) Balances as of December 31, 2022 $ (3,426 ) $ 1,200 $ 6 $ (2,220 ) (1) Net of adjustments to DAC, PVFP, sales inducements, benefit reserves and policyholder contract balances. See note 4 for additional information. (2) See note 5 for additional information. Net Foreign unrealized currency investment Derivatives translation gains qualifying as and other (Amounts in millions) (losses) (1) hedges (2) adjustments Total Balances as of January 1, 2021 $ 2,214 $ 2,211 $ — $ 4,425 OCI before reclassifications (313 ) (45 ) 148 (210 ) Amounts reclassified from (to) OCI (51 ) (141 ) — (192 ) Current period OCI (364 ) (186 ) 148 (402 ) Balances as of December 31, 2021 before noncontrolling interests 1,850 2,025 148 4,023 Less: change in OCI attributable to noncontrolling interests (10 ) — 172 162 Balances as of December 31, 2021 $ 1,860 $ 2,025 $ (24 ) $ 3,861 (1) Net of adjustments to DAC, PVFP, sales inducements, benefit reserves and policyholder contract balances. See note 4 for additional information. (2) See note 5 for additional information. 278 Net Foreign unrealized currency investment Derivatives translation gains qualifying as and other (Amounts in millions) (losses) (1) hedges (2) adjustments Total Balances as of January 1, 2020 $ 1,456 $ 2,002 $ (25 ) $ 3,433 OCI before reclassifications 1,132 344 55 1,531 Amounts reclassified from (to) OCI (374 ) (135 ) — (509 ) Current period OCI 758 209 55 1,022 Balances as of December 31, 2020 before noncontrolling interests 2,214 2,211 30 4,455 Less: change in OCI attributable to noncontrolling interests — — 30 30 Balances as of December 31, 2020 $ 2,214 $ 2,211 $ — $ 4,425 (1) Net of adjustments to DAC, PVFP, sales inducements, benefit reserves and policyholder contract balances. See note 4 for additional information. (2) See note 5 for additional information. The foreign currency translation and other adjustments balance in the charts above included $34 million, $(1) million and $(15) million, respectively, net of taxes of $(8) million, $1 million and $4 million, respectively, related to a net unrecognized postretirement benefit obligation as of December 31, 2022, 2021 and 2020. The balance also included taxes of $ 2 after-tax The following table shows reclassifications out of accumulated other comprehensive income (loss), net of taxes, for the periods presented: Amount reclassified from accumulated other comprehensive income (loss) Affected line item in the Years ended December 31, consolidated statements (Amounts in millions) 2022 2021 2020 of income Net unrealized investment (gains) losses: Unrealized (gains) losses on investments (1) $ 74 $ (65 ) $ (474 ) Net investment (gains) losses Income taxes (16 ) 14 100 Provision for income taxes Total $ 58 $ (51 ) $ (374 ) Derivatives designated as hedges: Interest rate swaps hedging assets $ (225 ) $ (217 ) $ (196 ) Net investment income Interest rate swaps hedging assets (9 ) (1 ) (12 ) Net investment (gains) losses Interest rate swaps hedging liabilities 3 1 — Interest expense Income taxes 80 76 73 Provision for income taxes Total $ (151 ) $ (141 ) $ (135 ) (1) Amounts exclude adjustments to DAC, PVFP, sales inducements, benefit reserves and policyholder contract balances.

Noncontrolling Interests

Noncontrolling Interests	12 Months Ended
Noncontrolling Interests	Dec. 31, 2022
Noncontrolling Interests	(22) Noncontrolling Interests Enact Holdings On September 15, 2021, Enact Holdings, Genworth Financial’s indirect subsidiary, priced the IPO of its common shares. All of the shares were offered by the selling stockholder, Genworth Holdings, Genworth Financial’s wholly owned subsidiary, with the net proceeds from the IPO retained by Genworth Holdings. Genworth Holdings sold 13,310,400 of Enact Holdings’ common shares at an IPO price of $19.00 per common share. In addition to the shares sold in the IPO, 14,655,600 common shares were sold in a concurrent private sale (“Private Sale”) at a price per share of $17.86, which was equal to the IPO price less the underwriting discount per share. Genworth Holdings also granted the underwriters a 30-day Offering and as of December 31, 2022, we beneficially owned approximately The gross proceeds of the Offering, before payment of underwriter fees and other expenses, were $553 million. Costs directly related to the Offering, including underwriter fees and other expenses, were $24 million. Consistent with applicable accounting guidance, changes in the ownership of a subsidiary that do not result in a loss of control are accounted for as equity transactions with no gain or loss recognized through earnings. Any difference between the carrying value and the fair value related to the change in ownership is recorded as an adjustment to stockholders’ equity. A summary of these changes in ownership interests and the effect on stockholders’ equity was as follows for the year ended December 31, 2021: (Amounts in millions) Net income available to Genworth Financial, Inc.’s common stockholders $ 904 Transfers to noncontrolling interests: Decrease in Genworth Financial, Inc.’s paid-in (167 ) Net transfers to noncontrolling interests (167 ) Change from net income available to Genworth Financial, Inc.’s common stockholders and transfers to noncontrolling interests $ 737 On November 1, 2022, Enact Holdings announced the approval by its board of directors of a share repurchase program under which Enact Holdings may repurchase up to million of its outstanding common stock. Genworth Holdings has agreed to participate in order to maintain its overall ownership at its current level. Enact Holdings began share repurchases under the program in the fourth quarter of 2022. Dividends of $46 million and $37 million were paid to owners of noncontrolling interests of Enact Holdings in 2022 and 2021, respectively. Genworth Australia Prior to the sale of Genworth Australia on March 3, 2021, we held approximately 52% of its common shares on a consolidated basis through subsidiaries and accounted for the portion attributable to noncontrolling interests as a component of total equity. Upon sale closing, we deconsolidated Genworth Australia, which included the de-recognition of the carrying value of ownership interest attributable to noncontrolling interests of $500 million from total equity in our consolidated balance sheet.

Discontinued Operations

Discontinued Operations	12 Months Ended
Discontinued Operations	Dec. 31, 2022
Discontinued Operations	(23) Discontinued Operations Australia mortgage insurance business On March 3, 2021, we completed the sale of our entire ownership interest of approximately 52% in Genworth Australia through an underwriting agreement and received approximately AUD483 million ($370 million) of net cash proceeds. The following table provides a summary of the gain (loss) on sale associated with the disposition of Genworth Australia for the year ended December 31, 2021: (Amounts in millions) Net cash proceeds $ 370 Add: carrying value of noncontrolling interests (1) 657 Total adjusted consideration (2) 1,027 Carrying value of the disposal group before accumulated other comprehensive (income) loss 1,040 Add: total accumulated other comprehensive (income) loss of disposal group (3) 109 Total adjusted carrying value of the disposal group 1,149 Pre-tax (122 ) Tax benefit on sale 122 After-tax $ — (1) In accordance with accounting guidance on the deconsolidation of a subsidiary or group of assets, the carrying amount of any noncontrolling interests in the subsidiary sold (adjusted to reflect amounts in accumulated other comprehensive income (loss) recognized upon final disposition) is added to the total fair value of the consideration received. (2) Represents the aggregate of the net cash proceeds received upon sale closing plus the adjusted carrying amount of noncontrolling interests in the subsidiary sold. (3) Amount consists of $160 million of cumulative losses on foreign currency translation adjustments, partially offset by cumulative unrealized investment gains of $29 million and deferred tax gains of $22 million. In addition, we recorded an after-tax A summary of operating results related to Genworth Australia reported as discontinued operations was as follows for the years ended December 31: (Amounts in millions) 2021 2020 Revenues: Premiums $ 51 $ 274 Net investment income 4 33 Net investment gains (losses) (5 ) 66 Policy fees and other income — 1 Total revenues 50 374 Benefits and expenses: Benefits and other changes in policy reserves 11 177 Acquisition and operating expenses, net of deferrals 7 53 Amortization of deferred acquisition costs and intangibles 6 29 Goodwill impairment — 5 Interest expense 1 7 Total benefits and expenses 25 271 Income before income taxes and gain (loss) on sale (1) 25 103 Provision for income taxes 8 40 Income before gain (loss) on sale 17 63 Gain (loss) on sale, net of taxes — — Income from discontinued operations, net of taxes 17 63 Less: net income from discontinued operations attributable to noncontrolling interests 8 34 Income from discontinued operations available to Genworth Financial, Inc.’s $ 9 $ 29 (1) The years ended December 31, 2021 and 2020 include pre-tax Lifestyle protection insurance On December 1, 2015, Genworth Financial, through its subsidiaries, completed the sale of its lifestyle protection insurance business to AXA. In 2017, AXA sued us for damages on an indemnity in the 2015 agreement related to alleged remediation it paid to customers who purchased payment protection insurance (“PPI”). On July 20, 2020, we reached a settlement agreement related to losses incurred from mis-selling mis-selling As of December 31, 2021, we accrued approximately £22 million ($30 million) of estimated future claims that were still in process of being invoiced. In February 2022, Genworth Holdings paid AXA $30 million, which constitutes the majority of the estimated remaining unprocessed claims. We have established our current best estimate for claims still being processed by AXA of approximately $2 million as of December 31, 2022; however, there may be future adjustments to this estimate. If amounts are different from our estimate, it could result in an adjustment to our liability and an additional amount reflected in income (loss) from discontinued operations. For the years ended December 31, 2022, 2021 and 2020, we recorded after-tax For the year ended December 31, 2022, we also recorded $5 million of net favorable tax adjustments and other after-tax In the event AXA recovers amounts from third parties related to the mis-selling losses, including from the distributor responsible for the sale of the policies, we have certain rights to share in those recoveries to recoup payments for the underlying mis-selling losses. As of December 31, 2022 and 2021, we have not recorded any amounts associated with recoveries from third parties. In addition to the future claims still being processed under the settlement agreement, we also have an unrelated liability that is owed to AXA associated with certain tax items, including a tax gross up on underwriting losses attributable to a product sold by a distributor in our former lifestyle protection insurance business. As of December 31, 2022 and 2021, the balance of the liability was $6 million and $4 million, respectively, and is included as liabilities related to discontinued operations in our consolidated balance sheets. For the years ended December 31, 2021 and 2020, we recorded after-tax

Schedule I Genworth Financial,

Schedule I Genworth Financial, Inc. Summary of Investments-Other Than Investments in Related Parties	12 Months Ended
	Dec. 31, 2022
Schedule I Genworth Financial, Inc. Summary of Investments-Other Than Investments in Related Parties	Schedule I Genworth Financial, Inc. Summary of Investments—Other Than Investments in Related Parties (Amounts in millions) As of December 31, 2022, the amortized cost or cost, fair value and carrying value of our invested assets were as follows: Amortized cost Fair Carrying Type of investment or cost value value Fixed maturity securities: Bonds: U.S. government, agencies and authorities $ 3,446 $ 3,341 $ 3,341 State and political subdivisions 2,726 2,399 2,399 Non-U.S. government 731 645 645 Public utilities 5,112 4,638 4,638 All other corporate bonds 38,819 35,560 35,560 Total fixed maturity securities 50,834 46,583 46,583 Equity securities 341 319 319 Commercial mortgage loans, net 7,010 xxxxx 7,010 Policy loans 2,139 xxxxx 2,139 Limited partnerships 1,675 xxxxx 2,331 Other invested assets (1) 529 xxxxx 566 Total investments $ 62,528 xxxxx $ 58,948 (1) The amount shown in the consolidated balance sheet for other invested assets differs from amortized cost or cost presented, as other invested assets include certain assets with a carrying amount that differs from amortized cost or cost. See Report of Independent Registered Public Accounting Firm

Schedule II Genworth Financial,

Schedule II Genworth Financial, Inc. (Parent Company Only)	12 Months Ended
Schedule II Genworth Financial, Inc. (Parent Company Only)	Dec. 31, 2022
Schedule II Genworth Financial, Inc. (Parent Company Only)	Schedule II Genworth Financial, Inc. (Parent Company Only) Balance Sheets (Amounts in millions) December 31, 2022 2021 Assets: Investments in subsidiaries $ 10,008 $ 15,517 Deferred tax asset 6 4 Other assets 3 5 Total assets $ 10,017 $ 15,526 Liabilities and stockholders’ equity Liabilities: Other liabilities $ 7 $ 4 Intercompany notes payable 26 12 Total liabilities 33 16 Commitments and contingencies Stockholders’ equity: Common stock 1 1 Additional paid-in 11,869 11,858 Accumulated other comprehensive income (loss) (2,220 ) 3,861 Retained earnings 3,098 2,490 Treasury stock, at cost (2,764 ) (2,700 ) Total Genworth Financial, Inc.’s stockholders’ equity 9,984 15,510 Total liabilities and stockholders’ equity $ 10,017 $ 15,526 Schedule II Genworth Financial, Inc. (Parent Company Only) Statements of Income (Amounts in millions) Years ended December 31, 2022 2021 2020 Revenues: Net investment income $ — $ (3 ) $ (3 ) Total revenues — (3 ) (3 ) Expenses: Acquisition and operating expenses, net of deferrals 31 25 31 Interest expense — (1 ) 1 Total expenses 31 24 32 Loss before income taxes and equity in income of subsidiaries (31 ) (27 ) (35 ) Benefit from income taxes (3 ) (1 ) (2 ) Equity in income of subsidiaries 637 930 210 Income from continuing operations 609 904 177 Income from discontinued operations, net of taxes — — 1 Net income available to Genworth Financial, Inc.’s common stockholders $ 609 $ 904 $ 178 Schedule II Genworth Financial, Inc. (Parent Company Only) Statements of Comprehensive Income (Amounts in millions) Years ended December 31, 2022 2021 2020 Net income available to Genworth Financial, Inc.’s common stockholders $ 609 $ 904 $ 178 Other comprehensive income (loss), net of taxes: Net unrealized gains (losses) on securities without an allowance for credit losses (5,286 ) (334 ) 764 Net unrealized gains (losses) on securities with an allowance for credit losses — 6 (6 ) Derivatives qualifying as hedges (825 ) (186 ) 209 Foreign currency translation and other adjustments 30 (24 ) 25 Total other comprehensive income (loss) (6,081 ) (538 ) 992 Total comprehensive income (loss) available to Genworth Financial, Inc.’s common stockholders $ (5,472 ) $ 366 $ 1,170 Schedule II Genworth Financial, Inc. (Parent Company Only) Statements of Cash Flows (Amounts in millions) Years ended December 31, 2022 2021 2020 Cash flows from (used by) operating activities: Net income available to Genworth Financial, Inc.‘s common stockholders $ 609 $ 904 $ 178 Less income from discontinued operations, net of taxes — — (1 ) Adjustments to reconcile net income available to Genworth Financial, Inc.’s common stockholders to net cash from (used by) operating activities: Equity in income from subsidiaries (637 ) (930 ) (210 ) Deferred income taxes (6 ) — (1 ) Stock-based compensation expense 27 40 39 Change in certain assets and liabilities: Accrued investment income and other assets 2 (1 ) 2 Current tax liabilities 2 (5 ) (1 ) Other liabilities and other policy-related balances 15 (13 ) 11 Net cash from (used by) operating activities 12 (5 ) 17 Cash flows from (used) by investing activities: Intercompany notes receivable, net — — (10 ) Capital contributions paid to subsidiaries (3 ) (2 ) (2 ) Net cash used by investing activities (3 ) (2 ) (12 ) Cash flows from (used by) financing activities: Intercompany notes payable, net 64 12 — Treasury stock acquired in connection with share repurchases (64 ) — — Other, net (9 ) (5 ) (5 ) Net cash from (used by) financing activities (9 ) 7 (5 ) Effect of exchange rate changes on cash, cash equivalents and restricted cash — — — Cash, cash equivalents and restricted cash at beginning of year — — — Cash, cash equivalents and restricted cash at end of year $ — $ — $ — Schedule II Genworth Financial, Inc. (Parent Company Only) Notes to Schedule II Years Ended December 31, 2022, 2021 and 2020 (1) Organization and Basis of Presentation Genworth Holdings (formerly known as Genworth Financial, Inc.) was incorporated in Delaware in 2003 in preparation for an IPO of its common stock, which was completed on May 28, 2004. On April 1, 2013, Genworth Holdings completed a holding company reorganization pursuant to which Genworth Holdings became a direct, 100% owned subsidiary of a new public holding company that it had formed. The new public holding company was incorporated in Delaware on December 5, 2012, in connection with the reorganization, and was renamed Genworth Financial upon the completion of the reorganization. Genworth Financial is a holding company whose subsidiaries offer mortgage and long-term care insurance products and service life insurance, as well as annuities and other investment products. The parent company financial information reflects Genworth Financial’s direct subsidiaries using the equity method of accounting. Under this method, investments in subsidiaries are recorded at cost and adjusted for the subsidiaries’ cumulative results of operations, capital contributions and distributions, and other changes in equity. The parent company financial statements should be read in conjunction with the consolidated financial statements of Genworth Financial and its subsidiaries and the notes thereto. As of December 31, 2022, the investments in subsidiaries balance was $10.0 billion, a decrease of approximately billion compared to December 31, 2021. The decrease was largely due to a reduction in the accumulated other comprehensive income of Genworth Financial’s subsidiaries driven predominantly by rising interest rates during 2022 that resulted in significantly higher unrealized losses on available-for-sale investment securities as of December 31, 2022. On May 2, 2022, Genworth Financial’s Board of Directors authorized a share repurchase program under which Genworth Financial may repurchase up to $350 million of its outstanding Class A common stock. Pursuant to the program, during 2022, Genworth Financial repurchased 16,173,196 shares of its common stock at an average price of $3.94 per share for a total cost of $64 million, including costs paid in connection with acquiring the shares. The repurchased shares were recorded at cost and presented as treasury stock in a separate caption in equity in the parent company balance sheet. Genworth Financial also repurchased 5,912,297 shares from February 9 4 per share for a total cost (2) Accounting Changes On January 1, 2021, Genworth Financial adopted new accounting guidance related to simplifying the accounting for income taxes. The guidance eliminates certain exceptions related to the approach for intraperiod tax allocation, the methodology for calculating income taxes in an interim period and the recognition of deferred tax liabilities for outside basis differences. Genworth Financial adopted this new accounting guidance using the retrospective method or modified retrospective method for certain changes and prospective method for all other changes, which did not have a significant impact on Genworth Financial’s financial statements and disclosures. Schedule II Genworth Financial, Inc. (Parent Company Only) Notes to Schedule II Years Ended December 31, 2022, 2021 and 2020 (3) Commitments Genworth Financial provides a full and unconditional guarantee to the trustee of Genworth Holdings’ outstanding senior and subordinated notes and the holders of the senior and subordinated notes, on an unsecured unsubordinated and subordinated basis, respectively, of the full and punctual payment of the principal of, premium, if any, and interest on, and all other amounts payable under, the outstanding senior and subordinated notes, and the full and punctual payment of all other amounts payable by Genworth Holdings under the senior and subordinated notes indentures in respect of such senior and subordinated notes. (4) Income Taxes As of December 31, 2022 and 2021, Genworth Financial had a deferred tax asset of $6 million and $4 million, respectively, primarily comprised of share-based compensation. As of December 31, 2022 and 2021, Genworth Financial had a current income tax receivable of $ — — (5) Supplemental Cash Flow Information In 2022, Genworth Holdings forgave an intercompany loan of $50 million due from Genworth Financial. The extinguishment of the loan between the related parties was treated as a non-cash In 2020, Genworth Financial forgave an intercompany loan of $129 million due from Genworth Holdings. The extinguishment of the loan between the related parties was treated as a non-cash (6) Sale of Business On December 1, 2015, Genworth Financial completed the sale of its lifestyle protection insurance business to AXA through its subsidiaries. In 2017, AXA sued GFIH, Genworth Financial’s wholly-owned indirect subsidiary, and Genworth Holdings for damages on an indemnity in the 2015 agreement related to alleged remediation it paid to customers who purchased PPI. On July 20, 2020, Genworth Holdings reached a settlement agreement related to losses incurred from mis-selling mis-selling In addition, Genworth Financial completed the sale of Genworth Australia on March 3, 2021 through its subsidiaries. Income from discontinued operations related to the sale of this business is also included within equity in income of subsidiaries in the parent company statements of income for the periods presented herein. Schedule II Genworth Financial, Inc. (Parent Company Only) Notes to Schedule II Years Ended December 31, 2022, 2021 and 2020 Income from discontinued operations presented in the parent company statement of income for the year ended December 31, 2020 relates to tax adjustments incurred by Genworth Financial related to previously disposed businesses.

Schedule III Supplemental Insur

Schedule III Supplemental Insurance Information	12 Months Ended
Schedule III Supplemental Insurance Information	Dec. 31, 2022
Schedule III Supplemental Insurance Information	Schedule III Genworth Financial, Inc. Supplemental Insurance Information (Amounts in millions) Policyholder Deferred Future Policy Account Liability for Policy Unearned Segment Acquisition Costs Benefits Balances and Contract Claims Premiums December 31, 2022 Enact $ 26 $ — $ — $ 519 $ 203 U.S. Life Insurance 2,042 38,062 14,112 11,695 379 Runoff 132 2 3,001 14 2 Corporate and Other — — — 6 — Total $ 2,200 $ 38,064 $ 17,113 $ 12,234 $ 584 December 31, 2021 Enact $ 27 $ — $ — $ 641 $ 246 U.S. Life Insurance 1,008 41,526 16,343 11,183 423 Runoff 111 2 3,011 8 3 Corporate and Other — — — 9 — Total $ 1,146 $ 41,528 $ 19,354 $ 11,841 $ 672 Interest Credited Amortization of Net and Benefits and Deferred Other Premium Investment Other Changes in Acquisition Operating Premiums Segment Revenue Income Policy Reserves Costs Expenses Written December 31, 2022 Enact $ 940 $ 155 $ (94 ) $ 8 $ 283 $ 896 U.S. Life Insurance 2,773 2,769 4,623 247 1,103 2,741 Runoff — 214 216 23 42 — Corporate and Other 6 8 — — 78 6 Total $ 3,719 $ 3,146 $ 4,745 $ 278 $ 1,506 $ 3,643 December 31, 2021 Enact $ 975 $ 141 $ 125 $ 9 $ 287 $ 914 U.S. Life Insurance 2,454 3,029 4,576 318 887 2,419 Runoff — 194 189 19 54 — Corporate and Other 6 6 1 — 186 7 Total $ 3,435 $ 3,370 $ 4,891 $ 346 $ 1,414 $ 3,340 December 31, 2020 Enact $ 971 $ 133 $ 381 $ 14 $ 231 $ 894 U.S. Life Insurance 2,858 2,878 5,164 400 643 2,837 Runoff — 210 214 23 48 — Corporate and Other 7 6 4 — 234 7 Total $ 3,836 $ 3,227 $ 5,763 $ 437 $ 1,156 $ 3,738

Summary of Significant Accoun_2

Summary of Significant Accounting Policies (Policies)	12 Months Ended
Summary of Significant Accounting Policies (Policies)	Dec. 31, 2022
Premiums	a) Premiums For traditional long-duration insurance contracts, we report premiums as earned when due. For short-duration insurance contracts, we report premiums as revenue over the terms of the related insurance policies on a pro-rata For single premium mortgage insurance contracts, we report premiums over the estimated policy life in accordance with the expected pattern of risk emergence as further described in our accounting policy for unearned premiums. In addition, we refund post-delinquent premiums received to the insured party if the delinquent loan goes to claim. We record a liability for premiums received on the delinquent loans consistent with our expectations of the rates at which delinquencies go to claim (“claim rates”). Premiums received under annuity contracts without significant mortality risk and premiums received on investment and universal life insurance products are not reported as revenues but rather as deposits and are included in liabili ti
Net Investment Income and Net Investment Gains and Losses	b) Net Investment Income and Net Investment Gains and Losses Investment income is recognized when earned. Income or loss upon call or prepayment of available-for-sale Investment income on mortgage-backed and asset-backed securities is initially based upon yield, cash flow and prepayment assumptions at the date of purchase. Subsequent revisions in those assumptions are recorded using the retrospective or prospective method. Under the retrospective method used for mortgage-backed and asset-backed securities of high credit quality (ratings equal to or greater than “AA” or that are backed by a U.S. agency) which cannot be contractually prepaid in such a manner that we would not recover a substantial portion of the initial investment, amortized cost of the security is adjusted to the amount that would have existed had the revised assumptions been in place at the date of purchase. The adjustments to amortized cost are recorded as a charge or credit to net investment income. Under the prospective method, which is used for all other mortgage-backed
Policy Fees and Other Income	c) Policy Fees and Other Income Policy fees and other income consists primarily of insurance charges assessed on universal and term universal life insurance contracts and fees assessed against customer account values. For universal and term universal life insurance contracts, charges to policyholder accounts for cost of insurance are recognized as revenue when due. Variable product fees are charged to variable annuity contractholders and variable life insurance policyholders based upon the daily net assets of the contractholder’s and policyholder’s account values and are recognized as revenue when charged. Policy surrender fees are recognized as income when the policy is surrendered.
Investment Securities	d) Investment Securities At the time of purchase, we designate our fixed maturity securities as either available-for-sale available-for-sale Allowance for Credit Losses and Write-Downs of Available-For-Sale We regularly review securities in an unrealized loss position to determine whether the decline in fair value is related to credit losses or other factors. If we have either (i) the intent to sell the security, or (ii) it is more likely than not that we will be required to sell the security prior to recovering the amortized cost, we record a reduction to the security’s amortized cost and recognize the loss in net investment gains (losses) for the difference between the security’s amortized cost and fair value. If neither of the two preceding conditions exist, we determine whether the decline in fair value is related to credit losses or other factors. In making this assessment, we consider the extent to which fair value is less than amortized cost, any changes to the rating of the security by a rating agency/agencies and adverse conditions specifically related to the security, among other factors. If a credit loss exists, the present value of cash flows expected to be collected from the security is compared to the amortized cost basis of the security and a credit loss allowance is recognized in net investment gains (losses), limited to the amount that the fair value is less than the amortized cost basis. Losses are written off against the allowance when deemed uncollectible or when we intend to sell or expect we will be required to sell a security prior to recovering its amortized cost. When there is an allowance for credit losses, we reassess the credit losses each balance sheet date and subsequent increases or decreases are recorded as an adjustment to the allowance for credit losses, with a corresponding gain or loss recorded in net investment gains (losses). Estimating the cash flows expected to be collected is a quantitative and qualitative process that incorporates information received from third-party sources along with internal assumptions and judgments. When developing the estimate of cash flows expected to be collected at the individual security level, we utilize an analytical model that provides for various loss scenarios and consider the industry sector, current levels of subordination, geographic location and other relevant characteristics of the security or underlying assets, as well as reasonable and supportable forecasts. We regularly monitor our investment portfolio to ensure that securities with a credit loss are identified in a timely manner and any losses are recognized in the proper period. Accrued interest is included in accrued investment income in our consolidated balance sheet and had a carrying value of $511 million and $523 million as of December 31, 2022 and 2021, respectively. We exclude available-for-sale available-for-sale
Fair Value Measurements	e) Fair Value Measurements Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. We have fixed maturity securities, equity securities, short-term investments, limited partnerships, derivatives, embedded derivatives, separate account assets and certain other financial instruments, which are carried at fair value. Fair value measurements are based upon observable and unobservable inputs. Observable inputs reflect market data obtained from independent sources, while unobservable inputs reflect our view of market assumptions in the absence of observable market information. We utilize valuation techniques that maximize the use of observable inputs and minimize the use of unobservable inputs. All assets and liabilities carried at fair value are classified and disclosed in one of the following three categories: • Level 1—Quoted prices for identical instruments in active markets. • Level 2—Quoted prices for similar instruments in active markets; quoted prices for ide n • Level 3—Instruments for which significant value drivers are unobservable. Level 1 primarily consists of financial instruments whose value is based on quoted market prices such as actively traded equity securities and actively traded mutual fund investments. Level 2 includes those financial instruments that are valued using industry-standard pricing methodologies, models or other valuation methodologies. These models are primarily industry-standard models that consider various inputs, such as interest rate, credit spread and foreign exchange rates for the underlying financial instruments. All significant inputs are observable, or derived from observable information in the marketplace or are supported by observable levels at which transactions are executed in the marketplace. Financial instruments in this category primarily include: certain public and private corporate fixed maturity and equity securities; government or agency securities; certain mortgage-backed and asset-backed securities; certain non-exchange-traded Level 3 comprises financial instruments whose fair value is estimated based on industry-standard pricing methodologies and internally developed models utilizing significant inputs not based on, nor corroborated by, readily available market information. In certain instances, this category may also utilize non-binding quotes. This category primarily consists of certain less liquid fixed maturity and equity securities and certain derivative instruments or embedded derivatives where we cannot corroborate the significant valuation inputs with market observable data . As of each reporting period, all assets and liabilities recorded at fair value are classified in their entirety based on the lowest level of input that is significant to the fair value measurement. Our assessment of the significance of a particular input to the fair value measurement in its entirety requires judgment, and considers factors specific to the asset or liability, such as the relative impact on the fair value as a result of including a particular input. We review the fair value hierarchy classifications each reporting period. Changes in the observability of the valuation attributes may result in a reclassification of certain financial assets or liabilities. Such reclassifications are reported as transfers in and out of Level 3 at the beginning fair value for the reporting period in which the changes occur. See note 16 for additional information related to fair value measurements.
Commercial Mortgage Loans	f) Commercial Mortgage Loans The carrying value of commercial mortgage loans is stated at principal amounts outstanding, net of unamortized premium or discount, deferred expenses and allowance for credit losses. Interest on loans is recognized on an accrual basis at the applicable interest rate on the principal amount outstanding. Loan origination fees and direct costs, as well as premiums and discounts, are amortized as level yield adjustments over the respective loan terms. Unamortized net fees or costs are recognized upon early repayment of the loans. Loan commitment fees are deferred and amortized on an effective yield basis over the term of the loan. Commercial mortgage loans are considered past due when contractual payments have not been received from the borrower by the required payment date. Loans that are considered uncollectible are carried on non-accrual non-accrual loan-to-value. non-accrual We determine the adequacy of the allowance for credit losses utilizing an analytical model that provides various loss scenarios based on historical experience adjusted for current events, trends, economic conditions and reasonable and supportable forecasts that result in a loss in the loan portfolio over the estimated life of the loans. We revert to historical credit loss experience for periods beyond forecasts that are reasonable and supportable. The allowance for credit losses is measured on a collective basis with consideration for debt service coverage ratio, debt-to-value, Accrued interest related to commercial mortgage loans is included in accrued investment income in our consolidated balance sheet and had a carrying value of $22 million and $23 million as of December 31, 2022 and 2021. We do not measure an allowance for credit losses related to accrued interest as uncollectible accrue d interest related to our commercial mortgage loans is written off after 90 days and once collectability is determined to be uncertain and not probable. Amounts written off related to accrued interest are recorded as a credit loss expense included in net investment gains (losses).
Limited Partnerships	g) Limited Partnerships Limited partnerships are accounted for at fair value when our partnership interest is considered minor (generally less than 3% ownership in the limited partnerships) and we exercise no influence over operating and financial policies. For limited partnerships that do not have a readily determinable fair value, we utilize the net asset value (“NAV”) from the underlying fund statements as a practical expedient for fair value. Changes in the estimated fair value of these investments are included in net investment gains (losses) and income and expenses are reported in net investment income. Investment distributions are evaluated to determine whether the distribution is a return on investment, such as dividend income, or a return of capital. If our ownership percentage exceeds the minor threshold, limited partnerships are accounted for using the equity method of accounting. Our proportionate share of the earnings or losses for limited partnerships accounted for using the equity method of accounting is included in net investment income. In applying either method, we use financial information provided by the investee generally on a one-
Cash, Cash Equivalents and Restricted Cash	h) Cash, Cash Equivalents and Restricted Cash Certificates of deposit, money market funds and other highly liquid investments with original maturities of three months or less are considered cash equivalents in the consolidated balance sheets and consolidated statements of cash flows. Items with maturities greater than three months but less than one year at the time of acquisition are generally considered short-term investments.
Deferred Acquisition Costs	i) Deferred Acquisition Costs Acquisition costs include costs that are directly related to the successful acquisition of new or renewal insurance contracts. Acquisition costs are deferred and amortized to the extent they are recoverable from future profits. Long-Duration Contracts in-force Amortization for deferred annuity and universal life insurance contracts is based on expected gross profits. Expected gross profits are adjusted quarterly to reflect actual experience to date or for changes in underlying assumptions relating to future gross profits. Estimates of gross profits for DAC amortization are based on assumptions including interest rates, policyholder persistency or lapses, insured l if We are required to analyze the impacts from net unrealized investment gains and losses on our available-for-sale available-for-sale Therefore, DAC amortized based on expected gross profits is adjusted to reflect the effects that would have been recognized had the unrealized investment (gains) losses been actually realized with a corresponding amount recorded in other comprehensive income (loss) (“OCI”). DAC associated with traditional long-duration insurance contracts is not adjusted for unrealized investment (gains) or losses unless a premium deficiency would have resulted upon the (gain) or loss being realized. Short-Duration Contracts. We regularly review our assumptions and test DAC for recoverability at least annually. For deferred annuity and universal life insurance contracts, if the present value of expected future gross profits is less than the unamortized DAC for a line of business, a charge to net income (loss) is recorded for additional DAC amortization. For traditional long-duration and short-duration contracts, if the benefit reserve plus anticipated future premiums and interest income for a line of business are less than the current estimate of future benefits and expenses (including any unamortized DAC), a charge to net income (loss) is recorded for additional DAC amortization or for increased benefit reserves. See note 6 for additional information related to DAC including loss recognition and recoverability.
Intangible Assets	j) Intangible Assets Present Value of Future Profits. We regularly review our PVFP assumptions and periodically test PVFP for recoverability similar to our treatment of DAC. See note 7 for additional information related to PVFP including recoverability. Deferred Sales Inducements to Contractholders. Other Intangible Assets cash flows, which requires the use of estimates and judgment, and, if impaired, written down to fair value based on either discounted cash flows or appraised values. Intangible assets with indefinite lives are tested at least annually for impairment using a qualitative or quantitative assessment and are written down to fair value as required.
Reinsurance	k) Reinsurance Premium revenue, benefits and acquisition and operating expenses, net of deferrals, are reported net of the amounts relating to reinsurance ceded to other companies. Amounts due from reinsurers for incurred and estimated future claims are reflected in the reinsurance recoverable asset. Amounts received from reinsurers that represent recovery of acquisition costs are netted against DAC so that the net amount is capitalized. The cost of reinsurance is accounted for over the terms of the related treaties using assumptions consistent with those used to account for the underlying reinsured policies. Gains from cost of reinsurance are deferred and amortized to current period net income (loss) over the reinsurance contract period or life of the underlying reinsured contract. Premium revenue, benefits and acquisition and operating expenses, net of deferrals, for reinsurance contracts that do not qualify for reinsurance accounting are accounted for under the deposit method of accounting. Allowance for Credit Losses on Reinsurance Recoverables The allowance for credit losses related to reinsurance recoverables is evaluated based on historical loss experience adjusted for current events and reasonable and supportable forecasts from both internal and external sources. The allowance is measured by reinsurer, taking into consideration the reinsured product type and collateral type, and is calculated based on an externally reported probability of default corresponding to the reinsurer’s credit rating and the expected duration of the reinsurer’s contractual obligation to reimburse us for ceded claims on the underlying policies. Our estimate of the allowance reflects consideration for collateral securing the reinsurance agreements and expected recoveries of amounts previously charged off and expected to be charged off. We also consider other credit risk factors, including, among other factors, the historical frequency and severity of the associated insurance claims, aging of recoverables and regulatory, legal and economic factors, to determine if an additional incremental allowance for credit losses is required. No reversion adjustments are necessary as the starting point for our allowance for credit losses reflects historical loss experience covering the expected duration of the reinsurer’s contractual obligation to reimburse us. If available facts and circumstances indicate the reinsurance recoverable does not reflect expectations consistent with the collective analysis, the reinsurance recoverable is assessed on a separate basis. Write-offs are deducted from the allowance in the period the reinsurance recoverable is determined to be uncollectible.
Derivatives	l) Derivatives Derivative instruments are used to manage risk through one of four principal risk management strategies including: (i) liabilities; (ii) invested assets; (iii) portfolios of assets or liabilities; and (iv) forecasted transactions. On the date we enter into a derivative contract, management designates the derivative as a hedge of the identified exposure (cash flow or foreign currency). If a derivative does not qualify for hedge accounting, the changes in its fair value and all scheduled periodic settlement receipts and payments are reported in net income (loss). We formally document all relationships between hedging instruments and hedged items, as specifically identify the asset, liability or forecasted transaction that has been designated as a hedged item, state how the hedging instrument is expected to hedge the risks related to the hedged item and set forth the method that will be used to retrospectively and prospectively assess the hedging instrument’s effectiveness. We generally determine hedge effectiveness based on total changes in fair value of the hedged item attributable to the hedged risk and the total changes in fair value of the derivative instrument. We discontinue hedge accounting prospectively when: (i) it is determined that the derivative is no longer effective in offsetting changes in the cash flows of a hedged item; (ii) the derivative expires or is sold, terminated or exercised; (iii) the derivative is de-designated For all qualifying and highly effective cash flow hedges, changes in fair value of the derivative instrument are reported as a separate component of accumulated other comprehensive income (loss). When hedge accounting is discontinued because it is probable that a forecasted transaction will not occur, the derivative continues to be carried in the consolidated balance sheets at its fair value, and gains and losses that were accumulated in OCI are recognized immediately in net income (loss). When the hedged forecasted transaction is no longer probable, but is reasonably possible, the accumulated gain or loss remains in OCI and is recognized when the transaction affects net income (loss); however, prospective hedge accounting for the transaction is terminated. In all other situations in which hedge accounting is discontinued on a cash flow hedge, amounts previously deferred in OCI are reclassified into net income (loss) when net income (loss) is impacted by the variability of the cash flow of the hedged item. We may enter into contracts that are not themselves derivative instruments but contain embedded derivatives. For each contract, we assess whether the economic characteristics of the embedded derivative are clearly and closely related to those of the host contract and determine whether a separate instrument with the same terms as the embedded instrument would meet the definition of a derivative instrument. If it is determined that the embedded derivative possesses economic characteristics that are not clearly and closely related to the economic characteristics of the host contract, and that a separate instrument with the same terms would qualify as a derivative instrument, the embedded derivative is separated from the host contract and accounted for as a stand-alone derivative. Such embedded derivatives are recorded in the consolidated balance sheets at fair value and are classified consistent with their host contract. Changes in their fair value are recognized in current period net income (loss). If we are unable to properly identify and measure an embedded derivative for separation from its host contract, the entire contract is carried in the consolidated balance sheets at fair value, with changes in fair value recognized in current period net income (loss). Changes in the fair value of non-qualifying The majority of our derivative arrangements require the posting of collateral upon meeting certain net exposure thresholds. The amounts recognized for derivative counterparty collateral received by us are recorded in cash, cash equivalents and restricted cash with a corresponding amount recorded in other liabilities to represent our obligation to return the collateral retained by us. As of December 31, 2022 and 2021, the amount of cash collateral received from counterparties was $16 million and $255 million, respectively. We also receive non-cash re-pledge non-cash re-pledged. We pledged $ million and $ million of fixed maturity securities as of December 31, 2022 and 2021, respectively. Fixed maturity securities that we pledge as collateral remain in our consolidated balance sheet within fixed maturity securities available-for-sale. Any cash collateral pledged to a derivative counterparty is derecognized with a receivable recorded in other assets for the right to receive our cash collateral back from the counterparty. Daily changes in the fair value of the derivative contract, commonly referred to as variation margin, for derivatives cleared through a Central Clearing Party, such as the Chicago Mercantile Exchange are treated as daily settlements of the derivative contract.
Separate Accounts and Related Insurance Obligations	m) Separate Accounts and Related Insurance Obligations Separate account assets represent funds for which the investment income and investment gains and losses accrue directly to the contractholders and are reflected in our consolidated balance sheets at fair value, reported as summary total separate account assets with an equivalent summary total reported for liabilities. Amounts assessed against the contractholders for mortality, administrative and other services are included in revenues. Changes in liabilities for minimum guarantees are included in benefits and other changes in policy reserves. Net investment income, net investment gains (losses) and the related liability changes associated with the separate account are offset within the same line item in the consolidated statements of income. There are no gains or losses on transfers of assets from the general account to the separate account. We offer certain minimum guarantees associated with our variable annuity contracts. Our variable annuity contracts usually contain a basic guaranteed minimum death benefit (“GMDB”) which provides a minimum benefit to be paid upon the annuitant’s death equal to the larger of account value or the return of net deposits. Some variable annuity contracts permit contractholders to purchase through riders, at an additional charge, enhanced death benefits such as the highest contract anniversary value (“ratchets”), accumulated net deposits at a stated rate (“rollups”), or combinations thereof. Additionally, some of our variable annuity contracts provide the contractholder with living benefits such as a guaranteed minimum withdrawal benefit (“GMWB”) or certain types of guaranteed annuitization benefits. The GMWB allows contractholders to withdraw a pre-defined Most of our reserves for additional insurance and annuitization benefits are calculated by applying a benefit ratio to accumulated contractholder assessments, and then deducting accumulated paid claims. The benefit ratio is equal to the ratio of benefits to assessments, accumulated with interest and considering both past and anticipated future experience. The projections utilize stochastic scenarios of separate account returns incorporating reversion to the mean, as well as assumptions for mortality and lapses. Some of our minimum guarantees, mainly GMWBs, are accounted for as embedded derivatives; see notes 5 and 16 for additional information on these embedded derivatives and related fair value measurement disclosures.
Insurance Reserves	n) Insurance Reserves Future Policy Benefits The liability for future policy benefits is equal to the present value of ex pe and investment returns, health care experience (including type of care and cost of care), policyholder persistency or lapses (i.e., the probability that a policy or contract will remain in-force locked-in The liability for future policy benefits is evaluated at least annually to determine if a premium deficiency exists. Loss recognition testing is generally performed at the line of business level, with acquired blocks and certain reinsured blocks tested separately. If the liability for future policy benefits plus the current present value of expected future gross premiums are less than the current present value of expected future benefits and expenses (including any unamortized DAC), a charge to net income (loss) is recorded for accelerated DAC amortization and, if necessary, a premium deficiency reserve is established. If a charge is recorded, DAC amortization and the liability for future policy benefits are measured using updated assumptions, which become the new locked-in in-force We are also required to accrue additional future policy benefit reserves when the overall reserve is adequate, but profits are projected in early periods followed by losses projected in later periods. When this pattern of projected profits followed by projected losses exists, we ratably accrue this additional profits followed by losses liability over time, increasing reserves in the profitable periods to offset estimated losses expected during the periods that follow. We calculate and adjust the additional reserves using our current best estimate of the amount necessary to offset the losses in future periods, based on the pattern of expected income and current best estimate assumptions consistent with our loss recognition testing. We adjust the accrual rate prospectively, over the remaining profit periods, without any catch-up For long-term care insurance products, benefit reductions are treated as partial lapse of coverage with the balance of our future policy benefits and DAC both reduced in proportion to the reduced coverage. For level premium term life insurance products, we floor the liability for future policy benefits on each policy at zero. Estimates and actuarial assumptions used for establishing the liability for future policy benefits and in loss recognition testing involve the exercise of significant judgment, and changes in assumptions or deviations of actual experience from assumptions can have material impacts on our liability for future policy benefits and net income (loss). Because these assumptions relate to factors that are not known in advance, change over time, are difficult to accurately predict and are inherently uncertain, we cannot determine with precision the ultimate amounts we will pay for actual claims or the timing of those payments. Small changes in assumptions or small deviations of actual experience from assumptions can have, and in the past have had, material impacts on our reserves, results of operations and financial condition. The risk that our claims experience may differ significantly from our pricing and valuation assumptions is particularly significant for our long-term care insurance products. Long-term care insurance policies provide for long-duration coverage and, therefore, our actual claims experience will emerge over many years after pricing and locked-in Policyholder Account Balances The liability for policyholder account balances represents the contract value that has accrued to the benefit of the policyholder as of the balance sheet date for investment-type and universal and term universal life insurance contracts. We are also required to establish additional benefit reserves for guarantees or product features in addition to the contract value where the additional benefit reserves are calculated by applying a benefit ratio to accumulated contractholder assessments, and then deducting accumulated paid claims. The benefit ratio is equal to the ratio of benefits to assessments, accumulated with interest and considering both past and anticipated future claims experience, which includes assumptions for insured mortality (i.e. life expectancy or longevity), interest rates and policyholder persistency or lapses (i.e., the probability that a policy or contract will remain in-force Investment-type contracts are broadly defined to include contracts without significant mortality or morbidity risk. Payments received from sales of investment contracts are recognized by providing a liability equal to the current account value of the policyholders’ contracts. Interest rates credited to investment contracts are guaranteed for the initial policy term with renewal rates determined as necessary by management.
Liability for Policy and Contract Claims	o) Liability for Policy and Contract Claims The liability for policy and contract claims, or claim reserves, represents the amount needed to provide for the estimated ultimate cost of settling claims relating to insured events that have occurred on or before the end of the respective reporting period. The estimated liability includes requirements for future payments of: (i) claims that have been reported to the insurer; (ii) claims related to insured events that have occurred but that have not been reported to the insurer as of the date the liability is estimated; and (iii) claim adjustment expenses. Claim adjustment expenses include costs incurred in the claim settlement process such as legal fees and costs to record, process and adjust claims. Our liability for policy and contract claims is reviewed regularly, with changes in our estimates of future claims recorded through net income (loss). Estimates and actuarial assumptions used for establishing the liability for policy and contract claims involve the exercise of significant judgment, and changes in assumptions or deviations of actual experience from assumptions can have material impacts on our liability for policy and contract claims and net income (loss). Because these assumptions relate to factors that are not known in advance, change over time, are difficult to accurately predict and are inherently uncertain, we cannot determine with precision the ultimate amounts we will pay for actual claims or the timing of those payments. Small changes in assumptions or small deviations of actual experience from assumptions can have, and in the past have had, material impacts on our reserves, results of operations and financial condition. The liability for policy and contract claims for our long-term care insurance products represents the present value of the amount needed to provide for the estimated ultimate cost of settling claims relating to insured events that have occurred on or before the end of the respective reporting period. Key assumptions include projected interest rates and investment returns, health care experience (including type of care and cost of care), policyholder persistency or lapses (i.e., the probability that a policy or contract will remain in-force be amount. Because these assumptions relate to factors that are not known in advance, change over time, are difficult to accurately predict and are inherently uncertain, we cannot determine with precision the ultimate amounts we will pay for actual claims or the timing of those payments. Small changes in assumptions or small deviations of actual experience from assumptions can have, and in the past have had, material impacts on our reserves, results of operations and financial condition. The liabilities for our mortgage insurance policies represent our best estimates of the liabilities at the time based on known facts, trends and other external factors, including economic conditions, housing prices, unemployment, government housing policies, state foreclosure timeline, interest rates, tax policy, credit availability and mortgage products. For our mortgage insurance policies, reserves for losses and loss adjustment expenses are based on notices of mortgage loan defaults and estimates of defaults that have been incurred but have not been reported by loan servicers. Reserves for losses are established by estimating the number of loans in our inventory of delinquent loans that will result in a claim payment, which is referred to as the claim rate, and further estimating the amount of the claim payment, which is referred to as claim severity. The estimates are determined using a factor-based approach, in which assumptions of claim rates for loans in default and the average amount paid for loans that result in a claim are calculated using traditional actuarial techniques. As is common accounting practice in the mortgage insurance industry and in accordance with U.S. GAAP, we do not establish loss reserves for future claims on insured loans that are not in default or believed to be in default. Over time, as the status of the underlying delinquent loans moves toward foreclosure and the likelihood of the associated claim loss increases, the amount of the loss reserves associated with the potential claims may also increase. Management considers the liability for policy and contract claims provided to be its best estimate to cover the losses that have occurred. Management monitors actual experience, and where circumstances warrant, will revise its assumptions. The methods of determining such estimates and establishing the reserves are reviewed periodically and any adjustments are reflected in operations in the period in which they become known. Future developments may result in losses and loss expenses greater or less than the liability for policy and contract claims provided.
Unearned Premiums	p) Unearned Premiums For single premium insurance contracts, we recognize a portion of the revenue in premiums earned in the current period, while the remaining portion is deferred as unearned premiums and earned over time in accordance with the expected pattern of risk emergence. If single premium policies are cancelled and the premium is non-refundable,
Stock-Based Compensation	q) Stock-Based Compensation For share-based equity awards, we determine fair value on the grant date and recognize the related compensation expense, adjusted for expected forfeitures, through the income statement over the respective vesting period of the awards.
Employee Benefit Plans	r) Employee Benefit Plans We provide employees with a defined contribution pension plan and recognize expense t Some employees participate in defined benefit pension and postretirement benefit plans. We recognize expense for these plans based upon actuarial valuations performed by external experts. We estimate aggregate benefits by using assumptions for employee turnover, future compensation increases, rates of return on pension plan assets and future health care costs. We recognize an expense for differences between actual experience and estimates over the average future service period of participants. We recognize the overfunded or underfunded status of a defined benefit plan as an asset or liability in our consolidated balance sheets and recognize changes in that funded status in the year in which the changes occur through OCI.
Income Taxes	s) Income Taxes We determine deferred tax assets and/or liabilities by multiplying the differences between the financial reporting and tax reporting bases for assets and liabilities by the enacted tax rates expected to be in effect when such differences are recovered or settled if there is no change in law. The effect on deferred taxes of a change in tax rates is recognized in net income (loss) in the period that includes the enactment date. Valuation allowances on deferred tax assets are estimated based on our assessment of the realizability of such amounts. Under U.S. GAAP, we are generally required to record U.S. deferred taxes on the anticipated repatriation of foreign income as the income is recognized for financial reporting purposes. An exception under certain accounting guidance permits us not to record a U.S. deferred tax liability for foreign income that we expect to reinvest in our foreign operations and for which remittance will be postponed indefinitely. If it becomes apparent that we cannot positively assert that some or all undistributed income will be reinvested indefinitely, the related deferred taxes are recorded in that period based on the expected form of repatriation (i.e. distribution, loan or sale). In determining indefinite reinvestment, we regularly evaluate the capital needs of our domestic and foreign operations considering all available information, including operating and capital plans, regulatory capital requirements, parent company financing and cash flow needs, as well as the applicable tax laws to which our domestic and foreign subsidiaries are subject. Similarly, under another exception to the recognition of deferred taxes under U.S. GAAP, we do not record deferred taxes on U.S. domestic subsidiary entities for the excess of the financial statement carrying amount over the tax basis in the stock of the subsidiary (commonly referred to as “outside basis difference”) if we have the ability under the tax law and intent to recover the basis difference in a tax free manner. Deferred taxes would be recognized in the period of a change to our ability or intent. Our companies have elected to file a single U.S. consolidated income tax return (the “life/non-life life/non-life
Foreign Currency Translation	t) Foreign Currency Translation The determination of the functional currency is made based on the appropriate economic and management indicators. The assets and liabilities of foreign operations are translated into U.S. dollars at the exchange rates in effect at the balance sheet date
Variable Interest Entities	u) Variable Interest Entities We are involved in certain entities that are considered VIEs as defined under U.S. GAAP, and accordingly, we evaluate the VIE to determine whether we are the primary beneficiary and are required to consolidate the assets and liabilities of the entity. The primary beneficiary of a VIE is the enterprise that has the power to direct the activities of a VIE that most significantly impact the VIE’s economic performance and has the obligation to absorb losses or receive benefits that could potentially be significant to the VIE. The determination of the primary beneficiary for a VIE can be complex and requires management judgment regarding the expected results of the entity and how those results are absorbed by variable interest holders, as well as which party has the power to direct activities that most significantly impact the performance of the VIEs. Our primary involvement related to VIEs includes securitization transactions, certain investments, reinsurance transactions and certain mortgage insurance policies. We have a beneficial interest in a VIE where we are the servicer and transferor of certain assets that were sold to the VIE. Our primary economic interest in this VIE represents the excess interest of the commercial mortgage loans. This securitization entity was designed to have significant limitations on the types of assets owned, the types and extent of permitted activities and decision making rights and is comprised of an entity backed by commercial mortgage loans. As a result of our involvement in the entity’s design or having certain decision making ability regarding the assets held by the securitization entity, consolidation of the VIE is required. As of December 31, 2022 and 2021, we had $21 million and $29 million, respectively, of total securitized assets required to be consolidated. The assets held by the securitization entity are restricted and can only be used to fulfill the obligations of the securitization entity. We do not have any additional exposure or guarantees associated with this securitization entity. There was no new asset securitization activity in 2022. We have excess of loss reinsurance agreements with entities that are considered VIEs. Our involvement with these VIEs represents mortgage insurance claim coverage through excess of loss reinsurance, which includes significant insurance risk and a reasonable possibility of a significant loss but does not result in the unilateral power to direct the activities that most significantly affect the VIEs’ economic performance or result in the obligation to absorb losses or the right to receive benefits. Accordingly, consolidation of the VIEs is not required. The assets of the VIEs are deposited in reinsurance trusts for our benefit that will be the source of reinsurance claim payments. Refer to note 8 for additional information related to our reinsurance agreements with entities that are considered VIEs. We hold investments in certain structures that are considered VIEs. Our investments represent beneficial interests that are primarily in the form of structured securities or limited partnership investments. Our involvement in these structures typically represents a passive investment in the returns generated by the VIE and typically does not result in having significant influence over the economic performance of the VIE. We also provide mortgage insurance on certain residential mortgage loans originated and securitized by third parties using VIEs to issue mortgage-backed securities. While we provide mortgage insurance on the underlying loans, we do not typically have any ongoing involvement with the VIE other than our mortgage insurance coverage and do not act in a servicing capacity for the underlying loans held by the VIE.
Leases	v) Leases We have leased assets predominantly classified as operating leases, which are recognized both as a right-of-use in our non-lease non-lease one d-a lease liability
Accounting Pronouncements Recently Adopted	w) Accounting Changes Troubled Debt Restructurings On April 1, 2022, we elected to early adopt new accounting guidance related to troubled debt restructurings and the vintage disclosures included within the accounting guidance for credit losses on financial instruments. The guidance eliminates the recognition and measurement requirements for troubled debt restructurings and requires creditors to instead apply existing guidance related to loan refinancing and restructuring to determine whether a modification results in a new loan or a continuation of an existing loan. The guidance also expands disclosures for certain loan refinancings and restructurings by creditors when a borrower is experiencing financial difficulty and requires the presentation of gross write-offs by year of origination. We were permitted to early adopt this new accounting guidance as we adopted the accounting guidance related to credit losses on financial instruments on January 1, 2020. In accordance with the new accounting guidance, we adopted this guidance prospectively as of January 1, 2022, which did not have any impact at adoption. Simplification of Accounting for Income Taxes On January 1, 2021, we adopted new accounting guidance related to simplifying the accounting for income taxes. The guidance eliminates certain exceptions related to the approach for intraperiod tax allocation, the methodology for calculating income taxes in an interim period and the recognition of deferred tax liabilities for outside basis differences. We adopted this new accounting guidance using the retrospective method or modified retrospective method for certain changes and prospective method for all other changes, which did not have a significant impact on our consolidated financial statements and disclosures. Defined Benefit Plan Disclosures On January 1, 2020, we adopted new accounting guidance related to disclosure requirements for defined benefit plans as part of the Financial Accounting Standards Board’s (the “FASB”) disclosure framework project. The guidance adds, eliminates and modifies certain disclosure requirements for defined benefit pension and other postretirement benefit plans. We adopted this accounting guidance using the retrospective method, which did not have a significant impact on our consolidated financial statements and disclosures. Fair Value Disclosures On January 1, 2020, we adopted new accounting guidance related to fair value disclosure requirements as part of the FASB’s disclosure framework project. The guidance adds, eliminates and modifies certain disclosure requirements for fair value measurements. The guidance includes new disclosure requirements related to changes in unrealized gains and losses included in OCI for recurring Level 3 fair value measurements held at the end of the reporting period and the range and weighted-average of significant unobservable inputs used to develop Level 3 fair value measurements. We adopted this accounting guidance using the prospective method for the aforementioned disclosures, as well as the narrative description of measurement uncertainty, and the retrospective method for all other disclosures. This accounting guidance did not impact our consolidated financial statements but impacted our fair value disclosures. Accounting for Credit Losses on Financial Instruments On January 1, 2020, we adopted new accounting guidance related to accounting for credit losses on financial instruments. The guidance requires entities to recognize an allowance equal to its estimate of lifetime expected credit losses and applies to most financial instruments not measured at fair value, which primarily includes our commercial mortgage loans, bank loan investments and reinsurance recoverables. The guidance also requires the recognition of an allowance for expected credit losses as a liability in our consolidated balance sheet for off-balance instrument-by-instrument We adopted the guidance related to our investments carried at amortized cost, reinsurance recoverables and off-balance off-balance We adopted the guidance related to our available-for-sale available-for-sale Reference Rate Reform In March 2020, January 2021 and December 2022, the FASB issued new accounting guidance related to reference rate reform, which was effective for us on January 1, 2020. The guidance provides temporary guidance to ease the potential burden in accounting for, or recognizing the effects of, reference rate reform, which includes the transition away from the London Interbank Offered Rate (“LIBOR”) and other interbank offered rates to alternative reference rates, such as the Secured Overnight Financing Rate. This guidance provides optional practical expedients and exceptions for applying generally accepted accounting principles to investments, derivatives or other transactions affected by reference rate reform such as those that impact the assessment of derivative hedge effectiveness and contract modifications, to include continuing hedge accounting when certain critical terms of a hedging relationship change and modifying certain effectiveness assessments to exclude certain potential sources of ineffectiveness. The guidance was updated to clarify that the optional practical expedients and exceptions can be applied to derivatives that use an interest rate for margining, discounting, or contract price alignment. In addition to the optional practical expedients, the guidance includes a general principle that permits an entity to consider contract modifications due to reference rate reform to be an event that does not require contract remeasurement at the modification date or reassessment of a previous accounting determination. We adopted this guidance prospectively and it did not have a significant impact on our consolidated financial statements or disclosures. However, the amendments in this guidance may be elected over time through December 31, 2024 as reference rate reform activities occur and therefore, this guidance may impact our procedures, including our documentation of our cash flow hedge effectiveness, determined on an individual hedge basis, and the measurement of interest calculated on our floating rate junior subordinated notes, as we implement measures to transition away from LIBOR.
Accounting Pronouncements Not Yet Adopted	x) Accounting Pronouncements Not Yet Adopted In June 2022, the FASB issued new accounting guidance related to the fair value measurement of equity securities subject to contractual sale restrictions. The guidance clarifies existing fair value guidance on measuring the fair value of an equity security subject to contractual sale restrictions and adds new disclosures related to these securities. This guidance is currently effective for us on January 1, 2024 using the prospective method, with early adoption permitted, which we do not intend to elect. We do not expect a significant impact from this guidance on our consolidated financial statements and disclosures. In August 2018, the FASB issued new accounting guidance that significantly changes the recognition and measurement of long-duration insurance contracts, commonly known as long-duration targeted improvements (“LDTI”). This new accounting guidance directly impacts DAC, intangible assets and insurance liabilities in our U.S. life insurance companies, and also significantly increases our disclosure requirements. While the new guidance will have a significant impact on existing U.S. GAAP financial statements and disclosures, it will not impact the cash flows or underlying economics of the business, business strategy, statutory net income (loss) or risk-based capital of our U.S. life insurance companies, as well as have no impact on our Enact segment, Corporate and Other activities or management of capital. We will adopt this new accounting guidance for future reporting periods on the effective date of January 1, 2023 using the modified retrospective method for all topics except for market risk benefits (“MRBs”), which is required to be applied using the retrospective method. The new accounting guidance, for all topics, will be applied as of January 1, 2021 (the “Transition Date”) with an adjustment to beginning retained earnings and accumulated other comprehensive income (loss). In addition, we will re-present On the Transition Date, we will calculate a ratio of future benefits and expenses less the existing carrying value of reser ve discount rate immediately before the Transition Date (locked-in 2(n) Insurance Reserves Future Policy Benefits %, and the difference between the remeasured liability for future policy benefits and related reinsurance recoverables calculated under LDTI and the existing carrying value immediately before the Transition Date will be recorded as a decrease to retained earnings. For all cohorts as of the Transition Date, the liability for future policy benefits and related reinsurance recoverables is calculated using two different discount rates: the locked-in single-A Upon adoption, and as of the Transition Date, we estimate total stockholders’ equity will decrease by approximately $13.7 billion after-tax. $ billion related to the increase in the liability for future policy benefits and related reinsurance recoverables calculated using updated assumptions for cohorts with net premium ratios capped at %, as well as the recognition of MRBs at fair value. The remaining decrease to stockholders’ equity as of the Transition Date is expected to be attributable to a reduction in accumulated other comprehensive income (loss) of approximately $ billion, driven by the change in the discount rate used to measure the liability for future policy benefits and related reinsurance recoverables of approximately $ billion, partially offset by the elimination of shadow adjustments associated with traditional long-duration insurance contracts of approximately $ billion. Our long-term care insurance business will be the most significantly impacted from the adoption, due to the requirement to remeasure the liability for future policy benefits and related reinsurance recoverables at the single-A which at that time was materially lower than the locked-in As a result of adopting this new accounting guidance, beginning on the Transition Date, our insurance liabilities will be more sensitive to movements in interest rates, which will likely result in continued volatility to our stockholders’ equity. For example, if we applied the December 31, 2022 single-A estimated decrease to accumulated other comprehensive income (loss) at the Transition Date. We also expect our net income for the years ended December 31, 2022 and 2021 to decrease after adoption, largely driven by reduced earnings in our long-term care insurance business. The decreases in these years primarily relate to certain cohorts with net premium ratios capped at 100 %, unfavorable changes in assumptions and interest accretion resulting in higher interest expense on our liability for future policy benefits. In addition, we anticipate more volatility in net income (loss) largely from changes in the fair value of MRBs, which will be sensitive to changes in equity markets and interest rates. As a result of these sensitivities, we estimate the overall decrease in our net income for the year ended December 31, 2021 to be partially offset by changes in the fair value of MRBs driven by favorable equity market performance and interest rates. The key areas of change introduced by the adoption of LDTI and the related effect to our accounting policies are summarized in the table below. Less significant accounting policy changes from adopting LDTI are not included in the table below. Key Area Impacted Change to Accounting Policy Policy Elections and Other Significant Matters DAC and balances amortized on a basis consistent with DAC, including intangible assets and cost of reinsurance DAC associated with long-duration insurance contracts is grouped into cohorts consistent with groupings used to estimate the related liability for future policy benefits and is amortized on a constant level basis over the expected contract term, which approximates straight-line. Revised assumptions are recognized prospectively over the remaining term of the related contract. DAC and balances amortized on a basis consistent with DAC are no longer subject to impairment, shadow adjustments or recoverability testing; however, PVFP is still assessed for recoverability in connection with premium deficiency testing. The constant level basis we use to amortize DAC by product is as follows: • long-term care insurance – total life count • life insurance – face amount • fixed and variable annuities – policy count We apply the amortization rate at the beginning of the current reporting period, which reflects assumption updates, if applicable, and actual experience through the end of the current reporting period. For PVFP associated with investment contracts, we elected to amortize these intangible assets in a manner consistent with DAC. Cost of reinsurance is deferred and amortized in a manner consistent with DAC over the terms of the related reinsurance treaties. MRBs, which include contracts or contract features that protect the policyholder’s account balance and expose the insurer to other-than-nominal capital market risk, such as GMDBs, GMWBs and guaranteed payout floor benefits MRBs are measured at fair value with changes related to instrument-specific credit risk recorded as a separate component in accumulated other comprehensive income (loss) and remaining changes recorded in net income (loss). Liability for future policy benefits – level of aggregation For the purpose of calculating the net premium ratio used to measure the liability for future policy benefits, long-duration insurance contracts are grouped into annual cohorts on the basis of original contract issue date. For acquired contracts, the acquisition date is considered the original contract issue date. Traditional and limited-payment long-duration insurance contracts are grouped into annual calendar-year cohorts based on the contract issue date, product type and company. Limited-payment contracts are grouped into cohorts separately from other traditional products and riders are combined with the associated base policies. Key Area Impacted Change to Accounting Policy Policy Elections and Other Significant Matters Liability for future policy benefits – cash flow assumptions All cash flow assumptions used to estimate the liability for future policy benefits, except the discount rate, (see note 2 (n)—Insurance Reserves—Future Policy Benefits catch-up locked-in locked-in Cash flow assumptions no longer reflect a provision for adverse deviation, and the premium deficiency test and shadow adjustments are eliminated. We calculate a single liability for future policy benefits and therefore, all cash flows, including benefit payments (such as claims in course of settlement and incurred claims) are aggregated. As a result, our U.S. life insurance companies elected to combine their previously disclosed liability for policy and contract claims, excluding amounts related to certain life and annuity products not subject to the new accounting guidance, within the liability for future policy benefits and present the aggregate liability as one line item in our consolidated balance sheets. Cash flow assumptions will be formally reviewed and updated as necessary based on experience studies in the fourth quarter each year. We elected to update the net premium ratio quarterly for actual versus expected experience; therefore, during interim reporting periods we will replace forecasted cash flow assumptions with actual cash flows with any difference recorded in net income (loss). We made an entity-wide election not to update our expense assumptions and therefore, these assumptions remain locked-in Key Area Impacted Change to Accounting Policy Policy Elections and Other Significant Matters Liability for future policy benefits – discount rate assumptions The liability for future policy benefits is measured using two different discount rates, a current discount rate and a locked-in discount rate. The current discount rate is used to remeasure the liability for future policy benefits recorded in the consolidated balance sheets and is a current upper-medium grade fixed-income instrument yield, commonly interpreted to be a single-A rated bond rate, with the same duration as the corresponding liability. The locked-in discount rate is used to determine the amounts recorded to net income (loss) and is held constant for the purpose of calculating the net premium ratio and interest accretion. The difference between the liability measured using the locked-in rate and the liability measured using the current rate is recorded in accumulated other comprehensive income (loss). For policies in-force prior to the Transition Date, the locked-in discount rate is equal to the discount rate in effect immediately before the Transition Date. The methodology used to determine the current discount rate assumption maximizes the use of relevant observable inputs and minimizes the use of unobservable inputs. The current discount rate assumption is based on a single-A curve published by a market data service. For cash flows projected beyond the observable curve, we use estimation techniques consistent with Level 3 fair value measurements as defined in note 2 (e)—Fair Value Measurements to interpolate from the last observable rate to an estimated ultimate long-term rate.

Earnings (Loss) Per Share (Tabl

Earnings (Loss) Per Share (Tables)	12 Months Ended
Earnings (Loss) Per Share (Tables)	Dec. 31, 2022
Earnings (Loss) Per Share	Basic and diluted earnings (loss) per share are calculated by dividing each income (loss) category presented below by the weighted-average basic and diluted common shares outstanding for the years ended December 31: (Amounts in millions, except per share amounts) 2022 2021 2020 Weighted-average common shares used in basic earnings (loss) per share calculations 504.5 506.9 505.2 Potentially dilutive securities: Stock options, restricted stock units and other equity-based awards 6.5 7.8 6.4 Weighted-average common shares used in diluted earnings (loss) per share calculations 511.0 514.7 511.6 Income from continuing operations: Income from continuing operations $ 739 $ 918 $ 698 Less: net income from continuing operations attributable to noncontrolling interests 130 33 — Income from continuing operations available to Genworth Financial, Inc.’s common stockholders $ 609 $ 885 $ 698 Basic per share $ 1.21 $ 1.75 $ 1.38 Diluted per share $ 1.19 $ 1.72 $ 1.36 Income (loss) from discontinued operations: Income (loss) from discontinued operations, net of taxes $ — $ 27 $ (486 ) Less: net income from discontinued operations attributable to noncontrolling interests — 8 34 Income (loss) from discontinued operations available to Genworth Financial, Inc.’s common stockholders $ — $ 19 $ (520 ) Basic per share $ — $ 0.04 $ (1.03 ) Diluted per share $ — $ 0.04 $ (1.02 ) Net income (loss): Income from continuing operations $ 739 $ 918 $ 698 Income (loss) from discontinued operations, net of taxes — 27 (486 ) Net income 739 945 212 Less: net income attributable to noncontrolling interests 130 41 34 Net income available to Genworth Financial, Inc.’s common stockholders $ 609 $ 904 $ 178 Basic per share (1 ) $ 1.21 $ 1.78 $ 0.35 Diluted per share (1) $ 1.19 $ 1.76 $ 0.35 (1) May

Investments (Tables)

Investments (Tables)	12 Months Ended
Investments (Tables)	Dec. 31, 2022
Net Investment Income	Sources of net investment income were as follows for the years ended December 31: (Amounts in millions) 2022 2021 2020 Fixed maturity securities—taxable $ 2,296 $ 2,411 $ 2,448 Fixed maturity securities—non-taxable 5 7 6 Equity securities 10 9 12 Commercial mortgage loans 321 376 345 Policy loans 211 189 199 Limited partnerships 99 223 72 Other invested assets 267 241 223 Cash, cash equivalents, restricted cash and short-term investments 20 1 15 Gross investment income before expenses and fees 3,229 3,457 3,320 Expenses and fees (83 (87 ) (93 Net investment income $ 3,146 $ 3,370 $ 3,227
Net Investment Gains (Losses)	The following table sets forth net investment gains (losses) for the years ended December 31: (Amounts in millions) 2022 2021 2020 Realized investment gains (losses): Available-for-sale Realized gains $ 28 $ 67 $ 471 Realized losses (102 ) (10 ) (29 ) Net realized gains (losses) on available-for-sale (74 ) 57 442 Net realized gains (losses) on equity securities sold — (7 ) (1 ) Net realized gains (losses) on limited partnerships — 3 — Total net realized investment gains (losses) (74 ) 53 441 Net change in allowance for credit losses on available-for-sale — (6 ) (5 ) Write-down of available-for-sale (1 ) (2 ) (1 ) (4 ) Net unrealized gains (losses) on equity securities still held (35 ) 1 4 Net unrealized gains (losses) on limited partnerships 71 264 112 Commercial mortgage loans 4 (3 ) (2 ) Derivative instruments (2) 17 14 (49 ) Other 2 1 (5 ) Net investment gains (losses) $ (17 ) $ 323 $ 492 (1) Represents write-down of securities deemed uncollectible or that we intend to sell or will be required to sell prior to recovery of the amortized cost basis. (2) See note 5 for additional information on the impact of derivative instruments included in net investment gains (losses).
Allowance for credit losses related to fixed maturity securities	The following tables represent the allowance for credit losses aggregated by security type for available-for-sale fixed maturity securities as of and for the years ended December 31: 2021 Increase from Increase securities (decrease) Decrease without from securities due to change allowance in with allowance in intent or Beginning previous in previous Securities requirement Ending (Amounts in millions) balance periods periods sold to sell Write-offs Recoveries balance Fixed maturity securities: Non-U.S. $ 1 $ — $ 6 $ (7 ) $ — $ — $ — $ — Commercial mortgage-backed 3 — — — — (3 ) — — Total available-for-sale $ 4 $ — $ 6 $ (7 ) $ — $ (3 ) $ — $ — 2020 Increase from Increase securities (decrease) Decrease without from securities due to change allowance in with allowance in intent or Beginning previous in previous Securities requirement Ending (Amounts in millions) balance periods periods sold to sell Write-offs Recoveries balance Fixed maturity securities: Non-U.S. $ — $ 4 $ (2 ) $ (1 ) $ — $ — $ — $ 1 Commercial mortgage-backed — 3 — — — — — 3 Total available-for-sale $ — $ 7 $ (2 ) $ (1 ) $ — $ — $ — $ 4
Unrealized Investment Gains and Losses	Net unrealized gains and losses on available-for-sale (Amounts in millions) 2022 2021 2020 Net unrealized gains (losses) on fixed maturity securities without an allowance for credit losses (1) $ (4,251 ) $ 7,869 $ 10,159 Net unrealized gains (losses) on fixed maturity securities with an allowance for credit losses (1) — — (7 ) Adjustments to DAC, PVFP, sales inducements, benefit reserves and policyholder contract balances 44 (5,487 ) (7,302 ) Income taxes, net 710 (507 ) (611 ) Net unrealized investment gains (losses) (3,497 ) 1,875 2,239 Less: net unrealized investment gains (losses) attributable to noncontrolling interests (71 ) 15 25 Net unrealized investment gains (losses) attributable to Genworth Financial, Inc. $ (3,426 ) $ 1,860 $ 2,214 (1) Excludes foreign exchange.
Change in Net Unrealized Gains (Losses) on Available-for-Sale Investment Securities Reported in Accumulated Other Comprehensive Income (Loss)	The change in net unrealized gains (losses) on available-for-sale (Amounts in millions) 2022 2021 2020 Beginning balance $ 1,860 $ 2,214 $ 1,456 Unrealized gains (losses) arising during the period: Unrealized gains (losses) on fixed maturity securities (12,194 ) (2,218 ) 3,950 Adjustment to DAC (1) 1,332 30 122 Adjustment to PVFP 81 — (1 ) Adjustment to sales inducements 28 12 (5 ) Adjustment to benefit reserves and policyholder contract balances (2) 4,090 1,773 (2,629 ) Provision for income taxes 1,233 90 (305 ) Change in unrealized gains (losses) on investment securities (5,430 ) (313 ) 1,132 Reclassification adjustments to net investment (gains) losses, net of taxes of $(16), $14 and $100 58 (51 ) (374 ) Change in net unrealized investment gains (losses) (5,372 ) (364 ) 758 Less: change in net unrealized investment gains (losses) attributable to noncontrolling interests (86 ) (10 ) — Ending balance $ (3,426 ) $ 1,860 $ 2,214 (1) See note 6 for additional information. (2) See note 9 for additional information.
Fixed Maturity Securities	As of December 31, 2022, the amortized cost or cost, gross unrealized gains (losses), allowance for credit losses and fair value of our fixed maturity securities classified as available-for-sale Amortized Gross Gross Allowance cost or unrealized unrealized for credit Fair (Amounts in millions) cost gains losses losses value Fixed maturity securities: U.S. government, agencies and government-sponsored enterprises $ 3,446 $ 86 $ (191 ) $ — $ 3,341 State and political subdivisions 2,726 19 (346 ) — 2,399 Non-U.S. 731 15 (101 ) — 645 U.S. corporate: Utilities 4,295 50 (447 ) — 3,898 Energy 2,450 33 (221 ) — 2,262 Finance and insurance 8,005 59 (871 ) — 7,193 Consumer—non-cyclical 4,776 84 (403 ) — 4,457 Technology and communications 3,265 43 (361 ) — 2,947 Industrial 1,312 15 (130 ) — 1,197 Capital goods 2,290 41 (193 ) — 2,138 Consumer—cyclical 1,758 14 (155 ) — 1,617 Transportation 1,165 32 (97 ) — 1,100 Other 325 3 (18 ) — 310 Total U.S. corporate 29,641 374 (2,896 ) — 27,119 Non-U.S. Utilities 817 — (77 ) — 740 Energy 1,009 19 (68 ) — 960 Finance and insurance 2,124 30 (208 ) — 1,946 Consumer—non-cyclical 655 1 (90 ) — 566 Technology and communications 997 4 (107 ) — 894 Industrial 880 8 (70 ) — 818 Capital goods 606 3 (63 ) — 546 Consumer—cyclical 308 — (32 ) — 276 Transportation 392 12 (29 ) — 375 Other 932 15 (58 ) — 889 Total non-U.S. 8,720 92 (802 ) — 8,010 Residential mortgage-backed 1,059 7 (71 ) — 995 Commercial mortgage-backed 2,183 2 (277 ) — 1,908 Other asset-backed 2,328 1 (163 ) — 2,166 Total available-for-sale $ 50,834 $ 596 $ (4,847 ) $ — $ 46,583 As of December 31, 2021, the amortized cost or cost, gross unrealized gains (losses), allowance for credit losses and fair value of our fixed maturity securities classified as available-for-sale Amortized Gross Gross Allowance cost or unrealized unrealized for credit Fair (Amounts in millions) cost gains losses losses value Fixed maturity securities: U.S. government, agencies and government-sponsored enterprises $ 3,368 $ 1,184 $ — $ — $ 4,552 State and political subdivisions 2,982 474 (6 ) — 3,450 Non-U.S. 762 86 (13 ) — 835 U.S. corporate: Utilities 4,330 783 (9 ) — 5,104 Energy 2,581 363 (10 ) — 2,934 Finance and insurance 8,003 1,012 (24 ) — 8,991 Consumer—non-cyclical 5,138 1,029 (8 ) — 6,159 Technology and communications 3,345 476 (13 ) — 3,808 Industrial 1,322 175 (3 ) — 1,494 Capital goods 2,334 415 (4 ) — 2,745 Consumer—cyclical 1,703 203 (7 ) — 1,899 Transportation 1,122 249 — — 1,371 Other 379 41 (1 ) — 419 Total U.S. corporate 30,257 4,746 (79 ) — 34,924 Non-U.S. Utilities 867 63 (2 ) — 928 Energy 1,194 190 (1 ) — 1,383 Finance and insurance 2,171 270 (9 ) — 2,432 Consumer—non-cyclical 664 81 (2 ) — 743 Technology and communications 1,085 166 (1 ) — 1,250 Industrial 933 117 (3 ) — 1,047 Capital goods 640 66 (1 ) — 705 Consumer—cyclical 316 27 (2 ) — 341 Transportation 422 68 (1 ) — 489 Other 1,052 169 (4 ) — 1,217 Total non-U.S. 9,344 1,217 (26 ) — 10,535 Residential mortgage-backed 1,325 116 (1 ) — 1,440 Commercial mortgage-backed 2,435 152 (3 ) — 2,584 Other asset-backed 2,138 29 (7 ) — 2,160 Total available-for-sale $ 52,611 $ 8,004 $ (135 ) $ — $ 60,480
Gross Unrealized Losses and Fair Values of Securities in a Continuous Unrealized Loss Position	The following table presents the gross unrealized losses and fair values of our fixed maturity securities for which an allowance for credit losses has not been recorded, aggregated by investment type and length of time that individual fixed maturity securities have been in a continuous unrealized loss position, as of December 31, 2022: Less than 12 months 12 months or more Total Gross Gross Gross Fair unrealized Number of Fair unrealized Number of Fair unrealized Number of (Dollar amounts in millions) value losses securities value losses securities value losses securities Description of Securities Fixed maturity securities: U.S. government, agencies and government-sponsored enterprises $ 1,585 $ (189 ) 55 $ 17 $ (2 ) 6 $ 1,602 $ (191 ) 61 State and political subdivisions 1,559 (269 ) 258 261 (77 ) 66 1,820 (346 ) 324 Non-U.S. 351 (54 ) 59 152 (47 ) 23 503 (101 ) 82 U.S. corporate 18,480 (2,344 ) 2,452 2,001 (552 ) 236 20,481 (2,896 ) 2,688 Non-U.S. 5,593 (599 ) 732 748 (203 ) 111 6,341 (802 ) 843 Residential mortgage-backed 569 (51 ) 192 65 (20 ) 22 634 (71 ) 214 Commercial mortgage-backed 1,765 (255 ) 265 88 (22 ) 16 1,853 (277 ) 281 Other asset-backed 1,455 (83 ) 347 598 (80 ) 101 2,053 (163 ) 448 Total for fixed maturity securities in an unrealized loss position $ 31,357 $ (3,844 ) 4,360 $ 3,930 $ (1,003 ) 581 $ 35,287 $ (4,847 ) 4,941 % Below cost: <20% Below cost $ 27,596 $ (2,587 ) 3,835 $ 1,819 $ (291 ) 310 $ 29,415 $ (2,878 ) 4,145 20%-50% 3,757 (1,251 ) 523 2,111 (712 ) 271 5,868 (1,963 ) 794 >50% Below cost 4 (6 ) 2 — — — 4 (6 ) 2 Total for fixed maturity securities in an unrealized loss position $ 31,357 $ (3,844 ) 4,360 $ 3,930 $ (1,003 ) 581 $ 35,287 $ (4,847 ) 4,941 Investment grade $ 29,959 $ (3,687 ) 4,158 $ 3,590 $ (915 ) 537 $ 33,549 $ (4,602 ) 4,695 Below investment grade 1,398 (157 ) 202 340 (88 ) 44 1,738 (245 ) 246 Total for fixed maturity securities in an unrealized loss position $ 31,357 $ (3,844 ) 4,360 $ 3,930 $ (1,003 ) 581 $ 35,287 $ (4,847 ) 4,941 The following table presents the gross unrealized losses and fair values of our corporate securities for which an allowance for credit losses has not been recorded, aggregated by investment type and length of time that individual investment securities have been in a continuous unrealized loss position, based on industry, as of December 31, 2022: Less than 12 months 12 months or more Total Gross Gross Gross Fair unrealized Number of Fair unrealized Number of Fair unrealized Number of (Dollar amounts in millions) value losses securities value losses securities value losses securities Description of Securities U.S. corporate: Utilities $ 2,447 $ (398 ) 345 $ 187 $ (49 ) 37 $ 2,634 $ (447 ) 382 Energy 1,538 (187 ) 226 144 (34 ) 14 1,682 (221 ) 240 Finance and insurance 5,250 (668 ) 696 706 (203 ) 74 5,956 (871 ) 770 Consumer—non-cyclical 2,805 (342 ) 317 201 (61 ) 22 3,006 (403 ) 339 Technology and communications 2,259 (273 ) 304 271 (88 ) 32 2,530 (361 ) 336 Industrial 829 (105 ) 104 110 (25 ) 13 939 (130 ) 117 Capital goods 1,332 (153 ) 169 148 (40 ) 16 1,480 (193 ) 185 Consumer—cyclical 1,138 (108 ) 173 194 (47 ) 22 1,332 (155 ) 195 Transportation 746 (93 ) 95 21 (4 ) 5 767 (97 ) 100 Other 136 (17 ) 23 19 (1 ) 1 155 (18 ) 24 Subtotal, U.S. corporate securities 18,480 (2,344 ) 2,452 2,001 (552 ) 236 20,481 (2,896 ) 2,688 Non-U.S. Utilities 640 (63 ) 66 57 (14 ) 9 697 (77 ) 75 Energy 604 (61 ) 69 40 (7 ) 5 644 (68 ) 74 Finance and insurance 1,310 (122 ) 204 296 (86 ) 42 1,606 (208 ) 246 Consumer—non-cyclical 491 (74 ) 56 54 (16 ) 11 545 (90 ) 67 Technology and communications 740 (96 ) 93 39 (11 ) 8 779 (107 ) 101 Industrial 480 (45 ) 71 105 (25 ) 13 585 (70 ) 84 Capital goods 394 (46 ) 52 62 (17 ) 6 456 (63 ) 58 Consumer—cyclical 241 (28 ) 31 23 (4 ) 6 264 (32 ) 37 Transportation 180 (21 ) 26 29 (8 ) 5 209 (29 ) 31 Other 513 (43 ) 64 43 (15 ) 6 556 (58 ) 70 Subtotal, non-U.S. 5,593 (599 ) 732 748 (203 ) 111 6,341 (802 ) 843 Total for corporate securities in an unrealized loss position $ 24,073 $ (2,943 ) 3,184 $ 2,749 $ (755 ) 347 $ 26,822 $ (3,698 ) 3,531 The following table presents the gross unrealized losses and fair values of our fixed maturity securities for which an allowance for credit losses has not been recorded, aggregated by investment type and length of time that individual fixed maturity securities have been in a continuous unrealized loss position, as of December 31, 2021: Less than 12 months 12 months or more Total Gross Gross Gross Fair unrealized Number of Fair unrealized Number of Fair unrealized Number of (Dollar amounts in millions) value losses securities value losses securities value losses securities Description of Securities Fixed maturity securities: State and political subdivisions $ 339 $ (6 ) 67 $ — $ — — $ 339 $ (6 ) 67 Non-U.S. 173 (9 ) 28 19 (4 ) 1 192 (13 ) 29 U.S. corporate 2,593 (64 ) 266 196 (15 ) 22 2,789 (79 ) 288 Non-U.S. 912 (21 ) 124 62 (5 ) 8 974 (26 ) 132 Residential mortgage-backed 97 (1 ) 22 — — — 97 (1 ) 22 Commercial mortgage-backed 113 (2 ) 17 31 (1 ) 4 144 (3 ) 21 Other asset-backed 764 (7 ) 111 — — — 764 (7 ) 111 Total for fixed maturity securities in an unrealized loss position $ 4,991 $ (110 ) 635 $ 308 $ (25 ) 35 $ 5,299 $ (135 ) 670 % Below cost: <20% Below cost $ 4,991 $ (110 ) 635 $ 297 $ (20 ) 33 $ 5,288 $ (130 ) 668 20%-50% — — — 11 (5 ) 2 11 (5 ) 2 Total for fixed maturity securities in an unrealized loss position $ 4,991 $ (110 ) 635 $ 308 $ (25 ) 35 $ 5,299 $ (135 ) 670 Investment grade $ 4,644 $ (101 ) 587 $ 241 $ (12 ) 25 $ 4,885 $ (113 ) 612 Below investment grade 347 (9 ) 48 67 (13 ) 10 414 (22 ) 58 Total for fixed maturity securities in an unrealized loss position $ 4,991 $ (110 ) 635 $ 308 $ (25 ) 35 $ 5,299 $ (135 ) 670 The following table presents the gross unrealized losses and fair values of our corporate securities for which an allowance for credit losses has not been recorded, aggregated by investment type and length of time that individual investment securities have been in a continuous unrealized loss position, based on industry, as of December 31, 2021: Less than 12 months 12 months or more Total Gross Gross Gross Fair unrealized Number of Fair unrealized Number of Fair unrealized Number of (Dollar amounts in millions) value losses securities value losses securities value losses securities Description of Securities U.S. corporate: Utilities $ 211 $ (7 ) 32 $ 29 $ (2 ) 7 $ 240 $ (9 ) 39 Energy 166 (3 ) 18 25 (7 ) 4 191 (10 ) 22 Finance and insurance 960 (22 ) 89 62 (2 ) 3 1,022 (24 ) 92 Consumer—non-cyclical 296 (7 ) 30 14 (1 ) 2 310 (8 ) 32 Technology and communications 378 (12 ) 37 29 (1 ) 2 407 (13 ) 39 Industrial 143 (3 ) 18 — — — 143 (3 ) 18 Capital goods 171 (3 ) 16 18 (1 ) 2 189 (4 ) 18 Consumer—cyclical 268 (7 ) 26 — — — 268 (7 ) 26 Other — — — 19 (1 ) 2 19 (1 ) 2 Subtotal, U.S. corporate securities 2,593 (64 ) 266 196 (15 ) 22 2,789 (79 ) 288 Non-U.S. Utilities 69 (2 ) 9 — — — 69 (2 ) 9 Energy 64 (1 ) 10 — — — 64 (1 ) 10 Finance and insurance 366 (8 ) 43 18 (1 ) 2 384 (9 ) 45 Consumer—non-cyclical 67 (1 ) 12 6 (1 ) 1 73 (2 ) 13 Technology and communications 48 (1 ) 8 — — — 48 (1 ) 8 Industrial 122 (3 ) 14 — — — 122 (3 ) 14 Capital goods 78 (1 ) 8 — — — 78 (1 ) 8 Consumer—cyclical 22 (1 ) 8 15 (1 ) 3 37 (2 ) 11 Transportation 37 (1 ) 7 — — — 37 (1 ) 7 Other 39 (2 ) 5 23 (2 ) 2 62 (4 ) 7 Subtotal, non-U.S. 912 (21 ) 124 62 (5 ) 8 974 (26 ) 132 Total for corporate securities in an unrealized loss position $ 3,505 $ (85 ) 390 $ 258 $ (20 ) 30 $ 3,763 $ (105 ) 420
Maturity Distribution of Fixed Maturity Securities	The scheduled maturity distribution of fixed maturity securities as of December 31, 2022 is set forth below. Actual maturities may differ from contractual maturities because issuers of securities may have the right to call or prepay obligations with or without call or prepayment penalties. Amortized cost or Fair (Amounts in millions) cost value Due one year or less $ 1,239 $ 1,234 Due after one year through five years 8,264 7,931 Due after five years through ten years 13,120 11,915 Due after ten years 22,641 20,434 Subtotal 45,264 41,514 Residential mortgage-backed 1,059 995 Commercial mortgage-backed 2,183 1,908 Other asset-backed 2,328 2,166 Total $ 50,834 $ 46,583
Allowance for Credit Losses and Recorded Investment in Commercial Mortgage Loans	The following table sets forth the allowance for credit losses related to commercial mortgage loans as of and for the years ended December 31: (Amounts in millions) 2022 2021 2020 Allowance for credit losses: Beginning balance $ 26 $ 31 $ 13 Cumulative effect of change in accounting — — 16 Provision (5 ) 3 2 Write-offs — (8 ) — Recoveries 1 — — Ending balance $ 22 $ 26 $ 31
Commercial Mortgage Loans By Credit Quality Indicator	The following tables set forth commercial mortgage loans by year of origination and credit quality indicator as of December 31, 2022: 2017 and (Amounts in millions) 2022 2021 2020 2019 2018 prior Total Debt-to-value: 0% - 50% $ 42 $ 41 $ 98 $ 110 $ 204 $ 1,890 $ 2,385 51% - 60% 58 98 62 131 229 764 1,342 61% - 75% 848 788 334 460 380 445 3,255 76% - 100% — — — 8 28 14 50 Greater than 100% — — — — — — — Total amortized cost $ 948 $ 927 $ 494 $ 709 $ 841 $ 3,113 $ 7,032 Debt service coverage ratio: Less than 1.00 $ 7 $ 9 $ 6 $ 47 $ 58 $ 143 $ 270 1.00 - 1.25 17 1 16 19 94 125 272 1.26 - 1.50 290 70 65 163 140 390 1,118 1.51 - 2.00 580 614 207 270 348 1,066 3,085 Greater than 2.00 54 233 200 210 201 1,389 2,287 Total amortized cost $ 948 $ 927 $ 494 $ 709 $ 841 $ 3,113 $ 7,032
Loan To Value Ratio
Commercial Mortgage Loans By Credit Quality Indicator	The following tables set forth the debt-to-value of commercial mortgage loans by property type as of December 31: 2022 Greater (Amounts in millions) 0% - 50% 51% - 60% 61% - 75% 76% - 100% than 100% Total Property type: Retail $ 907 $ 649 $ 1,332 $ 28 $ — $ 2,916 Office 445 272 848 14 — 1,579 Industrial 668 243 545 — — 1,456 Apartments 184 90 279 8 — 561 Mixed use 93 79 199 — — 371 Other 88 9 52 — — 149 Total amortized cost $ 2,385 $ 1,342 $ 3,255 $ 50 $ — $ 7,032 % of total 34 % 19 % 46 % 1 % — % 100 % Weighted-average debt service coverage ratio 2.35 1.95 1.63 1.34 — 1.93 2021 (Amounts in millions) 0% - 50% 51% - 60% 61% - 75% 76% - 100% Greater 100% Total Property type: Retail $ 853 $ 611 $ 1,310 $ — $ — $ 2,774 Office 505 395 604 — 22 1,526 Industrial 745 240 435 — — 1,420 Apartments 200 102 283 — — 585 Mixed use 120 70 140 — — 330 Other 57 121 43 — — 221 Total amortized cost $ 2,480 $ 1,539 $ 2,815 $ — $ 22 $ 6,856 % of total 36 % 23 % 41 % — % — % 100 % Weighted-average debt service coverage ratio 2.36 1.83 1.61 — 0.68 1.93
Debt Service Coverage Ratio
Commercial Mortgage Loans By Credit Quality Indicator	The following tables set forth the debt service coverage ratio for fixed rate commercial mortgage loans by property type as of December 31: 2022 Greater (Amounts in millions) Less than 1.00 1.00 - 1.25 1.26 - 1.50 1.51 - 2.00 than 2.00 Total Property type: Retail $ 88 $ 68 $ 560 $ 1,380 $ 820 $ 2,916 Office 81 131 155 666 546 1,579 Industrial 20 44 194 574 624 1,456 Apartments 14 11 150 242 144 561 Mixed use 25 16 50 190 90 371 Other 42 2 9 33 63 149 Total amortized cost $ 270 $ 272 $ 1,118 $ 3,085 $ 2,287 $ 7,032 % of total 4 % 4 % 16 % 44 % 32 % 100 % Weighted-average debt-to-value 61 % 62 % 63 % 60 % 44 % 56 % 2021 Greater (Amounts in millions) Less than 1.00 1.00 - 1.25 1.26 - 1.50 1.51 - 2.00 than 2.00 Total Property type: Retail $ 102 $ 166 $ 405 $ 1,375 $ 726 $ 2,774 Office 67 109 167 593 590 1,526 Industrial 9 64 82 599 666 1,420 Apartments 17 62 84 225 197 585 Mixed use 24 32 40 118 116 330 Other 4 126 13 48 30 221 Total amortized cost $ 223 $ 559 $ 791 $ 2,958 $ 2,325 $ 6,856 % of total 3 % 8 % 12 % 43 % 34 % 100 % Weighted-average debt-to-value 68 % 61 % 61 % 60 % 43 % 55 %
Other Geographic Area \| Commercial Mortgage Loan
Distribution Across Property Type and Geographic Region for Commercial Mortgage Loans	The following tables set forth the distribution across property type and geographic region for commercial mortgage loans as of December 2022 2021 Carrying % of Carrying % of (Amounts in millions) value total value total Property type: Retail $ 2,916 42 % $ 2,774 40 % Office 1,579 22 1,526 22 Industrial 1,456 21 1,420 21 Apartments 561 8 585 9 Mixed use 371 5 330 5 Other 149 2 221 3 Subtotal 7,032 100 % 6,856 100 % Allowance for credit losses (22 ) (26 ) Total $ 7,010 $ 6,830 2022 2021 Carrying % of Carrying % of (Amounts in millions) value total value total Geographic region: South Atlantic $ 1,809 26 % $ 1,770 26 % Pacific 1,340 19 1,360 20 Mountain 1,023 15 892 13 Mid dle 988 14 964 14 West South Central 578 8 483 7 East North Central 454 6 465 7 West North Central 438 6 461 7 East South Central 218 3 224 3 New England 184 3 237 3 Subtotal 7,032 100 % 6,856 100 % Allowance for credit losses (22 ) (26 ) Total $ 7,010 $ 6,830

Derivative Instruments (Tables)

Derivative Instruments (Tables)	12 Months Ended
Derivative Instruments (Tables)	Dec. 31, 2022
Schedule Of Positions in Derivative Instruments	The following table sets forth our positions in derivative instruments as of December 31: Derivative assets Derivative liabilities Fair value Fair value Balance Balance (Amounts in millions) sheet classification 2022 2021 sheet classification 2022 2021 Derivatives designated as hedges Cash flow hedges: Interest rate swaps Other invested assets $ 24 $ 364 Other liabilities $ 522 $ 26 Foreign currency swaps Other invested assets 20 6 Other liabilities — — Total cash flow hedges 44 370 522 26 Total derivatives designated as hedges 44 370 522 26 Derivatives not designated as hedges Equity index options Other invested assets 6 42 Other liabilities — — Financial futures Other invested assets — — Other liabilities — — Other foreign currency contracts Other invested assets — 2 Other liabilities — — GMWB embedded derivatives Reinsurance (1) 16 19 Policyholder (2) 223 271 Fixed index annuity embedded derivatives Other assets — — Policyholder (3) 202 294 Indexed universal life embedded derivatives Reinsurance — — Policyholder (4) 15 25 Total derivatives not designated as hedges 22 63 440 590 Total derivatives $ 66 $ 433 $ 962 $ 616 (1) Represents embedded derivatives associated with the reinsured portion of our GMWB liabilities. (2) Represents the embedded derivatives associated with our GMWB liabilities, excluding the impact of reinsurance. (3) Represents the embedded derivatives associated with our fixed index annuity liabilities. (4) Represents the embedded derivatives associated with our indexed universal life liabilities.
Schedule of Notional Amounts Outstanding on Derivative Instruments	The following tables represent activity associated with derivative instruments as of the dates indicated: December 31, Maturities/ December 31, (Notional in millions) Measurement 2021 Additions terminations 2022 Derivatives designated as hedges Cash flow hedges: Interest rate swaps Notional $ 7,653 $ 1,109 $ (220 ) $ 8,542 Foreign currency swaps Notional 127 17 — 144 Total cash flow hedges 7,780 1,126 (220 ) 8,686 Total derivatives designated as hedges 7,780 1,126 (220 ) 8,686 Derivatives not designated as hedges Equity index options Notional 1,446 946 (1,456 ) 936 Financial futures Notional 946 4,405 (3,948 ) 1,403 Other foreign currency contracts Notional 83 — (83 ) — Total derivatives not designated as hedges 2,475 5,351 (5,487 ) 2,339 Total derivatives $ 10,255 $ 6,477 $ (5,707 ) $ 11,025 December 31, Maturities/ December 31, (Number of policies) Measurement 2021 Additions terminations 2022 Derivatives not designated as hedges GMWB embedded derivatives Policies 21,804 — (1,876 ) 19,928 Fixed index annuity embedded derivatives Policies 9,344 — (2,029 ) 7,315 Indexed universal life embedded derivatives Policies 806 — (35 ) 771
Schedule of Pre-Tax Income (Loss) Effects of Cash Flow Hedges	The following table provides information about the pre-tax income effects of cash flow hedges for the year ended December 31, 2022: Gain (loss) Gain (loss) reclassified into Classification of gain (loss) Gain (loss) Classification of gain recognized net income reclassified into recognized in (loss) recognized in (Amounts in millions) in OCI from OCI net income net income net income Interest rate swaps hedging assets $ (854 ) $ 225 Net investment income $ — Net investment Interest rate swaps hedging assets — 9 Net investment gains (losses) — Net investment Interest rate swaps hedging — (3 ) Interest expense — Net investment Foreign currency swaps 15 — Net investment income — Net investment Total $ (839 ) $ 231 $ — The following table provides information about the pre-tax income effects of cash flow hedges for the year ended December 31, 2021: Gain (loss) Gain (loss) reclassified into Classification of gain (loss) Gain (loss) Classification of gain recognized net income reclassified into recognized in (loss) recognized in (Amounts in millions) in OCI from OCI net income net income net income Interest rate swaps hedging assets $ (100 ) $ 217 Net investment $ — Net investment Interest rate swaps hedging assets — 1 Net investment — Net investment Interest rate swaps hedging 36 (1 ) Interest — Net investment Foreign currency 7 — Net investment — Net investment Total $ (57 ) $ 217 $ — The following table provides information about the pre-tax income effects of cash flow hedges for the year ended December 31, 2020: Gain (loss) Gain (loss) reclassified into Classification of gain (loss) Gain (loss) Classification of gain recognized net income reclassified into recognized in (loss) recognized in (Amounts in millions) in OCI from OCI net income net income net income Interest rate swaps hedging $ 482 $ 196 Net $ — Net investment Interest rate swaps hedging — 12 Net — Net investment Interest rate swaps hedging (38 ) — Interest — Net investment gains (losses) Foreign currency swaps (5 ) — Net — Net investment Total $ 439 $ 208 $ —
Reconciliation of Current Period Changes, Net of Applicable Income Taxes, for Derivatives Qualifying as Hedge	The following table provides a reconciliation of current period changes, net of applicable income taxes, for these designated derivatives presented in the separate component of stockholders’ equity labeled “derivatives qualifying as hedges,” for the years ended December 31: (Amounts in millions) 2022 2021 2020 Derivatives qualifying as effective accounting hedges as of January 1 $ 2,025 $ 2,211 $ 2,002 Current period increases (decreases) in fair value, net of deferred taxes of $165, $12 and $(95) (674 ) (45 ) 344 Reclassification to net (income), net of deferred taxes of $80, $76 and $73 (151 ) (141 ) (135 ) Derivatives qualifying as effective accounting hedges as of December 31 $ 1,200 $ 2,025 $ 2,211
Schedule of Pre-Tax Gain (Loss) Recognized in Net Income (loss) for Effects of Derivatives Not Designated as Hedges	The following table provides the pre-tax gain (loss) recognized in net income for the effects of derivatives not designated as hedges for the years ended December 31: Classification of gain (loss) recognized (Amounts in millions) 2022 2021 2020 in net income Interest rate swaps $ — $ 2 $ (11 ) Net investment gains (losses) Equity index options (20 ) 18 4 Net investment gains (losses) Financial futures (81 ) (123 ) 2 Net investment gains (losses) Other foreign currency contracts — — 6 Net investment gains (losses) GMWB embedded derivatives 66 124 (28 ) Net investment gains (losses) Fixed index annuity embedded derivatives 16 (32 ) (51 ) Net investment gains (losses) Indexed universal life embedded derivatives 27 24 17 Net investment gains (losses) Total derivatives not designated as hedges $ 8 $ 13 $ (61 )
Derivative Assets and Liabilities Subject to Master Netting Arrangement	The following table presents additional information about derivative assets and liabilities subject to an enforceable master netting arrangement as of December 31: 2022 2021 Derivative Derivative Net Derivative Derivative Net (Amounts in millions) assets (1) liabilities (1) derivatives assets (1) liabilities (1) derivatives Amounts presented in the balance sheet: Gross amounts recognized $ 50 $ 522 $ (472 ) $ 414 $ 26 $ 388 Gross amounts offset in the balance sheet — — — — — — Net amounts presented in the balance sheet 50 522 (472 ) 414 26 388 Gross amounts not offset in the balance sheet: Financial instruments (2) (25 ) (25 ) — (20 ) (20 ) — Collateral received (21 ) — (21 ) (308 ) — (308 ) Collateral pledged — (1,095 ) 1,095 — (536 ) 536 Over collateralization — 598 (598 ) 2 530 (528 ) Net amount $ 4 $ — $ 4 $ 88 $ — $ 88 (1) Does not include amounts related to embedded derivatives as of December 31, 2022 and 2021. (2) Amounts represent derivative assets and/or liabilities that are presented gross within the balance sheet but are held with the same counterparty where we have a master netting arrangement. This adjustment results in presenting the net asset and net liability position for each counterparty.

Deferred Acquisition Costs (Tab

Deferred Acquisition Costs (Tables)	12 Months Ended
Deferred Acquisition Costs (Tables)	Dec. 31, 2022
Activity Impacting Deferred Acquisition Costs	The following table presents the activity impacting DAC as of and for the years ended December 31: (Amounts in millions) 2022 2021 2020 Unamortized balance as of January 1 $ 2,438 $ 2,809 $ 3,243 Costs deferred — 8 3 Amortization, net of interest accretion (278 ) (379 ) (437 ) Unamortized balance as of December 31 2,160 2,438 2,809 Accumulated effect of net unrealized investment (gains) losses 40 (1,292 ) (1,322 ) Balance as of December 31 $ 2,200 $ 1,146 $ 1,487

Intangible Assets (Tables)

Intangible Assets (Tables)	12 Months Ended
Intangible Assets (Tables)	Dec. 31, 2022
Intangible Assets	The following table presents our intangible assets as of December 31: 2022 2021 Gross Gross carrying Accumulated carrying Accumulated (Amounts in millions) amount amortization amount amortization PVFP $ 2,146 $ (1,989 ) $ 2,065 $ (1,994 ) Capitalized software 482 (427 ) 465 (403 ) Deferred sales inducements to contractholders 325 (298 ) 295 (288 ) Other 158 (156 ) 159 (156 ) Total $ 3,111 $ (2,870 ) $ 2,984 $ (2,841 )
Activity in Present Value of Future Profits	The following table presents the activity in PVFP as of and for the years ended December 31: (Amounts in millions) 2022 2021 2020 Unamortized balance as of January 1 $ 152 $ 154 $ 154 Interest accreted at 5.18%, 5.23% and 5.19% 8 8 8 Amortization (3 ) (10 ) (8 ) Unamortized balance as of December 31 157 152 154 Accumulated effect of net unrealized investment (gains) losses — (81 ) (81 ) Balance as of December 31 $ 157 $ 71 $ 73
Percentage of Current PVFP Balance Estimated to be Amortized	The percentage of the PVFP balance net of interest accretion, before the effect of unrealized investment gains or losses, estimated to be amortized over each of the next five years is as follows: 2023 10.3 % 2024 10.3 % 2025 10.2 % 2026 10.1 % 2027 10.1 %

Reinsurance (Tables)

Reinsurance (Tables)	12 Months Ended
Reinsurance (Tables)	Dec. 31, 2022
Net Domestic Life Insurance In-Force	The following table sets forth net domestic life insurance in-force as of December 31: (Amounts in millions) 2022 2021 2020 Direct life insurance in-force $ 430,151 $ 471,147 $ 509,670 Amounts assumed from other companies 527 573 624 Amounts ceded to other companies (1) (383,350 ) (427,464 ) (458,999 ) Net life insurance in-force $ 47,328 $ 44,256 $ 51,295 Percentage of amount assumed to net 1 % 1 % 1 % (1) Includes amounts accounted for under the deposit method.
Schedule of Effects of Reinsurance on Premiums Written and Earned	The following table sets forth the effects of reinsurance on premiums written and earned for the years ended December 31: Written Earned (Amounts in millions) 2022 2021 2020 2022 2021 2020 Direct: Life insurance $ 738 $ 774 $ 795 $ 738 $ 775 $ 795 Accident and health insurance (1) 2,746 2,797 2,836 2,786 2,834 2,860 Mortgage insurance 979 990 947 1,023 1,050 1,023 Total direct 4,463 4,561 4,578 4,547 4,659 4,678 Assumed: Life insurance 1 2 1 1 2 2 Accident and health insurance (1) 292 300 313 295 304 322 Mortgage insurance 3 3 3 3 3 4 Total assumed 296 305 317 299 309 328 Ceded: Life insurance (2) (505 ) (913 ) (558 ) (505 ) (913 ) (559 ) Accident and health insurance (1) (531 ) (541 ) (550 ) (542 ) (548 ) (562 ) Mortgage insurance (80 ) (72 ) (49 ) (80 ) (72 ) (49 ) Total ceded (1,116 ) (1,526 ) (1,157 ) (1,127 ) (1,533 ) (1,170 ) Net premiums $ 3,643 $ 3,340 $ 3,738 $ 3,719 $ 3,435 $ 3,836 Percentage of amount assumed to net 8 % 9 % 9 % (1) Accident and health insurance is comprised almost entirely of our long-term care insurance products. (2) Effective December 1, 2021 and included in the year ended December 31, 2021, we entered into a reinsurance agreement with SCOR Global Life USA Reinsurance Company, under which we ceded premiums of $360
Schedule of Reinsurance Recoverable in Allowance for Credit Losses	The following table sets forth the changes in the allowance for credit losses related to reinsurance recoverables as of and for the years ended December 31: (Amounts in millions) 2022 2021 2020 Allowance for credit losses: Beginning balance $ 55 $ 45 $ — Cumulative effect of change in accounting — — 40 Provision 5 10 5 Write-offs — — — Recoveries — — — Ending balance $ 60 $ 55 $ 45
Schedule Of Credit Ratings on Reinsurance Recoverable	The following tables set forth A.M. Best Company, Inc.’s (“A.M. Best”) credit ratings related to our reinsurance recoverables, gross of the allowance for credit losses, as of December 31: 2022 (Amounts in millions) Collateralized Non-collateralized Total Credit rating: A++ $ — $ 570 $ 570 A+ 1,286 1,819 3,105 A 19 25 44 Not rated 12,687 89 12,776 Total reinsurance recoverable $ 13,992 $ 2,503 $ 16,495 2021 (Amounts in millions) Collateralized Non-collateralized Total Credit rating: A++ $ — $ 543 $ 543 A+ 1,581 1,510 3,091 A 18 41 59 Not rated 13,099 76 13,175 Total reinsurance recoverable $ 14,698 $ 2,170 $ 16,868

Insurance Reserves (Tables)

Insurance Reserves (Tables)	12 Months Ended
Insurance Reserves (Tables)	Dec. 31, 2022
Recorded Liabilities and Major Assumptions Underlying Future Policy Benefits	The following table sets forth our recorded liabilities and the major assumptions underlying our future policy benefits as of December 31: Mortality/ morbidity Interest rate (Amounts in millions) assumption assumption 2022 2021 Long-term care insurance contracts (a) 3.75% - 7.50 % $ 26,209 $ 28,232 Structured settlements with life contingencies (b) 1.00% - 8.00 % 7,900 8,075 Annuity contracts with life contingencies (b) 1.00% - 8.00 % 1,754 2,934 Traditional life insurance contracts ( c 3.00% - 7.50 % 1,872 1,956 Supplementary contracts with life contingencies (b) 1.00% - 8.00 % 329 331 Total future policy benefits $ 38,064 $ 41,528 (a) The 1983 Individual Annuitant Mortality Table or the 2000 U.S. Annuity Table, or the 1983 Group Annuitant Mortality Table or the 1994 Group Annuitant Mortality Table and company experience. (b) Assumptions for limited-payment contracts come from either the U.S. Population Table, the 1983 Group Annuitant Mortality Table, the 1983 Individual Annuitant Mortality Table, the Annuity 2000 Mortality Table or the 2012 Individual Annuity Reserving Table. (c) Principally modifications based on company experience of the Society of Actuaries 1965-70 1975-80
Recorded Liabilities for Policyholder Account Balances	The following table sets forth our recorded liabilities for policyholder account balances as of December 31: (Amounts in millions) 2022 2021 Annuity contracts $ 5,652 $ 6,816 Funding agreements 200 250 Structured settlements without life contingencies 930 1,027 Supplementary contracts without life contingencies 499 550 Other 13 14 Total investment contracts 7,294 8,657 Universal and term universal life insurance contracts 9,819 10,697 Total policyholder account balances $ 17,113 $ 19,354
Information about Variable Annuity Products with Death and Living Benefit Guarantees	The following table sets forth information about our variable annuity products with death and living benefit guarantees as of December 31: (Dollar amounts in millions) 2022 2021 Account values with death benefit guarantees (net of reinsurance): Standard death benefits (return of net deposits) account value $ 1,878 $ 2,547 Net amount at risk $ 2 $ 1 Average attained age of contractholders 77 76 Enhanced death benefits (ratchet, rollup) account value $ 1,004 $ 1,326 Net amount at risk $ 187 $ 94 Average attained age of contractholders 76 76 Account values with living benefit guarantees: GMWBs $ 1,352 $ 1,893 Guaranteed annuitization benefits $ 767 $ 1,002
Account Balances of Variable Annuity Contract with Death or Living Benefit Guarantees Invested in Separate Account Investment Options	Account balances of variable annuity contracts with death or living benefit guarantees were invested in separate account investment options as follows as of December 31: (Amounts in millions) 2022 2021 Balanced funds $ 1,686 $ 2,397 Equity funds 721 913 Bond funds 214 297 Money market funds 186 189 Total $ 2,807 $ 3,796

Liability for Policy and Cont_2

Liability for Policy and Contract Claims (Tables)	12 Months Ended
Liability for Policy and Contract Claims (Tables)	Dec. 31, 2022
Schedule of Liability for Policy and Contract Claims	The following table sets forth our liability for policy and contract claims as of December 31: (Amounts in millions) 2022 2021 Liability for policy and contract claims for insurance lines other than short-duration contracts: U.S. Life Insurance segment: Long-term care insurance $ 11,380 $ 10,861 Life insurance 299 308 Fixed annuities 16 14 Runoff segment 14 8 Total 11,709 11,191 Liability for policy and contract claims related to short-duration contracts: Enact segment 519 641 Other mortgage insurance businesses 6 9 Total 525 650 Total liability for policy and contract claims $ 12,234 $ 11,841
Changes in Liability for Policy and Contract Claims	The following table sets forth changes in the liability for policy and contract claims for our long-term care insurance business for the dates indicated: (Amounts in millions) 2022 2021 2020 Beginning balance as of January 1 $ 10,861 $ 10,518 $ 10,239 Less reinsurance recoverables (2,260 ) (2,260 ) (2,283 ) Net balance as of January 8,601 8,258 7,956 Incurred related to insured events of: Current year 2,954 2,761 2,595 Prior years (458 ) (610 ) (398 ) Total incurred 2,496 2,151 2,197 Paid related to insured events of: Current year (211 ) (203 ) (189 ) Prior years (2,173 ) (2,011 ) (2,118 ) Total paid (2,384 ) (2,214 ) (2,307 ) Interest on liability for policy and contract claims 422 406 412 Net balance as of December 31 9,135 8,601 8,258 Add reinsurance recoverables 2,245 2,260 2,260 Ending balance as of December 31 $ 11,380 $ 10,861 $ 10,518
Schedule of Incurred Claims Net of Reinsurance, Cummulative Number of Reported Delinquencies, Total Incurred But Not Reported	The following table sets forth information about incurred claims, net of reinsurance, as well as cumulative number of reported delinquencies and the total of IBNR liabilities plus expected development on reported claims included within the net incurred claims amounts for our Enact segment as of December 31, 2022. The information about the incurred claims development for the years ended December , to and the historical reported delinquencies as of December , and prior are presented as supplementary information. Incurred claims and allocated claim adjustment expenses, net of reinsurance Total of Number of (2) (Dollar For the years ended December 31, Accident (1) 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 Unaudited 2013 $ 475 $ 407 $ 392 $ 387 $ 384 $ 382 $ 381 $ 381 $ 381 $ 381 $ — 22,502 2014 — 328 288 269 261 259 258 259 259 258 — 17,809 2015 — — 235 208 187 181 180 180 179 179 — 15,400 2016 — — — 198 160 138 136 137 136 135 — 13,970 2017 — — — — 171 121 102 105 104 102 — 15,097 2018 — — — — — 117 84 84 78 73 — 11,269 2019 — — — — — — 106 111 98 71 — 11,883 2020 — — — — — — — 365 362 107 — 38,863 2021 — — — — — — — — 141 119 1 12,585 2022 — — — — — — — — — 220 24 14,329 Total incurred $ 1,645 (1) Represents the year in which first monthly mortgage payments have been missed by the borrower. (2) Represents reported and outstanding delinquencies less actual cures as of December 31 for each respective accident year.
Schedule of Paid Claims Deveopment, Net of Reinsurance	The following table sets forth paid claims development, net of reinsurance, for our Enact segment for the year ended December 31, 2022. The information about paid claims development for the years ended December 31, 2013 to 2021 is presented as supplementary information. (Amounts in millions) Cumulative paid claims and allocated claim adjustment expenses, net of reinsurance Accident year (1) 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 Unaudited 2013 $ 44 $ 202 $ 297 $ 340 $ 362 $ 372 $ 375 $ 376 $ 377 $ 378 2014 — 22 127 195 233 247 253 254 255 255 2015 — — 12 85 145 167 173 175 176 177 2016 — — — 10 64 110 124 127 128 129 2017 — — — — 6 46 77 87 90 92 2018 — — — — — 3 32 48 55 59 2019 — — — — — — 2 18 31 38 2020 — — — — — — — 1 8 13 2021 — — — — — — — — — 2 2022 — — — — — — — — — — Total paid $ 1,143 Total incurred $ 1,645 Total paid 1,143 All outstanding liabilities before 2013 17 Liability for policy and contract claims $ 519 (1) Represents the year in which first monthly mortgage payments have been missed by the borrower.
Schedule of Average Payout of Incurred Claims by Age	The following table sets forth our average payout of incurred claims by age for our Enact segment as of December 31, 2022: Average annual percentage payout of incurred claims by age Years 1 2 3 4 5 6 7 8 9 10 Unaudited Percentage of payout 4.8 % 30.1 % 24.5 % 11.2 % 4.1 % 1.8 % 0.7 % 0.3 % 0.2 % 0.1 %

Borrowings and Other Financin_2

Borrowings and Other Financings (Tables)	12 Months Ended
Borrowings and Other Financings (Tables)	Dec. 31, 2022
Schedule of Long Term Borrowings	The following table sets forth total long-term borrowings as of December 31: (Amounts in millions) 2022 2021 Genworth Holdings 4.80% Senior Notes, due 2024 $ — $ 282 6.50% Senior Notes, due 2034 285 298 Floating Rate Junior Subordinated Notes, due 2066 599 598 Subtotal 884 1,178 Bond consent fees (10 ) (12 ) Deferred borrowing charges (6 ) (7 ) Total Genworth Holdings 868 1,159 Enact Holdings 6.50% Senior Notes, due 2025 750 750 Deferred borrowing charges (7 ) (10 ) Total Enact Holdings 743 740 Total $ 1,611 $ 1,899
Principal Amounts of Long-Term Borrowings by Maturity	Principal amounts under our long-term borrowings by maturity were as follows as of December 31, 2022: (Amounts in millions) 2023 $ — 2024 — 2025 750 2026 — 2027 and thereafter 887 Total $ 1,637

Income Taxes (Tables)

Income Taxes (Tables)	12 Months Ended
Income Taxes (Tables)	Dec. 31, 2022
Components of Income before Income Taxes	Income from continuing operations before income taxes included the following components for the years ended December 31: (Amounts in millions) 2022 2021 2020 Domestic $ 978 $ 1,184 $ 931 Foreign — (3 ) (3 ) Income from continuing operations before income taxes $ 978 $ 1,181 $ 928
Components of Income Tax Provision	The total provision for income taxes was as follows for the years ended December 31: (Amounts in millions) 2022 2021 2020 Current federal income taxes $ — $ (32 ) $ — Deferred federal income taxes 239 288 226 Total federal income taxes 239 256 226 Current state income taxes 4 5 3 Deferred state income taxes (5 ) 2 2 Total state income taxes (1 ) 7 5 Current foreign income taxes — — — Deferred foreign income taxes 1 — (1 ) Total foreign income taxes 1 — (1 ) Total provision for income taxes $ 239 $ 263 $ 230
Reconciliation of Federal Statutory Tax Rate to Effective Income Tax Rate	The reconciliation of the federal statutory tax rate to the effective income tax rate was as follows for the years ended December 31: 2022 2021 2020 Statutory U.S. federal income tax rate 21.0 % 21.0 % 21.0 % Increase (reduction) in rate resulting from: Tax on income from terminated swaps 3.2 2.5 3.0 Reduction in uncertain tax positions — (1.8 ) — Other, net 0.2 0.6 0.8 Effective rate 24.4 % 22.3 % 24.8 %
Components of Net Deferred Income Tax Liability	The components of our deferred income taxes were as follows as of December 31: (Amounts in millions) 2022 2021 Assets: Foreign tax credit carryforwards $ 156 $ 174 Net operating loss carryforwards 4 202 Capital loss carryforwards 146 142 State income taxes 396 388 Insurance reserves 161 178 Accrued commission and general expenses 113 118 Liabilities associated with discontinued operations 122 122 Net unrealized losses on investment securities 897 — Net unrealized losses on derivatives 102 — Other 9 18 Gross deferred income tax assets 2,106 1,342 Valuation allowance (583 ) (382 ) Total deferred income tax assets 1,523 960 Liabilities: Net unrealized gains on investment securities — 506 Net unrealized gains on derivatives — 73 DAC 29 98 PVFP and other intangibles 37 38 Insurance reserves transition adjustment 74 99 Investments 20 10 Other 19 17 Total deferred income tax liabilities 179 841 Net deferred income tax asset $ 1,344 $ 119
Reconciliation of Unrecognized Tax Benefits	A reconciliation of the beginning and ending amount of unrecognized tax benefits was as follows: (Amounts in millions) 2022 2021 2020 Balance as of January 1 $ 40 $ 62 $ 64 Tax positions related to the current period: Gross additions — — — Gross reductions (3 ) (3 ) (3 ) Tax positions related to the prior years: Gross additions — — 1 Gross reductions (4 ) (19 ) — Balance as of December 31 $ 33 $ 40 $ 62

Stock-Based Compensation (Table

Stock-Based Compensation (Tables)	12 Months Ended
Stock-Based Compensation (Tables)	Dec. 31, 2022
Summary of Cash Award Activity	The following table summarizes cash award activity as of December 31, 2022 and 2021: Performance- Time-based based Cash settled RSUs cash awards cash awards Number of Weighted-average Number of Number of (Awards in thousands) awards fair value awards awards Balance as of January 1, 2021 — $ — 30,429 6,938 Granted — $ — 15,473 — Performance adjustment — $ — — 5,838 Vested — $ — (14,774 ) (12,776 ) Forfeited — $ — (3,432 ) — Balance as of January 1, 2022 — $ — 27,696 — Granted 2,957 $ 4.27 208 — Performance adjustment — $ — — — Vested (23 ) $ 4.17 (13,992 ) — Forfeited (180 ) $ 4.31 (1,020 ) — Balance as of December 31, 2022 2,754 $ 4.27 12,892 —
Status of Other Equity-Based Awards	The following tables summarize the status of our other equity-based awards as of December 31, 2022 and 2021: RSUs PSUs DSUs SARs Weighted- Weighted- average Weighted- Weighted- average Number grant Number average Number average Number grant of date fair of fair of fair of date fair (Awards in thousands) awards value awards value awards value awards value Balance as of January 1, 2021 2,534 $ 3.48 5,734 $ 3.79 1,537 $ 3.95 7,030 $ 3.32 Granted 1,391 $ 3.31 2,510 $ 3.45 315 $ 2.52 — $ — Performance adjustment (1) — $ — 626 $ 3.58 — $ — — $ — Exercised (1,474 ) $ 3.47 (1,365 ) $ 3.58 (15 ) $ 7.46 — $ — Terminated (134 ) $ 3.53 — $ — — $ — (835 ) $ 3.04 Balance as of January 1, 2022 2,317 $ 3.38 7,505 $ 3.70 1,837 $ 3.42 6,195 $ 3.36 Granted 1,105 $ 4.25 2,182 $ 4.47 281 $ 2.51 — $ — Performance adjustment (1) — $ — 2,308 $ 4.61 — $ — — $ — Exercised (1,004 ) $ 3.39 (4,616 ) $ 4.61 (954 ) $ 4.02 — $ — Terminated (299 ) $ 3.52 (718 ) $ 3.55 — $ — (2,295 ) $ 2.52 Balance as of December 31, 2022 2,119 $ 3.81 6,661 $ 3.65 1,164 $ 2.44 3,900 $ 3.85 (1) The performance adjustment relates to additional awards expected to be earned through the achievement of certain performance metrics .
Summary of Other Equity Awards Valuation Assumptions	The valuation assumptions used in the Monte Carlo simulation to calculate the total relative shareholder return performance metric for the PSUs granted in 2022 and 2021 were as follows: 2022 2021 Valuation-date stock $ 4.27 $ 3.31 Volatility 64.6 % 65.0 % Dividend yield — % — % Risk-free rate 1.8 % 0.3 % Valuation maximum 800% of grant-date stock price 800% of grant-date stock price
Summary of Enact Holdings' Equity-Based Awards	The following table summarizes the status of Enact Holdings’ equity-based awards as of December 31, 2022 and 2021: RSUs DSUs PSUs Weighted- Weighted- Weighted- Number average Number average Number average of fair of fair of fair (Awards in thousands) awards value awards value awards value Balance as of January 1, 2021 — $ — — $ — — $ — Granted 628 $ 19.02 17 $ 20.87 — $ — Dividend equivalents 36 $ 21.25 — $ — — $ — Vested — $ — — $ — — $ — Terminated (10 ) $ 19.00 — $ — — $ — Balance as of January 1, 2022 654 $ 19.02 17 $ 20.87 — $ — Granted 322 $ 22.18 78 $ 22.02 156 $ 22.15 Dividend equivalents 62 $ 24.00 5 $ 24.00 10 $ 24.00 Vested (3 ) $ 19.00 — $ — — $ — Terminated (26 ) $ 19.73 — $ — — $ — Balance as of December 31, 2022 1,009 $ 20.07 100 $ 21.81 166 $ 22.15

Fair Value of Financial Instr_2

Fair Value of Financial Instruments (Tables)	12 Months Ended
Fair Value of Financial Instruments (Tables)	Dec. 31, 2022
Summary of Significant Inputs Used by Third-Party Pricing Services for Certain Fair Value Measurements of Fixed Maturity Securities that Classified as Level 2	The following table presents a summary of the significant inputs used by our pricing services for certain fair value measurements of fixed maturity securities that are classified as Level 2 as of December 31, 2022: (Amounts in millions) Fair value Primary methodologies Significant inputs U.S. government, agencies and $ 3,341 Price quotes from trading desk, broker feeds Bid side prices, trade prices, Option Adjusted Spread State and political subdivisions $ 2,344 Multi-dimensional attribute-based modeling systems, third-party pricing vendors Trade prices, material event notices, Municipal Market Data Non-U.S. $ 645 Matrix pricing, spread priced to Benchmark yields, trade prices, broker quotes, comparative bid-offer U.S. corporate $ 23,537 Multi-dimensional attribute-based Bid side prices to Treasury Curve, Issuer Curve, which includes sector, quality, duration, OAS percentage and change for spread matrix, trade prices, comparative transactions, Trade Reporting and Compliance Engine (“TRACE”) reports Non-U.S. $ 6,305 Multi-dimensional attribute-based OAS-based Benchmark yields, trade prices, broker quotes, comparative transactions, issuer spreads, bid-offer Residential mortgage-backed $ 973 OAS-based Prepayment and default assumptions, aggregation of bonds with similar characteristics, including collateral type, vintage, tranche type, weighted-average life, weighted-average loan age, issuer program and delinquency ratio, pay up and pay down factors, TRACE reports Commercial mortgage-backed $ 1,896 Multi-dimensional attribute-based Credit risk, interest rate risk, prepayment speeds, new issue Other asset-backed $ 2,072 Multi-dimensional attribute-based Spreads to daily updated swap curves, spreads derived from
Assets by Class of Instrument that are Measured at Fair Value on Recurring Basis	The following tables set forth our assets by class of instrument that are measured at fair value on a recurring basis as of December 31: 2022 (Amounts in millions) Total Level 1 Level 2 Level 3 NAV (1) Assets Investments: Fixed maturity securities: U.S. government, agencies and government-sponsored enterprises $ 3,341 $ — $ 3,341 $ — $ — State and political subdivisions 2,399 — 2,344 55 — Non-U.S. 645 — 645 — — U.S. corporate: Utilities 3,898 — 3,056 842 — Energy 2,262 — 2,146 116 — Finance and insurance 7,193 — 6,506 687 — Consumer—non-cyclical 4,457 — 4,375 82 — Technology and communications 2,947 — 2,923 24 — Industrial 1,197 — 1,175 22 — Capital goods 2,138 — 2,104 34 — Consumer—cyclical 1,617 — 1,504 113 — Transportation 1,100 — 1,057 43 — Other 310 — 151 159 — Total U.S. corporate 27,119 — 24,997 2,122 — Non-U.S. corporate: Utilities 740 — 445 295 — Energy 960 — 842 118 — Finance and insurance 1,946 — 1,821 125 — Consumer—non-cyclical 566 — 493 73 — Technology and communications 894 — 868 26 — Industrial 818 — 770 48 — Capital goods 546 — 451 95 — Consumer—cyclical 276 — 212 64 — Transportation 375 — 355 20 — Other 889 — 868 21 — Total non-U.S. corporate 8,010 — 7,125 885 — Residential mortgage-backed 995 — 973 22 — Commercial mortgage-backed 1,908 — 1,896 12 — Other asset-backed 2,166 — 2,072 94 — Total fixed maturity securities 46,583 — 43,393 3,190 — Equity securities 319 239 46 34 — Limited partnerships 1,816 — — 24 1,792 Other invested assets: Derivative assets: Interest rate swaps 24 — 24 — — Foreign currency swaps 20 — 20 — — Equity index options 6 — — 6 — Total derivative assets 50 — 44 6 — Short-term investments 3 — 3 — — Total other invested assets 53 — 47 6 — Reinsurance recoverable (2) 16 — — 16 — Separate account assets 4,417 4,417 — — — Total assets $ 53,204 $ 4,656 $ 43,486 $ 3,270 $ 1,792 (1) Limited partnerships that are measured at fair value using the NAV per share (or its equivalent) practical expedient have not been categorized in the fair value hierarchy. (2) Represents embedded derivatives associated with the reinsured portion of our GMWB liabilities. 2021 (Amounts in millions) Total Level 1 Level 2 Level 3 NAV (1) Assets Investments: Fixed maturity securities: U.S. government, agencies and government-sponsored enterprises $ 4,552 $ — $ 4,552 $ — $ — State and political subdivisions 3,450 — 3,368 82 — Non-U.S. 835 — 833 2 — U.S. corporate: Utilities 5,104 — 4,154 950 — Energy 2,934 — 2,858 76 — Finance and insurance 8,991 — 8,306 685 — Consumer—non-cyclical 6,159 — 6,055 104 — Technology and communications 3,808 — 3,779 29 — Industrial 1,494 — 1,457 37 — Capital goods 2,745 — 2,700 45 — Consumer—cyclical 1,899 — 1,762 137 — Transportation 1,371 — 1,307 64 — Other 419 — 165 254 — Total U.S. corporate 34,924 — 32,543 2,381 — Non-U.S. corporate: Utilities 928 — 583 345 — Energy 1,383 — 1,238 145 — Finance and insurance 2,432 — 2,272 160 — Consumer—non-cyclical 743 — 680 63 — Technology and communications 1,250 — 1,222 28 — Industrial 1,047 — 954 93 — Capital goods 705 — 532 173 — Consumer—cyclical 341 — 265 76 — Transportation 489 — 436 53 — Other 1,217 — 1,191 26 — Total non-U.S. corporate 10,535 — 9,373 1,162 — Residential mortgage-backed 1,440 — 1,413 27 — Commercial mortgage-backed 2,584 — 2,568 16 — Other asset-backed 2,160 — 2,022 138 — Total fixed maturity securities 60,480 — 56,672 3,808 — Equity securities 198 101 60 37 — Limited partnerships 1,462 — — 26 1,436 Other invested assets: Derivative assets: Interest rate swaps 364 — 364 — — Foreign currency swaps 6 — 6 — — Equity index options 42 — — 42 — Other foreign currency contracts 2 — 2 — — Total derivative assets 414 — 372 42 — Short-term investments 26 — 26 — — Total other invested assets 440 — 398 42 — Reinsurance recoverable (2) 19 — — 19 — Separate account assets 6,066 6,066 — — — Total assets $ 68,665 $ 6,167 $ 57,130 $ 3,932 $ 1,436 (1) Limited partnerships that are measured at fair value using the NAV per share (or its equivalent) practical expedient have not been categorized in the fair value hierarchy. (2) Represents embedded derivatives associated with the reinsured portion of our GMWB liabilities.
Assets Measured at Fair Value on Recurring Basis and Utilized Significant Unobservable (Level 3) Inputs to Determine Fair Value	The following tables present additional information about assets measured at fair value on a recurring basis and for which we have utilized significant unobservable (Level 3) inputs to determine fair value as of and for the dates indicated: Beginning balance as of January 1, Total realized and Ending balance as of December 31, 2022 Total gains (losses) (Amounts in millions) Included in net income Included Purchases Sales Issuances Settlements Transfer into Level 3 (1) Transfer out of Level 3 (1) Included Included Fixed maturity securities: State political subdivisions $ 82 $ 3 $ (30 ) $ — $ — $ — $ — $ — $ — $ 55 $ 3 $ (31 ) Non-U.S. government 2 — — 2 (3 ) — (1 ) — — — — — U.S. corporate: Utilities 950 — (211 ) 130 — — (19 ) 3 (11 ) 842 — (210 ) Energy 76 — (19 ) — — — (9 ) 68 — 116 — (20 ) Finance and insurance 685 — (147 ) 216 — — (19 ) 8 (56 ) 687 — (141 ) Consumer—non-cyclical 104 — (13 ) — — — (9 ) — — 82 — (13 ) Technology and communications 29 — (5 ) — — — — — — 24 — (5 ) Industrial 37 — (4 ) — — — (11 ) — — 22 — (4 ) Capital goods 45 — (7 ) — — — (4 ) — — 34 — (7 ) Consumer—cyclical 137 — (18 ) — — — (6 ) — — 113 — (18 ) Transportation 64 — (8 ) 5 — — (5 ) — (13 ) 43 — (7 ) Other 254 — (27 ) — (41 ) — (10 ) — (17 ) 159 — (28 ) Total U.S. corporate 2,381 — (459 ) 351 (41 ) — (92 ) 79 (97 ) 2,122 — (453 ) Non-U.S. corporate: Utilities 345 — (56 ) 24 — — (18 ) — — 295 — (55 ) Energy 145 — (15 ) 13 (21 ) — (24 ) 20 — 118 — (15 ) Finance and insurance 160 5 (40 ) — — — — — — 125 5 (41 ) Consumer—non-cyclical 63 — (8 ) 9 — — — 18 (9 ) 73 — (8 ) Technology and communications 28 — (2 ) — — — — — — 26 — (2 ) Industrial 93 — (33 ) 22 — — (20 ) — (14 ) 48 — (31 ) Capital goods 173 — (16 ) — (10 ) — (52 ) — — 95 — (16 ) Consumer—cyclical 76 — (15 ) — — — — 17 (14 ) 64 — (16 ) Transportation 53 — (3 ) — — — (30 ) — — 20 — (3 ) Other 26 — (5 ) — — — — — — 21 — (4 ) Total non-U.S. corporate 1,162 5 (193 ) 68 (31 ) — (144 ) 55 (37 ) 885 5 (191 ) Residential mortgage-backed 27 — (8 ) 14 — — (2 ) 4 (13 ) 22 — (6 ) Commercial mortgage-backed 16 — (5 ) — — — — 1 — 12 — (6 ) Other asset-backed 138 — (15 ) 77 (6 ) — (7 ) — (93 ) 94 — (13 ) Total fixed maturity securities 3,808 8 (710 ) 512 (81 ) — (246 ) 139 (240 ) 3,190 8 (700 ) Equity securities 37 — — 1 (3 ) — — — (1 ) 34 — — Limited partnerships 26 (2 ) — — — — — — — 24 (2 ) — Other invested assets: Derivative assets: Equity index options 42 (20 ) — 13 — — (29 ) — — 6 (7 ) — Total derivative assets 42 (20 ) — 13 — — (29 ) — — 6 (7 ) — Total other invested assets 42 (20 ) — 13 — — (29 ) — — 6 (7 ) — Reinsurance recoverable (2) 19 (4 ) — — — 1 — — — 16 (4 ) — Total Level 3 assets $ 3,932 $ (18 ) $ (710 ) $ 526 $ (84 ) $ 1 $ (275 ) $ 139 $ (241 ) $ 3,270 $ (5 ) $ (700 ) (1) The transfers into and out of Level 3 for fixed maturity securities were related to changes in the primary pricing source and changes in the observability of external information used in determining the fair value, such as external ratings or credit spreads, as well as changes in the industry sectors assigned to specific securities. (2) Represents embedded derivatives associated with the reinsured portion of our GMWB liabilities. Beginning balance as of January 1, Total realized and Ending balance as of December 31, 2021 Total gains (losses) (Amounts in millions) Included in net income Included Purchases Sales Issuances Settlements Transfer into Level 3 (1) Transfer out of Level 3 (1) Included Included Fixed maturity securities: State political subdivisions $ 66 $ 3 $ 13 $ — $ — $ — $ — $ — $ — $ 82 $ 3 $ 13 Non-U.S. government — — — 2 — — — — — 2 — — U.S. corporate: Utilities 842 — 3 118 — — (18 ) 18 (13 ) 950 — 4 Energy 128 — 4 50 — — (10 ) 8 (104 ) 76 — 1 Finance and insurance 607 — (18 ) 233 — — (46 ) 17 (108 ) 685 — (16 ) Consumer—non-cyclical 109 — (2 ) — — — (3 ) 3 (3 ) 104 — (2 ) Technology and communications 47 — (1 ) 12 — — — 4 (33 ) 29 — (1 ) Industrial 40 — — 17 — — (20 ) — — 37 — (1 ) Capital goods 60 — (1 ) — — — (14 ) — — 45 — (2 ) Consumer—cyclical 150 — — — — — (5 ) — (8 ) 137 — — Transportation 70 — (1 ) — — — (5 ) — — 64 — (1 ) Other 219 — (1 ) — — — (32 ) 88 (20 ) 254 — 1 Total U.S. corporate 2,272 — (17 ) 430 — — (153 ) 138 (289 ) 2,381 — (17 ) Non-U.S. corporate: Utilities 352 — (5 ) 30 — — (8 ) — (24 ) 345 — (6 ) Energy 245 — 7 — — — (28 ) — (79 ) 145 — 3 Finance and insurance 305 3 (1 ) 1 (2 ) — (62 ) — (84 ) 160 5 (14 ) Consumer—non-cyclical 67 1 (2 ) 8 — — (14 ) 3 — 63 — (2 ) Technology and communications 28 — — — — — — — — 28 — (1 ) Industrial 95 2 (4 ) 14 — — (14 ) — — 93 — (2 ) Capital goods 178 — 1 25 — — — — (31 ) 173 — — Consumer—cyclical 146 — — 17 — — — — (87 ) 76 — — Transportation 109 3 (3 ) — — — (49 ) — (7 ) 53 — — Other 83 6 (3 ) — — — (45 ) — (15 ) 26 — (1 ) Total non-U.S. 1,608 15 (10 ) 95 (2 ) — (220 ) 3 (327 ) 1,162 5 (23 ) Residential mortgage-backed 14 — — 5 — — (2 ) 10 — 27 — — Commercial mortgage-backed 20 — (2 ) 1 — — (3 ) — — 16 1 (2 ) Other asset-backed 109 — — 69 — — (25 ) 35 (50 ) 138 — — Total fixed maturity securities 4,089 18 (16 ) 602 (2 ) — (403 ) 186 (666 ) 3,808 9 (29 ) Equity securities 51 — — — (9 ) — (5 ) — — 37 — — Limited partnerships 17 1 — 8 — — — — — 26 1 — Other invested assets: Derivative assets: Equity index options 63 18 — 31 — — (70 ) — — 42 10 — Total derivative assets 63 18 — 31 — — (70 ) — — 42 10 — Total other invested assets 63 18 — 31 — — (70 ) — — 42 10 — Reinsurance recoverable (2) 26 (9 ) — — — 2 — — — 19 (9 ) — Total Level 3 assets $ 4,246 $ 28 $ (16 ) $ 641 $ (11 ) $ 2 $ (478 ) $ 186 $ (666 ) $ 3,932 $ 11 $ (29 ) (1) The transfers into and out of Level 3 for fixed maturity securities were related to changes in the primary pricing source and changes in the observability of external information used in determining the fair value, such as external ratings or credit spreads, as well as changes in the industry sectors assigned to specific securities. (2) Represents embedded derivatives associated with the reinsured portion of our GMWB liabilities. Beginning balance as of January 1, Total realized and Ending balance as of December 31, 2020 Total gains (losses) (Amounts in millions) Included net income Included Purchases Sales Issuances Settlements Transfer into Level 3 (1) Transfer out of Level 3 (1) Included Included Fixed maturity securities: State political subdivisions $ 102 $ 3 $ (11 ) $ — $ — $ — $ (1 ) $ — $ (27 ) $ 66 $ 3 $ (11 ) Non-U.S. government — — — — — — (1 ) 1 — — — — U.S. corporate: Utilities 865 9 8 76 (13 ) — (56 ) 42 (89 ) 842 — 14 Energy 129 1 1 30 (21 ) — (21 ) 22 (13 ) 128 — (3 ) Finance and insurance 572 2 16 167 — — (41 ) — (109 ) 607 — 19 Consumer—non-cyclical 94 — 4 8 — — (22 ) 25 — 109 — 4 Technology and communications 50 — 3 82 — — (1 ) 13 (100 ) 47 — 5 Industrial 40 — — — — — — — — 40 — — Capital goods 102 — — — — — (8 ) 11 (45 ) 60 — 1 Consumer—cyclical 173 3 4 15 — — (36 ) 47 (56 ) 150 — 6 Transportation 78 — (1 ) — — — (4 ) 27 (30 ) 70 — 2 Other 136 — 2 25 — — (7 ) 87 (24 ) 219 — 2 Total U.S. corporate 2,239 15 37 403 (34 ) — (196 ) 274 (466 ) 2,272 — 50 Non-U.S. corporate: Utilities 374 — 10 13 — — — 28 (73 ) 352 — 9 Energy 247 — (5 ) 7 — — (28 ) 24 — 245 — (5 ) Finance and insurance 234 4 17 15 — — (10 ) 77 (32 ) 305 4 17 Consumer—non-cyclical 59 — 3 20 — — — 1 (16 ) 67 — 2 Technology and communications 28 — — — — — — — — 28 — 1 Industrial 104 — 4 — — — (5 ) — (8 ) 95 — 3 Capital goods 161 1 1 20 — — (39 ) 34 — 178 — 1 Consumer—cyclical 147 — 3 21 — — (26 ) 32 (31 ) 146 — 2 Transportation 191 — 1 7 — — (10 ) 22 (102 ) 109 — 4 Other 140 9 (1 ) 6 — — (72 ) 1 — 83 — 2 Total non-U.S. 1,685 14 33 109 — — (190 ) 219 (262 ) 1,608 4 36 Residential mortgage-backed 27 — (1 ) — — — (1 ) 4 (15 ) 14 — — Commercial mortgage-backed 6 — 1 — — — — 20 (7 ) 20 — 1 Other asset-backed 93 — 1 124 — — (16 ) 10 (103 ) 109 — — Total fixed maturity securities 4,152 32 60 636 (34 ) — (405 ) 528 (880 ) 4,089 7 76 Equity securities 51 — — 6 (7 ) — — 1 — 51 — — Limited partnerships 16 (2 ) — 3 — — — — — 17 (2 ) — Other invested assets: Derivative assets: Equity index options 81 4 — 59 — — (81 ) — — 63 5 — Total derivative assets 81 4 — 59 — — (81 ) — — 63 5 — Total other invested assets 81 4 — 59 — — (81 ) — — 63 5 — Reinsurance recoverable (2) 20 4 — — — 2 — — — 26 4 — Total Level 3 assets $ 4,320 $ 38 $ 60 $ 704 $ (41 ) $ 2 $ (486 ) $ 529 $ (880 ) $ 4,246 $ 14 $ 76 (1) The transfers into and out of Level 3 for fixed maturity securities were related to changes in the primary pricing source and changes in the observability of external information used in determining the fair value, such as external ratings or credit spreads, as well as changes in the industry sectors assigned to specific securities. (2) Represents embedded derivatives associated with the reinsured portion of our GMWB liabilities.
Gains and Losses Included in Net Income (Loss) from Assets Measured at Fair Value	The following table presents the gains and losses included in net income from assets measured at fair value on a recurring basis and for which we have utilized significant unobservable (Level 3) inputs to determine fair value and the related income statement line item in which these gains and losses were presented for the years ended December 31: (Amounts in millions) 2022 2021 2020 Total realized and unrealized gains (losses) included in net income: Net investment income $ 8 $ 19 $ 32 Net investment gains (26 ) 9 6 To t l $ (18 ) $ 28 $ 38 Total gains (losses) included in net income attributable to assets still held: Net investment income $ 8 $ 9 $ 7 Net investment gains (13 ) 2 7 T ot l $ (5 ) $ 11 $ 14
Summary of Significant Unobservable Inputs Used for Certain Asset Fair Value Measurements	The following table presents a summary of the significant unobservable inputs used for certain asset fair value measurements that are based on internal models and classified as Level 3 as of December 31, 2022 : (Amounts in millions) Valuation technique Fair value Unobservable input Range Weighted-average (1) Fixed maturity securities: U.S. corporate: Utilities Internal models $ 813 Credit spreads 55 bps - 279 bps 168 bps Energy Internal models 45 Credit spreads 132 bps - 272 bps 197 bps Finance and insurance Internal models 674 Credit spreads 67 bps - 292 bps 208 bps Consumer—non-cyclical Internal models 82 Credit spreads 71 bps - 272 bps 152 bps Technology and communications Internal models 24 Credit spreads 113 bps - 181 bps 153 bps Industrial Internal models 22 Credit spreads 132 bps - 239 bps 161 bps Capital goods Internal models 34 Credit spreads 85 bps - 211 bps 159 bps Consumer—cyclical Internal models 113 Credit spreads 105 bps - 222 bps 154 bps Transportation Internal models 43 Credit spreads 49 bps - 188 bps 126 bps Other Internal models 111 Credit spreads 90 bps - 153 bps 102 bps Total U.S. corporate Internal models $ 1,961 Credit spreads 49 bps - 292 bps 176 bps Non-U.S. corporate: Utilities Internal models $ 295 Credit spreads 82 bps - 224 bps 145 bps Energy Internal models 110 Credit spreads 102 bps - 239 bps 171 bps Finance and insurance Internal models 124 Credit spreads 136 bps - 203 bps 161 bps Consumer—non-cyclical Internal models 70 Credit spreads 71 bps - 163 bps 110 bps Technology and communications Internal models 25 Credit spreads 102 bps - 138 bps 126 bps Industrial Internal models 48 Credit spreads 85 bps - 197 bps 149 bps Capital goods Internal models 95 Credit spreads 71 bps - 272 bps 167 bps Consumer—cyclical Internal models 50 Credit spreads 102 bps - 197 bps 159 bps Transportation Internal models 20 Credit spreads 138 bps - 197 bps 150 bps Other Internal models 21 Credit spreads 84 bps - 158 bps 132 bps Total non-U.S. corporate Internal models $ 858 Credit spreads 71 bps - 272 bps 150 bps Derivative assets: Equity index options Discounted cash flows $ 6 Equity index 6 % - 25 % 20% (1) Unobservable inputs weighted by the relative fair value of the associated instrument for fixed maturity securities and by notional for derivative assets.
Liabilities by Class of Instrument that are Measured at Fair Value on Recurring Basis	The following tables set forth our liabilities by class of instrument that are measured at fair value on a recurring basis as of December 31: 2022 (Amounts in millions) Total Level 1 Level 2 Level 3 Liabilities Policyholder account balances: GMWB embedded derivatives (1) $ 223 $ — $ — $ 223 Fixed index annuity embedded derivatives 202 — — 202 Indexed universal life embedded derivatives 15 — — 15 Total policyholder account balances 440 — — 440 Derivative liabilities: Interest rate swaps 522 — 522 — Total derivative liabilities 522 — 522 — Total liabilities $ 962 $ — $ 522 $ 440 (1) Represents embedded derivatives associated with our GMWB liabilities, excluding the impact of reinsurance. 2021 (Amounts in millions) Total Level 1 Level 2 Level 3 Liabilities Policyholder account balances: GMWB embedded derivatives (1) $ 271 $ — $ — $ 271 Fixed index annuity embedded derivatives 294 — — 294 Indexed universal life embedded derivatives 25 — — 25 Total policyholder account balances 590 — — 590 Derivative liabilities: Interest rate swaps 26 — 26 — Total derivative liabilities 26 — 26 — Total liabilities $ 616 $ — $ 26 $ 590 (1) Represents embedded derivatives associated with our GMWB liabilities, excluding the impact of reinsurance.
Liabilities Measured at Fair Value on Recurring Basis and Utilized Significant Unobservable (Level 3) Inputs to Determine Fair Value	The following tables present additional information about liabilities measured at fair value on a recurring basis and for which we have utilized significant unobservable (Level 3) inputs to determine fair value as of and for the dates indicated: Beginning as of Total realized and Ending as of Total (gains) losses (Amounts in millions) Included in net Included Purchases Sales Issuances Settlements Transfer Transfer Included Included Policyholder account balances: GMWB derivatives (1) $ 271 $ (70 ) $ — $ — $ — $ 22 $ — $ — $ — $ 223 $ (66 ) $ — Fixed index annuity embedded derivatives 294 (16 ) — — — — (73 ) — (3 ) 202 (16 ) — Indexed universal life embedded derivatives 25 (27 ) — — — 17 — — — 15 (27 ) — Total policyholder account balances 590 (113 ) — — — 39 (73 ) — (3 ) 440 (109 ) — Total Level 3 liabilities $ 590 $ (113 ) $ — $ — $ — $ 39 $ (73 ) $ — $ (3 ) $ 440 $ (109 ) $ — (1) Represents embedded derivatives associated with our GMWB liabilities, excluding the impact of reinsurance. Beginning as of Total realized and Ending as of Total (gains) losses (Amounts in millions) Included in Included Purchases Sales Issuances Settlements Transfer Transfer Included Included Policyholder account balances: GMWB derivatives (1) $ 379 $ (133 ) $ — $ — $ — $ 25 $ — $ — $ — $ 271 $ (127 ) $ — Fixed index annuity embedded derivatives 399 32 — — — — (136 ) — (1 ) 294 32 — Indexed universal life embedded derivatives 26 (24 ) — — — 23 — — — 25 (24 ) — Total policyholder account balances 804 (125 ) — — — 48 (136 ) — (1 ) 590 (119 ) — Total Level 3 liabilities $ 804 $ (125 ) $ — $ — $ — $ 48 $ (136 ) $ — $ (1 ) $ 590 $ (119 ) $ — (1) Represents embedded derivatives associated with our GMWB liabilities, excluding the impact of reinsurance. Beginning as of Total realized and Ending as of Total (gains) losses (Amounts in millions) Included in Included Purchases Sales Issuances Settlements Transfer Transfer Included Included Policyholder account balances: GMWB derivatives (1) $ 323 $ 32 $ — $ — $ — $ 24 $ — $ — $ — $ 379 $ 38 $ — Fixed index annuity embedded derivatives 452 51 — — — — (104 ) — — 399 51 — Indexed universal life embedded derivatives 19 (17 ) — — — 24 — — — 26 (17 ) — Total policyholder account balances 794 66 — — — 48 (104 ) — — 804 72 — Total Level 3 liabilities $ 794 $ 66 $ — $ — $ — $ 48 $ (104 ) $ — $ — $ 804 $ 72 $ — (1) Represents embedded derivatives associated with our GMWB liabilities, excluding the impact of reinsurance.
Gains and Losses Included in Net (Income) from Liabilities Measured at Fair Value	The following table presents the gains and losses included in net (income) from liabilities measured at fair value on a recurring basis and for which we have utilized significant unobservable (Level 3) inputs to determine fair value and the related income statement line item in which these gains and losses were presented for the years ended December 31: (Amounts in millions) 2022 2021 2020 Total realized and unrealized (gains) losses included in net (income): Net investment income $ — $ — $ — Net investment (gains (113 ) (125 ) 66 To t al $ (113 ) $ (125 ) $ 66 Total (gains) losses included in net (income) attributable to liabilities still held: Net investment income $ — $ — $ — Net (gains) losses (109 ) (119 ) 72 To ta l $ (109 ) $ (119 ) $ 72
Summary of Significant Unobservable Inputs Used for Certain Liability Fair Value Measurements	The following table presents a summary of the significant unobservable inputs used for certain liability fair value measurements that are based on internal models and classified as Level (Amounts in millions) Valuation technique Fair value Unobservable input Range Weighted-average (1) Policyholder account Withdrawal utilization rate 61 % - 77 % Lapse rate 2 % - 2 % Non-performance risk (credit spreads) 40 bps - 69 bps GMWB e (2) Stochastic cash flow model $ 223 Equity index volatility 21 % - 25 % Fixed index annuity Option budget method $ 202 Expected future interest credited — % 3 % 1 % Indexed universal life Option budget method $ 15 Expected future interest credited 2 % - 5 % (1) Unobservable inputs weighted by the policyholder account balances associated with the instrument. (2) Represents embedded derivatives associated with our GMWB liabilities, excluding the impact of reinsurance. The unobservable inputs associated with GMWB embedded derivatives are not interrelated and therefore, a directional change in one input will not affect the other inputs.
Fair Value Financial Instruments Not Required to be Carried at Fair Value	The following represents our estimated fair value of financial assets and liabilities that are not required to be carried at fair value as of December 31: 2022 Notional Carrying Fair value (Amounts in millions) amount amount Total Level 1 Level 2 Level 3 Assets: Commercial mortgage loans, net (1 ) $ 7,010 $ 6,345 $ — $ — $ 6,345 Bank loan investments (1 ) 467 474 — — 474 Liabilities: Long-term borrowings (2) (1 ) 1,611 1,346 — 1,346 — Investment contracts (1 ) 7,409 7,169 — — 7,169 Other firm commitments: Commitments to fund bank loan investments $ 70 — — — — — Ordinary course of business lending commitments 24 — — — — — (1) These financial instruments do not have notional amounts. (2) See note 12 for additional information related to borrowings. 2021 Notional Carrying Fair value (Amounts in millions) amount amount Total Level 1 Level 2 Level 3 Assets: Commercial mortgage loans, net (1 ) $ 6,830 $ 7,224 $ — $ — $ 7,224 Bank loan investments (1 ) 363 370 — — 370 Liabilities: Long-term borrowings (2) (1 ) 1,899 1,767 — 1,767 — Investment contracts (1 ) 8,657 9,352 — — 9,352 Other firm commitments: Commitments to fund bank loan investments $ 141 — — — — — Ordinary course of business lending commitments 125 — — — — — (1) These financial instruments do not have notional amounts. (2) See note 12 for additional information related to borrowings.
Summary of carrying value of limited partnerships and commitments to fund	The following table presents the carrying value of limited partnerships and commitments to fund as of December 31: 2022 2021 Carrying Commitments Carrying Commitments (Amounts in millions) value to fund value to fund Limited partnerships accounted for at NAV: Private equity funds (1) $ 1,647 $ 1,107 $ 1,312 $ 950 Real estate funds (2) 82 79 67 101 Infrastructure funds (3) 63 29 57 13 Total limited partnerships accounted for at NAV 1,792 1,215 1,436 1,064 Limited partnerships accounted for at fair value 24 1 26 1 Limited partnerships accounted for under the equity method of accounting 515 149 437 120 Low-income (4) — — 1 — Total $ 2,331 $ 1,365 $ 1,900 $ 1,185 (1) This class employs various investment strategies such as leveraged buyout, growth equity, venture capital and mezzanine financing, generally investing in debt or equity positions directly in companies or assets of various sizes across diverse industries globally, primarily concentrated in North America. (2) This class invests in real estate in North America, Europe and Asia via direct property ownership, joint ventures, mortgages and investments in debt and equity instruments. (3) This class invests in the debt or equity of cash flow generating assets diversified across a variety of industries, including transportation, energy infrastructure, renewable power, social infrastructure, power generation, water, telecommunications and other regulated entities globally. (4) Relates to limited partnership investments that invest in affordable housing projects that qualify for the Low-Income

Insurance Subsidiary Financia_2

Insurance Subsidiary Financial Information and Regulatory Matters (Tables)	12 Months Ended
	Dec. 31, 2022
Schedule of Combined Statutory Net Income (Loss) and Statutory Capital and Surplus	The tables below include the combined statutory net income and statutory capital and surplus for our U.S. domiciled insurance subsidiaries for the periods indicated: Years ended December 31, (Amounts in millions) 2022 2021 2020 Combined statutory net income (loss): Life insurance subsidiaries, excluding captive life reinsurance subsidiaries $ 276 $ 654 $ 197 Mortgage insurance subsidiaries 747 593 404 Combined statutory net income, excluding captive reinsurance subsidiaries 1,023 1,247 601 Captive life insurance subsidiaries 253 (1,351 ) 9 Combined statutory net income (loss) $ 1,276 $ (104 ) $ 610 As of December 31, (Amounts in millions) 2022 2021 Combined statutory capital and surplus: Life insurance subsidiaries, excluding captive life reinsurance subsidiaries $ 3,082 $ 2,945 Mortgage insurance subsidiaries 4,687 4,439 Combined statutory capital and surplus $ 7,769 $ 7,384

Segment Information (Tables)

Segment Information (Tables)	12 Months Ended
Segment Information (Tables)	Dec. 31, 2022
Summary of Segments and Corporate and Other Activities	The following is a summary of our segments and Corporate and Other activities as of and for the years ended December 31: U.S. Life Corporate 2022 Enact Insurance Runoff and Other Total (Amounts in millions) Premiums $ 940 $ 2,773 $ — $ 6 $ 3,719 Net investment income 155 2,769 214 8 3,146 Net investment gains (losses) (2 ) 16 (16 ) (15 ) (17 ) Policy fees and other income 2 543 114 — 659 Total revenues 1,095 6,101 312 (1 ) 7,507 Benefits and other changes in policy reserves (94 ) 4,301 35 — 4,242 Interest credited — 322 181 — 503 Acquisition and operating expenses, net of deferrals 227 1,078 42 24 1,371 Amortization of deferred acquisition costs and intangibles 12 272 23 — 307 Interest expense 52 — — 54 106 Total benefits and expenses 197 5,973 281 78 6,529 Income (loss) from continuing operations before income taxes 898 128 31 (79 ) 978 Provision (benefit) for income taxes 194 55 5 (15 ) 239 Income (loss) from continuing operations 704 73 26 (64 ) 739 Income from discontinued operations, net of taxes — — — — — Net income (loss) 704 73 26 (64 ) 739 Less: net income from continuing operations attributable to noncontrolling interests 130 — — — 130 Less: net income from discontinued operations attributable to noncontrolling interests — — — — — Net income (loss) available to Genworth Financial, Inc.’s common stockholders $ 574 $ 73 $ 26 $ (64 ) $ 609 Net income (loss) available to Genworth Financial, Inc.’s common stockholders: Income (loss) from continuing operations available to Genworth Financial, Inc.’s common stockholders $ 574 $ 73 $ 26 $ (64 ) $ 609 Income from discontinued operations available to Genworth Financial, Inc.’s common stockholders — — — — — Net income (loss) available to Genworth Financial, Inc.’s common stockholders $ 574 $ 73 $ 26 $ (64 ) $ 609 Total assets $ 5,712 $ 70,977 $ 7,888 $ 1,865 $ 86,442 U.S. Life Corporate 2021 Enact Insurance Runoff and Other Total (Amounts in millions) Premiums $ 975 $ 2,454 $ — $ 6 $ 3,435 Net investment income 141 3,029 194 6 3,370 Net investment gains (losses) (2 ) 329 3 (7 ) 323 Policy fees and other income 4 565 134 1 704 Total revenues 1,118 6,377 331 6 7,832 Benefits and other changes in policy reserves 125 4,230 27 1 4,383 Interest credited — 346 162 — 508 Acquisition and operating expenses, net of deferrals 230 865 53 75 1,223 Amortization of deferred acquisition costs and intangibles 15 340 20 2 377 Interest expense 51 — — 109 160 Total benefits and expenses 421 5,781 262 187 6,651 Income (loss) from continuing operations before income taxes 697 596 69 (181 ) 1,181 Provision (benefit) for income taxes 148 155 13 (53 ) 263 Income (loss) from continuing operations 549 441 56 (128 ) 918 Income from discontinued operations, net of taxes — — — 27 27 Net income (loss) 549 441 56 (101 ) 945 Less: net income from continuing operations attributable to noncontrolling interests 33 — — — 33 Less: net income from discontinued operations attributable to noncontrolling interests — — — 8 8 Net income (loss) available to Genworth Financial, Inc.’s common stockholders $ 516 $ 441 $ 56 $ (109 ) $ 904 Net income (loss) available to Genworth Financial, Inc.’s common stockholders: Income (loss) from continuing operations available to Genworth Financial, Inc.’s common stockholders $ 516 $ 441 $ 56 $ (128 ) $ 885 Income from discontinued operations available to Genworth Financial, Inc.’s common stockholders — — — 19 19 Net income (loss) available to Genworth Financial, Inc.’s common stockholders $ 516 $ 441 $ 56 $ (109 ) $ 904 Total assets $ 5,850 $ 81,210 $ 9,460 $ 2,651 $ 99,171 U.S. Life Corporate 2020 Enact Insurance Runoff and Other Total (Amounts in millions) Premiums $ 971 $ 2,858 $ — $ 7 $ 3,836 Net investment income 133 2,878 210 6 3,227 Net investment gains (losses) (4 ) 517 (26 ) 5 492 Policy fees and other income 6 595 130 (2 ) 729 Total revenues 1,106 6,848 314 16 8,284 Benefits and other changes in policy reserves 381 4,781 48 4 5,214 Interest credited — 383 166 — 549 Acquisition and operating expenses, net of deferrals 206 620 48 61 935 Amortization of deferred acquisition costs and intangibles 21 418 23 1 463 Interest expense 18 5 — 172 195 Total benefits and expenses 626 6,207 285 238 7,356 Income (loss) from continuing operations before income taxes 480 641 29 (222 ) 928 Provision (benefit) for income taxes 102 163 4 (39 ) 230 Income (loss) from continuing operations 378 478 25 (183 ) 698 Loss from discontinued operations, net of taxes — — — (486 ) (486 ) Net income (loss) 378 478 25 (669 ) 212 Less: net income from continuing operations attributable to noncontrolling interests — — — — — Less: net income from discontinued operations attributable to noncontrolling interests — — — 34 34 Net income (loss) available to Genworth Financial, Inc.’s common stockholders $ 378 $ 478 $ 25 $ (703 ) $ 178 Net income (loss) available to Genworth Financial, Inc.’s common stockholders: Income (loss) from continuing operations available to Genworth Financial, Inc.’s common stockholders $ 378 $ 478 $ 25 $ (183 ) $ 698 Loss from discontinued operations available to Genworth Financial, Inc.’s common stockholders — — — (520 ) (520 ) Net income (loss) available to Genworth Financial, Inc.’s common stockholders $ 378 $ 478 $ 25 $ (703 ) $ 178
Summary of Revenues of Major Product Groups for Segments and Corporate and Other Activities	The following is a summary of revenues of major product groups for our segments and Corporate and Other activities for the years ended December 31: (Amounts in millions) 2022 2021 2020 Revenues: Enact segment $ 1,095 $ 1,118 $ 1,106 U.S. Life Insurance segment: Long-term care insurance 4,459 4,875 4,960 Life insurance 1,253 996 1,357 Fixed annuities 389 506 531 U.S. Life Insurance segment 6,101 6,377 6,848 Runoff segment 312 331 314 Corporate and Other activities (1 ) 6 16 Total revenues $ 7,507 $ 7,832 $ 8,284
Summary of Net Operating Income (Loss) for Segments and Corporate and Other Activities	The following tables present the reconciliation of net income available to Genworth Financial, Inc.’s common stockholders to adjusted operating income available to Genworth Financial, Inc.’s common stockholders and a summary of adjusted operating income (loss) available to Genworth Financial, Inc.’s common stockholders for our segments and Corporate and Other activities for the years ended December 31: (Amounts in millions) 2022 2021 2020 Net income available to Genworth Financial, Inc.’s common stockholders $ 609 $ 904 $ 178 Add: net income from continuing operations attributable to noncontrolling interests 130 33 — Add: net income from discontinued operations attributable to noncontrolling interests — 8 34 Net income 739 945 212 Less: income (loss) from discontinued operations, net of taxes — 27 (486 ) Income from continuing operations 739 918 698 Less: net income from continuing operations attributable to noncontrolling interests 130 33 — Income from continuing operations available to Genworth Financial, Inc.’s common stockholders 609 885 698 Adjustments to income from continuing operations available to Genworth Financial, Inc.’s common stockholders: Net investment (gains) losses, net (1) 14 (324 ) (503 ) Losses on early extinguishment of debt 6 45 9 Initial loss from life block transaction — 92 — Expenses related to restructuring 2 34 3 Pension plan termination costs 8 — — Taxes on adjustments (6 ) 33 103 Adjusted operating income available to Genworth Financial, Inc.’s common stockholders $ 633 $ 765 $ 310 (1) For the years ended December 31, 2022, 2021 and 2020, net investment (gains) losses were adjusted f (3) million, $(1) million and $ (11) million, respectively. (Amounts in millions) 2022 2021 2020 Adjusted operating income (loss) available to Genworth Financial, Inc.’s common stockholders: Enact segment $ 578 $ 520 $ 381 U.S. Life Insurance segment: Long-term care insurance 142 445 237 Life insurance (148 ) (269 ) (247 ) Fixed annuities 72 91 78 U.S. Life Insurance segment 66 267 68 Runoff segment 37 54 43 Corporate and Other activities (48 ) (76 ) (182 ) Adjusted operating income available to Genworth Financial, Inc.’s common stockholders $ 633 $ 765 $ 310
Schedule of Revenue, Net Income and Assets by Geographic Location	The following is a summary of geographic region activity as of and for the years ended December 31: 2022 (Amounts in millions) United States International (1) Total Total revenues $ 7,499 $ 8 $ 7,507 Income (loss) from continuing operations $ 739 $ — $ 739 Net income (loss) $ 739 $ — $ 739 Total assets $ 86,400 $ 42 $ 86,442 2021 (Amounts in millions) United States International (1) Total Total revenues $ 7,825 $ 7 $ 7,832 Income (loss) from continuing operations $ 921 $ (3 ) $ 918 Net income (loss) $ 948 $ (3 ) $ 945 Total assets $ 99,117 $ 54 $ 99,171 2020 (Amounts in millions) United States International (1) Total Total revenues $ 8,275 $ 9 $ 8,284 Income (loss) from continuing operations $ 700 $ (2 ) $ 698 Net income $ 214 $ (2 ) $ 212 (1) Predominantly comprised of operations in Mexico.

Quarterly Results of Operatio_2

Quarterly Results of Operations (unaudited) (Tables)	12 Months Ended
Quarterly Results of Operations (unaudited) (Tables)	Dec. 31, 2022
Quarterly Results of Operations	Our unaudited quarterly results of operations for the year ended December 31, 2022 are summarized in the table below. Three months ended March 31, June 30, September 30, December 31, (Amounts in millions, except per share amounts) 2022 2022 2022 2022 Total revenues $ 1,892 $ 1,881 $ 1,839 $ 1,895 Total benefits and expenses (1), (2) $ 1,653 $ 1,588 $ 1,653 $ 1,635 Income from continuing operations (1), (2) $ 181 $ 220 $ 134 $ 204 Income (loss) from discontinued operations, net of taxes $ (2 ) $ (1 ) $ 5 $ (2 ) Net income (1), (2) $ 179 $ 219 $ 139 $ 202 Net income from continuing operations attributable to noncontrolling interests $ 30 $ 38 $ 35 $ 27 Net income from discontinued operations attributable to noncontrolling interests $ — $ — $ — $ — Net income available to Genworth Financial, Inc.’s common stockholders (1), (2) $ 149 $ 181 $ 104 $ 175 Net income available to Genworth Financial, Inc.’s common stockholders: Income from continuing operations available to Genworth Financial, Inc.’s common stockholders $ 151 $ 182 $ 99 $ 177 Income (loss) from discontinued operations available to Genworth Financial, Inc.’s (2 ) (1 ) 5 (2 ) Net income available to Genworth Financial, Inc.’s common stockholders $ 149 $ 181 $ 104 $ 175 Income from continuing operations available to Genworth Financial, Inc.’s common stockholders per share: Basic $ 0.30 $ 0.36 0.20 $ 0.36 Diluted $ 0.29 $ 0.36 $ 0.19 $ 0.35 Net income available to Genworth Financial, Inc.’s common stockholders per share: Basic $ 0.29 $ 0.36 $ 0.21 $ 0.35 Diluted $ 0.29 $ 0.35 $ 0.20 $ 0.35 Weighted-average common shares outstanding: Basic 508.3 509.0 504.0 496.7 Diluted 517.4 514.2 509.4 503.2 (1) In the fourth quarter of 2022, our Enact segment recorded a pre-tax net favorable reserve adjustment of 42 million primarily related to COVID-19 delinquencies in 2020 and 2021 curing at levels above original reserve expectations. (2) In the fourth quarter of 2022, our life insurance business completed its annual review of assumptions for its universal and term universal life insurance products and recorded a pre-tax favorable unlocking of 43 million mostly attributable to higher interest rates. Our unaudited quarterly results of operations for the year ended December 31, 2021 are summarized in the table below. Three months ended March 31, June 30, September 30, December 31, (Amounts in millions, except per share amounts) 2021 2021 2021 2021 Total revenues (1) $ 1,985 $ 2,041 $ 2,070 $ 1,736 Total benefits and expenses (2) $ 1,752 $ 1,721 $ 1,697 $ 1,481 Income from continuing operations (1), (2), (3) $ 174 $ 245 $ 306 $ 193 Income (loss) from discontinued operations, net of taxes $ 21 $ (5 ) $ 12 $ (1 ) Net income (1), (2), (3) $ 195 $ 240 $ 318 $ 192 Net income from continuing operations attributable to noncontrolling interests (4) $ — $ — $ 4 $ 29 Net income from discontinued operations attributable to noncontrolling interests $ 8 $ — $ — $ — Net income available to Genworth Financial, Inc.’s (4) $ 187 $ 240 $ 314 $ 163 Net income available to Genworth Financial, Inc.’s common stockholders: Income from continuing operations available to Genworth Financial, Inc.’s common stockholders $ 174 $ 245 $ 302 $ 164 Income (loss) from discontinued operations available to Genworth Financial, Inc.’s common stockholders 13 (5 ) 12 (1 ) Net income available to Genworth Financial, Inc.’s common stockholders $ 187 $ 240 $ 314 $ 163 Income from continuing operations available to Genworth Financial, Inc.’s common stockholders per share: Basic $ 0.35 $ 0.48 $ 0.59 $ 0.32 Diluted $ 0.34 $ 0.47 $ 0.59 $ 0.32 Net income available to Genworth Financial, Inc.’s common stockholders per share: Basic $ 0.37 $ 0.47 $ 0.62 $ 0.32 Diluted $ 0.37 $ 0.47 $ 0.61 $ 0.32 Weighted-average common shares outstanding: Basic 506.0 507.0 507.4 507.4 Diluted 513.8 515.0 514.2 515.6 (1) In the fourth quarter of 2021, our life insurance business initially ceded $360 million of premiums associated with certain term life insurance policies under a new reinsurance treaty as part of a life block transaction. (2) In the fourth quarter of 2021, our life insurance business initially ceded $268 million of certain term life insurance reserves under a new reinsurance treaty as part of a life block transaction. Our life insurance business also completed its annual review of assumptions in the fourth quarter of 2021. This review resulted in higher total benefits and expenses of $87 million from an unfavorable unlocking in our term universal and universal life insurance products largely attributable to higher pre-COVID-19 (3) In the fourth quarter of 2021, our life insurance business recorded a net loss of $131 million predominantly driven by an initial loss of $73 million as a result of ceding certain term life insurance policies as part of a life block transaction, an unfavorable unlocking of $70 million associated with its annual review of assumptions and a DAC impairment of $32 million as a result of recoverability testing. (4) On September 20, 2021, we completed the minority IPO of Enact Holdings, which reduced our ownership percentage to 81.6%, and lowered our available net income by $29 million in the fourth quarter of 2021.

Changes in Accumulated Other _2

Changes in Accumulated Other Comprehensive Income (Loss) (Tables)	12 Months Ended
	Dec. 31, 2022
Component of Changes in Accumulated Other Comprehensive Income (Loss), Net of Taxes	The following tables show the changes in accumulated other comprehensive income (loss), net of taxes, by component as of and for the periods indicated: Net Foreign unrealized currency investment Derivatives translation gains qualifying as and other (Amounts in millions) (losses) (1) hedges (2) adjustments Total Balances as of January 1, 2022 $ 1,860 $ 2,025 $ (24 ) $ 3,861 OCI before reclassifications (5,430 ) (674 ) 37 (6,067 ) Amounts reclassified from (to) OCI 58 (151 ) (7 ) (100 ) Current period OCI (5,372 ) (825 ) 30 (6,167 ) Balances as of December 31, 2022 before noncontrolling interests (3,512 ) 1,200 6 (2,306 ) Less: change in OCI attributable to noncontrolling interests (86 ) — — (86 ) Balances as of December 31, 2022 $ (3,426 ) $ 1,200 $ 6 $ (2,220 ) (1) Net of adjustments to DAC, PVFP, sales inducements, benefit reserves and policyholder contract balances. See note 4 for additional information. (2) See note 5 for additional information. Net Foreign unrealized currency investment Derivatives translation gains qualifying as and other (Amounts in millions) (losses) (1) hedges (2) adjustments Total Balances as of January 1, 2021 $ 2,214 $ 2,211 $ — $ 4,425 OCI before reclassifications (313 ) (45 ) 148 (210 ) Amounts reclassified from (to) OCI (51 ) (141 ) — (192 ) Current period OCI (364 ) (186 ) 148 (402 ) Balances as of December 31, 2021 before noncontrolling interests 1,850 2,025 148 4,023 Less: change in OCI attributable to noncontrolling interests (10 ) — 172 162 Balances as of December 31, 2021 $ 1,860 $ 2,025 $ (24 ) $ 3,861 (1) Net of adjustments to DAC, PVFP, sales inducements, benefit reserves and policyholder contract balances. See note 4 for additional information. (2) See note 5 for additional information. 278 Net Foreign unrealized currency investment Derivatives translation gains qualifying as and other (Amounts in millions) (losses) (1) hedges (2) adjustments Total Balances as of January 1, 2020 $ 1,456 $ 2,002 $ (25 ) $ 3,433 OCI before reclassifications 1,132 344 55 1,531 Amounts reclassified from (to) OCI (374 ) (135 ) — (509 ) Current period OCI 758 209 55 1,022 Balances as of December 31, 2020 before noncontrolling interests 2,214 2,211 30 4,455 Less: change in OCI attributable to noncontrolling interests — — 30 30 Balances as of December 31, 2020 $ 2,214 $ 2,211 $ — $ 4,425 (1) Net of adjustments to DAC, PVFP, sales inducements, benefit reserves and policyholder contract balances. See note 4 for additional information. (2) See note 5 for additional information.
Reclassifications in (out) of Accumulated Other Comprehensive Income (Loss), Net of Taxes	The following table shows reclassifications out of accumulated other comprehensive income (loss), net of taxes, for the periods presented: Amount reclassified from accumulated other comprehensive income (loss) Affected line item in the Years ended December 31, consolidated statements (Amounts in millions) 2022 2021 2020 of income Net unrealized investment (gains) losses: Unrealized (gains) losses on investments (1) $ 74 $ (65 ) $ (474 ) Net investment (gains) losses Income taxes (16 ) 14 100 Provision for income taxes Total $ 58 $ (51 ) $ (374 ) Derivatives designated as hedges: Interest rate swaps hedging assets $ (225 ) $ (217 ) $ (196 ) Net investment income Interest rate swaps hedging assets (9 ) (1 ) (12 ) Net investment (gains) losses Interest rate swaps hedging liabilities 3 1 — Interest expense Income taxes 80 76 73 Provision for income taxes Total $ (151 ) $ (141 ) $ (135 ) (1) Amounts exclude adjustments to DAC, PVFP, sales inducements, benefit reserves and policyholder contract balances.

Noncontrolling Interests (Table

Noncontrolling Interests (Tables)	12 Months Ended
Noncontrolling Interests (Tables)	Dec. 31, 2022
Noncontrolling Interest [Abstract]
Summary of Changes in Ownership Interests	A summary of these changes in ownership interests and the effect on stockholders’ equity was as follows for the year ended December 31, 2021: (Amounts in millions) Net income available to Genworth Financial, Inc.’s common stockholders $ 904 Transfers to noncontrolling interests: Decrease in Genworth Financial, Inc.’s paid-in (167 ) Net transfers to noncontrolling interests (167 ) Change from net income available to Genworth Financial, Inc.’s common stockholders and transfers to noncontrolling interests $ 737

Discontinued Operations (Tables

Discontinued Operations (Tables)	12 Months Ended
Discontinued Operations (Tables)	Dec. 31, 2022
Schedule Of Income Loss On Sale Recorded In Our Disposition Group	The following table provides a summary of the gain (loss) on sale associated with the disposition of Genworth Australia for the year ended December 31, 2021: (Amounts in millions) Net cash proceeds $ 370 Add: carrying value of noncontrolling interests (1) 657 Total adjusted consideration (2) 1,027 Carrying value of the disposal group before accumulated other comprehensive (income) loss 1,040 Add: total accumulated other comprehensive (income) loss of disposal group (3) 109 Total adjusted carrying value of the disposal group 1,149 Pre-tax (122 ) Tax benefit on sale 122 After-tax $ — (1) In accordance with accounting guidance on the deconsolidation of a subsidiary or group of assets, the carrying amount of any noncontrolling interests in the subsidiary sold (adjusted to reflect amounts in accumulated other comprehensive income (loss) recognized upon final disposition) is added to the total fair value of the consideration received. (2) Represents the aggregate of the net cash proceeds received upon sale closing plus the adjusted carrying amount of noncontrolling interests in the subsidiary sold. (3) Amount consists of $160 million of cumulative losses on foreign currency translation adjustments, partially offset by cumulative unrealized investment gains of $29 million and deferred tax gains of $22 million.
Summary of Operating Results Related to Discontinued Operations	A summary of operating results related to Genworth Australia reported as discontinued operations was as follows for the years ended December 31: (Amounts in millions) 2021 2020 Revenues: Premiums $ 51 $ 274 Net investment income 4 33 Net investment gains (losses) (5 ) 66 Policy fees and other income — 1 Total revenues 50 374 Benefits and expenses: Benefits and other changes in policy reserves 11 177 Acquisition and operating expenses, net of deferrals 7 53 Amortization of deferred acquisition costs and intangibles 6 29 Goodwill impairment — 5 Interest expense 1 7 Total benefits and expenses 25 271 Income before income taxes and gain (loss) on sale (1) 25 103 Provision for income taxes 8 40 Income before gain (loss) on sale 17 63 Gain (loss) on sale, net of taxes — — Income from discontinued operations, net of taxes 17 63 Less: net income from discontinued operations attributable to noncontrolling interests 8 34 Income from discontinued operations available to Genworth Financial, Inc.’s $ 9 $ 29 (1) The years ended December 31, 2021 and 2020 include pre-tax

Nature of Business and Format_2

Nature of Business and Formation of Genworth - Additional Information (Detail) $ / shares in Units, $ in Millions	1 Months Ended	12 Months Ended
	Feb. 24, 2023 USD ($) $ / shares shares	Dec. 31, 2022 USD ($) Segment $ / shares shares	Dec. 31, 2021 USD ($)	Dec. 31, 2020 USD ($)	May 02, 2022 USD ($)	Apr. 01, 2013
Number of operating segments \| Segment		3
Stock repurchase program, authorized amount					$ 350
Number of shares repurchased \| shares	5,912,297	16,173,196
Average price per share repurchased \| $ / shares	$ 6.08	$ 3.94
Payments for repurchase of common stock	$ 36	$ 64	$ 0	$ 0
Stock repurchase program, remaining authorized repurchase amount	$ 250
Genworth Holdings
Percentage of subsidiary equity ownership						100%

Summary of Significant Accoun_3

Summary of Significant Accounting Policies - Additional Information (Detail) - USD ($) $ in Millions		12 Months Ended
		Dec. 31, 2022	Dec. 31, 2021	Jan. 01, 2021	Dec. 31, 2020	Jan. 01, 2020	Dec. 31, 2019
Accounting Policies [Abstract]
Non-accrual status of loans after number of days past due		90 days
Cash equivalents determination for original maturities of investments, maximum number of months		3 months
Retained earnings		$ 3,098	$ 2,490
Accumulated other comprehensive income (loss)		(2,220)	3,861		$ 4,425		$ 3,433
Operating Lease, Liability		$ 51
Operating Lease, Liability, Statement of Financial Position [Extensible Enumeration]		Operating Lease, Liability
Operating Lease, Weighted Average Remaining Lease Term		8 years
Operating lease weighted average discount rate		7%
Restricted commercial mortgage loans related to securitization entities		$ 21	29
2023		7
2024		11
2025		11
2026		9
2027		31
Imputed interest		$ 18
Short-term investments, minimum number of months		3 months
Short-term investments, maximum number of months		1 year
Total equity		$ 10,739	16,266		$ 15,820		14,632
Limited Partnerships
Accounting Policies [Abstract]
Minimum threshold ownership percentage of limited partnership interest, equity method		3%
Commercial mortgage loans
Accounting Policies [Abstract]
Accrued interest carrying value in Accrued investment income		$ 22	23
Cumulative effect of change in accounting
Accounting Policies [Abstract]
Total equity							$ (55)
Maximum [Member]
Accounting Policies [Abstract]
Operating lease term		16 years
Minimum [Member]
Accounting Policies [Abstract]
Operating lease term		1 year
Subject to enforceable master netting arrangement
Accounting Policies [Abstract]
Collateral received		$ (21)	(308)
Collateral pledged		1,095	536
Subject to enforceable master netting arrangement \| Derivative liabilities
Accounting Policies [Abstract]
Collateral received	[1]	0	0
Collateral pledged	[1]	(1,095)	(536)
Subject to enforceable master netting arrangement \| Derivative assets
Accounting Policies [Abstract]
Collateral received	[1]	(21)	(308)
Collateral pledged	[1]	0	0
Subject to enforceable master netting arrangement \| Non Cash Collateral \| Derivative liabilities
Accounting Policies [Abstract]
Collateral pledged		(1,095)	(536)
Subject to enforceable master netting arrangement \| Non Cash Collateral \| Derivative assets
Accounting Policies [Abstract]
Collateral received		(5)	(53)
Subject to enforceable master netting arrangement \| Cash Collateral \| Derivative assets
Accounting Policies [Abstract]
Collateral received		(16)	(255)
Fixed maturity securities
Accounting Policies [Abstract]
Accrued interest carrying value in Accrued investment income		$ 511	$ 523
Accounting Standards Update 2016-13 \| Off-balance sheet credit exposures \| Cumulative effect of change in accounting
Accounting Policies [Abstract]
Retained earnings						$ 1
Accounting Standards Update 2016-13 \| Reinsurance recoverables \| Cumulative effect of change in accounting
Accounting Policies [Abstract]
Retained earnings						31
Adoption of new accounting guidance, deferred tax impact						9
Accounting Standards Update 2016-13 \| Investments carried at amortized cost \| Cumulative effect of change in accounting
Accounting Policies [Abstract]
Retained earnings						23
Adoption of new accounting guidance, deferred tax impact						$ 6
Accounting Standards Update 2018-12
Accounting Policies [Abstract]
Net premium ratio, maximum				100%
Accounting Standards Update 2018-12 \| Net Income Impact
Accounting Policies [Abstract]
Net premium ratio, maximum				100%
Accounting Standards Update 2018-12 \| Cumulative effect of change in accounting
Accounting Policies [Abstract]
Retained earnings				$ 2,200
Accumulated other comprehensive income (loss)				$ 11,500
Net premium ratio percentage limit for cohorts				100%
Total equity				$ 13,700
Net premium ratio, maximum				100%
Accounting Standards Update 2018-12 \| Cumulative effect of change in accounting \| Discount Rate Change
Accounting Policies [Abstract]
Accumulated other comprehensive income (loss)				$ 17,100
Accounting Standards Update 2018-12 \| Cumulative effect of change in accounting \| Shadow Accounting Adjustments
Accounting Policies [Abstract]
Accumulated other comprehensive income (loss)				$ (5,600)

[1]Does not include amounts related to embedded derivatives as of December 31, 2022 and 2021.

Earning (Loss) Per Share (Detai

Earning (Loss) Per Share (Detail) - USD ($) $ / shares in Units, shares in Millions, $ in Millions	3 Months Ended																12 Months Ended
	Dec. 31, 2022		Sep. 30, 2022		Jun. 30, 2022		Mar. 31, 2022		Dec. 31, 2021		Sep. 30, 2021		Jun. 30, 2021		Mar. 31, 2021		Dec. 31, 2022		Dec. 31, 2021		Dec. 31, 2020
Earnings Per Share [Abstract]
Weighted-average common shares used in basic earnings (loss) per share calculations	496.7		504		509		508.3		507.4		507.4		507		506		504.5		506.9		505.2
Stock options, restricted stock units and other equity-based awards																	6.5		7.8		6.4
Weighted-average common shares used in diluted earnings (loss) per share calculations	503.2		509.4		514.2		517.4		515.6		514.2		515		513.8		511		514.7		511.6
Income from continuing operations:
Income from continuing operations	$ 204	[1],[2]	$ 134	[1],[2]	$ 220	[1],[2]	$ 181	[1],[2]	$ 193	[3],[4],[5]	$ 306	[3],[4],[5]	$ 245	[3],[4],[5]	$ 174	[3],[4],[5]	$ 739		$ 918		$ 698
Less: net income from continuing operations attributable to noncontrolling interests	27		35		38		30		29	[6]	4	[6]	0	[6]	0	[6]	130		33		0
Income from continuing operations available to Genworth Financial, Inc.'s common stockholders	$ 177		$ 99		$ 182		$ 151		$ 164		$ 302		$ 245		$ 174		$ 609		$ 885		$ 698
Basic per share	$ 0.36		$ 0.2		$ 0.36		$ 0.3		$ 0.32		$ 0.59		$ 0.48		$ 0.35		$ 1.21		$ 1.75		$ 1.38
Diluted per share	$ 0.35		$ 0.19		$ 0.36		$ 0.29		$ 0.32		$ 0.59		$ 0.47		$ 0.34		$ 1.19		$ 1.72		$ 1.36
Income (loss) from discontinued operations:
Income (loss) from discontinued operations, net of taxes	$ (2)		$ 5		$ (1)		$ (2)		$ (1)		$ 12		$ (5)		$ 21		$ 0		$ 27		$ (486)
Less: net income from discontinued operations attributable to noncontrolling interests	0		0		0		0		0		0		0		8		0		8		34
Income (loss) from discontinued operations available to Genworth Financial, Inc.'s common stockholders	(2)		5		(1)		(2)		(1)		12		(5)		13		$ 0		$ 19		$ (520)
Basic per share																	$ 0		$ 0.04		$ (1.03)
Diluted per share																	$ 0		$ 0.04		$ (1.02)
Net income (loss):
Income from continuing operations	204	[1],[2]	134	[1],[2]	220	[1],[2]	181	[1],[2]	193	[3],[4],[5]	306	[3],[4],[5]	245	[3],[4],[5]	174	[3],[4],[5]	$ 739		$ 918		$ 698
Income (loss) from discontinued operations, net of taxes	(2)		5		(1)		(2)		(1)		12		(5)		21		0		27		(486)
Net income	202	[1],[2]	139	[1],[2]	219	[1],[2]	179	[1],[2]	192	[3],[4],[5]	318	[3],[4],[5]	240	[3],[4],[5]	195	[3],[4],[5]	739		945		212
Less: net income attributable to noncontrolling interests																	130		41		34
Net income available to Genworth Financial, Inc.'s common stockholders	$ 175	[1],[2]	$ 104	[1],[2]	$ 181	[1],[2]	$ 149	[1],[2]	$ 163	[6]	$ 314	[6]	$ 240	[6]	$ 187	[6]	$ 609		$ 904		$ 178
Basic per share	$ 0.35		$ 0.21		$ 0.36		$ 0.29		$ 0.32		$ 0.62		$ 0.47		$ 0.37		$ 1.21	[7]	$ 1.78	[7]	$ 0.35	[7]
Diluted per share	$ 0.35		$ 0.2		$ 0.35		$ 0.29		$ 0.32		$ 0.61		$ 0.47		$ 0.37		$ 1.19	[7]	$ 1.76	[7]	$ 0.35	[7]

[1]In the fourth quarter of 2022, our Enact segment recorded a pre-tax net favorable reserve adjustment of $42 million primarily related to COVID-19 delinquencies in 2020 and 2021 curing at levels above original reserve expectations.[2]In the fourth quarter of 2022, our life insurance business completed its annual review of assumptions for its universal and term universal life insurance products and recorded a pre-tax favorable unlocking of $43 million mostly attributable to higher interest rates.[3]In the fourth quarter of 2021, our life insurance business initially ceded $268 million of certain term life insurance reserves under a new reinsurance treaty as part of a life block transaction. Our life insurance business also completed its annual review of assumptions in the fourth quarter of 2021. This review resulted in higher total benefits and expenses of $87 million from an unfavorable unlocking in our term universal and universal life insurance products largely attributable to higher pre-COVID-19 mortality. In our term universal life insurance products, we also recorded a DAC impairment of $41 million in the fourth quarter of 2021 principally due to lower future estimated gross profits.[4]In the fourth quarter of 2021, our life insurance business initially ceded $360 million of premiums associated with certain term life insurance policies under a new reinsurance treaty as part of a life block transaction.[5]In the fourth quarter of 2021, our life insurance business recorded a net loss of $131 million predominantly driven by an initial loss of $73 million as a result of ceding certain term life insurance policies as part of a life block transaction, an unfavorable unlocking of $70 million associated with its annual review of assumptions and a DAC impairment of $32 million as a result of recoverability testing.[6]On September 20, 2021, we completed the minority IPO of Enact Holdings, which reduced our ownership percentage to 81.6%, and lowered our available net income by $29 million in the fourth quarter of 2021.[7]May not total due to whole number calculation.

Net Investment Income (Detail)

Net Investment Income (Detail) - USD ($) $ in Millions	12 Months Ended
Net Investment Income (Detail) - USD ($) $ in Millions	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Net Investment Income [Line Items]
Gross investment income before expenses and fees	$ 3,229	$ 3,457	$ 3,320
Expenses and fees	(83)	(87)	(93)
Net investment income	3,146	3,370	3,227
Fixed maturity securities—taxable
Net Investment Income [Line Items]
Gross investment income before expenses and fees	2,296	2,411	2,448
Fixed maturity securities—non-taxable
Net Investment Income [Line Items]
Gross investment income before expenses and fees	5	7	6
Equity Securities
Net Investment Income [Line Items]
Gross investment income before expenses and fees	10	9	12
Commercial mortgage loans
Net Investment Income [Line Items]
Gross investment income before expenses and fees	321	376	345
Policy Loans
Net Investment Income [Line Items]
Gross investment income before expenses and fees	211	189	199
Limited Partnerships
Net Investment Income [Line Items]
Gross investment income before expenses and fees	99	223	72
Other invested assets
Net Investment Income [Line Items]
Gross investment income before expenses and fees	267	241	223
Cash, cash equivalents, restricted cash and short-term investments
Net Investment Income [Line Items]
Gross investment income before expenses and fees	$ 20	$ 1	$ 15

Net Investment Gains (Losses) (

Net Investment Gains (Losses) (Detail) - USD ($) $ in Millions		12 Months Ended
		Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Available-for-sale fixed maturity securities
Realized gains		$ 28	$ 67	$ 471
Realized losses		(102)	(10)	(29)
Net realized gains (losses) on available-for-sale fixed maturity securities		(74)	57	442
Net realized gains (losses) on equity securities sold		0	(7)	(1)
Net realized gains (losses) on limited partnerships		0	3	0
Total net realized investment gains (losses)		(74)	53	441
Net change in allowance for credit losses on available-for-sale fixed maturity securities		0	(6)	(5)
Write-down of available-for-sale fixed maturity securities	[1]	(2)	(1)	(4)
Net unrealized gains (losses) on equity securities still held		(35)	1	4
Net unrealized gains (losses) on limited partnerships		71	264	112
Commercial mortgage loans		4	(3)	(2)
Derivative instruments	[2]	17	14	(49)
Other		2	1	(5)
Total net investment gains (losses)		$ (17)	$ 323	$ 492

[1]Represents write-down of securities deemed uncollectible or that we intend to sell or will be required to sell prior to recovery of the amortized cost basis.[2]See note 5 for additional information on the impact of derivative instruments included in net investment gains (losses).

Net Investment Allowance for Cr

Net Investment Allowance for Credit Losses (Detail) - Fixed maturity securities - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Debt Securities, Available-for-sale, Allowance for Credit Loss [Line Items]
Beginning Balance	$ 4	$ 0
Increase from securities without allowance in previous periods	0	7
Increase (decrease) from securities with allowance in previous periods	6	(2)
Securities Sold	(7)	(1)
Decrease due to change in intent or requirement to sell	0	0
Write-offs	(3)	0
Recoveries	0	0
Ending Balance	0	4
Non-U.S. corporate
Debt Securities, Available-for-sale, Allowance for Credit Loss [Line Items]
Beginning Balance	1	0
Increase from securities without allowance in previous periods	0	4
Increase (decrease) from securities with allowance in previous periods	6	(2)
Securities Sold	(7)	(1)
Decrease due to change in intent or requirement to sell	0	0
Write-offs	0	0
Recoveries	0	0
Ending Balance	0	1
Commercial mortgage-backed
Debt Securities, Available-for-sale, Allowance for Credit Loss [Line Items]
Beginning Balance	3	0
Increase from securities without allowance in previous periods	0	3
Increase (decrease) from securities with allowance in previous periods	0	0
Securities Sold	0	0
Decrease due to change in intent or requirement to sell	0	0
Write-offs	(3)	0
Recoveries	0	0
Ending Balance	$ 0	$ 3

Investments - Additional Inform

Investments - Additional Information (Detail) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Schedule of Investments [Line Items]
Percentage of investment portfolio by which no other industry group exceeded	10%
Percentage of stockholders' equity by which no single issuer of fixed maturity securities exceeded	10
Commercial mortgage loans on nonaccrual status	$ 0
Total Assets	86,442	$ 99,171
Commercial mortgage loans, amortized cost	7,032	6,856
Commercial mortgage-backed
Schedule of Investments [Line Items]
Commercial mortgage loans,Allowance for credit losses	0
Limited Partnerships \| Variable interest Entity, not primary beneficiary
Schedule of Investments [Line Items]
Total Assets	$ 2,230	1,829
Finance and insurance \| Fixed maturity securities
Schedule of Investments [Line Items]
Percent of investment portfolio, greater than 10%	27%
Utilities \| Fixed maturity securities
Schedule of Investments [Line Items]
Percent of investment portfolio, greater than 10%	13%
Consumer-non-cyclical \| Fixed maturity securities
Schedule of Investments [Line Items]
Percent of investment portfolio, greater than 10%	14%
Insurance [Member]
Schedule of Investments [Line Items]
Securities on deposit with various state government insurance departments	$ 42	45
Technology and Communications \| Fixed maturity securities
Schedule of Investments [Line Items]
Percent of investment portfolio, greater than 10%	11%
Office
Schedule of Investments [Line Items]
Commercial mortgage loans, amortized cost	$ 1,579	1,526
Write-offs		8
Office \| 31 to 60 Past due
Schedule of Investments [Line Items]
Commercial mortgage loans, amortized cost		$ 22

Net Unrealized Gains and Losses

Net Unrealized Gains and Losses on Available-for-Sale Investment Securities Reflected as Separate Component of Accumulated Other Comprehensive Income (Loss) (Detail) - USD ($) $ in Millions		Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Components of Net Unrealized Investment Gains Losses Included in Accumulated Other Comprehensive Income Loss [Line Items]
Net unrealized gains (losses) on fixed maturity securities without an allowance for credit losses	[1]	$ (4,251)	$ 7,869	$ 10,159
Net unrealized gains (losses) on fixed maturity securities with an allowance for credit losses	[1]	0	0	(7)
Adjustments to DAC, PVFP, sales inducements, benefit reserves and policyholder contract balances		44	(5,487)	(7,302)
Income taxes, net		710	(507)	(611)
Net unrealized investment gains (losses)		(3,497)	1,875	2,239
Less: net unrealized investment gains (losses) attributable to noncontrolling interests		(71)	15	25
Net unrealized investment gains (losses)		$ (3,426)	$ 1,860	$ 2,214	$ 1,456

[1]Excludes foreign exchange.

Change in Net Unrealized Gains

Change in Net Unrealized Gains (Losses) on Available-for-Sale Securities Reported in Accumulated Other Comprehensive Income (Loss) (Detail) - USD ($) $ in Millions		12 Months Ended
		Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Investments [Abstract]
Net unrealized investment gains (losses), beginning of period		$ 1,860	$ 2,214	$ 1,456
Unrealized gains (losses) on fixed maturity securities		(12,194)	(2,218)	3,950
Adjustment to DAC	[1]	1,332	30	122
Adjustment to PVFP		81	0	(1)
Adjustment to sales inducements		28	12	(5)
Adjustment to benefit reserves and policyholder contract balances	[2]	4,090	1,773	(2,629)
Provision for income taxes		1,233	90	(305)
Change in unrealized gains (losses) on investment securities		(5,430)	(313)	1,132
Reclassification adjustments to net investment (gains) losses, net of taxes of $(16), $14 and $100		58	(51)	(374)
Change in net unrealized investment gains (losses)		(5,372)	(364)	758
Less: change in net unrealized investment gains (losses) attributable to noncontrolling interests		(86)	(10)	0
Net unrealized investment gains (losses), end of period		$ (3,426)	$ 1,860	$ 2,214

[1]See note 6 for additional information.[2]See note 9 for additional information.

Change in Net Unrealized Gain_2

Change in Net Unrealized Gains (Losses) on Available-for-Sale Securities Reported in Accumulated Other Comprehensive Income (Loss) (Parenthetical) (Detail) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Components of Net Unrealized Investment Gains Losses Included in Accumulated Other Comprehensive Income Loss [Line Items]
Reclassification adjustments to net investment (gains) losses, taxes	$ (16)	$ 14	$ 100

Amortized Cost or Cost, Gross U

Amortized Cost or Cost, Gross Unrealized Gains (Losses), Allowance for Credit Losses and Fair Value of Fixed Maturity Securities Classified as Available-for-Sale (Detail) - USD ($) $ in Millions	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Schedule of Investments [Line Items]
Amortized cost or cost, fixed maturity securities	$ 50,834	$ 52,611
Fair value, fixed maturity securities	46,583	60,480
Fixed maturity securities
Schedule of Investments [Line Items]
Amortized cost or cost, fixed maturity securities	50,834	52,611
Gross unrealized gains, fixed maturity securities	596	8,004
Gross unrealized losses, fixed maturity securities	(4,847)	(135)
Allowance for credit losses	0	0	$ (4)	$ 0
Fair value, fixed maturity securities	46,583	60,480
Fixed maturity securities \| U.S. government, agencies and government-sponsored enterprises
Schedule of Investments [Line Items]
Amortized cost or cost, fixed maturity securities	3,446	3,368
Gross unrealized gains, fixed maturity securities	86	1,184
Gross unrealized losses, fixed maturity securities	(191)	0
Allowance for credit losses	0	0
Fair value, fixed maturity securities	3,341	4,552
Fixed maturity securities \| State and Political Subdivisions
Schedule of Investments [Line Items]
Amortized cost or cost, fixed maturity securities	2,726	2,982
Gross unrealized gains, fixed maturity securities	19	474
Gross unrealized losses, fixed maturity securities	(346)	(6)
Allowance for credit losses	0	0
Fair value, fixed maturity securities	2,399	3,450
Fixed maturity securities \| Non-U.S. government
Schedule of Investments [Line Items]
Amortized cost or cost, fixed maturity securities	731	762
Gross unrealized gains, fixed maturity securities	15	86
Gross unrealized losses, fixed maturity securities	(101)	(13)
Allowance for credit losses	0	0
Fair value, fixed maturity securities	645	835
Fixed maturity securities \| U.S. corporate
Schedule of Investments [Line Items]
Amortized cost or cost, fixed maturity securities	29,641	30,257
Gross unrealized gains, fixed maturity securities	374	4,746
Gross unrealized losses, fixed maturity securities	(2,896)	(79)
Allowance for credit losses	0	0
Fair value, fixed maturity securities	27,119	34,924
Fixed maturity securities \| U.S. corporate \| Utilities
Schedule of Investments [Line Items]
Amortized cost or cost, fixed maturity securities	4,295	4,330
Gross unrealized gains, fixed maturity securities	50	783
Gross unrealized losses, fixed maturity securities	(447)	(9)
Allowance for credit losses	0	0
Fair value, fixed maturity securities	3,898	5,104
Fixed maturity securities \| U.S. corporate \| Energy
Schedule of Investments [Line Items]
Amortized cost or cost, fixed maturity securities	2,450	2,581
Gross unrealized gains, fixed maturity securities	33	363
Gross unrealized losses, fixed maturity securities	(221)	(10)
Allowance for credit losses	0	0
Fair value, fixed maturity securities	2,262	2,934
Fixed maturity securities \| U.S. corporate \| Finance and insurance
Schedule of Investments [Line Items]
Amortized cost or cost, fixed maturity securities	8,005	8,003
Gross unrealized gains, fixed maturity securities	59	1,012
Gross unrealized losses, fixed maturity securities	(871)	(24)
Allowance for credit losses	0	0
Fair value, fixed maturity securities	7,193	8,991
Fixed maturity securities \| U.S. corporate \| Consumer-non-cyclical
Schedule of Investments [Line Items]
Amortized cost or cost, fixed maturity securities	4,776	5,138
Gross unrealized gains, fixed maturity securities	84	1,029
Gross unrealized losses, fixed maturity securities	(403)	(8)
Allowance for credit losses	0	0
Fair value, fixed maturity securities	4,457	6,159
Fixed maturity securities \| U.S. corporate \| Technology and communications
Schedule of Investments [Line Items]
Amortized cost or cost, fixed maturity securities	3,265	3,345
Gross unrealized gains, fixed maturity securities	43	476
Gross unrealized losses, fixed maturity securities	(361)	(13)
Allowance for credit losses	0	0
Fair value, fixed maturity securities	2,947	3,808
Fixed maturity securities \| U.S. corporate \| Industrial
Schedule of Investments [Line Items]
Amortized cost or cost, fixed maturity securities	1,312	1,322
Gross unrealized gains, fixed maturity securities	15	175
Gross unrealized losses, fixed maturity securities	(130)	(3)
Allowance for credit losses	0	0
Fair value, fixed maturity securities	1,197	1,494
Fixed maturity securities \| U.S. corporate \| Capital goods
Schedule of Investments [Line Items]
Amortized cost or cost, fixed maturity securities	2,290	2,334
Gross unrealized gains, fixed maturity securities	41	415
Gross unrealized losses, fixed maturity securities	(193)	(4)
Allowance for credit losses	0	0
Fair value, fixed maturity securities	2,138	2,745
Fixed maturity securities \| U.S. corporate \| Consumer-cyclical
Schedule of Investments [Line Items]
Amortized cost or cost, fixed maturity securities	1,758	1,703
Gross unrealized gains, fixed maturity securities	14	203
Gross unrealized losses, fixed maturity securities	(155)	(7)
Allowance for credit losses	0	0
Fair value, fixed maturity securities	1,617	1,899
Fixed maturity securities \| U.S. corporate \| Transportation
Schedule of Investments [Line Items]
Amortized cost or cost, fixed maturity securities	1,165	1,122
Gross unrealized gains, fixed maturity securities	32	249
Gross unrealized losses, fixed maturity securities	(97)	0
Allowance for credit losses	0	0
Fair value, fixed maturity securities	1,100	1,371
Fixed maturity securities \| U.S. corporate \| Other
Schedule of Investments [Line Items]
Amortized cost or cost, fixed maturity securities	325	379
Gross unrealized gains, fixed maturity securities	3	41
Gross unrealized losses, fixed maturity securities	(18)	(1)
Allowance for credit losses	0	0
Fair value, fixed maturity securities	310	419
Fixed maturity securities \| Non-U.S. corporate
Schedule of Investments [Line Items]
Amortized cost or cost, fixed maturity securities	8,720	9,344
Gross unrealized gains, fixed maturity securities	92	1,217
Gross unrealized losses, fixed maturity securities	(802)	(26)
Allowance for credit losses	0	0	(1)	0
Fair value, fixed maturity securities	8,010	10,535
Fixed maturity securities \| Non-U.S. corporate \| Utilities
Schedule of Investments [Line Items]
Amortized cost or cost, fixed maturity securities	817	867
Gross unrealized gains, fixed maturity securities	0	63
Gross unrealized losses, fixed maturity securities	(77)	(2)
Allowance for credit losses	0	0
Fair value, fixed maturity securities	740	928
Fixed maturity securities \| Non-U.S. corporate \| Energy
Schedule of Investments [Line Items]
Amortized cost or cost, fixed maturity securities	1,009	1,194
Gross unrealized gains, fixed maturity securities	19	190
Gross unrealized losses, fixed maturity securities	(68)	(1)
Allowance for credit losses	0	0
Fair value, fixed maturity securities	960	1,383
Fixed maturity securities \| Non-U.S. corporate \| Finance and insurance
Schedule of Investments [Line Items]
Amortized cost or cost, fixed maturity securities	2,124	2,171
Gross unrealized gains, fixed maturity securities	30	270
Gross unrealized losses, fixed maturity securities	(208)	(9)
Allowance for credit losses	0	0
Fair value, fixed maturity securities	1,946	2,432
Fixed maturity securities \| Non-U.S. corporate \| Consumer-non-cyclical
Schedule of Investments [Line Items]
Amortized cost or cost, fixed maturity securities	655	664
Gross unrealized gains, fixed maturity securities	1	81
Gross unrealized losses, fixed maturity securities	(90)	(2)
Allowance for credit losses	0	0
Fair value, fixed maturity securities	566	743
Fixed maturity securities \| Non-U.S. corporate \| Technology and communications
Schedule of Investments [Line Items]
Amortized cost or cost, fixed maturity securities	997	1,085
Gross unrealized gains, fixed maturity securities	4	166
Gross unrealized losses, fixed maturity securities	(107)	(1)
Allowance for credit losses	0	0
Fair value, fixed maturity securities	894	1,250
Fixed maturity securities \| Non-U.S. corporate \| Industrial
Schedule of Investments [Line Items]
Amortized cost or cost, fixed maturity securities	880	933
Gross unrealized gains, fixed maturity securities	8	117
Gross unrealized losses, fixed maturity securities	(70)	(3)
Allowance for credit losses	0	0
Fair value, fixed maturity securities	818	1,047
Fixed maturity securities \| Non-U.S. corporate \| Capital goods
Schedule of Investments [Line Items]
Amortized cost or cost, fixed maturity securities	606	640
Gross unrealized gains, fixed maturity securities	3	66
Gross unrealized losses, fixed maturity securities	(63)	(1)
Allowance for credit losses	0	0
Fair value, fixed maturity securities	546	705
Fixed maturity securities \| Non-U.S. corporate \| Consumer-cyclical
Schedule of Investments [Line Items]
Amortized cost or cost, fixed maturity securities	308	316
Gross unrealized gains, fixed maturity securities	0	27
Gross unrealized losses, fixed maturity securities	(32)	(2)
Allowance for credit losses	0	0
Fair value, fixed maturity securities	276	341
Fixed maturity securities \| Non-U.S. corporate \| Transportation
Schedule of Investments [Line Items]
Amortized cost or cost, fixed maturity securities	392	422
Gross unrealized gains, fixed maturity securities	12	68
Gross unrealized losses, fixed maturity securities	(29)	(1)
Allowance for credit losses	0	0
Fair value, fixed maturity securities	375	489
Fixed maturity securities \| Non-U.S. corporate \| Other
Schedule of Investments [Line Items]
Amortized cost or cost, fixed maturity securities	932	1,052
Gross unrealized gains, fixed maturity securities	15	169
Gross unrealized losses, fixed maturity securities	(58)	(4)
Allowance for credit losses	0	0
Fair value, fixed maturity securities	889	1,217
Fixed maturity securities \| Residential mortgage-backed
Schedule of Investments [Line Items]
Amortized cost or cost, fixed maturity securities	1,059	1,325
Gross unrealized gains, fixed maturity securities	7	116
Gross unrealized losses, fixed maturity securities	(71)	(1)
Allowance for credit losses	0	0
Fair value, fixed maturity securities	995	1,440
Fixed maturity securities \| Commercial mortgage-backed
Schedule of Investments [Line Items]
Amortized cost or cost, fixed maturity securities	2,183	2,435
Gross unrealized gains, fixed maturity securities	2	152
Gross unrealized losses, fixed maturity securities	(277)	(3)
Allowance for credit losses	0	0	$ (3)	$ 0
Fair value, fixed maturity securities	1,908	2,584
Fixed maturity securities \| Other asset-backed
Schedule of Investments [Line Items]
Amortized cost or cost, fixed maturity securities	2,328	2,138
Gross unrealized gains, fixed maturity securities	1	29
Gross unrealized losses, fixed maturity securities	(163)	(7)
Allowance for credit losses	0	0
Fair value, fixed maturity securities	$ 2,166	$ 2,160

Gross Unrealized Losses and Fai

Gross Unrealized Losses and Fair Value of Investment Securities (Detail) $ in Millions	Dec. 31, 2022 USD ($) Securities	Dec. 31, 2021 USD ($) Securities
Schedule of Investments [Line Items]
Less than 12 months, Fair value	$ 31,357	$ 4,991
Less than 12 months, Gross unrealized losses	$ (3,844)	$ (110)
Less than 12 months, Number of securities in a continuous loss position \| Securities	4,360	635
12 months or more, Fair value	$ 3,930	$ 308
12 months or more, Gross unrealized losses	$ (1,003)	$ (25)
12 months or more, Number of securities in a continuous loss position \| Securities	581	35
Total, Fair value	$ 35,287	$ 5,299
Total, Gross unrealized losses	$ (4,847)	$ (135)
Total, Number of securities in a continuous loss position \| Securities	4,941	670
Investment grade
Schedule of Investments [Line Items]
Less than 12 months, Fair value	$ 29,959	$ 4,644
Less than 12 months, Gross unrealized losses	$ (3,687)	$ (101)
Less than 12 months, Number of securities in a continuous loss position \| Securities	4,158	587
12 months or more, Fair value	$ 3,590	$ 241
12 months or more, Gross unrealized losses	$ (915)	$ (12)
12 months or more, Number of securities in a continuous loss position \| Securities	537	25
Total, Fair value	$ 33,549	$ 4,885
Total, Gross unrealized losses	$ (4,602)	$ (113)
Total, Number of securities in a continuous loss position \| Securities	4,695	612
Below investment grade
Schedule of Investments [Line Items]
Less than 12 months, Fair value	$ 1,398	$ 347
Less than 12 months, Gross unrealized losses	$ (157)	$ (9)
Less than 12 months, Number of securities in a continuous loss position \| Securities	202	48
12 months or more, Fair value	$ 340	$ 67
12 months or more, Gross unrealized losses	$ (88)	$ (13)
12 months or more, Number of securities in a continuous loss position \| Securities	44	10
Total, Fair value	$ 1,738	$ 414
Total, Gross unrealized losses	$ (245)	$ (22)
Total, Number of securities in a continuous loss position \| Securities	246	58
Fixed maturity securities
Schedule of Investments [Line Items]
Less than 12 months, Fair value	$ 31,357	$ 4,991
Less than 12 months, Gross unrealized losses	$ (3,844)	$ (110)
Less than 12 months, Number of securities in a continuous loss position \| Securities	4,360	635
12 months or more, Fair value	$ 3,930	$ 308
12 months or more, Gross unrealized losses	$ (1,003)	$ (25)
12 months or more, Number of securities in a continuous loss position \| Securities	581	35
Total, Fair value	$ 35,287	$ 5,299
Total, Gross unrealized losses	$ (4,847)	$ (135)
Total, Number of securities in a continuous loss position \| Securities	4,941	670
Fixed maturity securities \| Less Than 20 Percent Below Cost
Schedule of Investments [Line Items]
Less than 12 months, Fair value	$ 27,596	$ 4,991
Less than 12 months, Gross unrealized losses	$ (2,587)	$ (110)
Less than 12 months, Number of securities in a continuous loss position \| Securities	3,835	635
12 months or more, Fair value	$ 1,819	$ 297
12 months or more, Gross unrealized losses	$ (291)	$ (20)
12 months or more, Number of securities in a continuous loss position \| Securities	310	33
Total, Fair value	$ 29,415	$ 5,288
Total, Gross unrealized losses	$ (2,878)	$ (130)
Total, Number of securities in a continuous loss position \| Securities	4,145	668
Fixed maturity securities \| 20 To 50 percent below cost
Schedule of Investments [Line Items]
Less than 12 months, Fair value	$ 3,757	$ 0
Less than 12 months, Gross unrealized losses	$ (1,251)	$ 0
Less than 12 months, Number of securities in a continuous loss position \| Securities	523	0
12 months or more, Fair value	$ 2,111	$ 11
12 months or more, Gross unrealized losses	$ (712)	$ (5)
12 months or more, Number of securities in a continuous loss position \| Securities	271	2
Total, Fair value	$ 5,868	$ 11
Total, Gross unrealized losses	$ (1,963)	$ (5)
Total, Number of securities in a continuous loss position \| Securities	794	2
Fixed maturity securities \| Greater Than 50 Percent Below Cost
Schedule of Investments [Line Items]
Less than 12 months, Fair value	$ 4
Less than 12 months, Gross unrealized losses	$ (6)
Less than 12 months, Number of securities in a continuous loss position \| Securities	2
12 months or more, Fair value	$ 0
12 months or more, Gross unrealized losses	$ 0
12 months or more, Number of securities in a continuous loss position \| Securities	0
Total, Fair value	$ 4
Total, Gross unrealized losses	$ (6)
Total, Number of securities in a continuous loss position \| Securities	2
Fixed maturity securities \| U.S. government, agencies and government-sponsored enterprises
Schedule of Investments [Line Items]
Less than 12 months, Fair value	$ 1,585
Less than 12 months, Gross unrealized losses	$ (189)
Less than 12 months, Number of securities in a continuous loss position \| Securities	55
12 months or more, Fair value	$ 17
12 months or more, Gross unrealized losses	$ (2)
12 months or more, Number of securities in a continuous loss position \| Securities	6
Total, Fair value	$ 1,602
Total, Gross unrealized losses	$ (191)
Total, Number of securities in a continuous loss position \| Securities	61
Fixed maturity securities \| State and Political Subdivisions
Schedule of Investments [Line Items]
Less than 12 months, Fair value	$ 1,559	$ 339
Less than 12 months, Gross unrealized losses	$ (269)	$ (6)
Less than 12 months, Number of securities in a continuous loss position \| Securities	258	67
12 months or more, Fair value	$ 261	$ 0
12 months or more, Gross unrealized losses	$ (77)	$ 0
12 months or more, Number of securities in a continuous loss position \| Securities	66	0
Total, Fair value	$ 1,820	$ 339
Total, Gross unrealized losses	$ (346)	$ (6)
Total, Number of securities in a continuous loss position \| Securities	324	67
Fixed maturity securities \| Non-U.S. government
Schedule of Investments [Line Items]
Less than 12 months, Fair value	$ 351	$ 173
Less than 12 months, Gross unrealized losses	$ (54)	$ (9)
Less than 12 months, Number of securities in a continuous loss position \| Securities	59	28
12 months or more, Fair value	$ 152	$ 19
12 months or more, Gross unrealized losses	$ (47)	$ (4)
12 months or more, Number of securities in a continuous loss position \| Securities	23	1
Total, Fair value	$ 503	$ 192
Total, Gross unrealized losses	$ (101)	$ (13)
Total, Number of securities in a continuous loss position \| Securities	82	29
Fixed maturity securities \| U.S. corporate
Schedule of Investments [Line Items]
Less than 12 months, Fair value	$ 18,480	$ 2,593
Less than 12 months, Gross unrealized losses	$ (2,344)	$ (64)
Less than 12 months, Number of securities in a continuous loss position \| Securities	2,452	266
12 months or more, Fair value	$ 2,001	$ 196
12 months or more, Gross unrealized losses	$ (552)	$ (15)
12 months or more, Number of securities in a continuous loss position \| Securities	236	22
Total, Fair value	$ 20,481	$ 2,789
Total, Gross unrealized losses	$ (2,896)	$ (79)
Total, Number of securities in a continuous loss position \| Securities	2,688	288
Fixed maturity securities \| Non-U.S. corporate
Schedule of Investments [Line Items]
Less than 12 months, Fair value	$ 5,593	$ 912
Less than 12 months, Gross unrealized losses	$ (599)	$ (21)
Less than 12 months, Number of securities in a continuous loss position \| Securities	732	124
12 months or more, Fair value	$ 748	$ 62
12 months or more, Gross unrealized losses	$ (203)	$ (5)
12 months or more, Number of securities in a continuous loss position \| Securities	111	8
Total, Fair value	$ 6,341	$ 974
Total, Gross unrealized losses	$ (802)	$ (26)
Total, Number of securities in a continuous loss position \| Securities	843	132
Fixed maturity securities \| Residential mortgage-backed
Schedule of Investments [Line Items]
Less than 12 months, Fair value	$ 569	$ 97
Less than 12 months, Gross unrealized losses	$ (51)	$ (1)
Less than 12 months, Number of securities in a continuous loss position \| Securities	192	22
12 months or more, Fair value	$ 65	$ 0
12 months or more, Gross unrealized losses	$ (20)	$ 0
12 months or more, Number of securities in a continuous loss position \| Securities	22	0
Total, Fair value	$ 634	$ 97
Total, Gross unrealized losses	$ (71)	$ (1)
Total, Number of securities in a continuous loss position \| Securities	214	22
Fixed maturity securities \| Commercial mortgage-backed
Schedule of Investments [Line Items]
Less than 12 months, Fair value	$ 1,765	$ 113
Less than 12 months, Gross unrealized losses	$ (255)	$ (2)
Less than 12 months, Number of securities in a continuous loss position \| Securities	265	17
12 months or more, Fair value	$ 88	$ 31
12 months or more, Gross unrealized losses	$ (22)	$ (1)
12 months or more, Number of securities in a continuous loss position \| Securities	16	4
Total, Fair value	$ 1,853	$ 144
Total, Gross unrealized losses	$ (277)	$ (3)
Total, Number of securities in a continuous loss position \| Securities	281	21
Fixed maturity securities \| Other asset-backed
Schedule of Investments [Line Items]
Less than 12 months, Fair value	$ 1,455	$ 764
Less than 12 months, Gross unrealized losses	$ (83)	$ (7)
Less than 12 months, Number of securities in a continuous loss position \| Securities	347	111
12 months or more, Fair value	$ 598	$ 0
12 months or more, Gross unrealized losses	$ (80)	$ 0
12 months or more, Number of securities in a continuous loss position \| Securities	101	0
Total, Fair value	$ 2,053	$ 764
Total, Gross unrealized losses	$ (163)	$ (7)
Total, Number of securities in a continuous loss position \| Securities	448	111

Gross Unrealized Losses and F_2

Gross Unrealized Losses and Fair Value of Corporate Securities Based on Industries (Detail) $ in Millions	Dec. 31, 2022 USD ($) Securities	Dec. 31, 2021 USD ($) Securities
Available for Sale Securities Continuous Unrealized Loss Position [Line Items]
Less than 12 months, Fair value	$ 31,357	$ 4,991
Less than 12 months, Gross unrealized losses	$ (3,844)	$ (110)
Less than 12 months, Number of securities in a continuous loss position \| Securities	4,360	635
12 months or more, Fair value	$ 3,930	$ 308
12 months or more, Gross unrealized losses	$ (1,003)	$ (25)
12 months or more, Number of securities in a continuous loss position \| Securities	581	35
Fair value	$ 35,287	$ 5,299
Gross unrealized losses	$ (4,847)	$ (135)
Number of securities in a continuous loss position \| Securities	4,941	670
Fixed maturity securities
Available for Sale Securities Continuous Unrealized Loss Position [Line Items]
Less than 12 months, Fair value	$ 31,357	$ 4,991
Less than 12 months, Gross unrealized losses	$ (3,844)	$ (110)
Less than 12 months, Number of securities in a continuous loss position \| Securities	4,360	635
12 months or more, Fair value	$ 3,930	$ 308
12 months or more, Gross unrealized losses	$ (1,003)	$ (25)
12 months or more, Number of securities in a continuous loss position \| Securities	581	35
Fair value	$ 35,287	$ 5,299
Gross unrealized losses	$ (4,847)	$ (135)
Number of securities in a continuous loss position \| Securities	4,941	670
Fixed maturity securities \| U.S. corporate
Available for Sale Securities Continuous Unrealized Loss Position [Line Items]
Less than 12 months, Fair value	$ 18,480	$ 2,593
Less than 12 months, Gross unrealized losses	$ (2,344)	$ (64)
Less than 12 months, Number of securities in a continuous loss position \| Securities	2,452	266
12 months or more, Fair value	$ 2,001	$ 196
12 months or more, Gross unrealized losses	$ (552)	$ (15)
12 months or more, Number of securities in a continuous loss position \| Securities	236	22
Fair value	$ 20,481	$ 2,789
Gross unrealized losses	$ (2,896)	$ (79)
Number of securities in a continuous loss position \| Securities	2,688	288
Fixed maturity securities \| U.S. corporate \| Utilities
Available for Sale Securities Continuous Unrealized Loss Position [Line Items]
Less than 12 months, Fair value	$ 2,447	$ 211
Less than 12 months, Gross unrealized losses	$ (398)	$ (7)
Less than 12 months, Number of securities in a continuous loss position \| Securities	345	32
12 months or more, Fair value	$ 187	$ 29
12 months or more, Gross unrealized losses	$ (49)	$ (2)
12 months or more, Number of securities in a continuous loss position \| Securities	37	7
Fair value	$ 2,634	$ 240
Gross unrealized losses	$ (447)	$ (9)
Number of securities in a continuous loss position \| Securities	382	39
Fixed maturity securities \| U.S. corporate \| Energy
Available for Sale Securities Continuous Unrealized Loss Position [Line Items]
Less than 12 months, Fair value	$ 1,538	$ 166
Less than 12 months, Gross unrealized losses	$ (187)	$ (3)
Less than 12 months, Number of securities in a continuous loss position \| Securities	226	18
12 months or more, Fair value	$ 144	$ 25
12 months or more, Gross unrealized losses	$ (34)	$ (7)
12 months or more, Number of securities in a continuous loss position \| Securities	14	4
Fair value	$ 1,682	$ 191
Gross unrealized losses	$ (221)	$ (10)
Number of securities in a continuous loss position \| Securities	240	22
Fixed maturity securities \| U.S. corporate \| Finance and insurance
Available for Sale Securities Continuous Unrealized Loss Position [Line Items]
Less than 12 months, Fair value	$ 5,250	$ 960
Less than 12 months, Gross unrealized losses	$ (668)	$ (22)
Less than 12 months, Number of securities in a continuous loss position \| Securities	696	89
12 months or more, Fair value	$ 706	$ 62
12 months or more, Gross unrealized losses	$ (203)	$ (2)
12 months or more, Number of securities in a continuous loss position \| Securities	74	3
Fair value	$ 5,956	$ 1,022
Gross unrealized losses	$ (871)	$ (24)
Number of securities in a continuous loss position \| Securities	770	92
Fixed maturity securities \| U.S. corporate \| Consumer-non-cyclical
Available for Sale Securities Continuous Unrealized Loss Position [Line Items]
Less than 12 months, Fair value	$ 2,805	$ 296
Less than 12 months, Gross unrealized losses	$ (342)	$ (7)
Less than 12 months, Number of securities in a continuous loss position \| Securities	317	30
12 months or more, Fair value	$ 201	$ 14
12 months or more, Gross unrealized losses	$ (61)	$ (1)
12 months or more, Number of securities in a continuous loss position \| Securities	22	2
Fair value	$ 3,006	$ 310
Gross unrealized losses	$ (403)	$ (8)
Number of securities in a continuous loss position \| Securities	339	32
Fixed maturity securities \| U.S. corporate \| Technology and communications
Available for Sale Securities Continuous Unrealized Loss Position [Line Items]
Less than 12 months, Fair value	$ 2,259	$ 378
Less than 12 months, Gross unrealized losses	$ (273)	$ (12)
Less than 12 months, Number of securities in a continuous loss position \| Securities	304	37
12 months or more, Fair value	$ 271	$ 29
12 months or more, Gross unrealized losses	$ (88)	$ (1)
12 months or more, Number of securities in a continuous loss position \| Securities	32	2
Fair value	$ 2,530	$ 407
Gross unrealized losses	$ (361)	$ (13)
Number of securities in a continuous loss position \| Securities	336	39
Fixed maturity securities \| U.S. corporate \| Industrial
Available for Sale Securities Continuous Unrealized Loss Position [Line Items]
Less than 12 months, Fair value	$ 829	$ 143
Less than 12 months, Gross unrealized losses	$ (105)	$ (3)
Less than 12 months, Number of securities in a continuous loss position \| Securities	104	18
12 months or more, Fair value	$ 110	$ 0
12 months or more, Gross unrealized losses	$ (25)	$ 0
12 months or more, Number of securities in a continuous loss position \| Securities	13	0
Fair value	$ 939	$ 143
Gross unrealized losses	$ (130)	$ (3)
Number of securities in a continuous loss position \| Securities	117	18
Fixed maturity securities \| U.S. corporate \| Capital goods
Available for Sale Securities Continuous Unrealized Loss Position [Line Items]
Less than 12 months, Fair value	$ 1,332	$ 171
Less than 12 months, Gross unrealized losses	$ (153)	$ (3)
Less than 12 months, Number of securities in a continuous loss position \| Securities	169	16
12 months or more, Fair value	$ 148	$ 18
12 months or more, Gross unrealized losses	$ (40)	$ (1)
12 months or more, Number of securities in a continuous loss position \| Securities	16	2
Fair value	$ 1,480	$ 189
Gross unrealized losses	$ (193)	$ (4)
Number of securities in a continuous loss position \| Securities	185	18
Fixed maturity securities \| U.S. corporate \| Consumer-cyclical
Available for Sale Securities Continuous Unrealized Loss Position [Line Items]
Less than 12 months, Fair value	$ 1,138	$ 268
Less than 12 months, Gross unrealized losses	$ (108)	$ (7)
Less than 12 months, Number of securities in a continuous loss position \| Securities	173	26
12 months or more, Fair value	$ 194	$ 0
12 months or more, Gross unrealized losses	$ (47)	$ 0
12 months or more, Number of securities in a continuous loss position \| Securities	22	0
Fair value	$ 1,332	$ 268
Gross unrealized losses	$ (155)	$ (7)
Number of securities in a continuous loss position \| Securities	195	26
Fixed maturity securities \| U.S. corporate \| Transportation
Available for Sale Securities Continuous Unrealized Loss Position [Line Items]
Less than 12 months, Fair value	$ 746
Less than 12 months, Gross unrealized losses	$ (93)
Less than 12 months, Number of securities in a continuous loss position \| Securities	95
12 months or more, Fair value	$ 21
12 months or more, Gross unrealized losses	$ (4)
12 months or more, Number of securities in a continuous loss position \| Securities	5
Fair value	$ 767
Gross unrealized losses	$ (97)
Number of securities in a continuous loss position \| Securities	100
Fixed maturity securities \| U.S. corporate \| Other
Available for Sale Securities Continuous Unrealized Loss Position [Line Items]
Less than 12 months, Fair value	$ 136	$ 0
Less than 12 months, Gross unrealized losses	$ (17)	$ 0
Less than 12 months, Number of securities in a continuous loss position \| Securities	23	0
12 months or more, Fair value	$ 19	$ 19
12 months or more, Gross unrealized losses	$ (1)	$ (1)
12 months or more, Number of securities in a continuous loss position \| Securities	1	2
Fair value	$ 155	$ 19
Gross unrealized losses	$ (18)	$ (1)
Number of securities in a continuous loss position \| Securities	24	2
Fixed maturity securities \| Non-U.S. corporate
Available for Sale Securities Continuous Unrealized Loss Position [Line Items]
Less than 12 months, Fair value	$ 5,593	$ 912
Less than 12 months, Gross unrealized losses	$ (599)	$ (21)
Less than 12 months, Number of securities in a continuous loss position \| Securities	732	124
12 months or more, Fair value	$ 748	$ 62
12 months or more, Gross unrealized losses	$ (203)	$ (5)
12 months or more, Number of securities in a continuous loss position \| Securities	111	8
Fair value	$ 6,341	$ 974
Gross unrealized losses	$ (802)	$ (26)
Number of securities in a continuous loss position \| Securities	843	132
Fixed maturity securities \| Non-U.S. corporate \| Utilities
Available for Sale Securities Continuous Unrealized Loss Position [Line Items]
Less than 12 months, Fair value	$ 640	$ 69
Less than 12 months, Gross unrealized losses	$ (63)	$ (2)
Less than 12 months, Number of securities in a continuous loss position \| Securities	66	9
12 months or more, Fair value	$ 57	$ 0
12 months or more, Gross unrealized losses	$ (14)	$ 0
12 months or more, Number of securities in a continuous loss position \| Securities	9	0
Fair value	$ 697	$ 69
Gross unrealized losses	$ (77)	$ (2)
Number of securities in a continuous loss position \| Securities	75	9
Fixed maturity securities \| Non-U.S. corporate \| Energy
Available for Sale Securities Continuous Unrealized Loss Position [Line Items]
Less than 12 months, Fair value	$ 604	$ 64
Less than 12 months, Gross unrealized losses	$ (61)	$ (1)
Less than 12 months, Number of securities in a continuous loss position \| Securities	69	10
12 months or more, Fair value	$ 40	$ 0
12 months or more, Gross unrealized losses	$ (7)	$ 0
12 months or more, Number of securities in a continuous loss position \| Securities	5	0
Fair value	$ 644	$ 64
Gross unrealized losses	$ (68)	$ (1)
Number of securities in a continuous loss position \| Securities	74	10
Fixed maturity securities \| Non-U.S. corporate \| Finance and insurance
Available for Sale Securities Continuous Unrealized Loss Position [Line Items]
Less than 12 months, Fair value	$ 1,310	$ 366
Less than 12 months, Gross unrealized losses	$ (122)	$ (8)
Less than 12 months, Number of securities in a continuous loss position \| Securities	204	43
12 months or more, Fair value	$ 296	$ 18
12 months or more, Gross unrealized losses	$ (86)	$ (1)
12 months or more, Number of securities in a continuous loss position \| Securities	42	2
Fair value	$ 1,606	$ 384
Gross unrealized losses	$ (208)	$ (9)
Number of securities in a continuous loss position \| Securities	246	45
Fixed maturity securities \| Non-U.S. corporate \| Consumer-non-cyclical
Available for Sale Securities Continuous Unrealized Loss Position [Line Items]
Less than 12 months, Fair value	$ 491	$ 67
Less than 12 months, Gross unrealized losses	$ (74)	$ (1)
Less than 12 months, Number of securities in a continuous loss position \| Securities	56	12
12 months or more, Fair value	$ 54	$ 6
12 months or more, Gross unrealized losses	$ (16)	$ (1)
12 months or more, Number of securities in a continuous loss position \| Securities	11	1
Fair value	$ 545	$ 73
Gross unrealized losses	$ (90)	$ (2)
Number of securities in a continuous loss position \| Securities	67	13
Fixed maturity securities \| Non-U.S. corporate \| Technology and communications
Available for Sale Securities Continuous Unrealized Loss Position [Line Items]
Less than 12 months, Fair value	$ 740	$ 48
Less than 12 months, Gross unrealized losses	$ (96)	$ (1)
Less than 12 months, Number of securities in a continuous loss position \| Securities	93	8
12 months or more, Fair value	$ 39	$ 0
12 months or more, Gross unrealized losses	$ (11)	$ 0
12 months or more, Number of securities in a continuous loss position \| Securities	8	0
Fair value	$ 779	$ 48
Gross unrealized losses	$ (107)	$ (1)
Number of securities in a continuous loss position \| Securities	101	8
Fixed maturity securities \| Non-U.S. corporate \| Industrial
Available for Sale Securities Continuous Unrealized Loss Position [Line Items]
Less than 12 months, Fair value	$ 480	$ 122
Less than 12 months, Gross unrealized losses	$ (45)	$ (3)
Less than 12 months, Number of securities in a continuous loss position \| Securities	71	14
12 months or more, Fair value	$ 105	$ 0
12 months or more, Gross unrealized losses	$ (25)	$ 0
12 months or more, Number of securities in a continuous loss position \| Securities	13	0
Fair value	$ 585	$ 122
Gross unrealized losses	$ (70)	$ (3)
Number of securities in a continuous loss position \| Securities	84	14
Fixed maturity securities \| Non-U.S. corporate \| Capital goods
Available for Sale Securities Continuous Unrealized Loss Position [Line Items]
Less than 12 months, Fair value	$ 394	$ 78
Less than 12 months, Gross unrealized losses	$ (46)	$ (1)
Less than 12 months, Number of securities in a continuous loss position \| Securities	52	8
12 months or more, Fair value	$ 62	$ 0
12 months or more, Gross unrealized losses	$ (17)	$ 0
12 months or more, Number of securities in a continuous loss position \| Securities	6	0
Fair value	$ 456	$ 78
Gross unrealized losses	$ (63)	$ (1)
Number of securities in a continuous loss position \| Securities	58	8
Fixed maturity securities \| Non-U.S. corporate \| Consumer-cyclical
Available for Sale Securities Continuous Unrealized Loss Position [Line Items]
Less than 12 months, Fair value	$ 241	$ 22
Less than 12 months, Gross unrealized losses	$ (28)	$ (1)
Less than 12 months, Number of securities in a continuous loss position \| Securities	31	8
12 months or more, Fair value	$ 23	$ 15
12 months or more, Gross unrealized losses	$ (4)	$ (1)
12 months or more, Number of securities in a continuous loss position \| Securities	6	3
Fair value	$ 264	$ 37
Gross unrealized losses	$ (32)	$ (2)
Number of securities in a continuous loss position \| Securities	37	11
Fixed maturity securities \| Non-U.S. corporate \| Transportation
Available for Sale Securities Continuous Unrealized Loss Position [Line Items]
Less than 12 months, Fair value	$ 180	$ 37
Less than 12 months, Gross unrealized losses	$ (21)	$ (1)
Less than 12 months, Number of securities in a continuous loss position \| Securities	26	7
12 months or more, Fair value	$ 29	$ 0
12 months or more, Gross unrealized losses	$ (8)	$ 0
12 months or more, Number of securities in a continuous loss position \| Securities	5	0
Fair value	$ 209	$ 37
Gross unrealized losses	$ (29)	$ (1)
Number of securities in a continuous loss position \| Securities	31	7
Fixed maturity securities \| Non-U.S. corporate \| Other
Available for Sale Securities Continuous Unrealized Loss Position [Line Items]
Less than 12 months, Fair value	$ 513	$ 39
Less than 12 months, Gross unrealized losses	$ (43)	$ (2)
Less than 12 months, Number of securities in a continuous loss position \| Securities	64	5
12 months or more, Fair value	$ 43	$ 23
12 months or more, Gross unrealized losses	$ (15)	$ (2)
12 months or more, Number of securities in a continuous loss position \| Securities	6	2
Fair value	$ 556	$ 62
Gross unrealized losses	$ (58)	$ (4)
Number of securities in a continuous loss position \| Securities	70	7
Fixed maturity securities \| Corporate Debt Securities
Available for Sale Securities Continuous Unrealized Loss Position [Line Items]
Less than 12 months, Fair value	$ 24,073	$ 3,505
Less than 12 months, Gross unrealized losses	$ (2,943)	$ (85)
Less than 12 months, Number of securities in a continuous loss position \| Securities	3,184	390
12 months or more, Fair value	$ 2,749	$ 258
12 months or more, Gross unrealized losses	$ (755)	$ (20)
12 months or more, Number of securities in a continuous loss position \| Securities	347	30
Fair value	$ 26,822	$ 3,763
Gross unrealized losses	$ (3,698)	$ (105)
Number of securities in a continuous loss position \| Securities	3,531	420

Scheduled Maturity Distribution

Scheduled Maturity Distribution of Fixed Maturity Securities (Detail) - USD ($) $ in Millions	Dec. 31, 2022	Dec. 31, 2021
Amortized cost or cost
Due one year or less	$ 1,239
Due after one year through five years	8,264
Due after five years through ten years	13,120
Due after ten years	22,641
Subtotal	45,264
Amortized cost or cost, fixed maturity securities	50,834	$ 52,611
Fair value
Due one year or less	1,234
Due after one year through five years	7,931
Due after five years through ten years	11,915
Due after ten years	20,434
Subtotal	41,514
Fair value, fixed maturity securities	46,583	$ 60,480
Residential mortgage-backed
Amortized cost or cost
Fixed maturity securities	1,059
Fair value
Fixed maturity securities	995
Commercial mortgage-backed
Amortized cost or cost
Fixed maturity securities	2,183
Fair value
Fixed maturity securities	1,908
Other asset-backed
Amortized cost or cost
Fixed maturity securities	2,328
Fair value
Fixed maturity securities	$ 2,166

Distribution Across Property Ty

Distribution Across Property Type and Geographic Region for Commercial Mortgage Loans (Detail) - USD ($) $ in Millions	Dec. 31, 2022	Dec. 31, 2021
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Commercial mortgage loans, amortized cost	$ 7,032	$ 6,856
% of total	100%	100%
Allowance for credit losses	$ (22)	$ (26)
Commercial mortgage loans, net	7,010	6,830
Commercial Mortgage Loan
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Commercial mortgage loans, amortized cost	$ 7,032	$ 6,856
% of total	100%	100%
Allowance for credit losses	$ (22)	$ (26)
Commercial mortgage loans, net	7,010	6,830
South Atlantic \| Commercial Mortgage Loan
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Commercial mortgage loans, amortized cost	$ 1,809	$ 1,770
% of total	26%	26%
Pacific \| Commercial Mortgage Loan
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Commercial mortgage loans, amortized cost	$ 1,340	$ 1,360
% of total	19%	20%
Middle Atlantic \| Commercial Mortgage Loan
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Commercial mortgage loans, amortized cost	$ 988	$ 964
% of total	14%	14%
Mountain \| Commercial Mortgage Loan
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Commercial mortgage loans, amortized cost	$ 1,023	$ 892
% of total	15%	13%
West North Central \| Commercial Mortgage Loan
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Commercial mortgage loans, amortized cost	$ 438	$ 461
% of total	6%	7%
East North Central \| Commercial Mortgage Loan
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Commercial mortgage loans, amortized cost	$ 454	$ 465
% of total	6%	7%
West South Central \| Commercial Mortgage Loan
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Commercial mortgage loans, amortized cost	$ 578	$ 483
% of total	8%	7%
New England \| Commercial Mortgage Loan
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Commercial mortgage loans, amortized cost	$ 184	$ 237
% of total	3%	3%
East South Central \| Commercial Mortgage Loan
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Commercial mortgage loans, amortized cost	$ 218	$ 224
% of total	3%	3%
Retail
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Commercial mortgage loans, amortized cost	$ 2,916	$ 2,774
% of total	42%	40%
Industrial
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Commercial mortgage loans, amortized cost	$ 1,456	$ 1,420
% of total	21%	21%
Office
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Commercial mortgage loans, amortized cost	$ 1,579	$ 1,526
% of total	22%	22%
Apartments
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Commercial mortgage loans, amortized cost	$ 561	$ 585
% of total	8%	9%
Mixed Use
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Commercial mortgage loans, amortized cost	$ 371	$ 330
% of total	5%	5%
Other
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Commercial mortgage loans, amortized cost	$ 149	$ 221
% of total	2%	3%

Allowance for Credit Losses and

Allowance for Credit Losses and Recorded Investment in Commercial Mortgage Loans (Detail) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Financing Receivable, Allowance for Credit Losses [Line Items]
Beginning balance	$ 26
Ending balance	22	$ 26
Allowance for Credit Losses
Financing Receivable, Allowance for Credit Losses [Line Items]
Beginning balance	26	31	$ 13
Cumulative effect of change in accounting	0	0	16
Provision	(5)	3	2
Write-offs	0	(8)	0
Recoveries	1	0	0
Ending balance	$ 22	$ 26	$ 31

Commercial Mortgage Loans By Ye

Commercial Mortgage Loans By Year of Origination and Credit Quality Indicator (Detail) - USD ($) $ in Millions	Dec. 31, 2022	Dec. 31, 2021
Disclosure Of Commercial Mortgage Loans By Year Of Origination And Credit Quality Indicator [Line Items]
Commercial mortgage loans, amortized cost	$ 7,032	$ 6,856
Fixed Rate Commercial Mortgage Loans
Disclosure Of Commercial Mortgage Loans By Year Of Origination And Credit Quality Indicator [Line Items]
Commercial mortgage loans, amortized cost	7,032	6,856
0% - 50%
Disclosure Of Commercial Mortgage Loans By Year Of Origination And Credit Quality Indicator [Line Items]
Commercial mortgage loans, amortized cost	2,385	2,480
0% - 50% \| Fixed Rate Commercial Mortgage Loans
Disclosure Of Commercial Mortgage Loans By Year Of Origination And Credit Quality Indicator [Line Items]
Commercial mortgage loans, amortized cost	2,385
51% - 60%
Disclosure Of Commercial Mortgage Loans By Year Of Origination And Credit Quality Indicator [Line Items]
Commercial mortgage loans, amortized cost	1,342	1,539
51% - 60% \| Fixed Rate Commercial Mortgage Loans
Disclosure Of Commercial Mortgage Loans By Year Of Origination And Credit Quality Indicator [Line Items]
Commercial mortgage loans, amortized cost	1,342
61% - 75%
Disclosure Of Commercial Mortgage Loans By Year Of Origination And Credit Quality Indicator [Line Items]
Commercial mortgage loans, amortized cost	3,255	2,815
61% - 75% \| Fixed Rate Commercial Mortgage Loans
Disclosure Of Commercial Mortgage Loans By Year Of Origination And Credit Quality Indicator [Line Items]
Commercial mortgage loans, amortized cost	3,255
76% - 100%
Disclosure Of Commercial Mortgage Loans By Year Of Origination And Credit Quality Indicator [Line Items]
Commercial mortgage loans, amortized cost	50	0
76% - 100% \| Fixed Rate Commercial Mortgage Loans
Disclosure Of Commercial Mortgage Loans By Year Of Origination And Credit Quality Indicator [Line Items]
Commercial mortgage loans, amortized cost	50
Greater than 100%
Disclosure Of Commercial Mortgage Loans By Year Of Origination And Credit Quality Indicator [Line Items]
Commercial mortgage loans, amortized cost	0	22
Greater than 100% \| Fixed Rate Commercial Mortgage Loans
Disclosure Of Commercial Mortgage Loans By Year Of Origination And Credit Quality Indicator [Line Items]
Commercial mortgage loans, amortized cost	0
Less than 1.00 \| Fixed Rate Commercial Mortgage Loans
Disclosure Of Commercial Mortgage Loans By Year Of Origination And Credit Quality Indicator [Line Items]
Commercial mortgage loans, amortized cost	270	223
1.00 - 1.25 \| Fixed Rate Commercial Mortgage Loans
Disclosure Of Commercial Mortgage Loans By Year Of Origination And Credit Quality Indicator [Line Items]
Commercial mortgage loans, amortized cost	272	559
1.26 - 1.50 \| Fixed Rate Commercial Mortgage Loans
Disclosure Of Commercial Mortgage Loans By Year Of Origination And Credit Quality Indicator [Line Items]
Commercial mortgage loans, amortized cost	1,118	791
1.51 - 2.00 \| Fixed Rate Commercial Mortgage Loans
Disclosure Of Commercial Mortgage Loans By Year Of Origination And Credit Quality Indicator [Line Items]
Commercial mortgage loans, amortized cost	3,085	2,958
Greater than 2.00 \| Fixed Rate Commercial Mortgage Loans
Disclosure Of Commercial Mortgage Loans By Year Of Origination And Credit Quality Indicator [Line Items]
Commercial mortgage loans, amortized cost	2,287	$ 2,325
2022 \| Fixed Rate Commercial Mortgage Loans
Disclosure Of Commercial Mortgage Loans By Year Of Origination And Credit Quality Indicator [Line Items]
Commercial mortgage loans, amortized cost	948
2022 \| 0% - 50% \| Fixed Rate Commercial Mortgage Loans
Disclosure Of Commercial Mortgage Loans By Year Of Origination And Credit Quality Indicator [Line Items]
Commercial mortgage loans, amortized cost	42
2022 \| 51% - 60% \| Fixed Rate Commercial Mortgage Loans
Disclosure Of Commercial Mortgage Loans By Year Of Origination And Credit Quality Indicator [Line Items]
Commercial mortgage loans, amortized cost	58
2022 \| 61% - 75% \| Fixed Rate Commercial Mortgage Loans
Disclosure Of Commercial Mortgage Loans By Year Of Origination And Credit Quality Indicator [Line Items]
Commercial mortgage loans, amortized cost	848
2022 \| 76% - 100% \| Fixed Rate Commercial Mortgage Loans
Disclosure Of Commercial Mortgage Loans By Year Of Origination And Credit Quality Indicator [Line Items]
Commercial mortgage loans, amortized cost	0
2022 \| Greater than 100% \| Fixed Rate Commercial Mortgage Loans
Disclosure Of Commercial Mortgage Loans By Year Of Origination And Credit Quality Indicator [Line Items]
Commercial mortgage loans, amortized cost	0
2022 \| Less than 1.00 \| Fixed Rate Commercial Mortgage Loans
Disclosure Of Commercial Mortgage Loans By Year Of Origination And Credit Quality Indicator [Line Items]
Commercial mortgage loans, amortized cost	7
2022 \| 1.00 - 1.25 \| Fixed Rate Commercial Mortgage Loans
Disclosure Of Commercial Mortgage Loans By Year Of Origination And Credit Quality Indicator [Line Items]
Commercial mortgage loans, amortized cost	17
2022 \| 1.26 - 1.50 \| Fixed Rate Commercial Mortgage Loans
Disclosure Of Commercial Mortgage Loans By Year Of Origination And Credit Quality Indicator [Line Items]
Commercial mortgage loans, amortized cost	290
2022 \| 1.51 - 2.00 \| Fixed Rate Commercial Mortgage Loans
Disclosure Of Commercial Mortgage Loans By Year Of Origination And Credit Quality Indicator [Line Items]
Commercial mortgage loans, amortized cost	580
2022 \| Greater than 2.00 \| Fixed Rate Commercial Mortgage Loans
Disclosure Of Commercial Mortgage Loans By Year Of Origination And Credit Quality Indicator [Line Items]
Commercial mortgage loans, amortized cost	54
2021 \| Fixed Rate Commercial Mortgage Loans
Disclosure Of Commercial Mortgage Loans By Year Of Origination And Credit Quality Indicator [Line Items]
Commercial mortgage loans, amortized cost	927
2021 \| 0% - 50% \| Fixed Rate Commercial Mortgage Loans
Disclosure Of Commercial Mortgage Loans By Year Of Origination And Credit Quality Indicator [Line Items]
Commercial mortgage loans, amortized cost	41
2021 \| 51% - 60% \| Fixed Rate Commercial Mortgage Loans
Disclosure Of Commercial Mortgage Loans By Year Of Origination And Credit Quality Indicator [Line Items]
Commercial mortgage loans, amortized cost	98
2021 \| 61% - 75% \| Fixed Rate Commercial Mortgage Loans
Disclosure Of Commercial Mortgage Loans By Year Of Origination And Credit Quality Indicator [Line Items]
Commercial mortgage loans, amortized cost	788
2021 \| 76% - 100% \| Fixed Rate Commercial Mortgage Loans
Disclosure Of Commercial Mortgage Loans By Year Of Origination And Credit Quality Indicator [Line Items]
Commercial mortgage loans, amortized cost	0
2021 \| Greater than 100% \| Fixed Rate Commercial Mortgage Loans
Disclosure Of Commercial Mortgage Loans By Year Of Origination And Credit Quality Indicator [Line Items]
Commercial mortgage loans, amortized cost	0
2021 \| Less than 1.00 \| Fixed Rate Commercial Mortgage Loans
Disclosure Of Commercial Mortgage Loans By Year Of Origination And Credit Quality Indicator [Line Items]
Commercial mortgage loans, amortized cost	9
2021 \| 1.00 - 1.25 \| Fixed Rate Commercial Mortgage Loans
Disclosure Of Commercial Mortgage Loans By Year Of Origination And Credit Quality Indicator [Line Items]
Commercial mortgage loans, amortized cost	1
2021 \| 1.26 - 1.50 \| Fixed Rate Commercial Mortgage Loans
Disclosure Of Commercial Mortgage Loans By Year Of Origination And Credit Quality Indicator [Line Items]
Commercial mortgage loans, amortized cost	70
2021 \| 1.51 - 2.00 \| Fixed Rate Commercial Mortgage Loans
Disclosure Of Commercial Mortgage Loans By Year Of Origination And Credit Quality Indicator [Line Items]
Commercial mortgage loans, amortized cost	614
2021 \| Greater than 2.00 \| Fixed Rate Commercial Mortgage Loans
Disclosure Of Commercial Mortgage Loans By Year Of Origination And Credit Quality Indicator [Line Items]
Commercial mortgage loans, amortized cost	233
2020 \| Fixed Rate Commercial Mortgage Loans
Disclosure Of Commercial Mortgage Loans By Year Of Origination And Credit Quality Indicator [Line Items]
Commercial mortgage loans, amortized cost	494
2020 \| 0% - 50% \| Fixed Rate Commercial Mortgage Loans
Disclosure Of Commercial Mortgage Loans By Year Of Origination And Credit Quality Indicator [Line Items]
Commercial mortgage loans, amortized cost	98
2020 \| 51% - 60% \| Fixed Rate Commercial Mortgage Loans
Disclosure Of Commercial Mortgage Loans By Year Of Origination And Credit Quality Indicator [Line Items]
Commercial mortgage loans, amortized cost	62
2020 \| 61% - 75% \| Fixed Rate Commercial Mortgage Loans
Disclosure Of Commercial Mortgage Loans By Year Of Origination And Credit Quality Indicator [Line Items]
Commercial mortgage loans, amortized cost	334
2020 \| 76% - 100% \| Fixed Rate Commercial Mortgage Loans
Disclosure Of Commercial Mortgage Loans By Year Of Origination And Credit Quality Indicator [Line Items]
Commercial mortgage loans, amortized cost	0
2020 \| Greater than 100% \| Fixed Rate Commercial Mortgage Loans
Disclosure Of Commercial Mortgage Loans By Year Of Origination And Credit Quality Indicator [Line Items]
Commercial mortgage loans, amortized cost	0
2020 \| Less than 1.00 \| Fixed Rate Commercial Mortgage Loans
Disclosure Of Commercial Mortgage Loans By Year Of Origination And Credit Quality Indicator [Line Items]
Commercial mortgage loans, amortized cost	6
2020 \| 1.00 - 1.25 \| Fixed Rate Commercial Mortgage Loans
Disclosure Of Commercial Mortgage Loans By Year Of Origination And Credit Quality Indicator [Line Items]
Commercial mortgage loans, amortized cost	16
2020 \| 1.26 - 1.50 \| Fixed Rate Commercial Mortgage Loans
Disclosure Of Commercial Mortgage Loans By Year Of Origination And Credit Quality Indicator [Line Items]
Commercial mortgage loans, amortized cost	65
2020 \| 1.51 - 2.00 \| Fixed Rate Commercial Mortgage Loans
Disclosure Of Commercial Mortgage Loans By Year Of Origination And Credit Quality Indicator [Line Items]
Commercial mortgage loans, amortized cost	207
2020 \| Greater than 2.00 \| Fixed Rate Commercial Mortgage Loans
Disclosure Of Commercial Mortgage Loans By Year Of Origination And Credit Quality Indicator [Line Items]
Commercial mortgage loans, amortized cost	200
2019 \| Fixed Rate Commercial Mortgage Loans
Disclosure Of Commercial Mortgage Loans By Year Of Origination And Credit Quality Indicator [Line Items]
Commercial mortgage loans, amortized cost	709
2019 \| 0% - 50% \| Fixed Rate Commercial Mortgage Loans
Disclosure Of Commercial Mortgage Loans By Year Of Origination And Credit Quality Indicator [Line Items]
Commercial mortgage loans, amortized cost	110
2019 \| 51% - 60% \| Fixed Rate Commercial Mortgage Loans
Disclosure Of Commercial Mortgage Loans By Year Of Origination And Credit Quality Indicator [Line Items]
Commercial mortgage loans, amortized cost	131
2019 \| 61% - 75% \| Fixed Rate Commercial Mortgage Loans
Disclosure Of Commercial Mortgage Loans By Year Of Origination And Credit Quality Indicator [Line Items]
Commercial mortgage loans, amortized cost	460
2019 \| 76% - 100% \| Fixed Rate Commercial Mortgage Loans
Disclosure Of Commercial Mortgage Loans By Year Of Origination And Credit Quality Indicator [Line Items]
Commercial mortgage loans, amortized cost	8
2019 \| Greater than 100% \| Fixed Rate Commercial Mortgage Loans
Disclosure Of Commercial Mortgage Loans By Year Of Origination And Credit Quality Indicator [Line Items]
Commercial mortgage loans, amortized cost	0
2019 \| Less than 1.00 \| Fixed Rate Commercial Mortgage Loans
Disclosure Of Commercial Mortgage Loans By Year Of Origination And Credit Quality Indicator [Line Items]
Commercial mortgage loans, amortized cost	47
2019 \| 1.00 - 1.25 \| Fixed Rate Commercial Mortgage Loans
Disclosure Of Commercial Mortgage Loans By Year Of Origination And Credit Quality Indicator [Line Items]
Commercial mortgage loans, amortized cost	19
2019 \| 1.26 - 1.50 \| Fixed Rate Commercial Mortgage Loans
Disclosure Of Commercial Mortgage Loans By Year Of Origination And Credit Quality Indicator [Line Items]
Commercial mortgage loans, amortized cost	163
2019 \| 1.51 - 2.00 \| Fixed Rate Commercial Mortgage Loans
Disclosure Of Commercial Mortgage Loans By Year Of Origination And Credit Quality Indicator [Line Items]
Commercial mortgage loans, amortized cost	270
2019 \| Greater than 2.00 \| Fixed Rate Commercial Mortgage Loans
Disclosure Of Commercial Mortgage Loans By Year Of Origination And Credit Quality Indicator [Line Items]
Commercial mortgage loans, amortized cost	210
2018 \| Fixed Rate Commercial Mortgage Loans
Disclosure Of Commercial Mortgage Loans By Year Of Origination And Credit Quality Indicator [Line Items]
Commercial mortgage loans, amortized cost	841
2018 \| 0% - 50% \| Fixed Rate Commercial Mortgage Loans
Disclosure Of Commercial Mortgage Loans By Year Of Origination And Credit Quality Indicator [Line Items]
Commercial mortgage loans, amortized cost	204
2018 \| 51% - 60% \| Fixed Rate Commercial Mortgage Loans
Disclosure Of Commercial Mortgage Loans By Year Of Origination And Credit Quality Indicator [Line Items]
Commercial mortgage loans, amortized cost	229
2018 \| 61% - 75% \| Fixed Rate Commercial Mortgage Loans
Disclosure Of Commercial Mortgage Loans By Year Of Origination And Credit Quality Indicator [Line Items]
Commercial mortgage loans, amortized cost	380
2018 \| 76% - 100% \| Fixed Rate Commercial Mortgage Loans
Disclosure Of Commercial Mortgage Loans By Year Of Origination And Credit Quality Indicator [Line Items]
Commercial mortgage loans, amortized cost	28
2018 \| Greater than 100% \| Fixed Rate Commercial Mortgage Loans
Disclosure Of Commercial Mortgage Loans By Year Of Origination And Credit Quality Indicator [Line Items]
Commercial mortgage loans, amortized cost	0
2018 \| Less than 1.00 \| Fixed Rate Commercial Mortgage Loans
Disclosure Of Commercial Mortgage Loans By Year Of Origination And Credit Quality Indicator [Line Items]
Commercial mortgage loans, amortized cost	58
2018 \| 1.00 - 1.25 \| Fixed Rate Commercial Mortgage Loans
Disclosure Of Commercial Mortgage Loans By Year Of Origination And Credit Quality Indicator [Line Items]
Commercial mortgage loans, amortized cost	94
2018 \| 1.26 - 1.50 \| Fixed Rate Commercial Mortgage Loans
Disclosure Of Commercial Mortgage Loans By Year Of Origination And Credit Quality Indicator [Line Items]
Commercial mortgage loans, amortized cost	140
2018 \| 1.51 - 2.00 \| Fixed Rate Commercial Mortgage Loans
Disclosure Of Commercial Mortgage Loans By Year Of Origination And Credit Quality Indicator [Line Items]
Commercial mortgage loans, amortized cost	348
2018 \| Greater than 2.00 \| Fixed Rate Commercial Mortgage Loans
Disclosure Of Commercial Mortgage Loans By Year Of Origination And Credit Quality Indicator [Line Items]
Commercial mortgage loans, amortized cost	201
2017 and prior \| Fixed Rate Commercial Mortgage Loans
Disclosure Of Commercial Mortgage Loans By Year Of Origination And Credit Quality Indicator [Line Items]
Commercial mortgage loans, amortized cost	3,113
2017 and prior \| 0% - 50% \| Fixed Rate Commercial Mortgage Loans
Disclosure Of Commercial Mortgage Loans By Year Of Origination And Credit Quality Indicator [Line Items]
Commercial mortgage loans, amortized cost	1,890
2017 and prior \| 51% - 60% \| Fixed Rate Commercial Mortgage Loans
Disclosure Of Commercial Mortgage Loans By Year Of Origination And Credit Quality Indicator [Line Items]
Commercial mortgage loans, amortized cost	764
2017 and prior \| 61% - 75% \| Fixed Rate Commercial Mortgage Loans
Disclosure Of Commercial Mortgage Loans By Year Of Origination And Credit Quality Indicator [Line Items]
Commercial mortgage loans, amortized cost	445
2017 and prior \| 76% - 100% \| Fixed Rate Commercial Mortgage Loans
Disclosure Of Commercial Mortgage Loans By Year Of Origination And Credit Quality Indicator [Line Items]
Commercial mortgage loans, amortized cost	14
2017 and prior \| Greater than 100% \| Fixed Rate Commercial Mortgage Loans
Disclosure Of Commercial Mortgage Loans By Year Of Origination And Credit Quality Indicator [Line Items]
Commercial mortgage loans, amortized cost	0
2017 and prior \| Less than 1.00 \| Fixed Rate Commercial Mortgage Loans
Disclosure Of Commercial Mortgage Loans By Year Of Origination And Credit Quality Indicator [Line Items]
Commercial mortgage loans, amortized cost	143
2017 and prior \| 1.00 - 1.25 \| Fixed Rate Commercial Mortgage Loans
Disclosure Of Commercial Mortgage Loans By Year Of Origination And Credit Quality Indicator [Line Items]
Commercial mortgage loans, amortized cost	125
2017 and prior \| 1.26 - 1.50 \| Fixed Rate Commercial Mortgage Loans
Disclosure Of Commercial Mortgage Loans By Year Of Origination And Credit Quality Indicator [Line Items]
Commercial mortgage loans, amortized cost	390
2017 and prior \| 1.51 - 2.00 \| Fixed Rate Commercial Mortgage Loans
Disclosure Of Commercial Mortgage Loans By Year Of Origination And Credit Quality Indicator [Line Items]
Commercial mortgage loans, amortized cost	1,066
2017 and prior \| Greater than 2.00 \| Fixed Rate Commercial Mortgage Loans
Disclosure Of Commercial Mortgage Loans By Year Of Origination And Credit Quality Indicator [Line Items]
Commercial mortgage loans, amortized cost	$ 1,389

Debt-to-Value of Commercial Mor

Debt-to-Value of Commercial Mortgage Loans by Property Type (Detail) $ in Millions	12 Months Ended
	Dec. 31, 2022 USD ($)	Dec. 31, 2021 USD ($)
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Commercial mortgage loans, amortized cost	$ 7,032	$ 6,856
Commercial mortgage loans, amortized cost	$ 7,032	$ 6,856
% of total	100%	100%
Weighted-average debt service coverage ratio	1.93	1.93
Retail
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Commercial mortgage loans, amortized cost	$ 2,916	$ 2,774
% of total	42%	40%
Industrial
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Commercial mortgage loans, amortized cost	$ 1,456	$ 1,420
% of total	21%	21%
Office
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Commercial mortgage loans, amortized cost	$ 1,579	$ 1,526
% of total	22%	22%
Apartments
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Commercial mortgage loans, amortized cost	$ 561	$ 585
% of total	8%	9%
Mixed Use
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Commercial mortgage loans, amortized cost	$ 371	$ 330
% of total	5%	5%
Other
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Commercial mortgage loans, amortized cost	$ 149	$ 221
% of total	2%	3%
0% - 50%
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Commercial mortgage loans, amortized cost	$ 2,385	$ 2,480
% of total	34%	36%
Weighted-average debt service coverage ratio	2.35	2.36
0% - 50% \| Retail
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Commercial mortgage loans, amortized cost	$ 907	$ 853
0% - 50% \| Industrial
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Commercial mortgage loans, amortized cost	668	745
0% - 50% \| Office
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Commercial mortgage loans, amortized cost	445	505
0% - 50% \| Apartments
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Commercial mortgage loans, amortized cost	184	200
0% - 50% \| Mixed Use
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Commercial mortgage loans, amortized cost	93	120
0% - 50% \| Other
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Commercial mortgage loans, amortized cost	88	57
51% - 60%
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Commercial mortgage loans, amortized cost	$ 1,342	$ 1,539
% of total	19%	23%
Weighted-average debt service coverage ratio	1.95	1.83
51% - 60% \| Retail
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Commercial mortgage loans, amortized cost	$ 649	$ 611
51% - 60% \| Industrial
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Commercial mortgage loans, amortized cost	243	240
51% - 60% \| Office
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Commercial mortgage loans, amortized cost	272	395
51% - 60% \| Apartments
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Commercial mortgage loans, amortized cost	90	102
51% - 60% \| Mixed Use
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Commercial mortgage loans, amortized cost	79	70
51% - 60% \| Other
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Commercial mortgage loans, amortized cost	9	121
61% - 75%
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Commercial mortgage loans, amortized cost	$ 3,255	$ 2,815
% of total	46%	41%
Weighted-average debt service coverage ratio	1.63	1.61
61% - 75% \| Retail
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Commercial mortgage loans, amortized cost	$ 1,332	$ 1,310
61% - 75% \| Industrial
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Commercial mortgage loans, amortized cost	545	435
61% - 75% \| Office
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Commercial mortgage loans, amortized cost	848	604
61% - 75% \| Apartments
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Commercial mortgage loans, amortized cost	279	283
61% - 75% \| Mixed Use
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Commercial mortgage loans, amortized cost	199	140
61% - 75% \| Other
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Commercial mortgage loans, amortized cost	52	43
76% - 100%
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Commercial mortgage loans, amortized cost	$ 50	$ 0
% of total	1%	0%
Weighted-average debt service coverage ratio	1.34	0
76% - 100% \| Retail
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Commercial mortgage loans, amortized cost	$ 28	$ 0
76% - 100% \| Industrial
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Commercial mortgage loans, amortized cost	0	0
76% - 100% \| Office
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Commercial mortgage loans, amortized cost	14	0
76% - 100% \| Apartments
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Commercial mortgage loans, amortized cost	8	0
76% - 100% \| Mixed Use
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Commercial mortgage loans, amortized cost	0	0
76% - 100% \| Other
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Commercial mortgage loans, amortized cost	0	0
Greater than 100%
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Commercial mortgage loans, amortized cost	$ 0	$ 22
% of total	0%	0%
Weighted-average debt service coverage ratio	0	0.68
Greater than 100% \| Retail
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Commercial mortgage loans, amortized cost	$ 0	$ 0
Greater than 100% \| Industrial
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Commercial mortgage loans, amortized cost	0	0
Greater than 100% \| Office
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Commercial mortgage loans, amortized cost	0	22
Greater than 100% \| Apartments
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Commercial mortgage loans, amortized cost	0	0
Greater than 100% \| Mixed Use
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Commercial mortgage loans, amortized cost	0	0
Greater than 100% \| Other
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Commercial mortgage loans, amortized cost	$ 0	$ 0

Debt Service Coverage Ratio for

Debt Service Coverage Ratio for Fixed Rate Commercial Mortgage Loans by Property Type (Detail) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Commercial mortgage loans, amortized cost	$ 7,032	$ 6,856
% of total	100%	100%
Fixed Rate Commercial Mortgage Loans
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Commercial mortgage loans, amortized cost	$ 7,032	$ 6,856
% of total	100%	100%
Weighted-average debt-to-value	56%	55%
Retail
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Commercial mortgage loans, amortized cost	$ 2,916	$ 2,774
% of total	42%	40%
Retail \| Fixed Rate Commercial Mortgage Loans
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Commercial mortgage loans, amortized cost	$ 2,916	$ 2,774
Industrial
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Commercial mortgage loans, amortized cost	$ 1,456	$ 1,420
% of total	21%	21%
Industrial \| Fixed Rate Commercial Mortgage Loans
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Commercial mortgage loans, amortized cost	$ 1,456	$ 1,420
Office
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Commercial mortgage loans, amortized cost	$ 1,579	$ 1,526
% of total	22%	22%
Office \| Fixed Rate Commercial Mortgage Loans
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Commercial mortgage loans, amortized cost	$ 1,579	$ 1,526
Apartments
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Commercial mortgage loans, amortized cost	$ 561	$ 585
% of total	8%	9%
Apartments \| Fixed Rate Commercial Mortgage Loans
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Commercial mortgage loans, amortized cost	$ 561	$ 585
Mixed Use
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Commercial mortgage loans, amortized cost	$ 371	$ 330
% of total	5%	5%
Mixed Use \| Fixed Rate Commercial Mortgage Loans
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Commercial mortgage loans, amortized cost	$ 371	$ 330
Other
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Commercial mortgage loans, amortized cost	$ 149	$ 221
% of total	2%	3%
Other \| Fixed Rate Commercial Mortgage Loans
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Commercial mortgage loans, amortized cost	$ 149	$ 221
Less than 1.00 \| Fixed Rate Commercial Mortgage Loans
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Commercial mortgage loans, amortized cost	$ 270	$ 223
% of total	4%	3%
Weighted-average debt-to-value	61%	68%
Less than 1.00 \| Retail \| Fixed Rate Commercial Mortgage Loans
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Commercial mortgage loans, amortized cost	$ 88	$ 102
Less than 1.00 \| Industrial \| Fixed Rate Commercial Mortgage Loans
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Commercial mortgage loans, amortized cost	20	9
Less than 1.00 \| Office \| Fixed Rate Commercial Mortgage Loans
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Commercial mortgage loans, amortized cost	81	67
Less than 1.00 \| Apartments \| Fixed Rate Commercial Mortgage Loans
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Commercial mortgage loans, amortized cost	14	17
Less than 1.00 \| Mixed Use \| Fixed Rate Commercial Mortgage Loans
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Commercial mortgage loans, amortized cost	25	24
Less than 1.00 \| Other \| Fixed Rate Commercial Mortgage Loans
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Commercial mortgage loans, amortized cost	42	4
1.00 - 1.25 \| Fixed Rate Commercial Mortgage Loans
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Commercial mortgage loans, amortized cost	$ 272	$ 559
% of total	4%	8%
Weighted-average debt-to-value	62%	61%
1.00 - 1.25 \| Retail \| Fixed Rate Commercial Mortgage Loans
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Commercial mortgage loans, amortized cost	$ 68	$ 166
1.00 - 1.25 \| Industrial \| Fixed Rate Commercial Mortgage Loans
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Commercial mortgage loans, amortized cost	44	64
1.00 - 1.25 \| Office \| Fixed Rate Commercial Mortgage Loans
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Commercial mortgage loans, amortized cost	131	109
1.00 - 1.25 \| Apartments \| Fixed Rate Commercial Mortgage Loans
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Commercial mortgage loans, amortized cost	11	62
1.00 - 1.25 \| Mixed Use \| Fixed Rate Commercial Mortgage Loans
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Commercial mortgage loans, amortized cost	16	32
1.00 - 1.25 \| Other \| Fixed Rate Commercial Mortgage Loans
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Commercial mortgage loans, amortized cost	2	126
1.26 - 1.50 \| Fixed Rate Commercial Mortgage Loans
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Commercial mortgage loans, amortized cost	$ 1,118	$ 791
% of total	16%	12%
Weighted-average debt-to-value	63%	61%
1.26 - 1.50 \| Retail \| Fixed Rate Commercial Mortgage Loans
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Commercial mortgage loans, amortized cost	$ 560	$ 405
1.26 - 1.50 \| Industrial \| Fixed Rate Commercial Mortgage Loans
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Commercial mortgage loans, amortized cost	194	82
1.26 - 1.50 \| Office \| Fixed Rate Commercial Mortgage Loans
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Commercial mortgage loans, amortized cost	155	167
1.26 - 1.50 \| Apartments \| Fixed Rate Commercial Mortgage Loans
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Commercial mortgage loans, amortized cost	150	84
1.26 - 1.50 \| Mixed Use \| Fixed Rate Commercial Mortgage Loans
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Commercial mortgage loans, amortized cost	50	40
1.26 - 1.50 \| Other \| Fixed Rate Commercial Mortgage Loans
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Commercial mortgage loans, amortized cost	9	13
1.51 - 2.00 \| Fixed Rate Commercial Mortgage Loans
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Commercial mortgage loans, amortized cost	$ 3,085	$ 2,958
% of total	44%	43%
Weighted-average debt-to-value	60%	60%
1.51 - 2.00 \| Retail \| Fixed Rate Commercial Mortgage Loans
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Commercial mortgage loans, amortized cost	$ 1,380	$ 1,375
1.51 - 2.00 \| Industrial \| Fixed Rate Commercial Mortgage Loans
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Commercial mortgage loans, amortized cost	574	599
1.51 - 2.00 \| Office \| Fixed Rate Commercial Mortgage Loans
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Commercial mortgage loans, amortized cost	666	593
1.51 - 2.00 \| Apartments \| Fixed Rate Commercial Mortgage Loans
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Commercial mortgage loans, amortized cost	242	225
1.51 - 2.00 \| Mixed Use \| Fixed Rate Commercial Mortgage Loans
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Commercial mortgage loans, amortized cost	190	118
1.51 - 2.00 \| Other \| Fixed Rate Commercial Mortgage Loans
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Commercial mortgage loans, amortized cost	33	48
Greater than 2.00 \| Fixed Rate Commercial Mortgage Loans
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Commercial mortgage loans, amortized cost	$ 2,287	$ 2,325
% of total	32%	34%
Weighted-average debt-to-value	44%	43%
Greater than 2.00 \| Retail \| Fixed Rate Commercial Mortgage Loans
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Commercial mortgage loans, amortized cost	$ 820	$ 726
Greater than 2.00 \| Industrial \| Fixed Rate Commercial Mortgage Loans
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Commercial mortgage loans, amortized cost	624	666
Greater than 2.00 \| Office \| Fixed Rate Commercial Mortgage Loans
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Commercial mortgage loans, amortized cost	546	590
Greater than 2.00 \| Apartments \| Fixed Rate Commercial Mortgage Loans
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Commercial mortgage loans, amortized cost	144	197
Greater than 2.00 \| Mixed Use \| Fixed Rate Commercial Mortgage Loans
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Commercial mortgage loans, amortized cost	90	116
Greater than 2.00 \| Other \| Fixed Rate Commercial Mortgage Loans
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Commercial mortgage loans, amortized cost	$ 63	$ 30

Schedule of Positions in Deriva

Schedule of Positions in Derivative Instruments (Detail) - USD ($) $ in Millions		Dec. 31, 2022	Dec. 31, 2021
Derivative [Line Items]
Derivative assets, fair value		$ 66	$ 433
Derivative liabilities, fair value		962	616
Policyholder account balances
Derivative [Line Items]
Derivative liabilities, fair value		440	590
Other liabilities
Derivative [Line Items]
Derivative liabilities, fair value		522	26
Other invested assets
Derivative [Line Items]
Derivative assets, fair value		50	414
Interest rate swaps \| Other liabilities
Derivative [Line Items]
Derivative liabilities, fair value		522	26
Interest rate swaps \| Other invested assets
Derivative [Line Items]
Derivative assets, fair value		24	364
Foreign currency swaps \| Other invested assets
Derivative [Line Items]
Derivative assets, fair value		20	6
Equity index options \| Other invested assets
Derivative [Line Items]
Derivative assets, fair value		6	42
Other foreign currency contracts \| Other invested assets
Derivative [Line Items]
Derivative assets, fair value			2
GMWB embedded derivatives \| Policyholder account balances
Derivative [Line Items]
Derivative liabilities, fair value	[1]	223	271
GMWB embedded derivatives \| Reinsurance recoverable
Derivative [Line Items]
Derivative assets, fair value	[2]	16	19
Fixed index annuity embedded derivatives \| Policyholder account balances
Derivative [Line Items]
Derivative liabilities, fair value		202	294
Indexed universal life embedded derivatives \| Policyholder account balances
Derivative [Line Items]
Derivative liabilities, fair value		15	25
Designated As Hedging Instrument
Derivative [Line Items]
Derivative assets, fair value		44	370
Derivative liabilities, fair value		522	26
Designated As Hedging Instrument \| Cash Flow Hedges
Derivative [Line Items]
Derivative assets, fair value		44	370
Derivative liabilities, fair value		522	26
Designated As Hedging Instrument \| Cash Flow Hedges \| Interest rate swaps \| Other liabilities
Derivative [Line Items]
Derivative liabilities, fair value		522	26
Designated As Hedging Instrument \| Cash Flow Hedges \| Interest rate swaps \| Other invested assets
Derivative [Line Items]
Derivative assets, fair value		24	364
Designated As Hedging Instrument \| Cash Flow Hedges \| Foreign currency swaps \| Other liabilities
Derivative [Line Items]
Derivative liabilities, fair value		0	0
Designated As Hedging Instrument \| Cash Flow Hedges \| Foreign currency swaps \| Other invested assets
Derivative [Line Items]
Derivative assets, fair value		20	6
Derivatives not designated as hedges
Derivative [Line Items]
Derivative assets, fair value		22	63
Derivative liabilities, fair value		440	590
Derivatives not designated as hedges \| Equity index options \| Other liabilities
Derivative [Line Items]
Derivative liabilities, fair value		0	0
Derivatives not designated as hedges \| Equity index options \| Other invested assets
Derivative [Line Items]
Derivative assets, fair value		6	42
Derivatives not designated as hedges \| Financial futures \| Other liabilities
Derivative [Line Items]
Derivative liabilities, fair value		0	0
Derivatives not designated as hedges \| Financial futures \| Other invested assets
Derivative [Line Items]
Derivative assets, fair value		0	0
Derivatives not designated as hedges \| Other foreign currency contracts \| Other liabilities
Derivative [Line Items]
Derivative liabilities, fair value		0	0
Derivatives not designated as hedges \| Other foreign currency contracts \| Other invested assets
Derivative [Line Items]
Derivative assets, fair value		0	2
Derivatives not designated as hedges \| GMWB embedded derivatives \| Policyholder account balances
Derivative [Line Items]
Derivative liabilities, fair value	[3]	223	271
Derivatives not designated as hedges \| GMWB embedded derivatives \| Reinsurance recoverable
Derivative [Line Items]
Derivative assets, fair value	[2]	16	19
Derivatives not designated as hedges \| Fixed index annuity embedded derivatives \| Policyholder account balances
Derivative [Line Items]
Derivative liabilities, fair value	[4]	202	294
Derivatives not designated as hedges \| Fixed index annuity embedded derivatives \| Other assets
Derivative [Line Items]
Derivative assets, fair value		0	0
Derivatives not designated as hedges \| Indexed universal life embedded derivatives \| Policyholder account balances
Derivative [Line Items]
Derivative liabilities, fair value	[5]	15	25
Derivatives not designated as hedges \| Indexed universal life embedded derivatives \| Reinsurance recoverable
Derivative [Line Items]
Derivative assets, fair value		$ 0	$ 0

[1]Represents embedded derivatives associated with our GMWB liabilities, excluding the impact of reinsurance.[2]Represents embedded derivatives associated with the reinsured portion of our GMWB liabilities.[3]Represents the embedded derivatives associated with our GMWB liabilities, excluding the impact of reinsurance.[4]Represents the embedded derivatives associated with our fixed index annuity liabilities.[5]Represents the embedded derivatives associated with our indexed universal life liabilities.

Activity Associated with Deriva

Activity Associated with Derivative Instruments (Detail) $ in Millions	12 Months Ended
	Dec. 31, 2022 USD ($) Policies
Derivative [Line Items]
Notional amount, beginning balance	$ 10,255
Additions	6,477
Maturities/ terminations	(5,707)
Notional amount, ending balance	11,025
Designated As Hedging Instrument
Derivative [Line Items]
Notional amount, beginning balance	7,780
Additions	1,126
Maturities/ terminations	(220)
Notional amount, ending balance	8,686
Designated As Hedging Instrument \| Cash Flow Hedges
Derivative [Line Items]
Notional amount, beginning balance	7,780
Additions	1,126
Maturities/ terminations	(220)
Notional amount, ending balance	8,686
Designated As Hedging Instrument \| Cash Flow Hedges \| Interest rate swaps
Derivative [Line Items]
Notional amount, beginning balance	7,653
Additions	1,109
Maturities/ terminations	(220)
Notional amount, ending balance	8,542
Designated As Hedging Instrument \| Cash Flow Hedges \| Foreign currency swaps
Derivative [Line Items]
Notional amount, beginning balance	127
Additions	17
Maturities/ terminations	0
Notional amount, ending balance	144
Derivatives not designated as hedges
Derivative [Line Items]
Notional amount, beginning balance	2,475
Additions	5,351
Maturities/ terminations	(5,487)
Notional amount, ending balance	2,339
Derivatives not designated as hedges \| Equity index options
Derivative [Line Items]
Notional amount, beginning balance	1,446
Additions	946
Maturities/ terminations	(1,456)
Notional amount, ending balance	936
Derivatives not designated as hedges \| Financial futures
Derivative [Line Items]
Notional amount, beginning balance	946
Additions	4,405
Maturities/ terminations	(3,948)
Notional amount, ending balance	1,403
Derivatives not designated as hedges \| Other foreign currency contracts
Derivative [Line Items]
Notional amount, beginning balance	83
Additions	0
Maturities/ terminations	(83)
Notional amount, ending balance	$ 0
Derivatives not designated as hedges \| GMWB embedded derivatives
Derivative [Line Items]
Notional amount, beginning balance \| Policies	21,804
Additions \| Policies	0
Maturities/ terminations \| Policies	(1,876)
Notional amount, ending balance \| Policies	19,928
Derivatives not designated as hedges \| Fixed index annuity embedded derivatives
Derivative [Line Items]
Notional amount, beginning balance \| Policies	9,344
Additions \| Policies	0
Maturities/ terminations \| Policies	(2,029)
Notional amount, ending balance \| Policies	7,315
Derivatives not designated as hedges \| Indexed universal life embedded derivatives
Derivative [Line Items]
Notional amount, beginning balance \| Policies	806
Additions \| Policies	0
Maturities/ terminations \| Policies	(35)
Notional amount, ending balance \| Policies	771

Schedule of Pre-Tax Income (Los

Schedule of Pre-Tax Income (Loss) Effects of Cash Flow Hedges (Detail) - Cash Flow Hedges - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Gain (loss) recognized in OCI	$ (839)	$ (57)	$ 439
Gain (loss) reclassified into net income from OCI	231	217	208
Gain (loss) recognized in net income (loss)	0	0	0
Interest Rate Swaps Hedging Assets \| Net Investment Income
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Gain (loss) recognized in OCI	(854)	(100)	482
Gain (loss) reclassified into net income from OCI	225	217	196
Interest Rate Swaps Hedging Assets \| Net Investment Gains (Losses)
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Gain (loss) recognized in OCI	0	0	0
Gain (loss) reclassified into net income from OCI	9	1	12
Gain (loss) recognized in net income (loss)	0	0	0
Interest Rate Swaps Hedging Liabilities \| Interest Expense
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Gain (loss) recognized in OCI	0	36	(38)
Gain (loss) reclassified into net income from OCI	(3)	(1)	0
Interest Rate Swaps Hedging Liabilities \| Net Investment Gains (Losses)
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Gain (loss) recognized in net income (loss)	0	0	0
Foreign currency swaps \| Net Investment Income
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Gain (loss) recognized in OCI	15	7	(5)
Gain (loss) reclassified into net income from OCI	0	0	0
Foreign currency swaps \| Net Investment Gains (Losses)
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Gain (loss) recognized in net income (loss)	$ 0	$ 0	$ 0

Reconciliation of Current Perio

Reconciliation of Current Period Changes, Net of Applicable Income Taxes, for Derivatives Qualifying as Hedges (Detail) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Derivative Instruments [Abstract]
Derivatives qualifying as effective accounting hedges as of January 1	$ 2,025	$ 2,211	$ 2,002
Current period increases (decreases) in fair value, net of deferred taxes of $165, $12 and $(95)	(674)	(45)	344
Reclassification to net (income), net of deferred taxes of $80, $76 and $73	(151)	(141)	(135)
Derivatives qualifying as effective accounting hedges as of December 31	$ 1,200	$ 2,025	$ 2,211

Reconciliation of Current Per_2

Reconciliation of Current Period Changes, Net of Applicable Income Taxes, for Derivatives Qualifying as Hedges (Parenthetical) (Detail) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Current period increases (decreases) in fair value, deferred taxes	$ 165	$ 12	$ (95)
Reclassification to net (income), deferred taxes	$ 80	$ 76	$ 73

Derivative Instruments - Additi

Derivative Instruments - Additional Information (Detail) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Derivative [Line Items]
Derivatives designated as cash flow hedges gain (loss), amount expected to be reclassified to future net income (loss), net of tax	$ 1,200	$ 2,025	$ 2,211	$ 2,002
Year by which all forecasted transactions associated with qualifying cash flow hedges are expected to occur	2057
Derivatives designated as cash flow hedges gain (loss), amount expected to be reclassified to net income in the next 12 months, net of tax	$ 143
Amount reclassified to net income in connection with forecasted transactions that were no longer considered probable of occurring	$ 11	$ 10	$ 15

Schedule of Pre-Tax Gain (Loss)

Schedule of Pre-Tax Gain (Loss) Recognized in Net Income (Loss) for Effects of Derivatives not Designated as Hedges (Detail) - Derivatives not designated as hedges - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Derivative [Line Items]
Pre-tax gain (loss) recognized in net income	$ 8	$ 13	$ (61)
Interest rate swaps \| Net Investment Gains (Losses)
Derivative [Line Items]
Pre-tax gain (loss) recognized in net income	0	2	(11)
Equity index options \| Net Investment Gains (Losses)
Derivative [Line Items]
Pre-tax gain (loss) recognized in net income	(20)	18	4
Financial futures \| Net Investment Gains (Losses)
Derivative [Line Items]
Pre-tax gain (loss) recognized in net income	(81)	(123)	2
Other foreign currency contracts \| Net Investment Gains (Losses)
Derivative [Line Items]
Pre-tax gain (loss) recognized in net income	0	0	6
GMWB embedded derivatives \| Net Investment Gains (Losses)
Derivative [Line Items]
Pre-tax gain (loss) recognized in net income	66	124	(28)
Fixed index annuity embedded derivatives \| Net Investment Gains (Losses)
Derivative [Line Items]
Pre-tax gain (loss) recognized in net income	16	(32)	(51)
Indexed universal life embedded derivatives \| Net Investment Gains (Losses)
Derivative [Line Items]
Pre-tax gain (loss) recognized in net income	$ 27	$ 24	$ 17

Additional Information about De

Additional Information about Derivative Assets and Liabilities Subject to Enforceable Master Netting Arrangement (Detail) - USD ($) $ in Millions		Dec. 31, 2022	Dec. 31, 2021
Derivative [Line Items]
Gross amounts recognized, derivatives assets		$ 66	$ 433
Gross amounts recognized, derivatives liabilities		962	616
Subject to enforceable master netting arrangement
Derivative [Line Items]
Gross amounts recognized, net derivatives		(472)	388
Gross amounts offset in the balance sheet, net derivatives		0	0
Net amounts presented in the balance sheet, net derivatives		(472)	388
Gross amounts not offset in the balance sheet, financial instruments, net derivatives	[1],[2]	0	0
Collateral received		(21)	(308)
Collateral pledged		1,095	536
Over collateralization, net derivatives		(598)	(528)
Net amount		4	88
Subject to enforceable master netting arrangement \| Derivative assets
Derivative [Line Items]
Gross amounts recognized, derivatives assets	[2]	50	414
Gross amounts offset in the balance sheet, derivatives assets	[2]	0	0
Net amounts presented in the balance sheet, derivatives assets	[2]	50	414
Gross amounts not offset in the balance sheet, financial instruments, derivatives assets	[1],[2]	(25)	(20)
Collateral received	[2]	(21)	(308)
Collateral pledged	[2]	0	0
Over collateralization, derivatives assets	[2]	0	2
Net amount, derivatives assets	[2]	4	88
Subject to enforceable master netting arrangement \| Derivative liabilities
Derivative [Line Items]
Gross amounts recognized, derivatives liabilities	[2]	522	26
Gross amounts offset in the balance sheet, derivatives liabilities	[2]	0	0
Net amounts presented in the balance sheet, derivatives liabilities	[2]	522	26
Gross amounts not offset in the balance sheet, financial instruments, derivative liabilities	[1],[2]	(25)	(20)
Collateral received	[2]	0	0
Collateral pledged	[2]	(1,095)	(536)
Over collateralization, derivatives liabilities	[2]	598	530
Net amount, derivatives liabilities	[2]	$ 0	$ 0

[1]Amounts represent derivative assets and/or liabilities that are presented gross within the balance sheet but are held with the same counterparty where we have a master netting arrangement. This adjustment results in presenting the net asset and net liability position for each counterparty.[2]Does not include amounts related to embedded derivatives as of December 31, 2022 and 2021.

Activity Impacting Deferred Acq

Activity Impacting Deferred Acquisition Costs (Detail) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Deferred Policy Acquisition Costs [Line Items]
Unamortized beginning balance	$ 2,438	$ 2,809	$ 3,243
Costs deferred	0	8	3
Amortization, net of interest accretion	(278)	(379)	(437)
Unamortized ending balance	2,160	2,438	2,809
Accumulated effect of net unrealized investment (gains) losses	40	(1,292)	(1,322)
Ending balance	$ 2,200	$ 1,146	$ 1,487

Deferred Acquisition Costs - Ad

Deferred Acquisition Costs - Additional Information (Detail) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Deferred Policy Acquisition Costs [Line Items]
Deferred Policy acquisition costs amortization	$ 278	$ 379	$ 437
Accumulated effect of net unrealized investment (gains) losses	40	(1,292)	(1,322)
Universal and term universal life insurance contracts \| Unlocking
Deferred Policy Acquisition Costs [Line Items]
Deferred policy acquisition costs, impairment loss	52	117	63
Deferred Policy acquisition costs amortization			48
Shadow accounting adjustment
Deferred Policy Acquisition Costs [Line Items]
Accumulated effect of net unrealized investment (gains) losses	$ 40	$ (1,292)	$ (1,322)

Intangible Assets (Detail)

Intangible Assets (Detail) - USD ($) $ in Millions	Dec. 31, 2022	Dec. 31, 2021
Finite-Lived Intangible Assets [Line Items]
Gross carrying amount	$ 3,111	$ 2,984
Accumulated amortization	(2,870)	(2,841)
Present Value of Future Profits
Finite-Lived Intangible Assets [Line Items]
Gross carrying amount	2,146	2,065
Accumulated amortization	(1,989)	(1,994)
Capitalized Software
Finite-Lived Intangible Assets [Line Items]
Gross carrying amount	482	465
Accumulated amortization	(427)	(403)
Deferred Sales Inducements To Contractholders
Finite-Lived Intangible Assets [Line Items]
Gross carrying amount	325	295
Accumulated amortization	(298)	(288)
Other Intangible Assets
Finite-Lived Intangible Assets [Line Items]
Gross carrying amount	158	159
Accumulated amortization	$ (156)	$ (156)

Intangible Assets - Additional

Intangible Assets - Additional Information (Detail) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Finite-Lived Intangible Assets [Line Items]
Amortization expense related to PVFP, capitalized software and other intangible assets	$ 19	$ 30	$ 26
Amortization expense related to deferred sales inducements	$ 10	$ 14	$ 16

Activity in Present Value of Fu

Activity in Present Value of Future Profits (Detail) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Finite-Lived Intangible Assets [Line Items]
Unamortized balance as of January 1	$ 152	$ 154	$ 154
Interest accreted at 5.18%, 5.23% and 5.19%	8	8	8
Amortization	(3)	(10)	(8)
Unamortized balance as of December 31	157	152	154
Accumulated effect of net unrealized investment (gains) losses	0	(81)	(81)
Balance as of December 31	$ 157	$ 71	$ 73

Activity in Present Value of _2

Activity in Present Value of Future Profits (Parenthetical) (Detail)	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Finite-Lived Intangible Assets [Line Items]
Interest accreted percentage	5.18%	5.23%	5.19%

Percentage of PVFP Balance Net

Percentage of PVFP Balance Net of Interest Accretion, before Effect of Unrealized Investment Gains or Losses, Estimated to be Amortized Over Next Five years (Detail)	Dec. 31, 2022
Finite-Lived Intangible Assets [Line Items]
2023	10.30%
2024	10.30%
2025	10.20%
2026	10.10%
2027	10.10%

Reinsurance - Additional Inform

Reinsurance - Additional Information (Detail) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Reinsurance Premiums for Insurance Companies, by Product Segment [Line Items]
Maximum amount of individual ordinary life insurance normally retained by us on any one individual life policy	$ 5
Reinsurance recoverable	16,435	$ 16,813
Reinsurance recoveries recognized as a reduction of benefits and other changes in reserves	2,537	2,850	$ 2,649
Reinsurance Recoverable, Past Due	16,495	16,868
U.S. Life Insurance Subsidiaries \| Fixed maturity securities
Reinsurance Premiums for Insurance Companies, by Product Segment [Line Items]
Assets pledged as collateral	10,218	13,123
U.S. Life Insurance Subsidiaries \| Commercial Mortgage Loan
Reinsurance Premiums for Insurance Companies, by Product Segment [Line Items]
Assets pledged as collateral	576	810
Scottish Re Group Limited [Member]
Reinsurance Premiums for Insurance Companies, by Product Segment [Line Items]
Reinsurance Recoverable, Past Due	52	40
Enact Holdings Inc [Member] \| Mortgage Insurance Policy [Member]
Reinsurance Premiums for Insurance Companies, by Product Segment [Line Items]
Excess of Loss Coverage	$ 325
Reinsurance coverage in excess of retention		1,170
Reinsurance treaty period	10 years
Enact Holdings Inc [Member] \| New Insurance Policy [Member]
Reinsurance Premiums for Insurance Companies, by Product Segment [Line Items]
Excess of Loss Coverage	$ 422	210
Union Fidelity Life Insurance Company \| Ceded Credit Risk
Reinsurance Premiums for Insurance Companies, by Product Segment [Line Items]
Reinsurance recoverable	$ 12,686	$ 13,095
Minimum amount of risk-based capital General Electric Company agreed to maintain in UFLIC	150%

Net Domestic Life Insurance In-

Net Domestic Life Insurance In-Force (Detail) - USD ($) $ in Millions		Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Reinsurance [Abstract]
Direct life insurance in-force		$ 430,151	$ 471,147	$ 509,670
Amounts assumed from other companies		527	573	624
Amounts ceded to other companies	[1]	(383,350)	(427,464)	(458,999)
Net life insurance in-force		$ 47,328	$ 44,256	$ 51,295
Percentage of amount assumed to net		1%	1%	1%

[1]Includes amounts accounted for under the deposit method.

Effects of Reinsurance on Premi

Effects of Reinsurance on Premiums Written and Earned (Detail) - USD ($) $ in Millions			12 Months Ended
		Dec. 01, 2021	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Reinsurance [Abstract]
Direct, Written			$ 4,463	$ 4,561	$ 4,578
Assumed, Written			296	305	317
Ceded, Written			(1,116)	(1,526)	(1,157)
Net premiums, Written			3,643	3,340	3,738
Direct, Earned			4,547	4,659	4,678
Assumed, Earned			299	309	328
Ceded, Earned		$ (360)	(1,127)	(1,533)	(1,170)
Net premiums, Earned			$ 3,719	$ 3,435	$ 3,836
Percentage of amount assumed to net			8%	9%	9%
Life insurance
Reinsurance [Abstract]
Direct, Written			$ 738	$ 774	$ 795
Assumed, Written			1	2	1
Ceded, Written	[1]		(505)	(913)	(558)
Direct, Earned			738	775	795
Assumed, Earned			1	2	2
Ceded, Earned	[1]		(505)	(913)	(559)
Accident and Health Insurance Product Line
Reinsurance [Abstract]
Direct, Written	[2]		2,746	2,797	2,836
Assumed, Written	[2]		292	300	313
Ceded, Written	[2]		(531)	(541)	(550)
Direct, Earned	[2]		2,786	2,834	2,860
Assumed, Earned	[2]		295	304	322
Ceded, Earned	[2]		(542)	(548)	(562)
Mortgage insurance
Reinsurance [Abstract]
Direct, Written			979	990	947
Assumed, Written			3	3	3
Ceded, Written			(80)	(72)	(49)
Direct, Earned			1,023	1,050	1,023
Assumed, Earned			3	3	4
Ceded, Earned			$ (80)	$ (72)	$ (49)

[1]Effective December 1, 2021 and included in the year ended December 31, 2021, we entered into a reinsurance agreement with SCOR Global Life USA Reinsurance Company, under which we ceded premiums of $360 million associated with certain term life insurance policies in connection with a life block transaction.[2]Accident and health insurance is comprised almost entirely of our long-term care insurance products.

Effects of Reinsurance on Pre_2

Effects of Reinsurance on Premiums Written and Earned (Parenthetical) (Detail) - USD ($) $ in Millions		12 Months Ended
	Dec. 01, 2021	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Policyholders Account In Life Insurance Business [Abstract]
Ceded Premiums Under New Reinsurance Treaty	$ 360	$ 1,127	$ 1,533	$ 1,170

Reinsurance - Schedule of Reins

Reinsurance - Schedule of Reinsurance Recoverable in Allowance for Credit Losses (Detail) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Beginning balance	$ 55	$ 45	$ 0
Cumulative effect of change in accounting	0	0	40
Provision	5	10	5
Write-offs	0	0	0
Recoveries	0	0	0
Ending balance	$ 60	$ 55	$ 45

Reinsurance - Schedule Of Credi

Reinsurance - Schedule Of Credit Ratings on Reinsurance Recoverable (Detail) - USD ($) $ in Millions	Dec. 31, 2022	Dec. 31, 2021
Reinsurance recoverable	$ 16,495	$ 16,868
A++
Reinsurance recoverable	570	543
A+
Reinsurance recoverable	3,105	3,091
A
Reinsurance recoverable	44	59
Non rated
Reinsurance recoverable	12,776	13,175
Collateralized
Reinsurance recoverable	13,992	14,698
Collateralized \| A++
Reinsurance recoverable	0	0
Collateralized \| A+
Reinsurance recoverable	1,286	1,581
Collateralized \| A
Reinsurance recoverable	19	18
Collateralized \| Non rated
Reinsurance recoverable	12,687	13,099
Non-collateralized
Reinsurance recoverable	2,503	2,170
Non-collateralized \| A++
Reinsurance recoverable	570	543
Non-collateralized \| A+
Reinsurance recoverable	1,819	1,510
Non-collateralized \| A
Reinsurance recoverable	25	41
Non-collateralized \| Non rated
Reinsurance recoverable	$ 89	$ 76

Recorded Liabilities and Major

Recorded Liabilities and Major Assumptions Underlying Future Policy Benefits (Detail) - USD ($) $ in Millions		Dec. 31, 2022	Dec. 31, 2021
Liability for Future Policy Benefit, by Product Segment [Line Items]
Future policy benefits		$ 38,064	$ 41,528
Long Term Care Insurance Contracts
Liability for Future Policy Benefit, by Product Segment [Line Items]
Future policy benefits	[1]	$ 26,209	28,232
Long Term Care Insurance Contracts \| Minimum
Liability for Future Policy Benefit, by Product Segment [Line Items]
Future policy benefits, Interest rate assumption	[1]	3.75%
Long Term Care Insurance Contracts \| Maximum
Liability for Future Policy Benefit, by Product Segment [Line Items]
Future policy benefits, Interest rate assumption	[1]	7.50%
Structured Settlements with Life Contingencies
Liability for Future Policy Benefit, by Product Segment [Line Items]
Future policy benefits	[2]	$ 7,900	8,075
Structured Settlements with Life Contingencies \| Minimum
Liability for Future Policy Benefit, by Product Segment [Line Items]
Future policy benefits, Interest rate assumption	[2]	1%
Structured Settlements with Life Contingencies \| Maximum
Liability for Future Policy Benefit, by Product Segment [Line Items]
Future policy benefits, Interest rate assumption	[2]	8%
Annuity Contracts with Life Contingencies
Liability for Future Policy Benefit, by Product Segment [Line Items]
Future policy benefits	[2]	$ 1,754	2,934
Annuity Contracts with Life Contingencies \| Minimum
Liability for Future Policy Benefit, by Product Segment [Line Items]
Future policy benefits, Interest rate assumption	[2]	1%
Annuity Contracts with Life Contingencies \| Maximum
Liability for Future Policy Benefit, by Product Segment [Line Items]
Future policy benefits, Interest rate assumption	[2]	8%
Traditional Life Insurance Contracts
Liability for Future Policy Benefit, by Product Segment [Line Items]
Future policy benefits	[3]	$ 1,872	1,956
Traditional Life Insurance Contracts \| Minimum
Liability for Future Policy Benefit, by Product Segment [Line Items]
Future policy benefits, Interest rate assumption	[3]	3%
Traditional Life Insurance Contracts \| Maximum
Liability for Future Policy Benefit, by Product Segment [Line Items]
Future policy benefits, Interest rate assumption	[3]	7.50%
Supplementary Contracts with Life Contingencies
Liability for Future Policy Benefit, by Product Segment [Line Items]
Future policy benefits	[2]	$ 329	$ 331
Supplementary Contracts with Life Contingencies \| Minimum
Liability for Future Policy Benefit, by Product Segment [Line Items]
Future policy benefits, Interest rate assumption	[2]	1%
Supplementary Contracts with Life Contingencies \| Maximum
Liability for Future Policy Benefit, by Product Segment [Line Items]
Future policy benefits, Interest rate assumption	[2]	8%

[1]The 1983 Individual Annuitant Mortality Table or the 2000 U.S. Annuity Table, or the 1983 Group Annuitant Mortality Table or the 1994 Group Annuitant Mortality Table and company experience.[2]Assumptions for limited-payment contracts come from either the U.S. Population Table, the 1983 Group Annuitant Mortality Table, the 1983 Individual Annuitant Mortality Table, the Annuity 2000 Mortality Table or the 2012 Individual Annuity Reserving Table.[3]Principally modifications based on company experience of the Society of Actuaries 1965-70 or 1975-80 Select and the Ultimate Tables, the 1941, 1958, 1980 and 2001 Commissioner’s Standard Ordinary Tables, the 1980 Commissioner’s Extended Term table and (IA) Standard Table 1996 (modified).

Insurance Reserves - Additional

Insurance Reserves - Additional Information (Detail) - USD ($) $ in Millions	3 Months Ended		12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Insurance Reserves [Line Items]
Future policy benefit reserves	$ 38,064	$ 41,528	$ 38,064	$ 41,528
Policyholder account values	17,113	19,354	17,113	19,354
Shadow accounting adjustment
Insurance Reserves [Line Items]
Future policy benefit reserves		3,200		3,200
Immediate Fixed Annuity \| Loss Recognition Testing
Insurance Reserves [Line Items]
Increase in future policy benefit reserves			0	0	$ 0
Universal and term universal life insurance contracts \| Shadow accounting adjustment
Insurance Reserves [Line Items]
Policyholder account values		900		900
Profits Followed By Losses \| Long-term Care Insurance
Insurance Reserves [Line Items]
Future policy benefit reserves	1,700	1,300	1,700	1,300
Long-term care insurance future policy benefit reserves present value of expected losses	$ 2,300	$ 2,500	$ 2,300	$ 2,500
Percentage of profits to be accrued to reserves	79%	76%	79%	76%
Unlocking \| Universal and term universal life insurance contracts
Insurance Reserves [Line Items]
Increase (decrease) in liability for policyholder account balances	$ (37)	$ 87
Federal Home Loan Bank
Insurance Reserves [Line Items]
Federal Home Loan Bank common stock held	25	28	$ 25	$ 28
Amount of funding agreements issued to the Federal Home Loan Bank	200	250	200	250
Pledged assets for Federal Home Loan Bank at fair value	520	907	520	907
Variable Annuity \| Nontraditional Long-Duration Contracts
Insurance Reserves [Line Items]
Nontraditional long-duration contracts liability	3,397	4,492	3,397	4,492
Guaranteed Minimum Death Benefit \| Nontraditional Long-Duration Contracts \| Annuity contracts
Insurance Reserves [Line Items]
Nontraditional long-duration contracts liability	137	135	137	135
Guaranteed Minimum Withdrawal And Guaranteed Annuitization Benefit Contracts
Insurance Reserves [Line Items]
Guaranteed annuitization benefit contracts	$ 860	$ 602	$ 860	$ 602

Recorded Liabilities for Policy

Recorded Liabilities for Policyholder Account Balances (Detail) - USD ($) $ in Millions	Dec. 31, 2022	Dec. 31, 2021
Insurance Reserves [Line Items]
Policyholder account balances	$ 17,113	$ 19,354
Investment contracts
Insurance Reserves [Line Items]
Policyholder account balances	7,294	8,657
Investment contracts \| Annuity contracts
Insurance Reserves [Line Items]
Policyholder account balances	5,652	6,816
Investment contracts \| Funding agreements
Insurance Reserves [Line Items]
Policyholder account balances	200	250
Investment contracts \| Structured settlements without life contingencies
Insurance Reserves [Line Items]
Policyholder account balances	930	1,027
Investment contracts \| Supplementary contracts without life contingencies
Insurance Reserves [Line Items]
Policyholder account balances	499	550
Investment contracts \| Other
Insurance Reserves [Line Items]
Policyholder account balances	13	14
Universal and term universal life insurance contract
Insurance Reserves [Line Items]
Policyholder account balances	$ 9,819	$ 10,697

Information about Variable Annu

Information about Variable Annuity Products with Death and Living Benefit Guarantees (Detail) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Guaranteed minimum standard death benefit
Net Amount at Risk by Product and Guarantee [Line Items]
Death benefits account value	$ 1,878	$ 2,547
Net amount at risk	$ 2	$ 1
Average attained age of contractholders	77 years	76 years
Guaranteed minimum enhanced death benefit
Net Amount at Risk by Product and Guarantee [Line Items]
Death benefits account value	$ 1,004	$ 1,326
Net amount at risk	$ 187	$ 94
Average attained age of contractholders	76 years	76 years
Guaranteed minimum living benefit
Net Amount at Risk by Product and Guarantee [Line Items]
Death benefits account value	$ 1,352	$ 1,893
Guaranteed annuitization benefits
Net Amount at Risk by Product and Guarantee [Line Items]
Death benefits account value	$ 767	$ 1,002

Account Balances of Variable An

Account Balances of Variable Annuity Contract with Death or Living Benefit Guarantees Invested in Separate Account Investment Options (Detail) - USD ($) $ in Millions	Dec. 31, 2022	Dec. 31, 2021
Schedule of Fair Value of Separate Accounts by Major Category of Investment [Line Items]
Separate account investment	$ 2,807	$ 3,796
Balanced funds
Schedule of Fair Value of Separate Accounts by Major Category of Investment [Line Items]
Separate account investment	1,686	2,397
Equity funds
Schedule of Fair Value of Separate Accounts by Major Category of Investment [Line Items]
Separate account investment	721	913
Bond funds
Schedule of Fair Value of Separate Accounts by Major Category of Investment [Line Items]
Separate account investment	214	297
Money market funds
Schedule of Fair Value of Separate Accounts by Major Category of Investment [Line Items]
Separate account investment	$ 186	$ 189

Liability for Policy and Cont_3

Liability for Policy and Contract Claims (Detail) - USD ($) $ in Millions		Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Liability for Claims and Claims Adjustment Expense [Line Items]
Total liability for policy and contract claims		$ 12,234	$ 11,841
Long-term Care Insurance
Liability for Claims and Claims Adjustment Expense [Line Items]
Total liability for policy and contract claims		11,380	10,861	$ 10,518	$ 10,239
Enact Segment
Liability for Claims and Claims Adjustment Expense [Line Items]
Total liability for policy and contract claims	[1]	519
Insurance lines other than short-duration contracts
Liability for Claims and Claims Adjustment Expense [Line Items]
Total liability for policy and contract claims		11,709	11,191
Insurance lines other than short-duration contracts \| Long-term Care Insurance
Liability for Claims and Claims Adjustment Expense [Line Items]
Total liability for policy and contract claims		11,380	10,861
Insurance lines other than short-duration contracts \| Life Insurance
Liability for Claims and Claims Adjustment Expense [Line Items]
Total liability for policy and contract claims		299	308
Insurance lines other than short-duration contracts \| Fixed Annuities
Liability for Claims and Claims Adjustment Expense [Line Items]
Total liability for policy and contract claims		16	14
Insurance lines other than short-duration contracts \| Runoff
Liability for Claims and Claims Adjustment Expense [Line Items]
Total liability for policy and contract claims		14	8
Short-duration contracts
Liability for Claims and Claims Adjustment Expense [Line Items]
Total liability for policy and contract claims		525	650
Short-duration contracts \| Enact Segment
Liability for Claims and Claims Adjustment Expense [Line Items]
Total liability for policy and contract claims		519	641
Short-duration contracts \| Other Countries Mortgage Insurance
Liability for Claims and Claims Adjustment Expense [Line Items]
Total liability for policy and contract claims		$ 6	$ 9

[1]Represents the year in which first monthly mortgage payments have been missed by the borrower.

Changes in Liability for Policy

Changes in Liability for Policy and Contract Claims (Detail) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Liability for Unpaid Claims and Claims Adjustment Expense [Roll Forward]
Beginning balance	$ 11,841
Ending balance	12,234	$ 11,841
Long-term Care Insurance
Liability for Unpaid Claims and Claims Adjustment Expense [Roll Forward]
Beginning balance	10,861	10,518	$ 10,239
Less reinsurance recoverables	(2,260)	(2,260)	(2,283)
Net beginning balance	8,601	8,258	7,956
Current year	2,954	2,761	2,595
Prior years	(458)	(610)	(398)
Total incurred	2,496	2,151	2,197
Current year	(211)	(203)	(189)
Prior years	(2,173)	(2,011)	(2,118)
Total paid	(2,384)	(2,214)	(2,307)
Interest on liability for policy and contract claims	422	406	412
Net ending balance	9,135	8,601	8,258
Add reinsurance recoverables	2,245	2,260	2,260
Ending balance	$ 11,380	$ 10,861	$ 10,518

Liability for Policy and Cont_4

Liability for Policy and Contract Claims - Additional Information (Detail) - USD ($) $ in Millions		3 Months Ended	12 Months Ended
		Dec. 31, 2020	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Liability for Claims and Claims Adjustment Expense [Line Items]
Liability for Claims and Claims Adjustment Expense			$ 12,234	$ 11,841
Long-term Care Insurance
Liability for Claims and Claims Adjustment Expense [Line Items]
Increase (Decrease) in claim reserves			519	343	$ 279
Incurred related to insured events of prior year			(458)	(610)	(398)
Increase (decrease) in reserves for liability for policy and contract claims			(95)		108
Additional increase (decrease) in reserves for liability for policy and contract claims			519		91
Liability for Claims and Claims Adjustment Expense		$ 10,518	11,380	10,861	10,518	$ 10,239
Long-term Care Insurance \| Covid Nineteen
Liability for Claims and Claims Adjustment Expense [Line Items]
Liability for Claims and Claims Adjustment Expense		199	137	$ 209	$ 199
Long-term Care Insurance \| Changes in Assumptions and Methodologies
Liability for Claims and Claims Adjustment Expense [Line Items]
Increase (Decrease) in claim reserves		$ (38)
Enact Segment
Liability for Claims and Claims Adjustment Expense [Line Items]
Increase (decrease) in reserves for liability for policy and contract claims			122
Liability for Claims and Claims Adjustment Expense	[1]		$ 519

[1]Represents the year in which first monthly mortgage payments have been missed by the borrower.

Incurred Claims, Net of Reinsur

Incurred Claims, Net of Reinsurance, Cumulative Number of Reported Delinquencies and Total of Incurred-But-Not-Reported Liabilities (Detail) - Enact Segment $ in Millions		Dec. 31, 2022 USD ($) Claim	Dec. 31, 2021 USD ($)	Dec. 31, 2020 USD ($)	Dec. 31, 2019 USD ($)	Dec. 31, 2018 USD ($)	Dec. 31, 2017 USD ($)	Dec. 31, 2016 USD ($)	Dec. 31, 2015 USD ($)	Dec. 31, 2014 USD ($)	Dec. 31, 2013 USD ($)
Claims Development [Line Items]
Incurred claims and allocated claim adjustment expenses, net of reinsurance	[1]	$ 1,645
Accident Year 2013
Claims Development [Line Items]
Incurred claims and allocated claim adjustment expenses, net of reinsurance	[1]	381	$ 381	$ 381	$ 381	$ 382	$ 384	$ 387	$ 392	$ 407	$ 475
Total of IBNR liabilities including expected development on reported claims
Number of reported delinquencies \| Claim	[2]	22,502
Accident Year 2014
Claims Development [Line Items]
Incurred claims and allocated claim adjustment expenses, net of reinsurance	[1]	$ 258	259	259	258	259	261	269	288	328	0
Total of IBNR liabilities including expected development on reported claims
Number of reported delinquencies \| Claim	[2]	17,809
Accident Year 2015
Claims Development [Line Items]
Incurred claims and allocated claim adjustment expenses, net of reinsurance	[1]	$ 179	179	180	180	181	187	208	235	0	0
Total of IBNR liabilities including expected development on reported claims
Number of reported delinquencies \| Claim	[2]	15,400
Accident Year 2016
Claims Development [Line Items]
Incurred claims and allocated claim adjustment expenses, net of reinsurance	[1]	$ 135	136	137	136	138	160	198	0	0	0
Total of IBNR liabilities including expected development on reported claims
Number of reported delinquencies \| Claim	[2]	13,970
Accident Year 2017
Claims Development [Line Items]
Incurred claims and allocated claim adjustment expenses, net of reinsurance	[1]	$ 102	104	105	102	121	171	0	0	0	0
Total of IBNR liabilities including expected development on reported claims
Number of reported delinquencies \| Claim	[2]	15,097
Accident Year 2018
Claims Development [Line Items]
Incurred claims and allocated claim adjustment expenses, net of reinsurance	[1]	$ 73	78	84	84	117	0	0	0	0	0
Total of IBNR liabilities including expected development on reported claims
Number of reported delinquencies \| Claim	[2]	11,269
Accident Year 2019
Claims Development [Line Items]
Incurred claims and allocated claim adjustment expenses, net of reinsurance	[1]	$ 71	98	111	106	0	0	0	0	0	0
Total of IBNR liabilities including expected development on reported claims
Number of reported delinquencies \| Claim	[2]	11,883
Accident Year 2020
Claims Development [Line Items]
Incurred claims and allocated claim adjustment expenses, net of reinsurance	[1]	$ 107	362	365	0	0	0	0	0	0	0
Total of IBNR liabilities including expected development on reported claims
Number of reported delinquencies \| Claim	[2]	38,863
Accident Year 2021
Claims Development [Line Items]
Incurred claims and allocated claim adjustment expenses, net of reinsurance	[1]	$ 119	141	0	0	0	0	0	0	0	0
Total of IBNR liabilities including expected development on reported claims		$ 1
Number of reported delinquencies \| Claim	[2]	12,585
Accident Year 2022
Claims Development [Line Items]
Incurred claims and allocated claim adjustment expenses, net of reinsurance	[1]	$ 220	$ 0	$ 0	$ 0	$ 0	$ 0	$ 0	$ 0	$ 0	$ 0
Total of IBNR liabilities including expected development on reported claims		$ 24
Number of reported delinquencies \| Claim	[2]	14,329

[1]Represents the year in which first monthly mortgage payments have been missed by the borrower.[2]Represents reported and outstanding delinquencies less actual cures as of December 31 for each respective accident year.

Paid Claims Development, Net of

Paid Claims Development, Net of Reinsurance (Detail) - USD ($) $ in Millions		12 Months Ended
		Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Claims Development [Line Items]
Liability for policy and contract claims		$ 12,234	$ 11,841
Enact Segment
Claims Development [Line Items]
Total incurred	[1]	1,645
Total paid	[1]	1,143
All outstanding liabilities before 2013	[1]	17
Liability for policy and contract claims	[1]	519
Enact Segment \| Accident Year 2013
Claims Development [Line Items]
Total incurred	[1]	381	381	$ 381	$ 381	$ 382	$ 384	$ 387	$ 392	$ 407	$ 475
Other	[1]	378	377	376	375	372	362	340	297	202	44
Enact Segment \| Accident Year 2014
Claims Development [Line Items]
Total incurred	[1]	258	259	259	258	259	261	269	288	328	0
Other	[1]	255	255	254	253	247	233	195	127	22	0
Enact Segment \| Accident Year 2015
Claims Development [Line Items]
Total incurred	[1]	179	179	180	180	181	187	208	235	0	0
Other	[1]	177	176	175	173	167	145	85	12	0	0
Enact Segment \| Accident Year 2016
Claims Development [Line Items]
Total incurred	[1]	135	136	137	136	138	160	198	0	0	0
Other	[1]	129	128	127	124	110	64	10	0	0	0
Enact Segment \| Accident Year 2017
Claims Development [Line Items]
Total incurred	[1]	102	104	105	102	121	171	0	0	0	0
Other	[1]	92	90	87	77	46	6	0	0	0	0
Enact Segment \| Accident Year 2018
Claims Development [Line Items]
Total incurred	[1]	73	78	84	84	117	0	0	0	0	0
Other	[1]	59	55	48	32	3	0	0	0	0	0
Enact Segment \| Accident Year 2019
Claims Development [Line Items]
Total incurred	[1]	71	98	111	106	0	0	0	0	0	0
Other	[1]	38	31	18	2	0	0	0	0	0	0
Enact Segment \| Accident Year 2020
Claims Development [Line Items]
Total incurred	[1]	107	362	365	0	0	0	0	0	0	0
Other	[1]	13	8	1	0	0	0	0	0	0	0
Enact Segment \| Accident Year 2021
Claims Development [Line Items]
Total incurred	[1]	119	141	0	0	0	0	0	0	0	0
Other	[1]	2	0	0	0	0	0	0	0	0	0
Enact Segment \| Accident Year 2022
Claims Development [Line Items]
Total incurred	[1]	220	0	0	0	0	0	0	0	0	0
Other	[1]	$ 0	$ 0	$ 0	$ 0	$ 0	$ 0	$ 0	$ 0	$ 0	$ 0

[1]Represents the year in which first monthly mortgage payments have been missed by the borrower.

Average Payout of Incurred Clai

Average Payout of Incurred Claims by Age (Detail) - Enact Segment	Dec. 31, 2022
Claims Development [Line Items]
Average annual percentage payout of incurred claims, net of reinsurance, by age, year one	4.80%
Average annual percentage payout of incurred claims, net of reinsurance, by age, year two	30.10%
Average annual percentage payout of incurred claims, net of reinsurance, by age, year three	24.50%
Average annual percentage payout of incurred claims, net of reinsurance, by age, year four	11.20%
Average annual percentage payout of incurred claims, net of reinsurance, by age, year five	4.10%
Average annual percentage payout of incurred claims, net of reinsurance, by age, year six	1.80%
Average annual percentage payout of incurred claims, net of reinsurance, by age, year seven	0.70%
Average annual percentage payout of incurred claims, net of reinsurance, by age, year eight	0.30%
Average annual percentage payout of incurred claims, net of reinsurance, by age, year nine	0.20%
Average annual percentage payout of incurred claims, net of reinsurance, by age, year ten	0.10%

Employee Benefit Plans - Additi

Employee Benefit Plans - Additional Information (Detail) - USD ($) $ in Millions		12 Months Ended
	Jan. 01, 2017	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Defined Benefit Plan Disclosure [Line Items]
Pre-tax pension plan termination costs		$ 8	$ 0	$ 0
Savings Plan
Defined Benefit Plan Disclosure [Line Items]
Defined contribution plan required years of service to vest for employees hired on or after January 1, 2011		2 years
Deposits recorded by our life insurance subsidiaries		$ 1	1
Costs associated with plan		$ 13	13	13
Maximum contribution to employees savings plans	5%
Savings Plan \| First 4% of pay deferred
Defined Benefit Plan Disclosure [Line Items]
Employer matching contribution, percent of match	100%
Maximum contribution to employees savings plans	4%
Savings Plan \| Next 2% of pay deferred
Defined Benefit Plan Disclosure [Line Items]
Employer matching contribution, percent of match	50%
Maximum contribution to employees savings plans	2%
Defined Contribution Pension Plan
Defined Benefit Plan Disclosure [Line Items]
Percentage funding of plan by Genworth		100%
Defined contribution pension plan required years of service to vest		3 years
Liability related to benefit plan		$ 8	11
Pension and Retiree Health and Life Insurance Benefit Plans
Defined Benefit Plan Disclosure [Line Items]
Costs associated with plan		22	18	$ 18
Retiree Health and Life Insurance Benefit Plans
Defined Benefit Plan Disclosure [Line Items]
Liability related to benefit plan		50	71
Change in other comprehensive income, (increase) reduction		$ 18	11
Age for retirees receiving policy coverage		65 years
Number of years before retirement eligibility at which retiree medical benefits are available to employees		10 years
Defined Benefit Pension Plans
Defined Benefit Plan Disclosure [Line Items]
Liability related to benefit plan		$ 47	65
Change in other comprehensive income, (increase) reduction		26	$ 6
First Colony Life Insurance Company Pension Plan
Defined Benefit Plan Disclosure [Line Items]
Defined benefit plan additional cash contributions by employer		0
Pre-tax pension plan termination costs		$ 8

Borrowings and Other Financin_3

Borrowings and Other Financings - Long Term Borrowings (Detail) - USD ($) $ in Millions	Dec. 31, 2022	Dec. 31, 2021
Debt Instrument [Line Items]
Total	$ 1,611	$ 1,899
Genworth Holdings
Debt Instrument [Line Items]
Long-term borrowings	884	1,178
Bond consent fees	(10)	(12)
Deferred borrowing charges	(6)	(7)
Total	868	1,159
Genworth Holdings \| 4.80% Senior Notes, Due 2024
Debt Instrument [Line Items]
Long-term borrowings	0	282
Genworth Holdings \| 6.50% Senior Notes, Due 2034
Debt Instrument [Line Items]
Long-term borrowings	285	298
Genworth Holdings \| Floating Rate Junior Subordinated Notes, due 2066
Debt Instrument [Line Items]
Long-term borrowings	599	598
Enact Holdings
Debt Instrument [Line Items]
Deferred borrowing charges	(7)	(10)
Total	743	740
Enact Holdings \| 6.50% Senior Notes, Due 2025
Debt Instrument [Line Items]
Long-term borrowings	$ 750	$ 750

Borrowings and Other Financin_4

Borrowings and Other Financings - Long Term Borrowings (Parenthetical) (Detail)	6 Months Ended	12 Months Ended
	Jun. 30, 2022	Dec. 31, 2022	Sep. 21, 2022
4.80% Senior Notes, Due 2024 \| Genworth Holdings
Debt Instrument [Line Items]
Interest rate	4.80%	4.80%	4.80%
Debt instrument, maturity year	2024	2024
6.50% Senior Notes, Due 2034 \| Genworth Holdings
Debt Instrument [Line Items]
Interest rate		6.50%
Debt instrument, maturity year		2034
Floating Rate Junior Subordinated Notes, due 2066 \| Genworth Holdings
Debt Instrument [Line Items]
Debt instrument, maturity year		2066
6.50% Senior Notes, Due 2025 \| Enact Holdings
Debt Instrument [Line Items]
Interest rate		6.50%
Debt instrument, maturity year		2025

Borrowings and Other Financin_5

Borrowings and Other Financings - Additional Information (Detail) - USD ($) $ in Millions			1 Months Ended	3 Months Ended	6 Months Ended	12 Months Ended
	Sep. 21, 2022	Jun. 30, 2022	Jan. 31, 2020	Dec. 31, 2022	Jun. 30, 2022	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Debt Instrument [Line Items]
Pre-tax gain (loss) on early extinguishment of debt						$ 6	$ 45	$ 9
Interest paid						$ 101	$ 186	$ 176
Genworth Holdings
Debt Instrument [Line Items]
Debt instrument, maturity month and year			2020-06
Pre-tax make-whole expense on redemption of senior notes			$ 9
Genworth Holdings \| Fixed Rate Senior Notes \| Minimum
Debt Instrument [Line Items]
Senior notes option to redeem						100%
Genworth Holdings \| Junior Notes, due 2066
Debt Instrument [Line Items]
Issued notes, aggregate principal amount				$ 600		$ 600
Debt instrument, maturity month and year						2066-11
Pre-tax gain (loss) on early extinguishment of debt				1
Debt instrument, interest rate terms						three-month LIBOR plus 2.0025%
Scheduled redemption date						Nov. 15, 2036
Right to defer the payment of interest on the 2066 Notes during period, years						10 years
Aggregate principal amount of notes repurchased				13		$ 13
Debt Instrument, Call Date, Latest						Nov. 15, 2046
Debt instrument unamortized discount				$ 1		$ 1
Genworth Holdings \| 4.80% Senior Notes, Due to 2024
Debt Instrument [Line Items]
Interest rate	4.80%	4.80%		4.80%	4.80%	4.80%
Debt instrument, maturity month and year	2024-02
Early redemption of senior notes	$ 155
Pre-tax make-whole expense on redemption of senior notes	2
Pre-tax gain (loss) on early extinguishment of debt					$ (4)
Debt instrument, maturity year					2024	2024
Interest paid	1
Aggregate principal amount of notes redeemed	152	$ 130			$ 130
Write off of bond consent fees and deferred borrowing costs	$ 1
Genworth Holdings \| 6.50% Senior Notes, Due 2034
Debt Instrument [Line Items]
Interest rate				6.50%		6.50%
Debt instrument, maturity month and year						2034-06
Aggregate principal amount of notes redeemed				$ 287		$ 287
Debt instrument unamortized discount				$ 2		$ 2
Enact Holdings \| Revolving Credit Facility
Debt Instrument [Line Items]
Line of credit facility, maximum borrowing capacity		$ 200			200
Debt Instrument, Term		5 years
Line of credit facility, additional borrowing capacity		$ 100			$ 100
Enact Holdings \| 6.50% Senior Notes, due 2025
Debt Instrument [Line Items]
Interest rate				6.50%		6.50%
Issued notes, aggregate principal amount				$ 750		$ 750
Debt instrument, maturity year						2025
Long term debt terms of interest payment						Interest on the notes is payable semi-annually
Long-term debt maturity date				Aug. 15, 2025		Aug. 15, 2025
Option to redeem, price percentage of principal						100%
Debt instrument, option to redeem date, prior to						Feb. 15, 2025
Debt instrument, option to redeem date, on or after						Feb. 15, 2025

Principal Amounts of Long-Term

Principal Amounts of Long-Term Borrowings by Maturity (Detail) $ in Millions	Dec. 31, 2022 USD ($)
Principal Amounts Of Long Term Debt Including Senior Notes And Non Recourse Funding By Maturity [Line Items]
2023	$ 0
2024	0
2025	750
2026	0
2027 and thereafter	887
Total	$ 1,637

Components of Income before Inc

Components of Income before Income Taxes (Detail) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Income Taxes [Abstract]
Domestic	$ 978	$ 1,184	$ 931
Foreign	0	(3)	(3)
Income from continuing operations before income taxes	$ 978	$ 1,181	$ 928

Components of Income Tax Provis

Components of Income Tax Provision (Detail) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Income Taxes [Abstract]
Current federal income taxes	$ 0	$ (32)	$ 0
Deferred federal income taxes	239	288	226
Total federal income taxes	239	256	226
Current state income taxes	4	5	3
Deferred state income taxes	(5)	2	2
Total state income taxes	(1)	7	5
Current foreign income taxes	0	0	0
Deferred foreign income taxes	1	0	(1)
Total foreign income taxes	1	0	(1)
Total provision for income taxes	$ 239	$ 263	$ 230

Income Taxes - Additional Infor

Income Taxes - Additional Information (Detail) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Income Taxes [Line Items]
Current income tax payable		$ (2)
Current income tax receivable	$ 3
Valuation allowances	583	382
Foreign tax credit carryforwards	$ 156	174
Foreign tax credit carryforwards, expiration year	2025
Net deferred tax asset	$ 1,344	119
Unrecognized tax benefits	33	40	$ 62	$ 64
Unrecognized tax benefits, amount that if recognized would affect the effective rate on continuing operations	21
Unrecognized tax benefits, interest and penalties (expense)	0	$ 2	$ 1
Unrecognized Tax Benefits, Decrease Resulting from Settlements with Taxing Authorities in 2020	$ 22
Statutory U.S. federal income tax rate	21%	21%	21%
Deferred tax assets, capital loss carryforwards	$ 146	$ 142
Deferred tax assets, deferred income	77
Accumulated other comprehensive income (loss)
Income Taxes [Line Items]
Increase (decrease) in the valuation allowance	200
Capital Loss Carryforward
Income Taxes [Line Items]
Tax credit carryforward, amount	$ 695
Tax credit carry forward expiration year	2026
Deferred tax assets, capital loss carryforwards	$ 1,267
Section 338 Election
Income Taxes [Line Items]
Maximum deferred tax assets related to Section 338 election deduction	$ 640
Percentage of tax savings associated with Section 338 deductions	80%
Forward Starting Swaps
Income Taxes [Line Items]
Statutory U.S. federal income tax rate	35%
Tax Matters Agreement
Income Taxes [Line Items]
Tax payments to former parent	$ 55

Reconciliation of Federal Statu

Reconciliation of Federal Statutory Tax Rate to Effective Income Tax Rate (Detail)	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Income Tax Examination [Line Items]
Statutory U.S. federal income tax rate	21%	21%	21%
Tax on income from terminated swaps	3.20%	2.50%	3%
Reduction in uncertain tax positions	0%	(1.80%)	0%
Other, net	0.20%	0.60%	0.80%
Effective rate	24.40%	22.30%	24.80%

Components Net Deferred Income

Components Net Deferred Income Tax Liability (Detail) - USD ($) $ in Millions	Dec. 31, 2022	Dec. 31, 2021
Income Taxes [Abstract]
Foreign tax credit carryforwards	$ 156	$ 174
Net operating loss carryforwards	4	202
Capital loss carryforwards	146	142
State income taxes	396	388
Insurance reserves	161	178
Accrued commission and general expenses	113	118
Liabilities associated with discontinued operations	122	122
Net unrealized losses on investment securities	897	0
Net unrealized losses on derivatives	102	0
Other	9	18
Gross deferred income tax assets	2,106	1,342
Valuation allowance	(583)	(382)
Total deferred income tax assets	1,523	960
Net unrealized gains on investment securities	0	506
Net unrealized gains on derivatives	0	73
DAC	29	98
PVFP and other intangibles	37	38
Insurance reserves transition adjustment	74	99
Investments	20	10
Other	19	17
Total deferred income tax liabilities	179	841
Net deferred income tax asset	$ 1,344	$ 119

Reconciliation of Unrecognized

Reconciliation of Unrecognized Tax Benefits (Detail) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Income Taxes [Abstract]
Balance as of January 1	$ 40	$ 62	$ 64
Gross additions, current period	0	0	0
Gross reductions, current period	(3)	(3)	(3)
Gross additions, prior years	0	0	1
Gross reductions, prior years	(4)	(19)	0
Balance as of December 31	$ 33	$ 40	$ 62

Supplemental Cash Flow Inform_2

Supplemental Cash Flow Information - Additional Information (Detail) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Supplemental Cash Flow Information [Abstract]
Net cash (paid) received for taxes	$ (5)	$ (7)	$ 3
Cash paid for interest	$ 101	$ 186	$ 176

Stock-Based Compensation - Addi

Stock-Based Compensation - Additional Information (Detail) - USD ($) $ / shares in Units, $ in Millions	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2012	Dec. 31, 2011
Share Based Employee Compensation [Line Items]
Stock-based compensation expense	$ 37	$ 40	$ 39
Unrecognized stock-based compensation expense	$ 16	17
Unrecognized stock-based compensation expense, expected weighted-average period of recognition (years)	2 years
Tax benefit realized from the exercise of share based awards	$ 5	4
Enact Holdings Inc.
Share Based Employee Compensation [Line Items]
Equity awards, total amount of shares authorized to be outstanding	4,000,000
Unrecognized stock-based compensation expense	$ 13	11
Unrecognized stock-based compensation expense, expected weighted-average period of recognition (years)	2 years
Stock-based compensation expense	$ 10	$ 2
Time Based Cash Awards
Share Based Employee Compensation [Line Items]
Granted stock options, fair value	$ 1	$ 1	$ 1
Average vesting period	3 years	3 years	3 years
Performance Stock Units ("PSUs")
Share Based Employee Compensation [Line Items]
Granted stock options, fair value	$ 4.47	$ 3.45	$ 3.03
Average vesting period	3 years	3 years	3 years
Stock-based compensation expense	$ 3	$ 16	$ 18
Performance metric grant-date fair value, metric two	$ 4.27	$ 3.31
Performance metric grant-date fair value	5.3	4.18
Performance Stock Units ("PSUs") \| Enact Holdings Inc.
Share Based Employee Compensation [Line Items]
Granted stock options, fair value	$ 22.15
Average vesting period	3 years
Stock-based compensation expense	$ 1
Restricted Stock Units
Share Based Employee Compensation [Line Items]
Granted stock options, fair value	$ 4.25	$ 3.31	$ 3.53
Average vesting period	3 years	3 years	3 years
Cash Settled Restricted Stock Units
Share Based Employee Compensation [Line Items]
Granted stock options, fair value	$ 4.27	$ 0
Description of shares vest as cash payment	one
Number of trading days immediately preceding the vesting date	20 days
Omnibus Incentive Plan
Share Based Employee Compensation [Line Items]
Equity awards, total amount of shares authorized to be outstanding				16,000,000
Equity awards, amount of shares authorized to grant					25,000,000
Stock-based compensation expense	$ 27	$ 38	$ 39
2018 Omnibus Incentive Plan
Share Based Employee Compensation [Line Items]
Equity awards, total amount of shares authorized to be outstanding	25,000,000
Equity awards, amount of shares authorized to grant	20,000,000
2021 Omnibus Incentive Plan
Share Based Employee Compensation [Line Items]
Equity awards, total amount of shares authorized to be outstanding	25,000,000
Equity awards, amount of shares authorized to grant	20,000,000

Stock-Based Compensation - Summ

Stock-Based Compensation - Summary of Other Equity Awards Valuation Assumptions (Detail) - $ / shares	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions and Methodology [Abstract]
Valuation-date stock price	$ 4.27	$ 3.31
Volatility	64.60%	65%
Dividend yield	0%	0%
Risk-free rate	1.80%	0.30%
Valuation maximum	800% of grant-date stock price	800% of grant-date stock price

Stock-Based Compensation - Su_2

Stock-Based Compensation - Summary of Cash Award Activity (Detail) - $ / shares shares in Thousands	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Cash Settled Restricted Stock Units
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Balance as of January 1, number of awards	0	0
Granted, number of awards	2,957	0
Performance adjustment	0	0
Vested, number of awards	(23)	0
Forfeited, number of awards	(180)	0
Balance as of December 31, number of awards	2,754	0	0
Balance as of January 1, weighted-average grant date fair value	$ 0	$ 0
Granted, weighted-average grant date fair value	4.27	0
Performance adjustment, weighted-average grant date fair value	0	0
Vested, weighted-average grant date fair value	4.17	0
Forfeited, weighted average grant date fair value	4.31	0
Balance as of December 31, weighted-average grant date fair value	$ 4.27	$ 0	$ 0
Performance Based Cash Awards
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Balance as of January 1, number of awards	0	6,938
Granted, number of awards	0	0
Performance adjustment	0	5,838
Vested, number of awards	0	(12,776)
Forfeited, number of awards	0	0
Balance as of December 31, number of awards	0	0	6,938
Time Based Cash Awards
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Balance as of January 1, number of awards	27,696	30,429
Granted, number of awards	208	15,473
Performance adjustment	0	0
Vested, number of awards	(13,992)	(14,774)
Forfeited, number of awards	(1,020)	(3,432)
Balance as of December 31, number of awards	12,892	27,696	30,429
Granted, weighted-average grant date fair value	$ 1	$ 1	$ 1

Stock Option Activity and Other

Stock Option Activity and Other Equity-Based Awards (Detail) - $ / shares shares in Thousands		12 Months Ended
		Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Restricted Stock Units
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Balance as of January 1, number of awards		2,317	2,534
Granted, number of awards		1,105	1,391
Performance adjustment	[1]	0	0
Exercised, number of awards		(1,004)	(1,474)
Terminated, number of awards		(299)	(134)
Balance as of December 31, number of awards		2,119	2,317	2,534
Balance as of January 1, weighted-average grant date fair value		$ 3.38	$ 3.48
Granted, weighted-average grant date fair value		4.25	3.31	$ 3.53
Performance adjustment, weighted-average grant date fair value	[1]	0	0
Exercised, weighted-average grant date fair value		3.39	3.47
Terminated, weighted-average grant date fair value		3.52	3.53
Balance as of December 31, weighted-average grant date fair value		$ 3.81	$ 3.38	$ 3.48
Performance Stock Units ("PSUs")
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Balance as of January 1, number of awards		7,505	5,734
Granted, number of awards		2,182	2,510
Performance adjustment	[1]	2,308	626
Exercised, number of awards		(4,616)	(1,365)
Terminated, number of awards		(718)	0
Balance as of December 31, number of awards		6,661	7,505	5,734
Balance as of January 1, weighted-average grant date fair value		$ 3.7	$ 3.79
Granted, weighted-average grant date fair value		4.47	3.45
Performance adjustment, weighted-average grant date fair value	[1]	4.61	3.58
Exercised, weighted-average grant date fair value		4.61	3.58
Terminated, weighted-average grant date fair value		3.55	0
Balance as of December 31, weighted-average grant date fair value		$ 3.65	$ 3.7	$ 3.79
Deferred Stock Units
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Balance as of January 1, number of awards		1,837	1,537
Granted, number of awards		281	315
Performance adjustment	[1]	0	0
Exercised, number of awards		(954)	(15)
Terminated, number of awards		0	0
Balance as of December 31, number of awards		1,164	1,837	1,537
Balance as of January 1, weighted-average grant date fair value		$ 3.42	$ 3.95
Granted, weighted-average grant date fair value		2.51	2.52
Performance adjustment, weighted-average grant date fair value	[1]	0	0
Exercised, weighted-average grant date fair value		4.02	7.46
Terminated, weighted-average grant date fair value		0	0
Balance as of December 31, weighted-average grant date fair value		$ 2.44	$ 3.42	$ 3.95
Stock Appreciation Rights
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Balance as of January 1, number of awards		6,195	7,030
Granted, number of awards		0	0
Performance adjustment	[1]	0	0
Exercised, number of awards		0	0
Terminated, number of awards		(2,295)	(835)
Balance as of December 31, number of awards		3,900	6,195	7,030
Balance as of January 1, weighted-average grant date fair value		$ 3.36	$ 3.32
Granted, weighted-average grant date fair value		0	0
Performance adjustment, weighted-average grant date fair value	[1]	0	0
Exercised, weighted-average grant date fair value		0	0
Terminated, weighted-average grant date fair value		2.52	3.04
Balance as of December 31, weighted-average grant date fair value		$ 3.85	$ 3.36	$ 3.32

[1]The performance adjustment relates to additional awards expected to be earned through the achievement of certain performance metrics.

Stock-Based Compensation - Su_3

Stock-Based Compensation - Summary of Enact Holdings' Equity-Based Awards (Details) - $ / shares shares in Thousands	6 Months Ended	12 Months Ended
	Jun. 30, 2022	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Restricted Stock Units
Number of awards
Balance as of January 1, number of awards	2,317	2,317	2,534
Granted		1,105	1,391
Vested, number of awards		(1,004)	(1,474)
Terminated, number of awards		(299)	(134)
Balance as of December 31, number of awards		2,119	2,317	2,534
Weighted average grant date fair value
Balance as of January 1, weighted-average grant date fair value	$ 3.38	$ 3.38	$ 3.48
Granted, weighted-average grant date fair value		4.25	3.31	$ 3.53
Vested, weighted-average grant date fair value		3.39	3.47
Terminated, weighted-average grant date fair value		3.52	3.53
Balance as of December 31, weighted-average grant date fair value		$ 3.81	$ 3.38	$ 3.48
Restricted Stock Units \| Enact Holdings Inc.
Number of awards
Balance as of January 1, number of awards	654	654	0
Granted		322	628
Dividend equivalents		62	36
Vested, number of awards		(3)	0
Terminated, number of awards		(26)	(10)
Balance as of December 31, number of awards		1,009	654	0
Weighted average grant date fair value
Balance as of January 1, weighted-average grant date fair value	$ 19.02	$ 19.02	$ 0
Granted, weighted-average grant date fair value		22.18	19.02
Dividend equivalents, weighted average grant date fair value		24	21.25
Vested, weighted-average grant date fair value		19	0
Terminated, weighted-average grant date fair value		19.73	19
Balance as of December 31, weighted-average grant date fair value		$ 20.07	$ 19.02	$ 0
Deferred Stock Units
Number of awards
Balance as of January 1, number of awards	1,837	1,837	1,537
Granted		281	315
Vested, number of awards		(954)	(15)
Terminated, number of awards		0	0
Balance as of December 31, number of awards		1,164	1,837	1,537
Weighted average grant date fair value
Balance as of January 1, weighted-average grant date fair value	$ 3.42	$ 3.42	$ 3.95
Granted, weighted-average grant date fair value		2.51	2.52
Vested, weighted-average grant date fair value		4.02	7.46
Terminated, weighted-average grant date fair value		0	0
Balance as of December 31, weighted-average grant date fair value		$ 2.44	$ 3.42	$ 3.95
Deferred Stock Units \| Enact Holdings Inc.
Number of awards
Balance as of January 1, number of awards	17	17	0
Granted		78	17
Dividend equivalents		5	0
Vested, number of awards		0	0
Terminated, number of awards		0	0
Balance as of December 31, number of awards		100	17	0
Weighted average grant date fair value
Balance as of January 1, weighted-average grant date fair value	$ 20.87	$ 20.87	$ 0
Granted, weighted-average grant date fair value	22.02		20.87
Dividend equivalents, weighted average grant date fair value	24		0
Vested, weighted-average grant date fair value	0		0
Terminated, weighted-average grant date fair value	0		0
Balance as of December 31, weighted-average grant date fair value	$ 21.81		20.87	$ 0
Performance Stock Units
Weighted average grant date fair value
Granted, weighted-average grant date fair value		$ 4.47	$ 3.45	$ 3.03
Performance Stock Units \| Enact Holdings Inc.
Number of awards
Balance as of January 1, number of awards	0	0	0
Granted		156	0
Dividend equivalents		10	0
Vested, number of awards		0	0
Terminated, number of awards		0	0
Balance as of December 31, number of awards		166	0	0
Weighted average grant date fair value
Balance as of January 1, weighted-average grant date fair value	$ 0	$ 0	$ 0
Granted, weighted-average grant date fair value		22.15	0
Dividend equivalents, weighted average grant date fair value		24	0
Vested, weighted-average grant date fair value		0	0
Terminated, weighted-average grant date fair value		0	0
Balance as of December 31, weighted-average grant date fair value		$ 22.15	$ 0	$ 0

Fair Value of Financial Instr_3

Fair Value of Financial Instruments - Additional Information (Detail) $ in Millions	12 Months Ended
	Dec. 31, 2022 USD ($)	Dec. 31, 2021 USD ($)
Fair Value of Financial Instruments [Line Items]
Available-for-sale debt securities	$ 46,583	$ 60,480
GMWB non-performance risk impact	$ 33	49
Period end valuation	0
Level 2
Fair Value of Financial Instruments [Line Items]
Available-for-sale debt securities	$ 43,393	56,672
Level 2 \| Nonrecurring fair value \| Other invested assets
Fair Value of Financial Instruments [Line Items]
Real estate owned	$ 26	4
Level 2 \| Fixed maturity securities \| Third-Party Pricing Services
Fair Value of Financial Instruments [Line Items]
Percentage of available for sale debt securities	88%
Level 2 \| Fixed maturity securities \| Internal models \| U.S. corporate
Fair Value of Financial Instruments [Line Items]
Available-for-sale debt securities	$ 1,460
Level 2 \| Fixed maturity securities \| Internal models \| Non-U.S. corporate
Fair Value of Financial Instruments [Line Items]
Available-for-sale debt securities	820
Level 3
Fair Value of Financial Instruments [Line Items]
Available-for-sale debt securities	3,190	$ 3,808
Level 3 \| Fixed maturity securities \| Internal models
Fair Value of Financial Instruments [Line Items]
Available-for-sale debt securities	2,940
Level 3 \| Fixed maturity securities \| Broker Quotes
Fair Value of Financial Instruments [Line Items]
Available-for-sale debt securities	$ 250
Fair Value Measured at Net Asset Value Per Share \| Limited Partnerships \| Maximum
Fair Value of Financial Instruments [Line Items]
Liquidation period	10 years
Contractual period	12 years
Fair Value Measured at Net Asset Value Per Share \| Limited Partnerships \| Minimum
Fair Value of Financial Instruments [Line Items]
Liquidation period	5 years
Contractual period	10 years

Fair Value of Financial Instr_4

Fair Value of Financial Instruments - Summary of Significant Inputs Used by Third-Party Pricing Services for Certain Fair Value Measurements of Fixed Maturity Securities that Classified as Level 2 (Detail) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Fair value measurements Significant unobservable inputs [Line Items]
Available-for-sale debt securities	$ 46,583	$ 60,480
Fixed maturity securities
Fair value measurements Significant unobservable inputs [Line Items]
Available-for-sale debt securities	46,583	60,480
Fixed maturity securities \| U.S. government, agencies and government-sponsored enterprises
Fair value measurements Significant unobservable inputs [Line Items]
Available-for-sale debt securities	3,341	4,552
Fixed maturity securities \| State and Political Subdivisions
Fair value measurements Significant unobservable inputs [Line Items]
Available-for-sale debt securities	2,399	3,450
Fixed maturity securities \| Non-U.S. government
Fair value measurements Significant unobservable inputs [Line Items]
Available-for-sale debt securities	645	835
Fixed maturity securities \| U.S. corporate
Fair value measurements Significant unobservable inputs [Line Items]
Available-for-sale debt securities	27,119	34,924
Fixed maturity securities \| Non-U.S. corporate
Fair value measurements Significant unobservable inputs [Line Items]
Available-for-sale debt securities	8,010	10,535
Fixed maturity securities \| Residential mortgage-backed
Fair value measurements Significant unobservable inputs [Line Items]
Available-for-sale debt securities	995	1,440
Fixed maturity securities \| Commercial mortgage-backed
Fair value measurements Significant unobservable inputs [Line Items]
Available-for-sale debt securities	1,908	2,584
Fixed maturity securities \| Other asset-backed
Fair value measurements Significant unobservable inputs [Line Items]
Available-for-sale debt securities	2,166	2,160
Level 2
Fair value measurements Significant unobservable inputs [Line Items]
Available-for-sale debt securities	43,393	56,672
Level 2 \| Fixed maturity securities \| U.S. government, agencies and government-sponsored enterprises
Fair value measurements Significant unobservable inputs [Line Items]
Available-for-sale debt securities	3,341	4,552
Level 2 \| Fixed maturity securities \| State and Political Subdivisions
Fair value measurements Significant unobservable inputs [Line Items]
Available-for-sale debt securities	2,344	3,368
Level 2 \| Fixed maturity securities \| Non-U.S. government
Fair value measurements Significant unobservable inputs [Line Items]
Available-for-sale debt securities	645	833
Level 2 \| Fixed maturity securities \| U.S. corporate
Fair value measurements Significant unobservable inputs [Line Items]
Available-for-sale debt securities	24,997	32,543
Level 2 \| Fixed maturity securities \| Non-U.S. corporate
Fair value measurements Significant unobservable inputs [Line Items]
Available-for-sale debt securities	7,125	9,373
Level 2 \| Fixed maturity securities \| Residential mortgage-backed
Fair value measurements Significant unobservable inputs [Line Items]
Available-for-sale debt securities	973	1,413
Level 2 \| Fixed maturity securities \| Commercial mortgage-backed
Fair value measurements Significant unobservable inputs [Line Items]
Available-for-sale debt securities	1,896	2,568
Level 2 \| Fixed maturity securities \| Other asset-backed
Fair value measurements Significant unobservable inputs [Line Items]
Available-for-sale debt securities	2,072	$ 2,022
Level 2 \| Third-Party Pricing Services \| Fixed maturity securities \| U.S. government, agencies and government-sponsored enterprises
Fair value measurements Significant unobservable inputs [Line Items]
Available-for-sale debt securities	$ 3,341
Primary methodologies	Price quotes from trading desk, broker feeds
Significant inputs	Bid side prices, trade prices, Option Adjusted Spread (“OAS”) to swap curve, Bond Market Association OAS, Treasury Curve, Agency Bullet Curve, maturity to issuer spread
Level 2 \| Third-Party Pricing Services \| Fixed maturity securities \| State and Political Subdivisions
Fair value measurements Significant unobservable inputs [Line Items]
Available-for-sale debt securities	$ 2,344
Primary methodologies	Multi-dimensional attribute-based modeling systems, third-party pricing vendors
Significant inputs	Trade prices, material event notices, Municipal Market Data benchmark yields, broker quotes
Level 2 \| Third-Party Pricing Services \| Fixed maturity securities \| Non-U.S. government
Fair value measurements Significant unobservable inputs [Line Items]
Available-for-sale debt securities	$ 645
Primary methodologies	Matrix pricing, spread priced to benchmark curves, price quotes from market makers
Significant inputs	Benchmark yields, trade prices, broker quotes, comparative transactions, issuer spreads, bid-offer spread, market research publications, third-party pricing sources
Level 2 \| Third-Party Pricing Services \| Fixed maturity securities \| U.S. corporate
Fair value measurements Significant unobservable inputs [Line Items]
Available-for-sale debt securities	$ 23,537
Primary methodologies	Multi-dimensional attribute-based modeling systems, broker quotes, price quotes from market makers, OAS-based models
Significant inputs	Bid side prices to Treasury Curve, Issuer Curve, which includes sector, quality, duration, OAS percentage and change for spread matrix, trade prices, comparative transactions, Trade Reporting and Compliance Engine (“TRACE”) reports
Level 2 \| Third-Party Pricing Services \| Fixed maturity securities \| Non-U.S. corporate
Fair value measurements Significant unobservable inputs [Line Items]
Available-for-sale debt securities	$ 6,305
Primary methodologies	Multi-dimensional attribute-based modeling systems, OAS-based models, price quotes from market makers
Significant inputs	Benchmark yields, trade prices, broker quotes, comparative transactions, issuer spreads, bid-offer spread, market research publications, third-party pricing sources
Level 2 \| Third-Party Pricing Services \| Fixed maturity securities \| Residential mortgage-backed
Fair value measurements Significant unobservable inputs [Line Items]
Available-for-sale debt securities	$ 973
Primary methodologies	OAS-based models, single factor binomial models, internally priced
Significant inputs	Prepayment and default assumptions, aggregation of bonds with similar characteristics, including collateral type, vintage, tranche type, weighted-average life, weighted-average loan age, issuer program and delinquency ratio, pay up and pay down factors, TRACE reports
Level 2 \| Third-Party Pricing Services \| Fixed maturity securities \| Commercial mortgage-backed
Fair value measurements Significant unobservable inputs [Line Items]
Available-for-sale debt securities	$ 1,896
Primary methodologies	Multi-dimensional attribute-based modeling systems, pricing matrix, spread matrix priced to swap curves, Trepp commercial mortgage-backed securities analytics model
Significant inputs	Credit risk, interest rate risk, prepayment speeds, new issue data, collateral performance, origination year, tranche type, original credit ratings, weighted-average life, cash flows, spreads derived from broker quotes, bid side prices, spreads to daily updated swap curves, TRACE reports
Level 2 \| Third-Party Pricing Services \| Fixed maturity securities \| Other asset-backed
Fair value measurements Significant unobservable inputs [Line Items]
Available-for-sale debt securities	$ 2,072
Primary methodologies	Multi-dimensional attribute-based modeling systems, spread matrix priced to swap curves, price quotes from market makers
Significant inputs	Spreads to daily updated swap curves, spreads derived from trade prices and broker quotes, bid side prices, new issue data, collateral performance, analysis of prepayment speeds, cash flows, collateral loss analytics, historical issue analysis, trade data from market makers, TRACE reports

Assets by Class of Instrument t

Assets by Class of Instrument that are Measured at Fair Value on Recurring Basis (Detail) - USD ($) $ in Millions		Dec. 31, 2022	Dec. 31, 2021
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		$ 46,583	$ 60,480
Available-for-sale equity securities		319	198
Derivative assets, fair value		66	433
Limited partnerships		2,331	1,900
Total other invested assets		566	820
Separate account assets		4,417	6,066
Total assets		53,204	68,665
Net Asset Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities	[1]	0	0
Available-for-sale equity securities	[1]	0	0
Limited partnerships	[1]	1,792	1,436
Separate account assets	[1]	0	0
Total assets	[1]	1,792	1,436
Other invested assets
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative assets, fair value		50	414
Short-term investments		3	26
Total other invested assets		53	440
Other invested assets \| Net Asset Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative assets, fair value	[1]	0	0
Short-term investments	[1]	0	0
Total other invested assets	[1]	0	0
Interest rate swaps \| Other invested assets
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative assets, fair value		24	364
Interest rate swaps \| Other invested assets \| Net Asset Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative assets, fair value	[1]	0	0
Foreign currency swaps \| Other invested assets
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative assets, fair value		20	6
Foreign currency swaps \| Other invested assets \| Net Asset Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative assets, fair value	[1]	0	0
Equity index options \| Other invested assets
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative assets, fair value		6	42
Equity index options \| Other invested assets \| Net Asset Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative assets, fair value	[1]	0	0
Other foreign currency contracts \| Other invested assets
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative assets, fair value			2
Other foreign currency contracts \| Other invested assets \| Net Asset Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative assets, fair value	[1]		0
GMWB embedded derivatives \| Reinsurance recoverable
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative assets, fair value	[2]	16	19
GMWB embedded derivatives \| Reinsurance recoverable \| Net Asset Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative assets, fair value	[1],[2]	0	0
Fixed maturity securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		46,583	60,480
Fixed maturity securities \| U.S. government, agencies and government-sponsored enterprises
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		3,341	4,552
Fixed maturity securities \| U.S. government, agencies and government-sponsored enterprises \| Net Asset Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities	[1]	0	0
Fixed maturity securities \| State and Political Subdivisions
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		2,399	3,450
Fixed maturity securities \| State and Political Subdivisions \| Net Asset Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities	[1]	0	0
Fixed maturity securities \| Non-U.S. government
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		645	835
Fixed maturity securities \| Non-U.S. government \| Net Asset Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities	[1]	0	0
Fixed maturity securities \| U.S. corporate
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		27,119	34,924
Fixed maturity securities \| U.S. corporate \| Net Asset Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities	[1]	0	0
Fixed maturity securities \| U.S. corporate \| Utilities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		3,898	5,104
Fixed maturity securities \| U.S. corporate \| Utilities \| Net Asset Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities	[1]	0	0
Fixed maturity securities \| U.S. corporate \| Energy
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		2,262	2,934
Fixed maturity securities \| U.S. corporate \| Energy \| Net Asset Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities	[1]	0	0
Fixed maturity securities \| U.S. corporate \| Finance and insurance
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		7,193	8,991
Fixed maturity securities \| U.S. corporate \| Finance and insurance \| Net Asset Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities	[1]	0	0
Fixed maturity securities \| U.S. corporate \| Consumer-non-cyclical
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		4,457	6,159
Fixed maturity securities \| U.S. corporate \| Consumer-non-cyclical \| Net Asset Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities	[1]	0	0
Fixed maturity securities \| U.S. corporate \| Technology and communications
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		2,947	3,808
Fixed maturity securities \| U.S. corporate \| Technology and communications \| Net Asset Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities	[1]	0	0
Fixed maturity securities \| U.S. corporate \| Industrial
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		1,197	1,494
Fixed maturity securities \| U.S. corporate \| Industrial \| Net Asset Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities	[1]	0	0
Fixed maturity securities \| U.S. corporate \| Capital goods
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		2,138	2,745
Fixed maturity securities \| U.S. corporate \| Capital goods \| Net Asset Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities	[1]	0	0
Fixed maturity securities \| U.S. corporate \| Consumer-cyclical
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		1,617	1,899
Fixed maturity securities \| U.S. corporate \| Consumer-cyclical \| Net Asset Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities	[1]	0	0
Fixed maturity securities \| U.S. corporate \| Transportation
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		1,100	1,371
Fixed maturity securities \| U.S. corporate \| Transportation \| Net Asset Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities	[1]	0	0
Fixed maturity securities \| U.S. corporate \| Other
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		310	419
Fixed maturity securities \| U.S. corporate \| Other \| Net Asset Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities	[1]	0	0
Fixed maturity securities \| Non-U.S. corporate
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		8,010	10,535
Fixed maturity securities \| Non-U.S. corporate \| Net Asset Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities	[1]	0	0
Fixed maturity securities \| Non-U.S. corporate \| Utilities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		740	928
Fixed maturity securities \| Non-U.S. corporate \| Utilities \| Net Asset Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities	[1]	0	0
Fixed maturity securities \| Non-U.S. corporate \| Energy
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		960	1,383
Fixed maturity securities \| Non-U.S. corporate \| Energy \| Net Asset Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities	[1]	0	0
Fixed maturity securities \| Non-U.S. corporate \| Finance and insurance
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		1,946	2,432
Fixed maturity securities \| Non-U.S. corporate \| Finance and insurance \| Net Asset Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities	[1]	0	0
Fixed maturity securities \| Non-U.S. corporate \| Consumer-non-cyclical
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		566	743
Fixed maturity securities \| Non-U.S. corporate \| Consumer-non-cyclical \| Net Asset Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities	[1]	0	0
Fixed maturity securities \| Non-U.S. corporate \| Technology and communications
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		894	1,250
Fixed maturity securities \| Non-U.S. corporate \| Technology and communications \| Net Asset Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities	[1]	0	0
Fixed maturity securities \| Non-U.S. corporate \| Industrial
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		818	1,047
Fixed maturity securities \| Non-U.S. corporate \| Industrial \| Net Asset Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities	[1]	0	0
Fixed maturity securities \| Non-U.S. corporate \| Capital goods
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		546	705
Fixed maturity securities \| Non-U.S. corporate \| Capital goods \| Net Asset Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities	[1]	0	0
Fixed maturity securities \| Non-U.S. corporate \| Consumer-cyclical
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		276	341
Fixed maturity securities \| Non-U.S. corporate \| Consumer-cyclical \| Net Asset Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities	[1]	0	0
Fixed maturity securities \| Non-U.S. corporate \| Transportation
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		375	489
Fixed maturity securities \| Non-U.S. corporate \| Transportation \| Net Asset Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities	[1]	0	0
Fixed maturity securities \| Non-U.S. corporate \| Other
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		889	1,217
Fixed maturity securities \| Non-U.S. corporate \| Other \| Net Asset Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities	[1]	0	0
Fixed maturity securities \| Residential mortgage-backed
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		995	1,440
Fixed maturity securities \| Residential mortgage-backed \| Net Asset Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities	[1]	0	0
Fixed maturity securities \| Commercial mortgage-backed
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		1,908	2,584
Fixed maturity securities \| Commercial mortgage-backed \| Net Asset Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities	[1]	0	0
Fixed maturity securities \| Other asset-backed
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		2,166	2,160
Fixed maturity securities \| Other asset-backed \| Net Asset Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities	[1]	0	0
Limited Partnerships
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Limited partnerships		1,816	1,462
Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		0	0
Available-for-sale equity securities		239	101
Limited partnerships		0	0
Separate account assets		4,417	6,066
Total assets		4,656	6,167
Level 1 \| Other invested assets
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative assets, fair value		0	0
Short-term investments		0	0
Total other invested assets		0	0
Level 1 \| Interest rate swaps \| Other invested assets
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative assets, fair value		0	0
Level 1 \| Foreign currency swaps \| Other invested assets
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative assets, fair value		0	0
Level 1 \| Equity index options \| Other invested assets
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative assets, fair value		0	0
Level 1 \| Other foreign currency contracts \| Other invested assets
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative assets, fair value			0
Level 1 \| GMWB embedded derivatives \| Reinsurance recoverable
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative assets, fair value	[2]	0	0
Level 1 \| Fixed maturity securities \| U.S. government, agencies and government-sponsored enterprises
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		0	0
Level 1 \| Fixed maturity securities \| State and Political Subdivisions
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		0	0
Level 1 \| Fixed maturity securities \| Non-U.S. government
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		0	0
Level 1 \| Fixed maturity securities \| U.S. corporate
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		0	0
Level 1 \| Fixed maturity securities \| U.S. corporate \| Utilities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		0	0
Level 1 \| Fixed maturity securities \| U.S. corporate \| Energy
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		0	0
Level 1 \| Fixed maturity securities \| U.S. corporate \| Finance and insurance
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		0	0
Level 1 \| Fixed maturity securities \| U.S. corporate \| Consumer-non-cyclical
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		0	0
Level 1 \| Fixed maturity securities \| U.S. corporate \| Technology and communications
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		0	0
Level 1 \| Fixed maturity securities \| U.S. corporate \| Industrial
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		0	0
Level 1 \| Fixed maturity securities \| U.S. corporate \| Capital goods
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		0	0
Level 1 \| Fixed maturity securities \| U.S. corporate \| Consumer-cyclical
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		0	0
Level 1 \| Fixed maturity securities \| U.S. corporate \| Transportation
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		0	0
Level 1 \| Fixed maturity securities \| U.S. corporate \| Other
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		0	0
Level 1 \| Fixed maturity securities \| Non-U.S. corporate
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		0	0
Level 1 \| Fixed maturity securities \| Non-U.S. corporate \| Utilities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		0	0
Level 1 \| Fixed maturity securities \| Non-U.S. corporate \| Energy
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		0	0
Level 1 \| Fixed maturity securities \| Non-U.S. corporate \| Finance and insurance
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		0	0
Level 1 \| Fixed maturity securities \| Non-U.S. corporate \| Consumer-non-cyclical
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		0	0
Level 1 \| Fixed maturity securities \| Non-U.S. corporate \| Technology and communications
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		0	0
Level 1 \| Fixed maturity securities \| Non-U.S. corporate \| Industrial
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		0	0
Level 1 \| Fixed maturity securities \| Non-U.S. corporate \| Capital goods
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		0	0
Level 1 \| Fixed maturity securities \| Non-U.S. corporate \| Consumer-cyclical
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		0	0
Level 1 \| Fixed maturity securities \| Non-U.S. corporate \| Transportation
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		0	0
Level 1 \| Fixed maturity securities \| Non-U.S. corporate \| Other
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		0	0
Level 1 \| Fixed maturity securities \| Residential mortgage-backed
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		0	0
Level 1 \| Fixed maturity securities \| Commercial mortgage-backed
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		0	0
Level 1 \| Fixed maturity securities \| Other asset-backed
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		0	0
Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		43,393	56,672
Available-for-sale equity securities		46	60
Limited partnerships		0	0
Separate account assets		0	0
Total assets		43,486	57,130
Level 2 \| Other invested assets
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative assets, fair value		44	372
Short-term investments		3	26
Total other invested assets		47	398
Level 2 \| Interest rate swaps \| Other invested assets
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative assets, fair value		24	364
Level 2 \| Foreign currency swaps \| Other invested assets
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative assets, fair value		20	6
Level 2 \| Equity index options \| Other invested assets
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative assets, fair value		0	0
Level 2 \| Other foreign currency contracts \| Other invested assets
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative assets, fair value			2
Level 2 \| GMWB embedded derivatives \| Reinsurance recoverable
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative assets, fair value	[2]	0	0
Level 2 \| Fixed maturity securities \| U.S. government, agencies and government-sponsored enterprises
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		3,341	4,552
Level 2 \| Fixed maturity securities \| State and Political Subdivisions
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		2,344	3,368
Level 2 \| Fixed maturity securities \| Non-U.S. government
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		645	833
Level 2 \| Fixed maturity securities \| U.S. corporate
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		24,997	32,543
Level 2 \| Fixed maturity securities \| U.S. corporate \| Utilities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		3,056	4,154
Level 2 \| Fixed maturity securities \| U.S. corporate \| Energy
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		2,146	2,858
Level 2 \| Fixed maturity securities \| U.S. corporate \| Finance and insurance
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		6,506	8,306
Level 2 \| Fixed maturity securities \| U.S. corporate \| Consumer-non-cyclical
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		4,375	6,055
Level 2 \| Fixed maturity securities \| U.S. corporate \| Technology and communications
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		2,923	3,779
Level 2 \| Fixed maturity securities \| U.S. corporate \| Industrial
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		1,175	1,457
Level 2 \| Fixed maturity securities \| U.S. corporate \| Capital goods
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		2,104	2,700
Level 2 \| Fixed maturity securities \| U.S. corporate \| Consumer-cyclical
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		1,504	1,762
Level 2 \| Fixed maturity securities \| U.S. corporate \| Transportation
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		1,057	1,307
Level 2 \| Fixed maturity securities \| U.S. corporate \| Other
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		151	165
Level 2 \| Fixed maturity securities \| Non-U.S. corporate
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		7,125	9,373
Level 2 \| Fixed maturity securities \| Non-U.S. corporate \| Utilities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		445	583
Level 2 \| Fixed maturity securities \| Non-U.S. corporate \| Energy
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		842	1,238
Level 2 \| Fixed maturity securities \| Non-U.S. corporate \| Finance and insurance
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		1,821	2,272
Level 2 \| Fixed maturity securities \| Non-U.S. corporate \| Consumer-non-cyclical
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		493	680
Level 2 \| Fixed maturity securities \| Non-U.S. corporate \| Technology and communications
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		868	1,222
Level 2 \| Fixed maturity securities \| Non-U.S. corporate \| Industrial
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		770	954
Level 2 \| Fixed maturity securities \| Non-U.S. corporate \| Capital goods
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		451	532
Level 2 \| Fixed maturity securities \| Non-U.S. corporate \| Consumer-cyclical
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		212	265
Level 2 \| Fixed maturity securities \| Non-U.S. corporate \| Transportation
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		355	436
Level 2 \| Fixed maturity securities \| Non-U.S. corporate \| Other
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		868	1,191
Level 2 \| Fixed maturity securities \| Residential mortgage-backed
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		973	1,413
Level 2 \| Fixed maturity securities \| Commercial mortgage-backed
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		1,896	2,568
Level 2 \| Fixed maturity securities \| Other asset-backed
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		2,072	2,022
Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		3,190	3,808
Available-for-sale equity securities		34	37
Limited partnerships		24	26
Separate account assets		0	0
Total assets		3,270	3,932
Level 3 \| Other invested assets
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative assets, fair value		6	42
Short-term investments		0	0
Total other invested assets		6	42
Level 3 \| Interest rate swaps \| Other invested assets
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative assets, fair value		0	0
Level 3 \| Foreign currency swaps \| Other invested assets
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative assets, fair value		0	0
Level 3 \| Equity index options \| Other invested assets
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative assets, fair value		6	42
Level 3 \| Other foreign currency contracts \| Other invested assets
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative assets, fair value			0
Level 3 \| GMWB embedded derivatives \| Reinsurance recoverable
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative assets, fair value	[2]	16	19
Level 3 \| Fixed maturity securities \| U.S. government, agencies and government-sponsored enterprises
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		0	0
Level 3 \| Fixed maturity securities \| State and Political Subdivisions
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		55	82
Level 3 \| Fixed maturity securities \| Non-U.S. government
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		0	2
Level 3 \| Fixed maturity securities \| U.S. corporate
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		2,122	2,381
Level 3 \| Fixed maturity securities \| U.S. corporate \| Utilities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		842	950
Level 3 \| Fixed maturity securities \| U.S. corporate \| Energy
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		116	76
Level 3 \| Fixed maturity securities \| U.S. corporate \| Finance and insurance
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		687	685
Level 3 \| Fixed maturity securities \| U.S. corporate \| Consumer-non-cyclical
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		82	104
Level 3 \| Fixed maturity securities \| U.S. corporate \| Technology and communications
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		24	29
Level 3 \| Fixed maturity securities \| U.S. corporate \| Industrial
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		22	37
Level 3 \| Fixed maturity securities \| U.S. corporate \| Capital goods
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		34	45
Level 3 \| Fixed maturity securities \| U.S. corporate \| Consumer-cyclical
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		113	137
Level 3 \| Fixed maturity securities \| U.S. corporate \| Transportation
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		43	64
Level 3 \| Fixed maturity securities \| U.S. corporate \| Other
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		159	254
Level 3 \| Fixed maturity securities \| Non-U.S. corporate
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		885	1,162
Level 3 \| Fixed maturity securities \| Non-U.S. corporate \| Utilities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		295	345
Level 3 \| Fixed maturity securities \| Non-U.S. corporate \| Energy
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		118	145
Level 3 \| Fixed maturity securities \| Non-U.S. corporate \| Finance and insurance
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		125	160
Level 3 \| Fixed maturity securities \| Non-U.S. corporate \| Consumer-non-cyclical
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		73	63
Level 3 \| Fixed maturity securities \| Non-U.S. corporate \| Technology and communications
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		26	28
Level 3 \| Fixed maturity securities \| Non-U.S. corporate \| Industrial
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		48	93
Level 3 \| Fixed maturity securities \| Non-U.S. corporate \| Capital goods
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		95	173
Level 3 \| Fixed maturity securities \| Non-U.S. corporate \| Consumer-cyclical
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		64	76
Level 3 \| Fixed maturity securities \| Non-U.S. corporate \| Transportation
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		20	53
Level 3 \| Fixed maturity securities \| Non-U.S. corporate \| Other
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		21	26
Level 3 \| Fixed maturity securities \| Residential mortgage-backed
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		22	27
Level 3 \| Fixed maturity securities \| Commercial mortgage-backed
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		12	16
Level 3 \| Fixed maturity securities \| Other asset-backed
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		$ 94	$ 138

[1]Limited partnerships that are measured at fair value using the NAV per share (or its equivalent) practical expedient have not been categorized in the fair value hierarchy.[2]Represents embedded derivatives associated with the reinsured portion of our GMWB liabilities.

Assets Measured at Fair Value o

Assets Measured at Fair Value on Recurring Basis and Utilized Significant Unobservable (Level 3) Inputs to Determine Fair Value (Detail) - USD ($) $ in Millions		12 Months Ended
		Dec. 31, 2022		Dec. 31, 2021		Dec. 31, 2020
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Beginning balance		$ 3,932		$ 4,246		$ 4,320
Total realized and unrealized gains (losses), Included in net income		$ (18)		$ 28		$ 38
Fair Value, Asset, Recurring Basis, Unobservable Input Reconciliation, Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration]		Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest		Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest		Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest
Total realized and unrealized gains (losses), Included in OCI		$ (710)		$ (16)		$ 60
Fair Value, Asset, Recurring Basis, Unobservable Input Reconciliation, Asset, Gain (Loss), Statement of Other Comprehensive Income or Comprehensive Income [Extensible Enumeration]		Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest		Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest		Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest
Purchases		$ 526		$ 641		$ 704
Sales		(84)		(11)		(41)
Issuances		1		2		2
Settlements		(275)		(478)		(486)
Transfer into Level 3		139	[1]	186	[1]	529	[2]
Transfer out of Level 3		(241)	[1]	(666)	[1]	(880)	[2]
Ending balance		3,270		3,932		4,246
Total gains (losses) included in net income attributable to assets still held		$ (5)		$ 11		$ 14
Fair Value, Asset, Recurring Basis, Still Held, Unrealized Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration]		Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest		Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest		Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest
Total gains (losses) included in OCI attributable to assets still held		$ (700)		$ (29)		$ 76
Other invested assets
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Beginning balance		42		63		81
Total realized and unrealized gains (losses), Included in net income		(20)		18		4
Total realized and unrealized gains (losses), Included in OCI		0		0		0
Purchases		13		31		59
Sales		0		0		0
Issuances		0		0		0
Settlements		(29)		(70)		(81)
Transfer into Level 3		0	[1]	0	[1]	0	[2]
Transfer out of Level 3		0	[1]	0	[1]	0	[2]
Ending balance		6		42		63
Total gains (losses) included in net income attributable to assets still held		(7)		10		5
Total gains (losses) included in OCI attributable to assets still held		0		0		0
Other invested assets \| Derivative assets
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Beginning balance		42		63		81
Total realized and unrealized gains (losses), Included in net income		(20)		18		4
Total realized and unrealized gains (losses), Included in OCI		0		0		0
Purchases		13		31		59
Sales		0		0		0
Issuances		0		0		0
Settlements		(29)		(70)		(81)
Transfer into Level 3		0	[1]	0	[1]	0	[2]
Transfer out of Level 3		0	[1]	0	[1]	0	[2]
Ending balance		6		42		63
Total gains (losses) included in net income attributable to assets still held		(7)		10		5
Total gains (losses) included in OCI attributable to assets still held		0		0		0
Other invested assets \| Derivative assets \| Equity index options
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Beginning balance		42		63		81
Total realized and unrealized gains (losses), Included in net income		(20)		18		4
Total realized and unrealized gains (losses), Included in OCI		0		0		0
Purchases		13		31		59
Sales		0		0		0
Issuances		0		0		0
Settlements		(29)		(70)		(81)
Transfer into Level 3		0	[1]	0	[1]	0	[2]
Transfer out of Level 3		0	[1]	0	[1]	0	[2]
Ending balance		6		42		63
Total gains (losses) included in net income attributable to assets still held		(7)		10		5
Total gains (losses) included in OCI attributable to assets still held		0		0		0
Reinsurance recoverable
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Beginning balance		19	[3]	26	[2]	20
Total realized and unrealized gains (losses), Included in net income		(4)	[3]	(9)	[2]	4
Total realized and unrealized gains (losses), Included in OCI		0	[3]	0	[2]	0
Purchases		0	[3]	0	[2]	0
Sales		0	[3]	0	[2]	0
Issuances		1	[3]	2	[2]	2
Settlements		0	[3]	0	[2]	0
Transfer into Level 3		0	[1],[3]	0	[2]	0	[2]
Transfer out of Level 3		0	[1],[3]	0	[2]	0	[2]
Ending balance		16	[3]	19	[3]	26	[2]
Total gains (losses) included in net income attributable to assets still held		(4)	[3]	(9)	[2]	4
Total gains (losses) included in OCI attributable to assets still held		0	[3]	0	[2]	0
Fixed maturity securities
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Beginning balance		3,808		4,089		4,152
Total realized and unrealized gains (losses), Included in net income		8		18		32
Total realized and unrealized gains (losses), Included in OCI		(710)		(16)		60
Purchases		512		602		636
Sales		(81)		(2)		(34)
Issuances		0		0		0
Settlements		(246)		(403)		(405)
Transfer into Level 3	[1]	139		186		528
Transfer out of Level 3	[1]	(240)		(666)		(880)
Ending balance		3,190		3,808		4,089
Total gains (losses) included in net income attributable to assets still held		8		9		7
Total gains (losses) included in OCI attributable to assets still held		(700)		(29)		76
Fixed maturity securities \| State and political subdivisions
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Beginning balance		82		66		102
Total realized and unrealized gains (losses), Included in net income		3		3		3
Total realized and unrealized gains (losses), Included in OCI		(30)		13		(11)
Purchases		0		0		0
Sales		0		0		0
Issuances		0		0		0
Settlements		0		0		(1)
Transfer into Level 3	[1]	0		0		0
Transfer out of Level 3	[1]	0		0		(27)
Ending balance		55		82		66
Total gains (losses) included in net income attributable to assets still held		3		3		3
Total gains (losses) included in OCI attributable to assets still held		(31)		13		(11)
Fixed maturity securities \| U.S. corporate
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Beginning balance		2,381		2,272		2,239
Total realized and unrealized gains (losses), Included in net income		0		0		15
Total realized and unrealized gains (losses), Included in OCI		(459)		(17)		37
Purchases		351		430		403
Sales		(41)		0		(34)
Issuances		0		0		0
Settlements		(92)		(153)		(196)
Transfer into Level 3	[1]	79		138		274
Transfer out of Level 3	[1]	(97)		(289)		(466)
Ending balance		2,122		2,381		2,272
Total gains (losses) included in net income attributable to assets still held		0		0		0
Total gains (losses) included in OCI attributable to assets still held		(453)		(17)		50
Fixed maturity securities \| U.S. corporate \| Utilities
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Beginning balance		950		842		865
Total realized and unrealized gains (losses), Included in net income		0		0		9
Total realized and unrealized gains (losses), Included in OCI		(211)		3		8
Purchases		130		118		76
Sales		0		0		(13)
Issuances		0		0		0
Settlements		(19)		(18)		(56)
Transfer into Level 3	[1]	3		18		42
Transfer out of Level 3	[1]	(11)		(13)		(89)
Ending balance		842		950		842
Total gains (losses) included in net income attributable to assets still held		0		0		0
Total gains (losses) included in OCI attributable to assets still held		(210)		4		14
Fixed maturity securities \| U.S. corporate \| Energy
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Beginning balance		76		128		129
Total realized and unrealized gains (losses), Included in net income		0		0		1
Total realized and unrealized gains (losses), Included in OCI		(19)		4		1
Purchases		0		50		30
Sales		0		0		(21)
Issuances		0		0		0
Settlements		(9)		(10)		(21)
Transfer into Level 3	[1]	68		8		22
Transfer out of Level 3	[1]	0		(104)		(13)
Ending balance		116		76		128
Total gains (losses) included in net income attributable to assets still held		0		0		0
Total gains (losses) included in OCI attributable to assets still held		(20)		1		(3)
Fixed maturity securities \| U.S. corporate \| Finance and insurance
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Beginning balance		685		607		572
Total realized and unrealized gains (losses), Included in net income		0		0		2
Total realized and unrealized gains (losses), Included in OCI		(147)		(18)		16
Purchases		216		233		167
Sales		0		0		0
Issuances		0		0		0
Settlements		(19)		(46)		(41)
Transfer into Level 3	[1]	8		17		0
Transfer out of Level 3	[1]	(56)		(108)		(109)
Ending balance		687		685		607
Total gains (losses) included in net income attributable to assets still held		0		0		0
Total gains (losses) included in OCI attributable to assets still held		(141)		(16)		19
Fixed maturity securities \| U.S. corporate \| Consumer-non-cyclical
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Beginning balance		104		109		94
Total realized and unrealized gains (losses), Included in net income		0		0		0
Total realized and unrealized gains (losses), Included in OCI		(13)		(2)		4
Purchases		0		0		8
Sales		0		0		0
Issuances		0		0		0
Settlements		(9)		(3)		(22)
Transfer into Level 3	[1]	0		3		25
Transfer out of Level 3	[1]	0		(3)		0
Ending balance		82		104		109
Total gains (losses) included in net income attributable to assets still held		0		0		0
Total gains (losses) included in OCI attributable to assets still held		(13)		(2)		4
Fixed maturity securities \| U.S. corporate \| Technology and communications
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Beginning balance		29		47		50
Total realized and unrealized gains (losses), Included in net income		0		0		0
Total realized and unrealized gains (losses), Included in OCI		(5)		(1)		3
Purchases		0		12		82
Sales		0		0		0
Issuances		0		0		0
Settlements		0		0		(1)
Transfer into Level 3	[1]	0		4		13
Transfer out of Level 3	[1]	0		(33)		(100)
Ending balance		24		29		47
Total gains (losses) included in net income attributable to assets still held		0		0		0
Total gains (losses) included in OCI attributable to assets still held		(5)		(1)		5
Fixed maturity securities \| U.S. corporate \| Industrial
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Beginning balance		37		40		40
Total realized and unrealized gains (losses), Included in net income		0		0		0
Total realized and unrealized gains (losses), Included in OCI		(4)		0		0
Purchases		0		17		0
Sales		0		0		0
Issuances		0		0		0
Settlements		(11)		(20)		0
Transfer into Level 3	[1]	0		0		0
Transfer out of Level 3	[1]	0		0		0
Ending balance		22		37		40
Total gains (losses) included in net income attributable to assets still held		0		0		0
Total gains (losses) included in OCI attributable to assets still held		(4)		(1)		0
Fixed maturity securities \| U.S. corporate \| Capital goods
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Beginning balance		45		60		102
Total realized and unrealized gains (losses), Included in net income		0		0		0
Total realized and unrealized gains (losses), Included in OCI		(7)		(1)		0
Purchases		0		0		0
Sales		0		0		0
Issuances		0		0		0
Settlements		(4)		(14)		(8)
Transfer into Level 3	[1]	0		0		11
Transfer out of Level 3	[1]	0		0		(45)
Ending balance		34		45		60
Total gains (losses) included in net income attributable to assets still held		0		0		0
Total gains (losses) included in OCI attributable to assets still held		(7)		(2)		1
Fixed maturity securities \| U.S. corporate \| Consumer-cyclical
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Beginning balance		137		150		173
Total realized and unrealized gains (losses), Included in net income		0		0		3
Total realized and unrealized gains (losses), Included in OCI		(18)		0		4
Purchases		0		0		15
Sales		0		0		0
Issuances		0		0		0
Settlements		(6)		(5)		(36)
Transfer into Level 3	[1]	0		0		47
Transfer out of Level 3	[1]	0		(8)		(56)
Ending balance		113		137		150
Total gains (losses) included in net income attributable to assets still held		0		0		0
Total gains (losses) included in OCI attributable to assets still held		(18)		0		6
Fixed maturity securities \| U.S. corporate \| Transportation
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Beginning balance		64		70		78
Total realized and unrealized gains (losses), Included in net income		0		0		0
Total realized and unrealized gains (losses), Included in OCI		(8)		(1)		(1)
Purchases		5		0		0
Sales		0		0		0
Issuances		0		0		0
Settlements		(5)		(5)		(4)
Transfer into Level 3	[1]	0		0		27
Transfer out of Level 3	[1]	(13)		0		(30)
Ending balance		43		64		70
Total gains (losses) included in net income attributable to assets still held		0		0		0
Total gains (losses) included in OCI attributable to assets still held		(7)		(1)		2
Fixed maturity securities \| U.S. corporate \| Other
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Beginning balance		254		219		136
Total realized and unrealized gains (losses), Included in net income		0		0		0
Total realized and unrealized gains (losses), Included in OCI		(27)		(1)		2
Purchases		0		0		25
Sales		(41)		0		0
Issuances		0		0		0
Settlements		(10)		(32)		(7)
Transfer into Level 3	[1]	0		88		87
Transfer out of Level 3	[1]	(17)		(20)		(24)
Ending balance		159		254		219
Total gains (losses) included in net income attributable to assets still held		0		0		0
Total gains (losses) included in OCI attributable to assets still held		(28)		1		2
Fixed maturity securities \| Non-U.S. corporate
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Beginning balance		1,162		1,608		1,685
Total realized and unrealized gains (losses), Included in net income		5		15		14
Total realized and unrealized gains (losses), Included in OCI		(193)		(10)		33
Purchases		68		95		109
Sales		(31)		(2)		0
Issuances		0		0		0
Settlements		(144)		(220)		(190)
Transfer into Level 3	[1]	55		3		219
Transfer out of Level 3	[1]	(37)		(327)		(262)
Ending balance		885		1,162		1,608
Total gains (losses) included in net income attributable to assets still held		5		5		4
Total gains (losses) included in OCI attributable to assets still held		(191)		(23)		36
Fixed maturity securities \| Non-U.S. corporate \| Utilities
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Beginning balance		345		352		374
Total realized and unrealized gains (losses), Included in net income		0		0		0
Total realized and unrealized gains (losses), Included in OCI		(56)		(5)		10
Purchases		24		30		13
Sales		0		0		0
Issuances		0		0		0
Settlements		(18)		(8)		0
Transfer into Level 3	[1]	0		0		28
Transfer out of Level 3	[1]	0		(24)		(73)
Ending balance		295		345		352
Total gains (losses) included in net income attributable to assets still held		0		0		0
Total gains (losses) included in OCI attributable to assets still held		(55)		(6)		9
Fixed maturity securities \| Non-U.S. corporate \| Energy
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Beginning balance		145		245		247
Total realized and unrealized gains (losses), Included in net income		0		0		0
Total realized and unrealized gains (losses), Included in OCI		(15)		7		(5)
Purchases		13		0		7
Sales		(21)		0		0
Issuances		0		0		0
Settlements		(24)		(28)		(28)
Transfer into Level 3	[1]	20		0		24
Transfer out of Level 3	[1]	0		(79)		0
Ending balance		118		145		245
Total gains (losses) included in net income attributable to assets still held		0		0		0
Total gains (losses) included in OCI attributable to assets still held		(15)		3		(5)
Fixed maturity securities \| Non-U.S. corporate \| Finance and insurance
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Beginning balance		160		305		234
Total realized and unrealized gains (losses), Included in net income		5		3		4
Total realized and unrealized gains (losses), Included in OCI		(40)		(1)		17
Purchases		0		1		15
Sales		0		(2)		0
Issuances		0		0		0
Settlements		0		(62)		(10)
Transfer into Level 3	[1]	0		0		77
Transfer out of Level 3	[1]	0		(84)		(32)
Ending balance		125		160		305
Total gains (losses) included in net income attributable to assets still held		5		5		4
Total gains (losses) included in OCI attributable to assets still held		(41)		(14)		17
Fixed maturity securities \| Non-U.S. corporate \| Consumer-non-cyclical
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Beginning balance		63		67		59
Total realized and unrealized gains (losses), Included in net income		0		1		0
Total realized and unrealized gains (losses), Included in OCI		(8)		(2)		3
Purchases		9		8		20
Sales		0		0		0
Issuances		0		0		0
Settlements		0		(14)		0
Transfer into Level 3	[1]	18		3		1
Transfer out of Level 3	[1]	(9)		0		(16)
Ending balance		73		63		67
Total gains (losses) included in net income attributable to assets still held		0		0		0
Total gains (losses) included in OCI attributable to assets still held		(8)		(2)		2
Fixed maturity securities \| Non-U.S. corporate \| Technology and communications
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Beginning balance		28		28		28
Total realized and unrealized gains (losses), Included in net income		0		0		0
Total realized and unrealized gains (losses), Included in OCI		(2)		0		0
Purchases		0		0		0
Sales		0		0		0
Issuances		0		0		0
Settlements		0		0		0
Transfer into Level 3	[1]	0		0		0
Transfer out of Level 3	[1]	0		0		0
Ending balance		26		28		28
Total gains (losses) included in net income attributable to assets still held		0		0		0
Total gains (losses) included in OCI attributable to assets still held		(2)		(1)		1
Fixed maturity securities \| Non-U.S. corporate \| Industrial
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Beginning balance		93		95		104
Total realized and unrealized gains (losses), Included in net income		0		2		0
Total realized and unrealized gains (losses), Included in OCI		(33)		(4)		4
Purchases		22		14		0
Sales		0		0		0
Issuances		0		0		0
Settlements		(20)		(14)		(5)
Transfer into Level 3	[1]	0		0		0
Transfer out of Level 3	[1]	(14)		0		(8)
Ending balance		48		93		95
Total gains (losses) included in net income attributable to assets still held		0		0		0
Total gains (losses) included in OCI attributable to assets still held		(31)		(2)		3
Fixed maturity securities \| Non-U.S. corporate \| Capital goods
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Beginning balance		173		178		161
Total realized and unrealized gains (losses), Included in net income		0		0		1
Total realized and unrealized gains (losses), Included in OCI		(16)		1		1
Purchases		0		25		20
Sales		(10)		0		0
Issuances		0		0		0
Settlements		(52)		0		(39)
Transfer into Level 3	[1]	0		0		34
Transfer out of Level 3	[1]	0		(31)		0
Ending balance		95		173		178
Total gains (losses) included in net income attributable to assets still held		0		0		0
Total gains (losses) included in OCI attributable to assets still held		(16)		0		1
Fixed maturity securities \| Non-U.S. corporate \| Consumer-cyclical
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Beginning balance		76		146		147
Total realized and unrealized gains (losses), Included in net income		0		0		0
Total realized and unrealized gains (losses), Included in OCI		(15)		0		3
Purchases		0		17		21
Sales		0		0		0
Issuances		0		0		0
Settlements		0		0		(26)
Transfer into Level 3	[1]	17		0		32
Transfer out of Level 3	[1]	(14)		(87)		(31)
Ending balance		64		76		146
Total gains (losses) included in net income attributable to assets still held		0		0		0
Total gains (losses) included in OCI attributable to assets still held		(16)		0		2
Fixed maturity securities \| Non-U.S. corporate \| Transportation
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Beginning balance		53		109		191
Total realized and unrealized gains (losses), Included in net income		0		3		0
Total realized and unrealized gains (losses), Included in OCI		(3)		(3)		1
Purchases		0		0		7
Sales		0		0		0
Issuances		0		0		0
Settlements		(30)		(49)		(10)
Transfer into Level 3	[1]	0		0		22
Transfer out of Level 3	[1]	0		(7)		(102)
Ending balance		20		53		109
Total gains (losses) included in net income attributable to assets still held		0		0		0
Total gains (losses) included in OCI attributable to assets still held		(3)		0		4
Fixed maturity securities \| Non-U.S. corporate \| Other
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Beginning balance		26		83		140
Total realized and unrealized gains (losses), Included in net income		0		6		9
Total realized and unrealized gains (losses), Included in OCI		(5)		(3)		(1)
Purchases		0		0		6
Sales		0		0		0
Issuances		0		0		0
Settlements		0		(45)		(72)
Transfer into Level 3	[1]	0		0		1
Transfer out of Level 3	[1]	0		(15)		0
Ending balance		21		26		83
Total gains (losses) included in net income attributable to assets still held		0		0		0
Total gains (losses) included in OCI attributable to assets still held		(4)		(1)		2
Fixed maturity securities \| Residential mortgage-backed
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Beginning balance		27		14		27
Total realized and unrealized gains (losses), Included in net income		0		0		0
Total realized and unrealized gains (losses), Included in OCI		(8)		0		(1)
Purchases		14		5		0
Sales		0		0		0
Issuances		0		0		0
Settlements		(2)		(2)		(1)
Transfer into Level 3	[1]	4		10		4
Transfer out of Level 3	[1]	(13)		0		(15)
Ending balance		22		27		14
Total gains (losses) included in net income attributable to assets still held		0		0		0
Total gains (losses) included in OCI attributable to assets still held		(6)		0		0
Fixed maturity securities \| Commercial mortgage-backed
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Beginning balance		16		20		6
Total realized and unrealized gains (losses), Included in net income		0		0		0
Total realized and unrealized gains (losses), Included in OCI		(5)		(2)		1
Purchases		0		1		0
Sales		0		0		0
Issuances		0		0		0
Settlements		0		(3)		0
Transfer into Level 3	[1]	1		0		20
Transfer out of Level 3	[1]	0		0		(7)
Ending balance		12		16		20
Total gains (losses) included in net income attributable to assets still held		0		1		0
Total gains (losses) included in OCI attributable to assets still held		(6)		(2)		1
Fixed maturity securities \| Other asset-backed
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Beginning balance		138		109		93
Total realized and unrealized gains (losses), Included in net income		0		0		0
Total realized and unrealized gains (losses), Included in OCI		(15)		0		1
Purchases		77		69		124
Sales		(6)		0		0
Issuances		0		0		0
Settlements		(7)		(25)		(16)
Transfer into Level 3	[1]	0		35		10
Transfer out of Level 3	[1]	(93)		(50)		(103)
Ending balance		94		138		109
Total gains (losses) included in net income attributable to assets still held		0		0		0
Total gains (losses) included in OCI attributable to assets still held		(13)		0		0
Fixed maturity securities \| Non-U.S. government
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Beginning balance		2		0		0
Total realized and unrealized gains (losses), Included in net income		0		0		0
Total realized and unrealized gains (losses), Included in OCI		0		0		0
Purchases		2		2		0
Sales		(3)		0		0
Issuances		0		0		0
Settlements		(1)		0		(1)
Transfer into Level 3		0	[1]	0	[1]	1
Transfer out of Level 3	[1]	0		0		0
Ending balance		0		2		0
Total gains (losses) included in net income attributable to assets still held		0		0		0
Total gains (losses) included in OCI attributable to assets still held		0		0		0
Equity Securities
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Beginning balance		37		51		51
Total realized and unrealized gains (losses), Included in net income		0		0		0
Total realized and unrealized gains (losses), Included in OCI		0		0		0
Purchases		1		0		6
Sales		(3)		(9)		(7)
Issuances		0		0		0
Settlements		0		(5)		0
Transfer into Level 3		0	[1]	0	[1]	1	[2]
Transfer out of Level 3		(1)	[1]	0	[1]	0	[2]
Ending balance		34		37		51
Total gains (losses) included in net income attributable to assets still held		0		0		0
Total gains (losses) included in OCI attributable to assets still held		0		0		0
Limited Partnerships
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Beginning balance		26		17		16
Total realized and unrealized gains (losses), Included in net income		(2)		1		(2)
Total realized and unrealized gains (losses), Included in OCI		0		0		0
Purchases		0		8		3
Sales		0		0		0
Issuances		0		0		0
Settlements		0		0		0
Transfer into Level 3		0	[1]	0	[1]	0	[2]
Transfer out of Level 3		0	[1]	0	[1]	0	[2]
Ending balance		24		26		17
Total gains (losses) included in net income attributable to assets still held		(2)		1		(2)
Total gains (losses) included in OCI attributable to assets still held		$ 0		$ 0		$ 0

[1]The transfers into and out of Level 3 for fixed maturity securities were related to changes in the primary pricing source and changes in the observability of external information used in determining the fair value, such as external ratings or credit spreads, as well as changes in the industry sectors assigned to specific securities.[2]Represents embedded derivatives associated with our GMWB liabilities, excluding the impact of reinsurance.[3]Represents embedded derivatives associated with the reinsured portion of our GMWB liabilities.

Gains and Losses Included in Ne

Gains and Losses Included in Net Income (Loss) from Assets Measured at Fair Value (Detail) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Fair value of financial instruments [Abstract]
Total realized and unrealized gains (losses) included in net income, assets	$ (18)	$ 28	$ 38
Fair Value, Asset, Recurring Basis, Unobservable Input Reconciliation, Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration]	Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest	Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest	Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest
Total gains (losses) included in net income attributable to assets still held, assets	$ (5)	$ 11	$ 14
Fair Value, Asset, Recurring Basis, Still Held, Unrealized Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration]	Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest	Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest	Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest
Net Investment Income
Fair value of financial instruments [Abstract]
Total realized and unrealized gains (losses) included in net income, assets	$ 8	$ 19	$ 32
Fair Value, Asset, Recurring Basis, Unobservable Input Reconciliation, Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration]	Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest	Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest	Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest
Total gains (losses) included in net income attributable to assets still held, assets	$ 8	$ 9	$ 7
Fair Value, Asset, Recurring Basis, Still Held, Unrealized Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration]	Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest	Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest	Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest
Net investment gains (losses)
Fair value of financial instruments [Abstract]
Total realized and unrealized gains (losses) included in net income, assets	$ (26)	$ 9	$ 6
Fair Value, Asset, Recurring Basis, Unobservable Input Reconciliation, Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration]	Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest	Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest	Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest
Total gains (losses) included in net income attributable to assets still held, assets	$ (13)	$ 2	$ 7
Fair Value, Asset, Recurring Basis, Still Held, Unrealized Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration]	Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest	Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest	Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest

Summary of Significant Unobserv

Summary of Significant Unobservable Inputs Used for Fair Value Measurements Classified As Level 3 (Detail) $ in Millions		12 Months Ended
		Dec. 31, 2022 USD ($) bps		Dec. 31, 2021 USD ($)
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Derivative liabilities, fair value \| $		$ 962		$ 616
Fixed maturity securities available-for-sale, at fair value \| $		46,583		60,480
Derivative assets, fair value \| $		66		433
Policyholder account balances
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Derivative liabilities, fair value \| $		440		590
Policyholder account balances \| GMWB embedded derivatives
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Derivative liabilities, fair value \| $	[1]	223		271
Policyholder account balances \| Fixed index annuity embedded derivatives
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Derivative liabilities, fair value \| $		202		294
Policyholder account balances \| Indexed universal life embedded derivatives
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Derivative liabilities, fair value \| $		15		25
Level 3
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Fixed maturity securities available-for-sale, at fair value \| $		$ 3,190		3,808
Level 3 \| Other invested assets \| Equity index options
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Valuation technique		Discounted cash flows
Derivative assets, fair value \| $		$ 6
Fair value input, equity index volatility, lower limit		6%
Fair value input, equity index volatility, upper limit		25%
Fair value input, equity index volatility, weighted-average	[2]	20%
Level 3 \| Policyholder account balances
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Derivative liabilities, fair value \| $		$ 440		590
Level 3 \| Policyholder account balances \| GMWB embedded derivatives
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Valuation technique	[3]	Stochastic cash flow model
Derivative liabilities, fair value \| $	[1]	$ 223	[3],[4]	271
Fair value, withdrawal utilization rate, lower limit		61%
Fair value, withdrawal utilization rate, upper limit		89%
Fair value, lapse rate, lower limit		2%
Fair value, lapse rate, upper limit		9%
Fair value input, credit spreads, lower limit		40
Fair value input, credit spreads, upper limit		83
Fair value input, credit spreads, weighted-average	[4]	69
Fair value input, equity index volatility, lower limit	[3]	21%
Fair value input, equity index volatility, upper limit	[3]	31%
Fair value, withdrawal utilization rate, weighted-average	[4]	77%
Fair value, lapse rate, weighted-average	[4]	2%
Fair value input, equity index volatility, weighted-average	[3],[4]	25%
Level 3 \| Policyholder account balances \| Fixed index annuity embedded derivatives
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Valuation technique		Option budget method
Derivative liabilities, fair value \| $		$ 202		294
Fair value, expected future interest credited, lower limit		0%
Fair value, expected future interest credited, upper limit		3%
Fair value, expected future interest credited, weighted-average	[4]	1%
Level 3 \| Policyholder account balances \| Indexed universal life embedded derivatives
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Valuation technique		Option budget method
Derivative liabilities, fair value \| $		$ 15		$ 25
Fair value, expected future interest credited, lower limit		2%
Fair value, expected future interest credited, upper limit		14%
Fair value, expected future interest credited, weighted-average	[4]	5%
Internal Models \| Level 3 \| U.S. corporate
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Valuation technique		Internal models
Fixed maturity securities available-for-sale, at fair value \| $		$ 1,961
Fair value input, credit spreads, lower limit		49
Fair value input, credit spreads, upper limit		292
Fair value input, credit spreads, weighted-average	[2]	176
Internal Models \| Level 3 \| Non-U.S. corporate
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Valuation technique		Internal models
Fixed maturity securities available-for-sale, at fair value \| $		$ 858
Fair value input, credit spreads, lower limit		71
Fair value input, credit spreads, upper limit		272
Fair value input, credit spreads, weighted-average	[2]	150
Internal Models \| Level 3 \| Utilities \| U.S. corporate
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Valuation technique		Internal models
Fixed maturity securities available-for-sale, at fair value \| $		$ 813
Fair value input, credit spreads, lower limit		55
Fair value input, credit spreads, upper limit		279
Fair value input, credit spreads, weighted-average	[2]	168
Internal Models \| Level 3 \| Utilities \| Non-U.S. corporate
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Valuation technique		Internal models
Fixed maturity securities available-for-sale, at fair value \| $		$ 295
Fair value input, credit spreads, lower limit		82
Fair value input, credit spreads, upper limit		224
Fair value input, credit spreads, weighted-average	[2]	145
Internal Models \| Level 3 \| Energy \| U.S. corporate
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Valuation technique		Internal models
Fixed maturity securities available-for-sale, at fair value \| $		$ 45
Fair value input, credit spreads, lower limit		132
Fair value input, credit spreads, upper limit		272
Fair value input, credit spreads, weighted-average	[2]	197
Internal Models \| Level 3 \| Energy \| Non-U.S. corporate
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Valuation technique		Internal models
Fixed maturity securities available-for-sale, at fair value \| $		$ 110
Fair value input, credit spreads, lower limit		102
Fair value input, credit spreads, upper limit		239
Fair value input, credit spreads, weighted-average	[2]	171
Internal Models \| Level 3 \| Finance and insurance \| U.S. corporate
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Valuation technique		Internal models
Fixed maturity securities available-for-sale, at fair value \| $		$ 674
Fair value input, credit spreads, lower limit		67
Fair value input, credit spreads, upper limit		292
Fair value input, credit spreads, weighted-average	[2]	208
Internal Models \| Level 3 \| Finance and insurance \| Non-U.S. corporate
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Valuation technique		Internal models
Fixed maturity securities available-for-sale, at fair value \| $		$ 124
Fair value input, credit spreads, lower limit		136
Fair value input, credit spreads, upper limit		203
Fair value input, credit spreads, weighted-average	[2]	161
Internal Models \| Level 3 \| Consumer-non-cyclical \| U.S. corporate
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Valuation technique		Internal models
Fixed maturity securities available-for-sale, at fair value \| $		$ 82
Fair value input, credit spreads, lower limit		71
Fair value input, credit spreads, upper limit		272
Fair value input, credit spreads, weighted-average	[2]	152
Internal Models \| Level 3 \| Consumer-non-cyclical \| Non-U.S. corporate
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Valuation technique		Internal models
Fixed maturity securities available-for-sale, at fair value \| $		$ 70
Fair value input, credit spreads, lower limit		71
Fair value input, credit spreads, upper limit		163
Fair value input, credit spreads, weighted-average	[2]	110
Internal Models \| Level 3 \| Technology and communications \| U.S. corporate
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Valuation technique		Internal models
Fixed maturity securities available-for-sale, at fair value \| $		$ 24
Fair value input, credit spreads, lower limit		113
Fair value input, credit spreads, upper limit		181
Fair value input, credit spreads, weighted-average	[2]	153
Internal Models \| Level 3 \| Technology and communications \| Non-U.S. corporate
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Valuation technique		Internal models
Fixed maturity securities available-for-sale, at fair value \| $		$ 25
Fair value input, credit spreads, lower limit		102
Fair value input, credit spreads, upper limit		138
Fair value input, credit spreads, weighted-average	[2]	126
Internal Models \| Level 3 \| Industrial \| U.S. corporate
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Valuation technique		Internal models
Fixed maturity securities available-for-sale, at fair value \| $		$ 22
Fair value input, credit spreads, lower limit		132
Fair value input, credit spreads, upper limit		239
Fair value input, credit spreads, weighted-average	[2]	161
Internal Models \| Level 3 \| Industrial \| Non-U.S. corporate
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Valuation technique		Internal models
Fixed maturity securities available-for-sale, at fair value \| $		$ 48
Fair value input, credit spreads, lower limit		85
Fair value input, credit spreads, upper limit		197
Fair value input, credit spreads, weighted-average	[2]	149
Internal Models \| Level 3 \| Capital goods \| U.S. corporate
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Valuation technique		Internal models
Fixed maturity securities available-for-sale, at fair value \| $		$ 34
Fair value input, credit spreads, lower limit		85
Fair value input, credit spreads, upper limit		211
Fair value input, credit spreads, weighted-average	[2]	159
Internal Models \| Level 3 \| Capital goods \| Non-U.S. corporate
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Valuation technique		Internal models
Fixed maturity securities available-for-sale, at fair value \| $		$ 95
Fair value input, credit spreads, lower limit		71
Fair value input, credit spreads, upper limit		272
Fair value input, credit spreads, weighted-average	[2]	167
Internal Models \| Level 3 \| Consumer-cyclical \| U.S. corporate
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Valuation technique		Internal models
Fixed maturity securities available-for-sale, at fair value \| $		$ 113
Fair value input, credit spreads, lower limit		105
Fair value input, credit spreads, upper limit		222
Fair value input, credit spreads, weighted-average	[2]	154
Internal Models \| Level 3 \| Consumer-cyclical \| Non-U.S. corporate
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Valuation technique		Internal models
Fixed maturity securities available-for-sale, at fair value \| $		$ 50
Fair value input, credit spreads, lower limit		102
Fair value input, credit spreads, upper limit		197
Fair value input, credit spreads, weighted-average	[2]	159
Internal Models \| Level 3 \| Transportation \| U.S. corporate
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Valuation technique		Internal models
Fixed maturity securities available-for-sale, at fair value \| $		$ 43
Fair value input, credit spreads, lower limit		49
Fair value input, credit spreads, upper limit		188
Fair value input, credit spreads, weighted-average	[2]	126
Internal Models \| Level 3 \| Transportation \| Non-U.S. corporate
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Valuation technique		Internal models
Fixed maturity securities available-for-sale, at fair value \| $		$ 20
Fair value input, credit spreads, lower limit		138
Fair value input, credit spreads, upper limit		197
Fair value input, credit spreads, weighted-average	[2]	150
Internal Models \| Level 3 \| Other \| U.S. corporate
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Valuation technique		Internal models
Fixed maturity securities available-for-sale, at fair value \| $		$ 111
Fair value input, credit spreads, lower limit		90
Fair value input, credit spreads, upper limit		153
Fair value input, credit spreads, weighted-average	[2]	102
Internal Models \| Level 3 \| Other \| Non-U.S. corporate
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Valuation technique		Internal models
Fixed maturity securities available-for-sale, at fair value \| $		$ 21
Fair value input, credit spreads, lower limit		84
Fair value input, credit spreads, upper limit		158
Fair value input, credit spreads, weighted-average	[2]	132

[1]Represents embedded derivatives associated with our GMWB liabilities, excluding the impact of reinsurance.[2]Unobservable inputs weighted by the relative fair value of the associated instrument for fixed maturity securities and by notional for derivative assets.[3]Represents embedded derivatives associated with our GMWB liabilities, excluding the impact of reinsurance. The unobservable inputs associated with GMWB embedded derivatives are not interrelated and therefore, a directional change in one input will not affect the other inputs.[4]Unobservable inputs weighted by the policyholder account balances associated with the instrument.

Liabilities by Class of Instrum

Liabilities by Class of Instrument that are Measured at Fair Value on Recurring Basis (Detail) - USD ($) $ in Millions		Dec. 31, 2022		Dec. 31, 2021
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative liabilities, fair value		$ 962		$ 616
Total liabilities		962		616
Other liabilities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative liabilities, fair value		522		26
Other liabilities \| Interest rate swaps
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative liabilities, fair value		522		26
Policyholder account balances
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative liabilities, fair value		440		590
Policyholder account balances \| GMWB embedded derivatives
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative liabilities, fair value	[1]	223		271
Policyholder account balances \| Fixed index annuity embedded derivatives
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative liabilities, fair value		202		294
Policyholder account balances \| Indexed universal life embedded derivatives
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative liabilities, fair value		15		25
Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total liabilities		0		0
Level 1 \| Other liabilities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative liabilities, fair value		0		0
Level 1 \| Other liabilities \| Interest rate swaps
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative liabilities, fair value		0		0
Level 1 \| Policyholder account balances
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative liabilities, fair value		0		0
Level 1 \| Policyholder account balances \| GMWB embedded derivatives
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative liabilities, fair value	[1]	0		0
Level 1 \| Policyholder account balances \| Fixed index annuity embedded derivatives
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative liabilities, fair value		0		0
Level 1 \| Policyholder account balances \| Indexed universal life embedded derivatives
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative liabilities, fair value		0		0
Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total liabilities		522		26
Level 2 \| Other liabilities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative liabilities, fair value		522		26
Level 2 \| Other liabilities \| Interest rate swaps
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative liabilities, fair value		522		26
Level 2 \| Policyholder account balances
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative liabilities, fair value		0		0
Level 2 \| Policyholder account balances \| GMWB embedded derivatives
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative liabilities, fair value	[1]	0		0
Level 2 \| Policyholder account balances \| Fixed index annuity embedded derivatives
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative liabilities, fair value		0		0
Level 2 \| Policyholder account balances \| Indexed universal life embedded derivatives
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative liabilities, fair value		0		0
Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total liabilities		440		590
Level 3 \| Other liabilities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative liabilities, fair value		0		0
Level 3 \| Other liabilities \| Interest rate swaps
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative liabilities, fair value		0		0
Level 3 \| Policyholder account balances
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative liabilities, fair value		440		590
Level 3 \| Policyholder account balances \| GMWB embedded derivatives
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative liabilities, fair value	[1]	223	[2],[3]	271
Level 3 \| Policyholder account balances \| Fixed index annuity embedded derivatives
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative liabilities, fair value		202		294
Level 3 \| Policyholder account balances \| Indexed universal life embedded derivatives
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative liabilities, fair value		$ 15		$ 25

[1]Represents embedded derivatives associated with our GMWB liabilities, excluding the impact of reinsurance.[2]Represents embedded derivatives associated with our GMWB liabilities, excluding the impact of reinsurance. The unobservable inputs associated with GMWB embedded derivatives are not interrelated and therefore, a directional change in one input will not affect the other inputs.[3]Unobservable inputs weighted by the policyholder account balances associated with the instrument.

Liabilities Measured at Fair Va

Liabilities Measured at Fair Value on Recurring Basis and Utilized Significant Unobservable (Level 3) Inputs to Determine Fair Value (Detail) - USD ($) $ in Millions		12 Months Ended
		Dec. 31, 2022		Dec. 31, 2021		Dec. 31, 2020
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Beginning balance		$ 590		$ 804		$ 794
Total realized and unrealized (gains) losses included in net (income)		$ (113)		$ (125)		$ 66
Fair Value, Liability, Recurring Basis, Unobservable Input Reconciliation, Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration]		Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest		Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest		Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest
Total realized and unrealized (gains) losses included in OCI		$ 0		$ 0		$ 0
Purchases		0		0		0
Sales		0		0		0
Issuances		39		48		48
Settlements		(73)		(136)		(104)
Transfer into Level 3		0		0		0
Transfer out of Level 3		(3)		(1)		0
Ending balance		440		590		804
Total (gains) losses included in net (income) attributable to liabilities still held		$ (109)		$ (119)		$ 72
Fair Value, Liability, Recurring Basis, Still Held, Unrealized Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration]		Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest		Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest		Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest
Total (gains) losses included in OCI attributable to liabilities still held		$ 0		$ 0		$ 0
Policyholder account balances
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Beginning balance		590		804		794
Total realized and unrealized (gains) losses included in net (income)		(113)		(125)		66
Total realized and unrealized (gains) losses included in OCI		0		0		0
Purchases		0		0		0
Sales		0		0		0
Issuances		39		48		48
Settlements		(73)		(136)		(104)
Transfer into Level 3		0		0		0
Transfer out of Level 3		(3)		(1)		0
Ending balance		440		590		804
Total (gains) losses included in net (income) attributable to liabilities still held		(109)		(119)		72
Total (gains) losses included in OCI attributable to liabilities still held		0		0		0
Policyholder account balances \| GMWB embedded derivatives
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Beginning balance	[1]	271		379		323
Total realized and unrealized (gains) losses included in net (income)	[1]	(70)		(133)		32
Total realized and unrealized (gains) losses included in OCI		0	[1]	0	[1]	0
Purchases	[1]	0		0		0
Sales	[1]	0		0		0
Issuances	[1]	22		25		24
Settlements	[1]	0		0		0
Transfer into Level 3	[1]	0		0		0
Transfer out of Level 3	[1]	0		0		0
Ending balance	[1]	223		271		379
Total (gains) losses included in net (income) attributable to liabilities still held	[1]	(66)		(127)		38
Total (gains) losses included in OCI attributable to liabilities still held	[1]	0		0		0
Policyholder account balances \| Fixed index annuity embedded derivatives
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Beginning balance		294		399		452
Total realized and unrealized (gains) losses included in net (income)		(16)		32		51
Total realized and unrealized (gains) losses included in OCI		0		0		0
Purchases		0		0		0
Sales		0		0		0
Issuances		0		0		0
Settlements		(73)		(136)		(104)
Transfer into Level 3		0		0		0
Transfer out of Level 3		(3)		(1)		0
Ending balance		202		294		399
Total (gains) losses included in net (income) attributable to liabilities still held		(16)		32		51
Total (gains) losses included in OCI attributable to liabilities still held		0		0		0
Policyholder account balances \| Indexed universal life embedded derivatives
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Beginning balance		25		26		19
Total realized and unrealized (gains) losses included in net (income)		(27)		(24)		(17)
Total realized and unrealized (gains) losses included in OCI		0		0		0
Purchases		0		0		0
Sales		0		0		0
Issuances		17		23		24
Settlements		0		0		0
Transfer into Level 3		0		0		0
Transfer out of Level 3		0		0		0
Ending balance		15		25		26
Total (gains) losses included in net (income) attributable to liabilities still held		(27)		(24)		(17)
Total (gains) losses included in OCI attributable to liabilities still held		$ 0		$ 0		$ 0

[1]Represents embedded derivatives associated with our GMWB liabilities, excluding the impact of reinsurance.

Gains and Losses Included in _2

Gains and Losses Included in Net (Income) from Liabilities Measured at Fair Value (Detail) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Total realized and unrealized (gains) losses included in net (income), liabilities	$ (113)	$ (125)	$ 66
Fair Value, Liability, Recurring Basis, Unobservable Input Reconciliation, Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration]	Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest	Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest	Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest
Total (gains) losses included in net (income) attributable to liabilities still held, liabilities	$ (109)	$ (119)	$ 72
Fair Value, Liability, Recurring Basis, Still Held, Unrealized Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration]	Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest	Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest	Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest
Net Investment Income
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Total realized and unrealized (gains) losses included in net (income), liabilities	$ 0	$ 0	$ 0
Fair Value, Liability, Recurring Basis, Unobservable Input Reconciliation, Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration]	Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest	Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest	Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest
Total (gains) losses included in net (income) attributable to liabilities still held, liabilities	$ 0	$ 0	$ 0
Fair Value, Liability, Recurring Basis, Still Held, Unrealized Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration]	Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest	Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest	Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest
Net investment (gains) losses
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Total realized and unrealized (gains) losses included in net (income), liabilities	$ (113)	$ (125)	$ 66
Fair Value, Liability, Recurring Basis, Unobservable Input Reconciliation, Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration]	Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest	Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest	Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest
Total (gains) losses included in net (income) attributable to liabilities still held, liabilities	$ (109)	$ (119)	$ 72
Fair Value, Liability, Recurring Basis, Still Held, Unrealized Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration]	Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest	Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest	Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest

Fair Value Financial Instrument

Fair Value Financial Instruments Not Required to Be Carried at Fair Value (Detail) - USD ($) $ in Millions	Dec. 31, 2022	Dec. 31, 2021
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Commercial mortgage loans	$ 7,010	$ 6,830
Liabilities:
Long-term borrowings	1,611	1,899
Off-balance sheet risk	1,365	1,185
Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Commercial mortgage loans	0	0
Bank loan investments	0	0
Liabilities:
Long-term borrowings	0	0
Investment contracts	0	0
Level 1 \| Commitments to fund bank loan investments
Liabilities:
Off-balance sheet risk	0	0
Level 1 \| Ordinary course of business lending commitments
Liabilities:
Off-balance sheet risk	0	0
Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Commercial mortgage loans	0	0
Bank loan investments	0	0
Liabilities:
Long-term borrowings	1,346	1,767
Investment contracts	0	0
Level 2 \| Commitments to fund bank loan investments
Liabilities:
Off-balance sheet risk	0	0
Level 2 \| Ordinary course of business lending commitments
Liabilities:
Off-balance sheet risk	0	0
Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Commercial mortgage loans	6,345	7,224
Bank loan investments	474	370
Liabilities:
Long-term borrowings	0	0
Investment contracts	7,169	9,352
Level 3 \| Commitments to fund bank loan investments
Liabilities:
Off-balance sheet risk	0	0
Level 3 \| Ordinary course of business lending commitments
Liabilities:
Off-balance sheet risk	0	0
Carrying value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Commercial mortgage loans	7,010	6,830
Bank loan investments	467	363
Liabilities:
Long-term borrowings	1,611	1,899
Investment contracts	7,409	8,657
Carrying value \| Commitments to fund bank loan investments
Liabilities:
Off-balance sheet risk	0	0
Carrying value \| Ordinary course of business lending commitments
Liabilities:
Off-balance sheet risk	0	0
Fair value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Commercial mortgage loans	6,345	7,224
Bank loan investments	474	370
Liabilities:
Long-term borrowings	1,346	1,767
Investment contracts	7,169	9,352
Fair value \| Commitments to fund bank loan investments
Liabilities:
Off-balance sheet risk	0	0
Fair value \| Ordinary course of business lending commitments
Liabilities:
Off-balance sheet risk	0	0
Notional amount \| Commitments to fund bank loan investments
Liabilities:
Off-balance sheet risk	70	141
Notional amount \| Ordinary course of business lending commitments
Liabilities:
Off-balance sheet risk	$ 24	$ 125

Summary of carrying value of li

Summary of carrying value of limited partnerships and commitments to fund (Detail) - USD ($) $ in Millions		Dec. 31, 2022	Dec. 31, 2021
Schedule of Carrying Value of Limited Partnerships and Commitments To Fund [Line Items]
Limited partnerships, carrying value		$ 2,331	$ 1,900
Off-balance sheet risk		1,365	1,185
Limited Partnerships
Schedule of Carrying Value of Limited Partnerships and Commitments To Fund [Line Items]
Limited partnerships, carrying value		1,816	1,462
Assets Measured Using Net Asset Value \| Limited Partnerships Private Equity Funds
Schedule of Carrying Value of Limited Partnerships and Commitments To Fund [Line Items]
Limited partnerships, carrying value	[1]	1,647	1,312
Off-balance sheet risk	[1]	1,107	950
Assets Measured Using Net Asset Value \| Limited Partnerships Real Estate Funds
Schedule of Carrying Value of Limited Partnerships and Commitments To Fund [Line Items]
Limited partnerships, carrying value	[2]	82	67
Off-balance sheet risk	[2]	79	101
Assets Measured Using Net Asset Value \| Limited Partnerships Infrastructure Funds
Schedule of Carrying Value of Limited Partnerships and Commitments To Fund [Line Items]
Limited partnerships, carrying value	[3]	63	57
Off-balance sheet risk	[3]	29	13
Assets Measured Using Net Asset Value \| Limited Partnerships
Schedule of Carrying Value of Limited Partnerships and Commitments To Fund [Line Items]
Limited partnerships, carrying value		1,792	1,436
Off-balance sheet risk		1,215	1,064
Accounted For Under Equity method of Accounting \| Limited Partnerships
Schedule of Carrying Value of Limited Partnerships and Commitments To Fund [Line Items]
Limited partnerships, carrying value		515	437
Off-balance sheet risk		149	120
Low-Income Housing Tax Credits \| Limited Partnerships
Schedule of Carrying Value of Limited Partnerships and Commitments To Fund [Line Items]
Limited partnerships, carrying value	[4]	0	1
Off-balance sheet risk	[4]	0	0
Accounted for at Fair Value \| Limited Partnerships
Schedule of Carrying Value of Limited Partnerships and Commitments To Fund [Line Items]
Limited partnerships, carrying value		24	26
Off-balance sheet risk		$ 1	$ 1

[1]This class employs various investment strategies such as leveraged buyout, growth equity, venture capital and mezzanine financing, generally investing in debt or equity positions directly in companies or assets of various sizes across diverse industries globally, primarily concentrated in North America.[2]This class invests in real estate in North America, Europe and Asia via direct property ownership, joint ventures, mortgages and investments in debt and equity instruments.[3]This class invests in the debt or equity of cash flow generating assets diversified across a variety of industries, including transportation, energy infrastructure, renewable power, social infrastructure, power generation, water, telecommunications and other regulated entities globally.[4]Relates to limited partnership investments that invest in affordable housing projects that qualify for the Low-Income Housing Tax Credit and are accounted for using the proportional amortization method.

Insurance Subsidiary Financia_3

Insurance Subsidiary Financial Information and Regulatory Matters - Additional Information (Detail) € in Millions, $ in Millions		3 Months Ended		12 Months Ended
	Dec. 31, 2021 USD ($)	Jun. 30, 2021 USD ($)	Jun. 30, 2021 EUR (€)	Dec. 31, 2022 USD ($) Ratio	Dec. 31, 2021 USD ($)	Dec. 31, 2020 USD ($)
Statutory Accounting Practices [Line Items]
Dividends paid to noncontrolling interests				$ 46	$ 37	$ 0
Moody's, Baa1 Rating
Statutory Accounting Practices [Line Items]
Credit rating				Baa1
PMIERs Amended Stipulation For Non Performing Loans Relating To Government Sponsored Enterprises \| Fitch, BBB+ Rating
Statutory Accounting Practices [Line Items]
Credit rating				BBB+
Settlement Of Amounts In Relation To Underwriting Losses On A Products Sold By A Distributor \| Genworth Financial International Holdings \| Gurantee Agreement
Statutory Accounting Practices [Line Items]
Loss Contingency Accrual, Payments		$ 18	€ 15
Forbearance Plan \| Payment Not Made On After Thirty First Of March Two Thousand And Twenty And Prior To Thirtieth Of April Two Thousand And Twenty One \| PMIERs Amended Stipulation For Non Performing Loans Relating To Government Sponsored Enterprises
Statutory Accounting Practices [Line Items]
Multiplier used for assessing risk based factor for non performing loans	0.3
Guarantees provided to third parties
Statutory Accounting Practices [Line Items]
Maximum potential amount of future obligation	$ 10			$ 69	10
Mexico Guarantee
Statutory Accounting Practices [Line Items]
Maximum potential amount of future obligation				175
Long-term Care Insurance
Statutory Accounting Practices [Line Items]
Statutory Reserve including additional reserve	572			670	572
Genworth European Mortgage Insurance Business
Statutory Accounting Practices [Line Items]
Maximum potential amount of future obligation				$ 950
Claims on policies in-force covered by guarantee, number of days subsequent to sale				90
Variable Annuity
Statutory Accounting Practices [Line Items]
Statutory Reserve including additional reserve	35			$ 35	35
Domestic subsidiaries
Statutory Accounting Practices [Line Items]
Combined statutory capital and surplus	7,384			7,769	7,384
Reinsurance returned capital value					104
Domestic subsidiaries \| Captive life reinsurance subsidiaries
Statutory Accounting Practices [Line Items]
Combined statutory capital and surplus	$ 98			96	98
Domestic subsidiaries \| Life insurance
Statutory Accounting Practices [Line Items]
Statutory Accounting Practices, Permitted Practice, Amount				$ 0	$ 0
Consolidated RBC ratio	289%			291%	289%
Domestic subsidiaries \| River Lake VIII
Statutory Accounting Practices [Line Items]
Contributed surplus	$ 37
Domestic subsidiaries \| River Lake VII
Statutory Accounting Practices [Line Items]
Contributed surplus	29
Insurance Subsidiaries \| Universal and term universal life insurance contracts \| Virginia and Delaware
Statutory Accounting Practices [Line Items]
Additional statutory reserves	231			$ (199)	$ 231	232
Insurance Subsidiary \| New York
Statutory Accounting Practices [Line Items]
Additional statutory reserve	68			98	68
Statutory Reserve including additional reserve	607			705	607
Genworth Holdings
Statutory Accounting Practices [Line Items]
Restricted net assets				10,000
Genworth Holdings \| International Subsidiaries
Statutory Accounting Practices [Line Items]
Dividends to parent company				370
Enact Holdings, Inc.
Statutory Accounting Practices [Line Items]
Amount of dividends our subsidiaries could pay in 2023 without obtaining regulatory approval				292
Dividends to parent company				$ 205	$ 163	437
Multiplier used for assessing risk based factor for non performing loans				0.3	0.3
Restricted Cash				$ 300
Net assets required	3,074			3,156	$ 3,074
Net assets in excess of the statutory requirement	2,003			2,050	2,003
Cumulative benefit in respect of asset required base	390			132	390
Net assets actually available	5,077			5,206	5,077
Debt instrument covenant minimum cash required				203
Dividends paid to noncontrolling interests				46	37
Dividends paid during the period				251	200	437
Investments and Cash				$ 453
Enact Holdings, Inc. \| Minimum
Statutory Accounting Practices [Line Items]
Liquidity as a percentage of outstanding debt to be maintained				13.50%
Enact Holdings, Inc. \| Domestic insurance subsidiaries
Statutory Accounting Practices [Line Items]
Amount of dividends our subsidiaries could pay in 2023 without obtaining regulatory approval				$ 292
Statutory contingency reserve, annual additions, percentage of earned premiums, minimum				50%
Minimum loss ratio requirement to hold statutory contingency reserve				35%
Period of time when statutory contingency reserve has to be held, in years				10 years
Statutory contingency reserve	$ 3,000			$ 3,600	$ 3,000
Maximum risk-to-capital ratio \| Ratio				25
Risk-to-capital ratio	12.2			12.8	12.2
Percentage of available assets to PMIERs required assets	165%
Number of days in advance for notice of intent to pay provided to the state insurance commissioner				30 days
U.S. Life Insurance Subsidiaries
Statutory Accounting Practices [Line Items]
Statutory Reserve including additional reserve				$ 849
Dividends paid during the period				0	$ 0	$ 0
Genworth Financial
Statutory Accounting Practices [Line Items]
Restricted net assets				$ 9,700
Enact Mortgage Insurance Corporation \| PMIERs Amended Requirement Relating To Government Sponsored Enterprises \| Twelve Months Ended Thirty First December Two Thousand And Twenty Two
Statutory Accounting Practices [Line Items]
Percentage of minimum required assets to be maintained as per statutory need				120%
Enact Mortgage Insurance Corporation \| PMIERs Amended Requirement Relating To Government Sponsored Enterprises \| Twelve Months Ended Thirty First December Two Thousand And Twenty Three
Statutory Accounting Practices [Line Items]
Percentage of minimum required assets to be maintained as per statutory need				125%

Schedule of Statutory Accountin

Schedule of Statutory Accounting Practices (Detail) - Domestic subsidiaries - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Statutory Accounting Practices [Line Items]
Combined statutory net income (loss)	$ 1,276	$ (104)	$ 610
Combined statutory capital and surplus	7,769	7,384
Life insurance subsidiaries, excluding captive life reinsurance subsidiaries
Statutory Accounting Practices [Line Items]
Combined statutory net income (loss)	276	654	197
Combined statutory capital and surplus	3,082	2,945
Mortgage insurance subsidiaries
Statutory Accounting Practices [Line Items]
Combined statutory net income (loss)	747	593	404
Combined statutory capital and surplus	4,687	4,439
Combined statutory net income, excluding captive reinsurance subsidiaries
Statutory Accounting Practices [Line Items]
Combined statutory net income (loss)	1,023	1,247	601
Captive life reinsurance subsidiaries
Statutory Accounting Practices [Line Items]
Combined statutory net income (loss)	253	(1,351)	$ 9
Combined statutory capital and surplus	$ 96	$ 98

Segment Information - Additiona

Segment Information - Additional Information (Detail) $ in Millions	1 Months Ended	3 Months Ended	12 Months Ended
	Jan. 31, 2020 USD ($)	Dec. 31, 2022 USD ($)	Dec. 31, 2022 USD ($) Segment	Dec. 31, 2021 USD ($)	Dec. 31, 2020 USD ($)
Segment Reporting Information [Line Items]
Number of operating segments \| Segment			3
Assumed tax rate on adjustments to adjusted operating income			21%	21%	21%
Assumed tax rate on adjustments to adjusted operating income			21%
Expenses related to restructuring			$ 2	$ 34	$ 3
Pre-tax gain (loss) on early extinguishment of debt			6	45	9
Initial loss from life block transaction			0	92	0
Pre-tax pension plan termination costs			8	0	$ 0
Floating Rate Subordinated Notes Due in 2050 \| Non-Recourse Funding Obligations
Segment Reporting Information [Line Items]
Pre-tax gain (loss) on early extinguishment of debt	$ (4)
Redemption of secured debt	$ 315
Debt instrument, maturity year	2050
Genworth Holdings
Segment Reporting Information [Line Items]
Pre-tax make-whole expense	$ 9
Debt instrument, maturity month and year	2020-06
Genworth Holdings \| Senior Notes 2023 and 2024
Segment Reporting Information [Line Items]
Pre-tax gain (loss) on early extinguishment of debt			15
Genworth Holdings \| Senior Notes 2021
Segment Reporting Information [Line Items]
Pre-tax gain (loss) on early extinguishment of debt			4	4
Pre-tax make-whole expense			6
Aggregate principal amount of notes repurchased		$ 146	$ 146	$ 84
Debt instrument, maturity year				2021
Debt instrument, maturity month and year			2021-09
Genworth Holdings \| Senior Notes 2022
Segment Reporting Information [Line Items]
Aggregate principal amount of notes repurchased		130	$ 130
Genworth Holdings \| Senior Notes 2023
Segment Reporting Information [Line Items]
Pre-tax make-whole expense			20
Aggregate principal amount of notes repurchased		91	$ 91
Debt instrument, maturity year			2023
Debt instrument, maturity month and year			2023-08
Genworth Holdings \| Senior Notes 2024
Segment Reporting Information [Line Items]
Pre-tax make-whole expense			$ 2
Aggregate principal amount of notes repurchased		118	$ 118
Debt instrument, maturity year			2024
Debt instrument, maturity month and year			2024-02
Write off of bond consent fees and deferred borrowing costs			$ 1
Genworth Holdings \| Senior Notes 2034
Segment Reporting Information [Line Items]
Pre-tax gain (loss) on early extinguishment of debt		1
Aggregate principal amount of notes repurchased		$ 13	$ 13

Summary of Segments and Corpora

Summary of Segments and Corporate and Other Activities (Detail) - USD ($) $ in Millions	3 Months Ended																12 Months Ended
	Dec. 31, 2022		Sep. 30, 2022		Jun. 30, 2022		Mar. 31, 2022		Dec. 31, 2021		Sep. 30, 2021		Jun. 30, 2021		Mar. 31, 2021		Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Segment Reporting Information [Line Items]
Premiums																	$ 3,719	$ 3,435	$ 3,836
Net investment income																	3,146	3,370	3,227
Net investment gains (losses)																	(17)	323	492
Policy fees and other income																	659	704	729
Total revenues	$ 1,895		$ 1,839		$ 1,881		$ 1,892		$ 1,736	[1]	$ 2,070	[1]	$ 2,041	[1]	$ 1,985	[1]	7,507	7,832	8,284
Benefits and other changes in policy reserves																	4,242	4,383	5,214
Interest credited																	503	508	549
Acquisition and operating expenses, net of deferrals																	1,371	1,223	935
Amortization of deferred acquisition costs and intangibles																	307	377	463
Interest expense																	106	160	195
Total benefits and expenses	1,635	[2],[3]	1,653	[2],[3]	1,588	[2],[3]	1,653	[2],[3]	1,481	[4]	1,697	[4]	1,721	[4]	1,752	[4]	6,529	6,651	7,356
Income (loss) from continuing operations before income taxes																	978	1,181	928
Provision (benefit) for income taxes																	239	263	230
Income from continuing operations	204	[2],[3]	134	[2],[3]	220	[2],[3]	181	[2],[3]	193	[1],[4],[5]	306	[1],[4],[5]	245	[1],[4],[5]	174	[1],[4],[5]	739	918	698
Net income (loss)	202	[2],[3]	139	[2],[3]	219	[2],[3]	179	[2],[3]	192	[1],[4],[5]	318	[1],[4],[5]	240	[1],[4],[5]	195	[1],[4],[5]	739	945	212
Less: net income from continuing operations attributable to noncontrolling interests	27		35		38		30		29	[6]	4	[6]	0	[6]	0	[6]	130	33	0
Less: net income from discontinued operations attributable to noncontrolling interests	0		0		0		0		0		0		0		8		0	8	34
Net income (loss) available to Genworth Financial, Inc.'s common stockholders	175	[2],[3]	104	[2],[3]	181	[2],[3]	149	[2],[3]	163	[6]	314	[6]	240	[6]	187	[6]	609	904	178
Income (loss) from continuing operations available to Genworth Financial, Inc.'s common stockholders	177		99		182		151		164		302		245		174		609	885	698
Income (loss) from discontinued operations available to Genworth Financial, Inc.'s common stockholders	(2)		$ 5		$ (1)		$ (2)		(1)		$ 12		$ (5)		$ 13		0	19	(520)
Total assets	86,442								99,171								86,442	99,171
Segment, Continuing Operations
Segment Reporting Information [Line Items]
Premiums																	3,719	3,435	3,836
Net investment income																	3,146	3,370	3,227
Net investment gains (losses)																	(17)	323	492
Policy fees and other income																	659	704	729
Total revenues																	7,507	7,832	8,284
Benefits and other changes in policy reserves																	4,242	4,383	5,214
Interest credited																	503	508	549
Acquisition and operating expenses, net of deferrals																	1,371	1,223	935
Amortization of deferred acquisition costs and intangibles																	307	377	463
Interest expense																	106	160	195
Total benefits and expenses																	6,529	6,651	7,356
Income (loss) from continuing operations before income taxes																	978	1,181	928
Provision (benefit) for income taxes																	239	263	230
Income from continuing operations																	739	918	698
Net income (loss)																	739	945	212
Less: net income from continuing operations attributable to noncontrolling interests																	130	33	0
Net income (loss) available to Genworth Financial, Inc.'s common stockholders																	609	904	178
Income (loss) from continuing operations available to Genworth Financial, Inc.'s common stockholders																	609	885	698
Discontinued Operations
Segment Reporting Information [Line Items]
Income from discontinued operations, net of taxes																	0	27	(486)
Less: net income from discontinued operations attributable to noncontrolling interests																	0	8	34
Income (loss) from discontinued operations available to Genworth Financial, Inc.'s common stockholders																	0	19	(520)
Enact
Segment Reporting Information [Line Items]
Total assets	5,712								5,850								5,712	5,850
Enact \| Segment, Continuing Operations
Segment Reporting Information [Line Items]
Premiums																	940	975	971
Net investment income																	155	141	133
Net investment gains (losses)																	(2)	(2)	(4)
Policy fees and other income																	2	4	6
Total revenues																	1,095	1,118	1,106
Benefits and other changes in policy reserves																	(94)	125	381
Interest credited																	0	0	0
Acquisition and operating expenses, net of deferrals																	227	230	206
Amortization of deferred acquisition costs and intangibles																	12	15	21
Interest expense																	52	51	18
Total benefits and expenses																	197	421	626
Income (loss) from continuing operations before income taxes																	898	697	480
Provision (benefit) for income taxes																	194	148	102
Income from continuing operations																	704	549	378
Net income (loss)																	704	549	378
Less: net income from continuing operations attributable to noncontrolling interests																	130	33	0
Net income (loss) available to Genworth Financial, Inc.'s common stockholders																	574	516	378
Income (loss) from continuing operations available to Genworth Financial, Inc.'s common stockholders																	574	516	378
Enact \| Discontinued Operations
Segment Reporting Information [Line Items]
Income from discontinued operations, net of taxes																	0	0	0
Less: net income from discontinued operations attributable to noncontrolling interests																	0	0	0
Income (loss) from discontinued operations available to Genworth Financial, Inc.'s common stockholders																	0	0	0
U.S. Life Insurance
Segment Reporting Information [Line Items]
Total assets	70,977								81,210								70,977	81,210
U.S. Life Insurance \| Segment, Continuing Operations
Segment Reporting Information [Line Items]
Premiums																	2,773	2,454	2,858
Net investment income																	2,769	3,029	2,878
Net investment gains (losses)																	16	329	517
Policy fees and other income																	543	565	595
Total revenues																	6,101	6,377	6,848
Benefits and other changes in policy reserves																	4,301	4,230	4,781
Interest credited																	322	346	383
Acquisition and operating expenses, net of deferrals																	1,078	865	620
Amortization of deferred acquisition costs and intangibles																	272	340	418
Interest expense																	0	0	5
Total benefits and expenses																	5,973	5,781	6,207
Income (loss) from continuing operations before income taxes																	128	596	641
Provision (benefit) for income taxes																	55	155	163
Income from continuing operations																	73	441	478
Net income (loss)																	73	441	478
Less: net income from continuing operations attributable to noncontrolling interests																	0	0	0
Net income (loss) available to Genworth Financial, Inc.'s common stockholders																	73	441	478
Income (loss) from continuing operations available to Genworth Financial, Inc.'s common stockholders																	73	441	478
U.S. Life Insurance \| Discontinued Operations
Segment Reporting Information [Line Items]
Income from discontinued operations, net of taxes																	0	0	0
Less: net income from discontinued operations attributable to noncontrolling interests																	0	0	0
Income (loss) from discontinued operations available to Genworth Financial, Inc.'s common stockholders																	0	0	0
Runoff
Segment Reporting Information [Line Items]
Total assets	7,888								9,460								7,888	9,460
Runoff \| Segment, Continuing Operations
Segment Reporting Information [Line Items]
Premiums																	0	0	0
Net investment income																	214	194	210
Net investment gains (losses)																	(16)	3	(26)
Policy fees and other income																	114	134	130
Total revenues																	312	331	314
Benefits and other changes in policy reserves																	35	27	48
Interest credited																	181	162	166
Acquisition and operating expenses, net of deferrals																	42	53	48
Amortization of deferred acquisition costs and intangibles																	23	20	23
Interest expense																	0	0	0
Total benefits and expenses																	281	262	285
Income (loss) from continuing operations before income taxes																	31	69	29
Provision (benefit) for income taxes																	5	13	4
Income from continuing operations																	26	56	25
Net income (loss)																	26	56	25
Less: net income from continuing operations attributable to noncontrolling interests																	0	0	0
Net income (loss) available to Genworth Financial, Inc.'s common stockholders																	26	56	25
Income (loss) from continuing operations available to Genworth Financial, Inc.'s common stockholders																	26	56	25
Runoff \| Discontinued Operations
Segment Reporting Information [Line Items]
Income from discontinued operations, net of taxes																	0	0	0
Less: net income from discontinued operations attributable to noncontrolling interests																	0	0	0
Income (loss) from discontinued operations available to Genworth Financial, Inc.'s common stockholders																	0	0	0
Corporate and Other
Segment Reporting Information [Line Items]
Total assets	$ 1,865								$ 2,651								1,865	2,651
Corporate and Other \| Segment, Continuing Operations
Segment Reporting Information [Line Items]
Premiums																	6	6	7
Net investment income																	8	6	6
Net investment gains (losses)																	(15)	(7)	5
Policy fees and other income																	0	1	(2)
Total revenues																	(1)	6	16
Benefits and other changes in policy reserves																	0	1	4
Interest credited																	0	0	0
Acquisition and operating expenses, net of deferrals																	24	75	61
Amortization of deferred acquisition costs and intangibles																	0	2	1
Interest expense																	54	109	172
Total benefits and expenses																	78	187	238
Income (loss) from continuing operations before income taxes																	(79)	(181)	(222)
Provision (benefit) for income taxes																	(15)	(53)	(39)
Income from continuing operations																	(64)	(128)	(183)
Net income (loss)																	(64)	(101)	(669)
Less: net income from continuing operations attributable to noncontrolling interests																	0	0	0
Net income (loss) available to Genworth Financial, Inc.'s common stockholders																	(64)	(109)	(703)
Income (loss) from continuing operations available to Genworth Financial, Inc.'s common stockholders																	(64)	(128)	(183)
Corporate and Other \| Discontinued Operations
Segment Reporting Information [Line Items]
Income from discontinued operations, net of taxes																	0	27	(486)
Less: net income from discontinued operations attributable to noncontrolling interests																	0	8	34
Income (loss) from discontinued operations available to Genworth Financial, Inc.'s common stockholders																	$ 0	$ 19	$ (520)

[1]In the fourth quarter of 2021, our life insurance business initially ceded $360 million of premiums associated with certain term life insurance policies under a new reinsurance treaty as part of a life block transaction.[2]In the fourth quarter of 2022, our Enact segment recorded a pre-tax net favorable reserve adjustment of $42 million primarily related to COVID-19 delinquencies in 2020 and 2021 curing at levels above original reserve expectations.[3]In the fourth quarter of 2022, our life insurance business completed its annual review of assumptions for its universal and term universal life insurance products and recorded a pre-tax favorable unlocking of $43 million mostly attributable to higher interest rates.[4]In the fourth quarter of 2021, our life insurance business initially ceded $268 million of certain term life insurance reserves under a new reinsurance treaty as part of a life block transaction. Our life insurance business also completed its annual review of assumptions in the fourth quarter of 2021. This review resulted in higher total benefits and expenses of $87 million from an unfavorable unlocking in our term universal and universal life insurance products largely attributable to higher pre-COVID-19 mortality. In our term universal life insurance products, we also recorded a DAC impairment of $41 million in the fourth quarter of 2021 principally due to lower future estimated gross profits.[5]In the fourth quarter of 2021, our life insurance business recorded a net loss of $131 million predominantly driven by an initial loss of $73 million as a result of ceding certain term life insurance policies as part of a life block transaction, an unfavorable unlocking of $70 million associated with its annual review of assumptions and a DAC impairment of $32 million as a result of recoverability testing.[6]On September 20, 2021, we completed the minority IPO of Enact Holdings, which reduced our ownership percentage to 81.6%, and lowered our available net income by $29 million in the fourth quarter of 2021.

Summary of Revenues for Segment

Summary of Revenues for Segments and Corporate and Other Activities (Detail) - USD ($) $ in Millions	3 Months Ended												12 Months Ended
	Dec. 31, 2022	Sep. 30, 2022	Jun. 30, 2022	Mar. 31, 2022	Dec. 31, 2021	[1]	Sep. 30, 2021	[1]	Jun. 30, 2021	[1]	Mar. 31, 2021	[1]	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Segment Reporting Information [Line Items]
Revenues	$ 1,895	$ 1,839	$ 1,881	$ 1,892	$ 1,736		$ 2,070		$ 2,041		$ 1,985		$ 7,507	$ 7,832	$ 8,284
Segment, Continuing Operations
Segment Reporting Information [Line Items]
Revenues													7,507	7,832	8,284
Segment, Continuing Operations \| Enact [Member]
Segment Reporting Information [Line Items]
Revenues													1,095	1,118	1,106
Segment, Continuing Operations \| Long-term Care Insurance
Segment Reporting Information [Line Items]
Revenues													4,459	4,875	4,960
Segment, Continuing Operations \| Life Insurance
Segment Reporting Information [Line Items]
Revenues													1,253	996	1,357
Segment, Continuing Operations \| Fixed Annuities
Segment Reporting Information [Line Items]
Revenues													389	506	531
Segment, Continuing Operations \| U.S. Life Insurance
Segment Reporting Information [Line Items]
Revenues													6,101	6,377	6,848
Segment, Continuing Operations \| Runoff
Segment Reporting Information [Line Items]
Revenues													312	331	314
Segment, Continuing Operations \| Corporate and Other
Segment Reporting Information [Line Items]
Revenues													$ (1)	$ 6	$ 16

[1]In the fourth quarter of 2021, our life insurance business initially ceded $360 million of premiums associated with certain term life insurance policies under a new reinsurance treaty as part of a life block transaction.

Summary of Net Operating Income

Summary of Net Operating Income (Loss) for Segments and Corporate and Other Activities (Detail) - USD ($) $ in Millions		3 Months Ended																12 Months Ended
		Dec. 31, 2022		Sep. 30, 2022		Jun. 30, 2022		Mar. 31, 2022		Dec. 31, 2021		Sep. 30, 2021		Jun. 30, 2021		Mar. 31, 2021		Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Segment Reporting Information [Line Items]
Net income available to Genworth Financial, Inc.'s common stockholders		$ 175	[1],[2]	$ 104	[1],[2]	$ 181	[1],[2]	$ 149	[1],[2]	$ 163	[3]	$ 314	[3]	$ 240	[3]	$ 187	[3]	$ 609	$ 904	$ 178
Add: net income from continuing operations attributable to noncontrolling interests		27		35		38		30		29	[3]	4	[3]	0	[3]	0	[3]	130	33	0
Add: net income from discontinued operations attributable to noncontrolling interests		0		0		0		0		0		0		0		8		0	8	34
Net income		202	[1],[2]	139	[1],[2]	219	[1],[2]	179	[1],[2]	192	[4],[5],[6]	318	[4],[5],[6]	240	[4],[5],[6]	195	[4],[5],[6]	739	945	212
Less: income (loss) from discontinued operations, net of taxes		(2)		5		(1)		(2)		(1)		12		(5)		21		0	27	(486)
Income from continuing operations		204	[1],[2]	134	[1],[2]	220	[1],[2]	181	[1],[2]	193	[4],[5],[6]	306	[4],[5],[6]	245	[4],[5],[6]	174	[4],[5],[6]	739	918	698
Less: net income from continuing operations attributable to noncontrolling interests		27		35		38		30		29	[3]	4	[3]	0	[3]	0	[3]	130	33	0
Income from continuing operations available to Genworth Financial, Inc.'s common stockholders		$ 177		$ 99		$ 182		$ 151		164		$ 302		$ 245		$ 174		609	885	698
Net investment (gains) losses, net	[7]																	14	(324)	(503)
Losses on early extinguishment of debt																		6	45	9
Initial loss from life block transaction																		0	92	0
Expenses related to restructuring																		2	34	3
Pension plan termination costs																		8	0	0
Taxes on adjustments																		(6)	33	103
Adjusted operating income available to Genworth Financial, Inc.'s common stockholders																		633	765	310
Life Insurance
Segment Reporting Information [Line Items]
Net income available to Genworth Financial, Inc.'s common stockholders										$ 131
Segment, Continuing Operations
Segment Reporting Information [Line Items]
Net income available to Genworth Financial, Inc.'s common stockholders																		609	904	178
Add: net income from continuing operations attributable to noncontrolling interests																		130	33	0
Net income																		739	945	212
Income from continuing operations																		739	918	698
Less: net income from continuing operations attributable to noncontrolling interests																		130	33	0
Income from continuing operations available to Genworth Financial, Inc.'s common stockholders																		609	885	698
Segment, Continuing Operations \| Long-term Care Insurance
Segment Reporting Information [Line Items]
Adjusted operating income available to Genworth Financial, Inc.'s common stockholders																		142	445	237
Segment, Continuing Operations \| Life Insurance
Segment Reporting Information [Line Items]
Adjusted operating income available to Genworth Financial, Inc.'s common stockholders																		(148)	(269)	(247)
Segment, Continuing Operations \| Fixed Annuities
Segment Reporting Information [Line Items]
Adjusted operating income available to Genworth Financial, Inc.'s common stockholders																		72	91	78
Segment, Continuing Operations \| U.S. Life Insurance
Segment Reporting Information [Line Items]
Net income available to Genworth Financial, Inc.'s common stockholders																		73	441	478
Add: net income from continuing operations attributable to noncontrolling interests																		0	0	0
Net income																		73	441	478
Income from continuing operations																		73	441	478
Less: net income from continuing operations attributable to noncontrolling interests																		0	0	0
Income from continuing operations available to Genworth Financial, Inc.'s common stockholders																		73	441	478
Adjusted operating income available to Genworth Financial, Inc.'s common stockholders																		66	267	68
Segment, Continuing Operations \| Runoff
Segment Reporting Information [Line Items]
Net income available to Genworth Financial, Inc.'s common stockholders																		26	56	25
Add: net income from continuing operations attributable to noncontrolling interests																		0	0	0
Net income																		26	56	25
Income from continuing operations																		26	56	25
Less: net income from continuing operations attributable to noncontrolling interests																		0	0	0
Income from continuing operations available to Genworth Financial, Inc.'s common stockholders																		26	56	25
Adjusted operating income available to Genworth Financial, Inc.'s common stockholders																		37	54	43
Segment, Continuing Operations \| Corporate and Other
Segment Reporting Information [Line Items]
Net income available to Genworth Financial, Inc.'s common stockholders																		(64)	(109)	(703)
Add: net income from continuing operations attributable to noncontrolling interests																		0	0	0
Net income																		(64)	(101)	(669)
Income from continuing operations																		(64)	(128)	(183)
Less: net income from continuing operations attributable to noncontrolling interests																		0	0	0
Income from continuing operations available to Genworth Financial, Inc.'s common stockholders																		(64)	(128)	(183)
Adjusted operating income available to Genworth Financial, Inc.'s common stockholders																		(48)	(76)	(182)
Segment, Continuing Operations \| Enact [Member]
Segment Reporting Information [Line Items]
Net income available to Genworth Financial, Inc.'s common stockholders																		574	516	378
Add: net income from continuing operations attributable to noncontrolling interests																		130	33	0
Net income																		704	549	378
Income from continuing operations																		704	549	378
Less: net income from continuing operations attributable to noncontrolling interests																		130	33	0
Income from continuing operations available to Genworth Financial, Inc.'s common stockholders																		574	516	378
Adjusted operating income available to Genworth Financial, Inc.'s common stockholders																		$ 578	$ 520	$ 381

[1]In the fourth quarter of 2022, our Enact segment recorded a pre-tax net favorable reserve adjustment of $42 million primarily related to COVID-19 delinquencies in 2020 and 2021 curing at levels above original reserve expectations.[2]In the fourth quarter of 2022, our life insurance business completed its annual review of assumptions for its universal and term universal life insurance products and recorded a pre-tax favorable unlocking of $43 million mostly attributable to higher interest rates.[3]On September 20, 2021, we completed the minority IPO of Enact Holdings, which reduced our ownership percentage to 81.6%, and lowered our available net income by $29 million in the fourth quarter of 2021.[4]In the fourth quarter of 2021, our life insurance business initially ceded $268 million of certain term life insurance reserves under a new reinsurance treaty as part of a life block transaction. Our life insurance business also completed its annual review of assumptions in the fourth quarter of 2021. This review resulted in higher total benefits and expenses of $87 million from an unfavorable unlocking in our term universal and universal life insurance products largely attributable to higher pre-COVID-19 mortality. In our term universal life insurance products, we also recorded a DAC impairment of $41 million in the fourth quarter of 2021 principally due to lower future estimated gross profits.[5]In the fourth quarter of 2021, our life insurance business initially ceded $360 million of premiums associated with certain term life insurance policies under a new reinsurance treaty as part of a life block transaction.[6]In the fourth quarter of 2021, our life insurance business recorded a net loss of $131 million predominantly driven by an initial loss of $73 million as a result of ceding certain term life insurance policies as part of a life block transaction, an unfavorable unlocking of $70 million associated with its annual review of assumptions and a DAC impairment of $32 million as a result of recoverability testing.[7]For the years ended December 31, 2022, 2021 and 2020, net investment (gains) losses were adjusted for DAC and other intangible amortization and certain benefit reserves of $(3) million, $(1) million and $(11) million, respectively.

Summary of Net Operating Inco_2

Summary of Net Operating Income (Loss) for Segments and Corporate and Other Activities (Parenthetical) (Detail) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Net Investment (Gains) Losses
Segment Reporting Information [Line Items]
Adjustment for DAC and other intangibles and certain benefit reserves	$ (3)	$ (1)	$ (11)

Schedule of Revenue, Net Income

Schedule of Revenue, Net Income and Assets by Geographic Location (Detail) - USD ($) $ in Millions		3 Months Ended																12 Months Ended
		Dec. 31, 2022		Sep. 30, 2022		Jun. 30, 2022		Mar. 31, 2022		Dec. 31, 2021		Sep. 30, 2021	[1]	Jun. 30, 2021	[1]	Mar. 31, 2021	[1]	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Segment Reporting Information [Line Items]
Total revenues		$ 1,895		$ 1,839		$ 1,881		$ 1,892		$ 1,736	[1]	$ 2,070		$ 2,041		$ 1,985		$ 7,507	$ 7,832	$ 8,284
Income (loss) from continuing operations		204	[2],[3]	134	[2],[3]	220	[2],[3]	181	[2],[3]	193	[1],[4],[5]	306	[4],[5]	245	[4],[5]	174	[4],[5]	739	918	698
Net income (loss)		202	[2],[3]	$ 139	[2],[3]	$ 219	[2],[3]	$ 179	[2],[3]	192	[1],[4],[5]	$ 318	[4],[5]	$ 240	[4],[5]	$ 195	[4],[5]	739	945	212
Total assets		86,442								99,171								86,442	99,171
Continuing Operations [Member]
Segment Reporting Information [Line Items]
Total revenues																		7,507	7,832	8,284
Income (loss) from continuing operations																		739	918	698
Net income (loss)																		739	945	212
Geographic Distribution, Domestic \| United States
Segment Reporting Information [Line Items]
Total assets		86,400								99,117								86,400	99,117
Geographic Distribution, Domestic \| United States \| Continuing Operations [Member]
Segment Reporting Information [Line Items]
Total revenues																		7,499	7,825	8,275
Income (loss) from continuing operations																		739	921	700
Net income (loss)																		739	948	214
Geographic Distribution, Foreign
Segment Reporting Information [Line Items]
Total assets	[6]	$ 42								$ 54								42	54
Geographic Distribution, Foreign \| Continuing Operations [Member]
Segment Reporting Information [Line Items]
Total revenues	[6]																	8	7	9
Income (loss) from continuing operations	[6]																	0	(3)	(2)
Net income (loss)	[6]																	$ 0	$ (3)	$ (2)

[1]In the fourth quarter of 2021, our life insurance business initially ceded $360 million of premiums associated with certain term life insurance policies under a new reinsurance treaty as part of a life block transaction.[2]In the fourth quarter of 2022, our Enact segment recorded a pre-tax net favorable reserve adjustment of $42 million primarily related to COVID-19 delinquencies in 2020 and 2021 curing at levels above original reserve expectations.[3]In the fourth quarter of 2022, our life insurance business completed its annual review of assumptions for its universal and term universal life insurance products and recorded a pre-tax favorable unlocking of $43 million mostly attributable to higher interest rates.[4]In the fourth quarter of 2021, our life insurance business initially ceded $268 million of certain term life insurance reserves under a new reinsurance treaty as part of a life block transaction. Our life insurance business also completed its annual review of assumptions in the fourth quarter of 2021. This review resulted in higher total benefits and expenses of $87 million from an unfavorable unlocking in our term universal and universal life insurance products largely attributable to higher pre-COVID-19 mortality. In our term universal life insurance products, we also recorded a DAC impairment of $41 million in the fourth quarter of 2021 principally due to lower future estimated gross profits.[5]In the fourth quarter of 2021, our life insurance business recorded a net loss of $131 million predominantly driven by an initial loss of $73 million as a result of ceding certain term life insurance policies as part of a life block transaction, an unfavorable unlocking of $70 million associated with its annual review of assumptions and a DAC impairment of $32 million as a result of recoverability testing.[6]Predominantly comprised of operations in Mexico.

Quarterly Results of Operatio_3

Quarterly Results of Operations (Detail) - USD ($) $ / shares in Units, shares in Millions, $ in Millions	3 Months Ended																12 Months Ended
	Dec. 31, 2022		Sep. 30, 2022		Jun. 30, 2022		Mar. 31, 2022		Dec. 31, 2021		Sep. 30, 2021		Jun. 30, 2021		Mar. 31, 2021		Dec. 31, 2022		Dec. 31, 2021		Dec. 31, 2020
Quarterly Results Of Operations [Abstract]
Total revenues	$ 1,895		$ 1,839		$ 1,881		$ 1,892		$ 1,736	[1]	$ 2,070	[1]	$ 2,041	[1]	$ 1,985	[1]	$ 7,507		$ 7,832		$ 8,284
Total benefits and expenses	1,635	[2],[3]	1,653	[2],[3]	1,588	[2],[3]	1,653	[2],[3]	1,481	[4]	1,697	[4]	1,721	[4]	1,752	[4]	6,529		6,651		7,356
Income (loss) from continuing operations	204	[2],[3]	134	[2],[3]	220	[2],[3]	181	[2],[3]	193	[1],[4],[5]	306	[1],[4],[5]	245	[1],[4],[5]	174	[1],[4],[5]	739		918		698
Income (loss) from discontinued operations, net of taxes	(2)		5		(1)		(2)		(1)		12		(5)		21		0		27		(486)
Net income	202	[2],[3]	139	[2],[3]	219	[2],[3]	179	[2],[3]	192	[1],[4],[5]	318	[1],[4],[5]	240	[1],[4],[5]	195	[1],[4],[5]	739		945		212
Net income from continuing operations attributable to noncontrolling interests	27		35		38		30		29	[6]	4	[6]	0	[6]	0	[6]	130		33		0
Net income from discontinued operations attributable to noncontrolling interests	0		0		0		0		0		0		0		8		0		8		34
Net income available to Genworth Financial, Inc.'s common stockholders	175	[2],[3]	104	[2],[3]	181	[2],[3]	149	[2],[3]	163	[6]	314	[6]	240	[6]	187	[6]	609		904		178
Net income available to Genworth Financial, Inc.'s common stockholders:
Income from continuing operations available to Genworth Financial, Inc.'s common stockholders	177		99		182		151		164		302		245		174		609		885		698
Income (loss) from discontinued operations available to Genworth Financial, Inc.'s common stockholders	(2)		5		(1)		(2)		(1)		12		(5)		13		0		19		(520)
Net income available to Genworth Financial, Inc.'s common stockholders	$ 175	[2],[3]	$ 104	[2],[3]	$ 181	[2],[3]	$ 149	[2],[3]	$ 163	[6]	$ 314	[6]	$ 240	[6]	$ 187	[6]	$ 609		$ 904		$ 178
Income from continuing operations available to Genworth Financial, Inc.'s common stockholders per share:
Basic	$ 0.36		$ 0.2		$ 0.36		$ 0.3		$ 0.32		$ 0.59		$ 0.48		$ 0.35		$ 1.21		$ 1.75		$ 1.38
Diluted	0.35		0.19		0.36		0.29		0.32		0.59		0.47		0.34		1.19		1.72		1.36
Net income available to Genworth Financial, Inc.'s common stockholders per share:
Basic	0.35		0.21		0.36		0.29		0.32		0.62		0.47		0.37		1.21	[7]	1.78	[7]	0.35	[7]
Diluted	$ 0.35		$ 0.2		$ 0.35		$ 0.29		$ 0.32		$ 0.61		$ 0.47		$ 0.37		$ 1.19	[7]	$ 1.76	[7]	$ 0.35	[7]
Weighted-average common shares outstanding:
Basic	496.7		504		509		508.3		507.4		507.4		507		506		504.5		506.9		505.2
Diluted	503.2		509.4		514.2		517.4		515.6		514.2		515		513.8		511		514.7		511.6

[1]In the fourth quarter of 2021, our life insurance business initially ceded $360 million of premiums associated with certain term life insurance policies under a new reinsurance treaty as part of a life block transaction.[2]In the fourth quarter of 2022, our Enact segment recorded a pre-tax net favorable reserve adjustment of $42 million primarily related to COVID-19 delinquencies in 2020 and 2021 curing at levels above original reserve expectations.[3]In the fourth quarter of 2022, our life insurance business completed its annual review of assumptions for its universal and term universal life insurance products and recorded a pre-tax favorable unlocking of $43 million mostly attributable to higher interest rates.[4]In the fourth quarter of 2021, our life insurance business initially ceded $268 million of certain term life insurance reserves under a new reinsurance treaty as part of a life block transaction. Our life insurance business also completed its annual review of assumptions in the fourth quarter of 2021. This review resulted in higher total benefits and expenses of $87 million from an unfavorable unlocking in our term universal and universal life insurance products largely attributable to higher pre-COVID-19 mortality. In our term universal life insurance products, we also recorded a DAC impairment of $41 million in the fourth quarter of 2021 principally due to lower future estimated gross profits.[5]In the fourth quarter of 2021, our life insurance business recorded a net loss of $131 million predominantly driven by an initial loss of $73 million as a result of ceding certain term life insurance policies as part of a life block transaction, an unfavorable unlocking of $70 million associated with its annual review of assumptions and a DAC impairment of $32 million as a result of recoverability testing.[6]On September 20, 2021, we completed the minority IPO of Enact Holdings, which reduced our ownership percentage to 81.6%, and lowered our available net income by $29 million in the fourth quarter of 2021.[7]May not total due to whole number calculation.

Quarterly Results of Operatio_4

Quarterly Results of Operations (Parenthetical) (Detail) - USD ($) $ in Millions			3 Months Ended																12 Months Ended
		Sep. 20, 2021	Dec. 31, 2022		Sep. 30, 2022		Jun. 30, 2022		Mar. 31, 2022		Dec. 31, 2021		Sep. 30, 2021		Jun. 30, 2021		Mar. 31, 2021		Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Quarterly Financial Information [Line Items]
Total benefits and expenses			$ 1,635	[1],[2]	$ 1,653	[1],[2]	$ 1,588	[1],[2]	$ 1,653	[1],[2]	$ 1,481	[3]	$ 1,697	[3]	$ 1,721	[3]	$ 1,752	[3]	$ 6,529	$ 6,651	$ 7,356
Net income loss			175	[1],[2]	104	[1],[2]	181	[1],[2]	149	[1],[2]	163	[4]	314	[4]	240	[4]	187	[4]	609	904	178
Life insurance reserves ceded	[5]		383,350								427,464								383,350	427,464	458,999
Income attributable to noncontrolling interests associated with minority IPO			27		$ 35		$ 38		$ 30		29	[4]	$ 4	[4]	$ 0	[4]	$ 0	[4]	$ 130	33	$ 0
Term Life Insurance \| Life Block Transaction
Quarterly Financial Information [Line Items]
Gains (losses) from life block transactions											73
Life insurance premiums ceded											360
Life insurance reserves ceded											268									$ 268
Enact Holdings Inc.
Quarterly Financial Information [Line Items]
Sale of stock percentage of ownership after transaction		81.60%
Minority IPO \| Income Attributable To Noncontrolling Interests
Quarterly Financial Information [Line Items]
Income attributable to noncontrolling interests associated with minority IPO											29
Unlocking \| Universal Life
Quarterly Financial Information [Line Items]
Total benefits and expenses											87
Unfavorable adjustment, net of taxes											70
Favorable Unfavorable Adjustment Before Taxes			43
Lower Future Gross Profits Estimated in the Future \| Universal Life
Quarterly Financial Information [Line Items]
Impairment of deferred acquisition costs											41
Deferred Policy Acquisition Costs Impairment Loss After Tax											32
Life Insurance
Quarterly Financial Information [Line Items]
Net income loss											$ 131
Enact Segment [Member]
Quarterly Financial Information [Line Items]
Favorable Reserve Adjustment Net Pretax			$ 42

[1]In the fourth quarter of 2022, our Enact segment recorded a pre-tax net favorable reserve adjustment of $42 million primarily related to COVID-19 delinquencies in 2020 and 2021 curing at levels above original reserve expectations.[2]In the fourth quarter of 2022, our life insurance business completed its annual review of assumptions for its universal and term universal life insurance products and recorded a pre-tax favorable unlocking of $43 million mostly attributable to higher interest rates.[3]In the fourth quarter of 2021, our life insurance business initially ceded $268 million of certain term life insurance reserves under a new reinsurance treaty as part of a life block transaction. Our life insurance business also completed its annual review of assumptions in the fourth quarter of 2021. This review resulted in higher total benefits and expenses of $87 million from an unfavorable unlocking in our term universal and universal life insurance products largely attributable to higher pre-COVID-19 mortality. In our term universal life insurance products, we also recorded a DAC impairment of $41 million in the fourth quarter of 2021 principally due to lower future estimated gross profits.[4]On September 20, 2021, we completed the minority IPO of Enact Holdings, which reduced our ownership percentage to 81.6%, and lowered our available net income by $29 million in the fourth quarter of 2021.[5]Includes amounts accounted for under the deposit method.

Commitments and Contingencies -

Commitments and Contingencies - Additional Information (Detail) - USD ($) $ in Millions					1 Months Ended	12 Months Ended
	Mar. 25, 2022	Aug. 11, 2021	Jul. 17, 2020	Jan. 31, 2020	Jan. 31, 2021	Dec. 31, 2019	Dec. 31, 2022	Mar. 31, 2022	Dec. 31, 2021	Sep. 11, 2019
Commitments and Contingencies Disclosure [Line Items]
Off-balance sheet risk							$ 1,365		$ 1,185
Commitments to Fund Limited Partnerships
Commitments and Contingencies Disclosure [Line Items]
Off-balance sheet risk							1,365
Commitments to Fund Private Placement Investments
Commitments and Contingencies Disclosure [Line Items]
Off-balance sheet risk							19
Commitments to Fund Bank Loan Investments
Commitments and Contingencies Disclosure [Line Items]
Off-balance sheet risk							70
Commitments to fund commercial mortgage loan investments
Commitments and Contingencies Disclosure [Line Items]
Off-balance sheet risk							$ 5
Other Litigation
Commitments and Contingencies Disclosure [Line Items]
Plaintiff's Motion Dismissed				$ 395
Loss Contingency, Damages Sought		$ 5			$ 5
Plaintiffs' motion				$ 15		$ 410
Restricted cash proceeds on sale per litigation										$ 450
Litigation \| Cost Of Insurance \| Life Insurance [Member]
Commitments and Contingencies Disclosure [Line Items]
Loss Contingency, Damages Sought			$ 5		$ 5
Contingent liability								$ 25
Litigation settlement, amount awarded to other party	$ 25

Component of Changes in Accumul

Component of Changes in Accumulated Other Comprehensive Income (Loss) (Detail) - USD ($) $ in Millions		12 Months Ended
		Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Accumulated Other Comprehensive Income (Loss) [Line Items]
Beginning balance		$ 3,861	$ 4,425	$ 3,433
OCI before reclassifications		(6,067)	(210)	1,531
Amounts reclassified from (to) OCI		(100)	(192)	(509)
Total other comprehensive income (loss)		(6,167)	(402)	1,022
Balances before nonnontrolling interests		(2,306)	4,023	4,455
Less: change in OCI attributable to noncontrolling interests		(86)	162	30
Ending balance		(2,220)	3,861	4,425
Net unrealized investment gains (losses)
Accumulated Other Comprehensive Income (Loss) [Line Items]
Beginning balance	[1]	1,860	2,214	1,456
OCI before reclassifications	[1]	(5,430)	(313)	1,132
Amounts reclassified from (to) OCI	[1]	58	(51)	(374)
Total other comprehensive income (loss)	[1]	(5,372)	(364)	758
Balances before nonnontrolling interests	[1]	(3,512)	1,850	2,214
Less: change in OCI attributable to noncontrolling interests	[1]	(86)	(10)	0
Ending balance	[1]	(3,426)	1,860	2,214
Derivatives qualifying as hedges
Accumulated Other Comprehensive Income (Loss) [Line Items]
Beginning balance	[2]	2,025	2,211	2,002
OCI before reclassifications	[2]	(674)	(45)	344
Amounts reclassified from (to) OCI	[2]	(151)	(141)	(135)
Total other comprehensive income (loss)	[2]	(825)	(186)	209
Balances before nonnontrolling interests	[2]	1,200	2,025	2,211
Less: change in OCI attributable to noncontrolling interests	[2]	0	0	0
Ending balance	[2]	1,200	2,025	2,211
Foreign currency translation and other adjustments
Accumulated Other Comprehensive Income (Loss) [Line Items]
Beginning balance		(24)	0	(25)
OCI before reclassifications		37	148	55
Amounts reclassified from (to) OCI		(7)	0	0
Total other comprehensive income (loss)		30	148	55
Balances before nonnontrolling interests		6	148	30
Less: change in OCI attributable to noncontrolling interests		0	172	30
Ending balance		$ 6	$ (24)	$ 0

[1]Net of adjustments to DAC, PVFP, sales inducements, benefit reserves and policyholder contract balances. See note 4 for additional information.[2]See note 5 for additional information.

Changes In Accumulated Other _3

Changes In Accumulated Other Comprehensive Income (Loss) - Additional Information (Detail) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Accumulated Other Comprehensive Income (Loss) [Line Items]
Unrecognized postretirement benefit obligation, current period OCI	$ 34	$ (1)	$ (15)
Unrecognized postretirement benefit obligation, current period OCI, tax	(8)	$ 1	4
Foreign currency translation and other adjustments, current period OCI, tax	$ 2		$ 21

Reclassifications In (Out) of A

Reclassifications In (Out) of Accumulated Other Comprehensive Income (Loss), Net of Taxes (Detail) - USD ($) $ in Millions		3 Months Ended																12 Months Ended
		Dec. 31, 2022	[1],[2]	Sep. 30, 2022	[1],[2]	Jun. 30, 2022	[1],[2]	Mar. 31, 2022	[1],[2]	Dec. 31, 2021	[3],[4],[5]	Sep. 30, 2021	[3],[4],[5]	Jun. 30, 2021	[3],[4],[5]	Mar. 31, 2021	[3],[4],[5]	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Net investment income																		$ (3,146)	$ (3,370)	$ (3,227)
Net investment (gains) losses																		17	(323)	(492)
Income taxes																		239	263	230
(Income) loss from continuing operations		$ (204)		$ (134)		$ (220)		$ (181)		$ (193)		$ (306)		$ (245)		$ (174)		(739)	(918)	(698)
Interest expense																		106	160	195
Amount reclassified from accumulated other comprehensive income (loss) \| Net unrealized investment (gains) losses
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Net investment (gains) losses	[6]																	74	(65)	(474)
Income taxes																		(16)	14	100
(Income) loss from continuing operations																		58	(51)	(374)
Amount reclassified from accumulated other comprehensive income (loss) \| Derivatives qualifying as hedges
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Income taxes																		80	76	73
(Income) loss from continuing operations																		(151)	(141)	(135)
Amount reclassified from accumulated other comprehensive income (loss) \| Derivatives qualifying as hedges \| Interest rate swaps \| Derivative liabilities
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Interest expense																		3	1	0
Amount reclassified from accumulated other comprehensive income (loss) \| Derivatives qualifying as hedges \| Interest rate swaps \| Derivative assets
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Net investment income																		(225)	(217)	(196)
Net investment (gains) losses																		$ (9)	$ (1)	$ (12)

[1]In the fourth quarter of 2022, our Enact segment recorded a pre-tax net favorable reserve adjustment of $42 million primarily related to COVID-19 delinquencies in 2020 and 2021 curing at levels above original reserve expectations.[2]In the fourth quarter of 2022, our life insurance business completed its annual review of assumptions for its universal and term universal life insurance products and recorded a pre-tax favorable unlocking of $43 million mostly attributable to higher interest rates.[3]In the fourth quarter of 2021, our life insurance business initially ceded $268 million of certain term life insurance reserves under a new reinsurance treaty as part of a life block transaction. Our life insurance business also completed its annual review of assumptions in the fourth quarter of 2021. This review resulted in higher total benefits and expenses of $87 million from an unfavorable unlocking in our term universal and universal life insurance products largely attributable to higher pre-COVID-19 mortality. In our term universal life insurance products, we also recorded a DAC impairment of $41 million in the fourth quarter of 2021 principally due to lower future estimated gross profits.[4]In the fourth quarter of 2021, our life insurance business initially ceded $360 million of premiums associated with certain term life insurance policies under a new reinsurance treaty as part of a life block transaction.[5]In the fourth quarter of 2021, our life insurance business recorded a net loss of $131 million predominantly driven by an initial loss of $73 million as a result of ceding certain term life insurance policies as part of a life block transaction, an unfavorable unlocking of $70 million associated with its annual review of assumptions and a DAC impairment of $32 million as a result of recoverability testing.[6]Amounts exclude adjustments to DAC, PVFP, sales inducements, benefit reserves and policyholder contract balances.

Noncontrolling Interests - Summ

Noncontrolling Interests - Summary of Changes in Ownership Interests (Details) - USD ($) $ in Millions

3 Months Ended

12 Months Ended

Dec. 31, 2022

[1],[2]

Sep. 30, 2022

[1],[2]

Jun. 30, 2022

[1],[2]

Mar. 31, 2022

[1],[2]

Dec. 31, 2021

[3]

Sep. 30, 2021

[3]

Jun. 30, 2021

[3]

Mar. 31, 2021

[3]

Dec. 31, 2022

Dec. 31, 2021

Dec. 31, 2020

Noncontrolling Interest [Abstract]

Net income available to Genworth Financial, Inc.'s common stockholders

$ 175

$ 104

$ 181

$ 149

$ 163

$ 314

$ 240

$ 187

$ 609

$ 904

$ 178

Transfers to noncontrolling interests:

Decrease in Genworth Financial, Inc.'s additional paid-in capital for initial sale of Enact Holdings shares to noncontrolling interests

(167)

Net transfers to noncontrolling interests

(167)

Change from net income available to Genworth Financial, Inc.'s common stockholders and transfers to noncontrolling interests

$ 737

[1]In the fourth quarter of 2022, our Enact segment recorded a pre-tax net favorable reserve adjustment of $42 million primarily related to COVID-19 delinquencies in 2020 and 2021 curing at levels above original reserve expectations.[2]In the fourth quarter of 2022, our life insurance business completed its annual review of assumptions for its universal and term universal life insurance products and recorded a pre-tax favorable unlocking of $43 million mostly attributable to higher interest rates.[3]On September 20, 2021, we completed the minority IPO of Enact Holdings, which reduced our ownership percentage to 81.6%, and lowered our available net income by $29 million in the fourth quarter of 2021.

Noncontrolling Interests - Addi

Noncontrolling Interests - Additional Information (Detail) - USD ($) $ / shares in Units, $ in Millions			12 Months Ended
	Sep. 16, 2021	Sep. 15, 2021	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020	Nov. 01, 2022	May 02, 2022	Mar. 03, 2021
Noncontrolling Interest [Line Items]
Payment of dividends minority interest			$ 46	$ 37	$ 0
Stockholders' Equity Attributable to Noncontrolling Interests			$ 755	756
Stock Repurchase Program, Authorized Amount							$ 350
Genworth Australia
Noncontrolling Interest [Line Items]
Beneficial ownership percentage of ordinary shares								52%
Stockholders' Equity Attributable to Noncontrolling Interests								$ 500
Enact Holdings Inc.
Noncontrolling Interest [Line Items]
Beneficial ownership percentage of ordinary shares			81.60%
Payment of dividends minority interest			$ 46	$ 37
Costs directly related to the Offering	$ 24
Proceeds from the sale of subsidiary shares gross	$ 553
Enact Holdings Inc. \| Enact Holdings Share Repurchase Program Plan [Member]
Noncontrolling Interest [Line Items]
Stock Repurchase Program, Authorized Amount						$ 75
Enact Holdings Inc. \| IPO
Noncontrolling Interest [Line Items]
Shares sold	13,310,400
Price per ordinary share	$ 19
Enact Holdings Inc. \| Private Placement
Noncontrolling Interest [Line Items]
Shares sold	14,655,600
Price per ordinary share	$ 17.86
Enact Holdings Inc. \| Over-Allotment Option
Noncontrolling Interest [Line Items]
Shares sold	1,996,560	1,996,560

Schedule Of Income Loss On Sale

Schedule Of Income Loss On Sale Recorded In Our Disposition Group (Detail) - Genworth Australia $ in Millions	12 Months Ended
	Dec. 31, 2021 USD ($)
Net cash proceeds	$ 370
Add: carrying value of noncontrolling interests	657	[1]
Total adjusted consideration	1,027	[2]
Carrying value of the disposal group before accumulated other comprehensive loss	1,040
Add: total accumulated other comprehensive loss of disposal group	109	[3]
Total adjusted carrying value of the disposal group	1,149
Pre-tax loss on sale	(122)
Tax benefit on sale	122
After-tax gain (loss) on sale	$ 0

[1]In accordance with accounting guidance on the deconsolidation of a subsidiary or group of assets, the carrying amount of any noncontrolling interests in the subsidiary sold (adjusted to reflect amounts in accumulated other comprehensive income (loss) recognized upon final disposition) is added to the total fair value of the consideration received.[2]Represents the aggregate of the net cash proceeds received upon sale closing plus the adjusted carrying amount of noncontrolling interests in the subsidiary sold.[3]Amount consists of $160 million of cumulative losses on foreign currency translation adjustments, partially offset by cumulative unrealized investment gains of $29 million and deferred tax gains of $22 million.

Schedule Of Income Loss On Sa_2

Schedule Of Income Loss On Sale Recorded In Our Disposition Group (Parenthetical) (Detail) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2022	Dec. 31, 2020	Dec. 31, 2019
Net unrealized investment gains (losses)	$ 1,860	$ (3,426)	$ 2,214	$ 1,456
Genworth Australia
Foreign currency translation and other adjustments	160
Deferred tax gains on accumulated other comprehensive income	22
Net unrealized investment gains (losses)	29
Favorable adjustment relating to refinement of tax matters agreement	$ 10

Discontinued Operations - Addit

Discontinued Operations - Additional Information (Detail) £ in Millions, $ in Millions, $ in Millions			12 Months Ended
	Mar. 03, 2021 AUD ($)	Mar. 03, 2021 USD ($)	Dec. 31, 2022 USD ($)	Dec. 31, 2021 USD ($)	Dec. 31, 2020 USD ($)	Feb. 28, 2022 USD ($)	Dec. 31, 2021 GBP (£)
Income Statement, Balance Sheet and Additional Disclosures by Planned Disposal Groups [Line Items]
Unrelated liability			$ 6	$ 4
Disposal group discontinued operations favorable tax adjustments and other expenses net of tax			5
Underwriting Liability [Member] \| AXA [Member]
Income Statement, Balance Sheet and Additional Disclosures by Planned Disposal Groups [Line Items]
Adjustments to underwriting loss				(4)	$ 23
Genworth Mortgage Insurance Australia Limited
Income Statement, Balance Sheet and Additional Disclosures by Planned Disposal Groups [Line Items]
Percentage of shareholding in the investee company	52%	52%
Proceeds from sale of disposal group including discontinuing operations	$ 483	$ 370
AXA Settlement Agreement
Income Statement, Balance Sheet and Additional Disclosures by Planned Disposal Groups [Line Items]
Income loss from discontinued operations after tax			(5)	4	$ (572)
AXA Settlement Agreement Promissory Note \| Discontinued Operations \| Future Claims
Income Statement, Balance Sheet and Additional Disclosures by Planned Disposal Groups [Line Items]
Loss Contingency, Estimate of Possible Loss			$ 2	$ 30		$ 30	£ 22

Summary of Operating Results Re

Summary of Operating Results Related to Discontinued Operations (Detail) - USD ($) $ in Millions		3 Months Ended																12 Months Ended
		Dec. 31, 2022		Sep. 30, 2022		Jun. 30, 2022		Mar. 31, 2022		Dec. 31, 2021		Sep. 30, 2021		Jun. 30, 2021		Mar. 31, 2021		Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Revenues:
Premiums																		$ 3,719	$ 3,435	$ 3,836
Net investment income																		3,146	3,370	3,227
Net investment gains (losses)																		(17)	323	492
Policy fees and other income																		659	704	729
Benefits and expenses:
Benefits and other changes in policy reserves																		4,242	4,383	5,214
Acquisition and operating expenses, net of deferrals																		1,371	1,223	935
Amortization of deferred acquisition costs and intangibles																		307	377	463
Total benefits and expenses		$ 1,635	[1],[2]	$ 1,653	[1],[2]	$ 1,588	[1],[2]	$ 1,653	[1],[2]	$ 1,481	[3]	$ 1,697	[3]	$ 1,721	[3]	$ 1,752	[3]	6,529	6,651	7,356
Income from discontinued operations, net of taxes		(2)		5		(1)		(2)		(1)		12		(5)		21		0	27	(486)
Less: net income from discontinued operations attributable to noncontrolling interests		0		0		0		0		0		0		0		8		0	8	34
Income (loss) from discontinued operations available to Genworth Financial, Inc.'s common stockholders		$ (2)		$ 5		$ (1)		$ (2)		$ (1)		$ 12		$ (5)		$ 13		$ 0	19	(520)
Assets Held For Sale Related To Discontinued Operations \| Genworth Australia
Revenues:
Premiums																			51	274
Net investment income																			4	33
Net investment gains (losses)																			(5)	66
Policy fees and other income																			0	1
Total revenues																			50	374
Benefits and expenses:
Benefits and other changes in policy reserves																			11	177
Acquisition and operating expenses, net of deferrals																			7	53
Amortization of deferred acquisition costs and intangibles																			6	29
Interest expense																			1	7
Goodwill impairment																			0	5
Total benefits and expenses																			25	271
Income before income taxes and gain (loss) on sale	[4]																		25	103
Provision for income taxes																			8	40
Income before gain (loss) on sale																			17	63
Gain (loss) on sale, net of taxes																			0	0
Income from discontinued operations, net of taxes																			17	63
Less: net income from discontinued operations attributable to noncontrolling interests																			8	34
Income (loss) from discontinued operations available to Genworth Financial, Inc.'s common stockholders																			$ 9	$ 29

[1]In the fourth quarter of 2022, our Enact segment recorded a pre-tax net favorable reserve adjustment of $42 million primarily related to COVID-19 delinquencies in 2020 and 2021 curing at levels above original reserve expectations.[2]In the fourth quarter of 2022, our life insurance business completed its annual review of assumptions for its universal and term universal life insurance products and recorded a pre-tax favorable unlocking of $43 million mostly attributable to higher interest rates.[3]In the fourth quarter of 2021, our life insurance business initially ceded $268 million of certain term life insurance reserves under a new reinsurance treaty as part of a life block transaction. Our life insurance business also completed its annual review of assumptions in the fourth quarter of 2021. This review resulted in higher total benefits and expenses of $87 million from an unfavorable unlocking in our term universal and universal life insurance products largely attributable to higher pre-COVID-19 mortality. In our term universal life insurance products, we also recorded a DAC impairment of $41 million in the fourth quarter of 2021 principally due to lower future estimated gross profits.[4]The years ended December 31, 2021 and 2020 include pre-tax income from discontinued operations available to Genworth Financial, Inc.’s common stockholders of $13 million and $54 million, respectively.

Summary of Operating Results _2

Summary of Operating Results Related to Discontinued Operations (Parenthetical) (Detail) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Genworth Australia \| Parent Company [Member]
Discontinued operation pretax income attributable to parent	$ 13	$ 54

Schedule I Genworth Financial_2

Schedule I Genworth Financial, Inc. Summary of Investments-Other than Investments in Related Parties (Detail) $ in Millions	Dec. 31, 2022 USD ($)
Summary of Investments, Other than Investments in Related Parties, Reportable Data [Line Items]
Amortized cost or cost	$ 62,528
Carrying value	58,948
Commercial mortgage loans
Summary of Investments, Other than Investments in Related Parties, Reportable Data [Line Items]
Amortized cost or cost	7,010
Carrying value	7,010
Policy Loans
Summary of Investments, Other than Investments in Related Parties, Reportable Data [Line Items]
Amortized cost or cost	2,139
Carrying value	2,139
Limited Partnerships
Summary of Investments, Other than Investments in Related Parties, Reportable Data [Line Items]
Amortized cost or cost	1,675
Carrying value	2,331
Other invested assets
Summary of Investments, Other than Investments in Related Parties, Reportable Data [Line Items]
Amortized cost or cost	529	[1]
Carrying value	566	[1]
Fixed maturity securities \| Bonds
Summary of Investments, Other than Investments in Related Parties, Reportable Data [Line Items]
Amortized cost or cost	50,834
Fair value	46,583
Carrying value	46,583
Fixed maturity securities \| Bonds \| U.S. government, agencies and authorities
Summary of Investments, Other than Investments in Related Parties, Reportable Data [Line Items]
Amortized cost or cost	3,446
Fair value	3,341
Carrying value	3,341
Fixed maturity securities \| Bonds \| State and Political Subdivisions
Summary of Investments, Other than Investments in Related Parties, Reportable Data [Line Items]
Amortized cost or cost	2,726
Fair value	2,399
Carrying value	2,399
Fixed maturity securities \| Bonds \| Non-U.S. government
Summary of Investments, Other than Investments in Related Parties, Reportable Data [Line Items]
Amortized cost or cost	731
Fair value	645
Carrying value	645
Fixed maturity securities \| Bonds \| Public Utilities
Summary of Investments, Other than Investments in Related Parties, Reportable Data [Line Items]
Amortized cost or cost	5,112
Fair value	4,638
Carrying value	4,638
Fixed maturity securities \| Bonds \| All Other Corporate Bonds
Summary of Investments, Other than Investments in Related Parties, Reportable Data [Line Items]
Amortized cost or cost	38,819
Fair value	35,560
Carrying value	35,560
Equity Securities
Summary of Investments, Other than Investments in Related Parties, Reportable Data [Line Items]
Amortized cost or cost	341
Fair value	319
Carrying value	$ 319

[1]The amount shown in the consolidated balance sheet for other invested assets differs from amortized cost or cost presented, as other invested assets include certain assets with a carrying amount that differs from amortized cost or cost.

Schedule II Genworth Financia_2

Schedule II Genworth Financial, Inc. (Parent Company Only) (Balance Sheets) (Detail) - USD ($) $ in Millions	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Assets
Deferred tax asset	$ 1,523	$ 960
Other assets	415	388
Total assets	86,442	99,171
Liabilities and stockholders' equity
Other liabilities	1,672	1,511
Total liabilities	75,703	82,905
Commitments and contingencies
Stockholders' equity:
Common stock	1	1
Additional paid-in capital	11,869	11,858
Net unrealized investment gains (losses)
Accumulated other comprehensive income (loss)	(2,220)	3,861	$ 4,425	$ 3,433
Retained earnings	3,098	2,490
Treasury stock, at cost	(2,764)	(2,700)
Total Genworth Financial, Inc.'s stockholders' equity	9,984	15,510
Total liabilities and equity	86,442	99,171
Parent Company
Assets
Investments in subsidiaries	10,008	15,517
Deferred tax asset	6	4
Other assets	3	5
Total assets	10,017	15,526
Liabilities and stockholders' equity
Other liabilities	7	4
Intercompany notes payable	26	12
Total liabilities	33	16
Commitments and contingencies
Stockholders' equity:
Common stock	1	1
Additional paid-in capital	11,869	11,858
Net unrealized investment gains (losses)
Accumulated other comprehensive income (loss)	(2,220)	3,861
Retained earnings	3,098	2,490
Treasury stock, at cost	(2,764)	(2,700)
Total Genworth Financial, Inc.'s stockholders' equity	9,984	15,510
Total liabilities and equity	$ 10,017	$ 15,526

Schedule II Genworth Financia_3

Schedule II Genworth Financial, Inc. (Parent Company Only) (Statements of Income) (Detail) - USD ($) $ in Millions	3 Months Ended																12 Months Ended
	Dec. 31, 2022		Sep. 30, 2022		Jun. 30, 2022		Mar. 31, 2022		Dec. 31, 2021		Sep. 30, 2021		Jun. 30, 2021		Mar. 31, 2021		Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Revenues:
Net investment income																	$ 3,146	$ 3,370	$ 3,227
Total revenues	$ 1,895		$ 1,839		$ 1,881		$ 1,892		$ 1,736	[1]	$ 2,070	[1]	$ 2,041	[1]	$ 1,985	[1]	7,507	7,832	8,284
Expenses:
Acquisition and operating expenses, net of deferrals																	1,371	1,223	935
Interest expense																	106	160	195
Loss before income taxes and equity in income of subsidiaries																	978	1,181	928
Benefit from income taxes																	239	263	230
Income from continuing operations	177		99		182		151		164		302		245		174		609	885	698
Income from discontinued operations, net of taxes	(2)		5		(1)		(2)		(1)		12		(5)		21		0	27	(486)
Net income available to Genworth Financial, Inc.'s common stockholders	$ 175	[2],[3]	$ 104	[2],[3]	$ 181	[2],[3]	$ 149	[2],[3]	$ 163	[4]	$ 314	[4]	$ 240	[4]	$ 187	[4]	609	904	178
Parent Company
Revenues:
Net investment income																	0	(3)	(3)
Total revenues																	0	(3)	(3)
Expenses:
Acquisition and operating expenses, net of deferrals																	31	25	31
Interest expense																	0	(1)	1
Total expenses																	31	24	32
Loss before income taxes and equity in income of subsidiaries																	(31)	(27)	(35)
Benefit from income taxes																	(3)	(1)	(2)
Equity in income of subsidiaries																	637	930	210
Income from continuing operations																	609	904	177
Income from discontinued operations, net of taxes																	0	0	1
Net income available to Genworth Financial, Inc.'s common stockholders																	$ 609	$ 904	$ 178

[1]In the fourth quarter of 2021, our life insurance business initially ceded $360 million of premiums associated with certain term life insurance policies under a new reinsurance treaty as part of a life block transaction.[2]In the fourth quarter of 2022, our Enact segment recorded a pre-tax net favorable reserve adjustment of $42 million primarily related to COVID-19 delinquencies in 2020 and 2021 curing at levels above original reserve expectations.[3]In the fourth quarter of 2022, our life insurance business completed its annual review of assumptions for its universal and term universal life insurance products and recorded a pre-tax favorable unlocking of $43 million mostly attributable to higher interest rates.[4]On September 20, 2021, we completed the minority IPO of Enact Holdings, which reduced our ownership percentage to 81.6%, and lowered our available net income by $29 million in the fourth quarter of 2021.

Schedule II Genworth Financia_4

Schedule II Genworth Financial, Inc. (Parent Company Only) (Statements of Comprehensive Income) (Detail) - USD ($) $ in Millions	3 Months Ended																12 Months Ended
	Dec. 31, 2022	[1],[2]	Sep. 30, 2022	[1],[2]	Jun. 30, 2022	[1],[2]	Mar. 31, 2022	[1],[2]	Dec. 31, 2021	[3],[4],[5]	Sep. 30, 2021	[3],[4],[5]	Jun. 30, 2021	[3],[4],[5]	Mar. 31, 2021	[3],[4],[5]	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Net income available to Genworth Financial, Inc.'s common stockholders	$ 202		$ 139		$ 219		$ 179		$ 192		$ 318		$ 240		$ 195		$ 739	$ 945	$ 212
Other comprehensive income (loss), net of taxes:
Net unrealized gains (losses) on securities without an allowance for credit losses																	(5,372)	(370)	764
Net unrealized gains (losses) on securities with an allowance for credit losses																	0	6	(6)
Derivatives qualifying as hedges																	(825)	(186)	209
Foreign currency translation and other adjustments																	30	148	55
Total other comprehensive income (loss)																	(6,167)	(402)	1,022
Total comprehensive income (loss) available to Genworth Financial, Inc.'s common stockholders																	(5,472)	366	1,170
Parent Company [Member]
Net income available to Genworth Financial, Inc.'s common stockholders																	609	904	178
Other comprehensive income (loss), net of taxes:
Net unrealized gains (losses) on securities without an allowance for credit losses																	(5,286)	(334)	764
Net unrealized gains (losses) on securities with an allowance for credit losses																	0	6	(6)
Derivatives qualifying as hedges																	(825)	(186)	209
Foreign currency translation and other adjustments																	30	(24)	25
Total other comprehensive income (loss)																	(6,081)	(538)	992
Total comprehensive income (loss) available to Genworth Financial, Inc.'s common stockholders																	$ (5,472)	$ 366	$ 1,170

[1]In the fourth quarter of 2022, our Enact segment recorded a pre-tax net favorable reserve adjustment of $42 million primarily related to COVID-19 delinquencies in 2020 and 2021 curing at levels above original reserve expectations.[2]In the fourth quarter of 2022, our life insurance business completed its annual review of assumptions for its universal and term universal life insurance products and recorded a pre-tax favorable unlocking of $43 million mostly attributable to higher interest rates.[3]In the fourth quarter of 2021, our life insurance business initially ceded $268 million of certain term life insurance reserves under a new reinsurance treaty as part of a life block transaction. Our life insurance business also completed its annual review of assumptions in the fourth quarter of 2021. This review resulted in higher total benefits and expenses of $87 million from an unfavorable unlocking in our term universal and universal life insurance products largely attributable to higher pre-COVID-19 mortality. In our term universal life insurance products, we also recorded a DAC impairment of $41 million in the fourth quarter of 2021 principally due to lower future estimated gross profits.[4]In the fourth quarter of 2021, our life insurance business initially ceded $360 million of premiums associated with certain term life insurance policies under a new reinsurance treaty as part of a life block transaction.[5]In the fourth quarter of 2021, our life insurance business recorded a net loss of $131 million predominantly driven by an initial loss of $73 million as a result of ceding certain term life insurance policies as part of a life block transaction, an unfavorable unlocking of $70 million associated with its annual review of assumptions and a DAC impairment of $32 million as a result of recoverability testing.

Schedule II Genworth Financia_5

Schedule II Genworth Financial, Inc. (Parent Company Only) (Statements of Cash Flows) (Detail) - USD ($) $ in Millions	1 Months Ended	3 Months Ended																12 Months Ended
	Feb. 24, 2023	Dec. 31, 2022		Sep. 30, 2022		Jun. 30, 2022		Mar. 31, 2022		Dec. 31, 2021		Sep. 30, 2021		Jun. 30, 2021		Mar. 31, 2021		Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Cash flows from (used by) operating activities:
Net income available to Genworth Financial, Inc.'s common stockholders		$ 202	[1],[2]	$ 139	[1],[2]	$ 219	[1],[2]	$ 179	[1],[2]	$ 192	[3],[4],[5]	$ 318	[3],[4],[5]	$ 240	[3],[4],[5]	$ 195	[3],[4],[5]	$ 739	$ 945	$ 212
Less (income) loss from discontinued operations, net of taxes		2		$ (5)		$ 1		2		1		$ (12)		$ 5		(21)		0	(27)	486
Adjustments to reconcile net income available to Genworth Financial, Inc.'s common stockholders to net cash from (used by) operating activities:
Deferred income taxes																		235	290	228
Stock-based compensation expense																		37	40	39
Change in certain assets and liabilities:
Accrued investment income and other assets																		(161)	(129)	(92)
Current tax liabilities																		(1)	(34)	6
Other liabilities and other policy-related balances																		129	310	830
Net cash from operating activities																		1,049	437	1,960
Cash flows from (used) by investing activities:
Net cash from (used by) investing activities																		733	896	(1,153)
Cash flows from (used by) financing activities:
Treasury stock acquired in connection with share repurchases	$ (36)																	(64)	0	0
Other, net																		(85)	32	(2)
Net cash used by financing activities																		(1,554)	(2,419)	(1,507)
Cash, cash equivalents and restricted cash at beginning of year								1,571								2,561		1,571	2,561
Cash, cash equivalents and restricted cash of continuing operations at end of period		1,799								1,571								1,799	1,571	2,561
Parent Company
Cash flows from (used by) operating activities:
Net income available to Genworth Financial, Inc.'s common stockholders																		609	904	178
Less (income) loss from discontinued operations, net of taxes																		0	0	(1)
Adjustments to reconcile net income available to Genworth Financial, Inc.'s common stockholders to net cash from (used by) operating activities:
Equity in income from subsidiaries																		(637)	(930)	(210)
Deferred income taxes																		(6)	0	(1)
Stock-based compensation expense																		27	40	39
Change in certain assets and liabilities:
Accrued investment income and other assets																		2	(1)	2
Current tax liabilities																		2	(5)	(1)
Other liabilities and other policy-related balances																		15	(13)	11
Net cash from operating activities																		12	(5)	17
Cash flows from (used) by investing activities:
Intercompany notes receivable, net																		0	0	(10)
Capital contributions paid to subsidiaries																		(3)	(2)	(2)
Net cash from (used by) investing activities																		(3)	(2)	(12)
Cash flows from (used by) financing activities:
Intercompany notes payable, net																		64	12	0
Treasury stock acquired in connection with share repurchases																		(64)	0	0
Other, net																		(9)	(5)	(5)
Net cash used by financing activities																		(9)	7	(5)
Effect of exchange rate changes on cash, cash equivalents and restricted cash																		0	0	0
Cash, cash equivalents and restricted cash at beginning of year								$ 0								$ 0		0	0	0
Cash, cash equivalents and restricted cash of continuing operations at end of period		$ 0								$ 0								$ 0	$ 0	$ 0

[1]In the fourth quarter of 2022, our Enact segment recorded a pre-tax net favorable reserve adjustment of $42 million primarily related to COVID-19 delinquencies in 2020 and 2021 curing at levels above original reserve expectations.[2]In the fourth quarter of 2022, our life insurance business completed its annual review of assumptions for its universal and term universal life insurance products and recorded a pre-tax favorable unlocking of $43 million mostly attributable to higher interest rates.[3]In the fourth quarter of 2021, our life insurance business initially ceded $268 million of certain term life insurance reserves under a new reinsurance treaty as part of a life block transaction. Our life insurance business also completed its annual review of assumptions in the fourth quarter of 2021. This review resulted in higher total benefits and expenses of $87 million from an unfavorable unlocking in our term universal and universal life insurance products largely attributable to higher pre-COVID-19 mortality. In our term universal life insurance products, we also recorded a DAC impairment of $41 million in the fourth quarter of 2021 principally due to lower future estimated gross profits.[4]In the fourth quarter of 2021, our life insurance business initially ceded $360 million of premiums associated with certain term life insurance policies under a new reinsurance treaty as part of a life block transaction.[5]In the fourth quarter of 2021, our life insurance business recorded a net loss of $131 million predominantly driven by an initial loss of $73 million as a result of ceding certain term life insurance policies as part of a life block transaction, an unfavorable unlocking of $70 million associated with its annual review of assumptions and a DAC impairment of $32 million as a result of recoverability testing.

Schedule II Genworth Financia_6

Schedule II Genworth Financial, Inc. (Parent Company Only) - Additional Information (Detail) - USD ($) $ / shares in Units, $ in Millions	1 Months Ended	3 Months Ended								12 Months Ended
	Feb. 24, 2023	Dec. 31, 2022	Sep. 30, 2022	Jun. 30, 2022	Mar. 31, 2022	Dec. 31, 2021	Sep. 30, 2021	Jun. 30, 2021	Mar. 31, 2021	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020	May 02, 2022	Apr. 01, 2013
Condensed Financial Statements, Captions [Line Items]
Deferred tax asset		$ 1,523				$ 960				$ 1,523	$ 960
Net cash received (paid) for taxes										$ 5	7	$ (3)
Number of shares repurchased	5,912,297									16,173,196
Stock repurchase program, remaining authorized repurchase amount	$ 250
Loss from discontinued operations, net of taxes		(2)	$ 5	$ (1)	$ (2)	(1)	$ 12	$ (5)	$ 21	$ 0	27	(486)
Stock repurchase program, authorized amount													$ 350
Average price per share repurchased	$ 6.08									$ 3.94
Payments for repurchase of common stock	$ 36									$ 64	0	0
Parent Company
Condensed Financial Statements, Captions [Line Items]
Deferred tax asset		6				4				6	4
Current income tax receivable		0				$ 2				0	2
Net cash received (paid) for taxes										1	4	0
Investments in subsidiaries		$ 10,000								10,000
Increase (decrease) in investments in subsidiaries										(5,500)
Loss from discontinued operations, net of taxes										0	0	1
Payments for repurchase of common stock										64	$ 0	0
Genworth Holdings
Condensed Financial Statements, Captions [Line Items]
Percentage of subsidiary equity ownership														100%
Related party loans forgiven										$ 50		129
Loss from discontinued operations, net of taxes												$ 549

Schedule III Genworth Financial

Schedule III Genworth Financial, Inc. Supplemental Insurance Information (Schedule of Supplemental Insurance Information) (Detail) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Supplementary Insurance Information, by Segment [Line Items]
Deferred Acquisition Costs	$ 2,200	$ 1,146
Future Policy Benefits	38,064	41,528
Policyholder Account Balances	17,113	19,354
Liability for Policy and Contract Claims	12,234	11,841
Unearned Premiums	584	672
Premium Revenue	3,719	3,435	$ 3,836
Net Investment Income	3,146	3,370	3,227
Interest Credited and Benefits and Other Changes in Policy Reserves	4,745	4,891	5,763
Amortization of Deferred Acquisition Costs	278	346	437
Other Operating Expenses	1,506	1,414	1,156
Premiums Written	3,643	3,340	3,738
Enact
Supplementary Insurance Information, by Segment [Line Items]
Deferred Acquisition Costs	26	27
Future Policy Benefits	0	0
Policyholder Account Balances	0	0
Liability for Policy and Contract Claims	519	641
Unearned Premiums	203	246
Premium Revenue	940	975	971
Net Investment Income	155	141	133
Interest Credited and Benefits and Other Changes in Policy Reserves	(94)	125	381
Amortization of Deferred Acquisition Costs	8	9	14
Other Operating Expenses	283	287	231
Premiums Written	896	914	894
U.S. Life Insurance
Supplementary Insurance Information, by Segment [Line Items]
Deferred Acquisition Costs	2,042	1,008
Future Policy Benefits	38,062	41,526
Policyholder Account Balances	14,112	16,343
Liability for Policy and Contract Claims	11,695	11,183
Unearned Premiums	379	423
Premium Revenue	2,773	2,454	2,858
Net Investment Income	2,769	3,029	2,878
Interest Credited and Benefits and Other Changes in Policy Reserves	4,623	4,576	5,164
Amortization of Deferred Acquisition Costs	247	318	400
Other Operating Expenses	1,103	887	643
Premiums Written	2,741	2,419	2,837
Runoff
Supplementary Insurance Information, by Segment [Line Items]
Deferred Acquisition Costs	132	111
Future Policy Benefits	2	2
Policyholder Account Balances	3,001	3,011
Liability for Policy and Contract Claims	14	8
Unearned Premiums	2	3
Premium Revenue	0	0	0
Net Investment Income	214	194	210
Interest Credited and Benefits and Other Changes in Policy Reserves	216	189	214
Amortization of Deferred Acquisition Costs	23	19	23
Other Operating Expenses	42	54	48
Premiums Written	0	0	0
Corporate and Other
Supplementary Insurance Information, by Segment [Line Items]
Deferred Acquisition Costs	0	0
Future Policy Benefits	0	0
Policyholder Account Balances	0	0
Liability for Policy and Contract Claims	6	9
Unearned Premiums	0	0
Premium Revenue	6	6	7
Net Investment Income	8	6	6
Interest Credited and Benefits and Other Changes in Policy Reserves	0	1	4
Amortization of Deferred Acquisition Costs	0	0	0
Other Operating Expenses	78	186	234
Premiums Written	$ 6	$ 7	$ 7